000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|ţpakki||N05AX08|01.04.2000||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|1369|2961|lyfalmen|V0045|1689|1|20|0|2,0000|Vistor hf|Janssen-Cilag AB|Risperídón||1369||1369|2961||1 000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|15|0|4,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|29986|39154|lyfsjukr|||1|1,8|0|24,0000|Icepharma hf|Roche|Epóetín||29986||29986|39154||2 000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|45059|57901|lyfsjukr|||1|1,8|0|36,0000|Icepharma hf|Roche|Epóetín||45059||45059|57901||2 000153|A02BC0102|Losec|sh-tfl|20|mg|7|stk|1|ţpakki||A02BC01|01.09.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|9669|14385|lyfalmen|V0457|6582|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||9669||9669|14385||2 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|28180|38184|lyfalmen|V0475|13464|1|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||28180||28180|38184||2 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|ţpakki||N05AH03|01.12.2003||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|36648|48894|lyfalmen|V0540|19911|1|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||36648||36648|48894||2 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|4340|6205|lyfsjukr|||1|0,9|0|0,0400|Vistor hf|Ferring|Atosíban||4340||4340|6205||1 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|4227|8190|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||4227||4227|8190||1 000237|G02CX0101|Tractocile|irţ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|11625|16318|lyfsjukr|||1|5|0|0,2300|Vistor hf|Ferring|Atosíban||11625||11625|16318||1 000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002|31.07.2015|R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|14881|21363|lyfalmen|||1|0,36|0|4,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||14881|21363||1 000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002|31.07.2015|R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|29554|39922|lyfalmen|||1|0,72|0|8,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||29554|39922||1 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|0|0|0|0|0|1|GSK|0|0|0|100|IKR|2175|3110|lyfsjukr|||1|5|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2175||2175|3110||1 000530|J07BF0301|Imovax Polio|stl|||0,5|ml|20|áf.spr|án nála|J07BF03|01.06.2005||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|25532|34835|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||25532||25532|34835||2 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|4446|7196|lyfalmen|||1|2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||4446||4446|7196||1 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2840|4985|lyfalmen|||1|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2840||2840|4985||1 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|pokar||B05BA02|01.04.2004||R|0|0|0|0|0|1|KAB|0|0|0|100|DKK|14232|19561|lyfsjukr|||1|1000|0||Icepharma hf|Fresenius Kabi AB|Fitusambönd||14232||14232|19561||2 000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|ţpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|2803|4934|lyfalmen|||1|30|0|60,0000|Icepharma hf|Pfizer ApS|Amlódipín||2803||2803|4934||1 000663|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|500|ml|12|pokar||B05BA02|01.12.2014||R|0|0|0|0|0|1|KAB|0|0|0|100|DKK|34437|44690|lyfsjukr|||1|6000|0||Icepharma hf|Fresenius Kabi AB|Fitusambönd||34437||34437|44690||2 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|3306|5627|lyfalmen|||1|2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3306||3306|5627||1 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|93565|118229|lyfsjukr|||1|6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||93565||93565|118229||2 000957|H01AC0101|Genotropin|sts|5|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.05.2001|31.08.2015|R|0|0|0|1|0|1|PER|0|1|0|100|DKK|20402|27234|lyfsjukr|||1|1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||20402||20402|27234||1 001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|4949|7076|lyfsjukr|||1|0,5|0|1,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||4949||4949|7076||1 001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|ţpakki||M01AH01|01.03.2003||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|1331|2908|lyfalmen|V0037|1819|1|10|0|10,0000|Icepharma hf|Pfizer ApS|Celekoxíb||1331||1331|2908||1 001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|ţpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4428|7171|lyfalmen|||1|30|0|120,0000|Icepharma hf|Pfizer ApS|Atorvastatín||4428||4428|7171||1 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|ţpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|14644|21064|lyfalmen|V0115|11873|1|100|0|400,0000|Icepharma hf|Pfizer ApS|Atorvastatín||14644||14644|21064||1 001291|C07AB0206|Seloken ZOC|forđatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1915|3712|lyfalmen|V0050|2421|1|100|0|15,8300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1915||1915|3712||1 001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|24747|32638|lyfsjukr|||1|2,5|0|5,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||24747||24747|32638||1 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5567|8739|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5567||5567|8739||1 001512|C04AD0301|Trental|forđatfl|400|mg|100|stk|1|ţpakki||C04AD03|01.05.2002||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|3289|5603|lyfalmen|||1|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||3289||3289|5603||1 001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|ţpakki||N06AB03|01.03.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|883|2177|lyfalmen|V0038|2177|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||800||800|2177||1 001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|ţpakki||N06AB03|01.03.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2456|4026|lyfalmen|V0039|3416|2|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||2143||2143|4026||1 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|20104|26864|lyfsjukr|||1|4104|0||Icepharma hf|Fresenius Kabi|Blöndur||20104||20104|26864||2 001599|B03AC0002|Venofer|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.07.2005||R|0|0|0|0|G|0|VIF|0|0|1|100|CHF|15800|22526|lyfalmen|V0637|19968|1|25|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||15800||15800|22526||1 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|27866|36518|lyfsjukr|||1|6160|0||Icepharma hf|Fresenius Kabi|Blöndur||27866||27866|36518||2 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|2217|3170|lyfsjukr|||1|10|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlergómetrín||2217||2217|3170||1 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|4513|7288|lyfalmen|V0444|7288|1|15|0|75,0000|Vistor hf|Alcon Laboratories Ltd.|Brinzólamíđ||4513||4513|7288||1 001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|ţpakki||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|356|1566|lyfalmen|V0004|550|1|7|0|4,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||356||356|1566||1 001954|N05AX0802|Rison|filmhtfl|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1946|2315|lyfalmen|V0291|2315|2|60|0|12,0000|Actavis Group hf|Actavis hf|Risperídón||900||900|2315||1 001957|N05AX0802|Rison|filmhtfl|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|6936|7958|lyfalmen|V0297|6720|2|60|0|48,0000|Actavis Group hf|Actavis hf|Risperídón||5000||5000|7958||1 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|0|0|0|0|0|0|BIG|0|0|1|100|SEK|3690|6155|lyfalmen|||1|45|0||Icepharma hf|Bioglan AB|Capsaicin||3690||3690|6155||2 001965|N05AX0802|Rison|filmhtfl|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|3353|3760|lyfalmen|V0292|3760|2|60|0|24,0000|Actavis Group hf|Actavis hf|Risperídón||1950||1950|3760||1 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|2436|4429|lyfalmen|V0004|2198|1|28|0|18,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||2436||2436|4429||1 001986|N05AX0802|Rison|filmhtfl|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|5263|5770|lyfalmen|V0296|5343|2|60|0|36,0000|Actavis Group hf|Actavis hf|Risperídón||3410||3410|5770||1 001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|3232|5525|lyfalmen|V0011|2925|1|56|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||3232||3232|5525||1 002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|ţpakki||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|640|1957|lyfalmen|V0005|595|1|7|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||640||640|1957||1 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|3584|6009|lyfalmen|V0005|2380|1|28|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||3584||3584|6009||1 002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|ţpakki||A07EC02|01.01.2000||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|4209|6870|lyfalmen|||1|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||4209|6870||2 002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|ţpakki|stakskammtar|A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|4597|7404|lyfalmen|V0011|2612|1|50|0|33,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4597||4597|7404||1 002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|23478|31060|lyfsjukr|||1|5760|0||Icepharma hf|Fresenius Kabi|Blöndur||23478||23478|31060||2 002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|ţpakki|stakskammtar|A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7578|11507|lyfalmen|V0012|2634|1|50|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||7578||7578|11507||1 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2852|5002|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||2852||2852|5002||1 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.08.2002||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|15693|22391|lyfalmen|V0492|3496|1|98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||15693||15693|22391||1 002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|80505|101986|lyfsjukr|||1|1|0|2,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||80505|101986||2 002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|41035|52896|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||41035|52896||2 002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|20891|27843|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||20891|27843||2 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis hf|Lóratadín|||||||1 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis hf|Lóratadín|||||||1 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.10.2000||L|1|0|0|0|G|0|ACA|0|0|1|100|IKR|||lyfalmen|V0362|2040|2|100|0|100,0000|Actavis Group hf|Actavis hf|Lóratadín|||||2307||1 002659|QP52AA0101|Droncit vet.|sts|57|mg/ml|10|ml|1|hgl|lausn|QP52AA01|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|SEK|2978|5133|vetorma|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|||2978||2978|5133||2 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|6,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1156|2667|lyfalmen|||1|5|0|28,0000|Icepharma hf|Santen Oy|Tímólól||1156||1156|2667||2 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|0|0|0|1|0|1|ALL|0|0|0|100|SEK|22875|30310|lyfsjukr|||1|1|0||Vistor hf|Allergan|Clostridium botulinum toxín-A||22875||22875|30310||1 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|12875|14339|lyfalmen|V0089|2677|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||9636||9636|14339||1 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|9587|14272|lyfalmen|V0515|4049|1|100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||9587||9587|14272||1 003099|L01DB0104|Myocet|irţ|50|mg|2|sett|1|pakki|ördreifa|L01DB01|01.07.2006||R|0|0|0|1|0|1|TBV|0|0|0|100|DKK|183772|230421|lyfsjukr|||1|2|0||Vistor hf|Teva Pharma B.V.|Doxórúbicín||183772||183772|230421||2 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|16307|23167|lyfalmen|V0253|6256|1|100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||16307||16307|23167||1 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|31645|42567|lyfalmen|V0516|5442|1|100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||31645||31645|42567||1 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|G|0|PFP|0|0|0|100|SEK|8584|12891|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||8584||8584|12891||1 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|G|0|PFP|0|0|0|100|SEK|12675|18573|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||12675||12675|18573||1 003192|QM01AX9001|Cartrophen vet.|stl|100|mg/ml|10|ml|1|hgl|lausn f.hunda|QM01AX90|01.08.2015||R|0|0|0|0|0|0|AEL|1|0|0|100|XEU|7564|14521|vetalmen|||0|10|0||Icepharma hf|Arthropharm Europe Limited|Pentosan Polysulfate Sodium||7564||7564|14521||2 003310|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|6115|9493|lyfalmen|V0356|8490|1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||6115||6115|9493||1 003325|R03AK0702|Symbicort mite Turbuhaler|innönddu|84,5|mcg/sk|120|skammtar|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|5734|8969|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||5734||5734|8969||1 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|ţpakki||A02BB01|01.08.2002||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|2856|5007|lyfalmen|||1|60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||2856||2856|5007||1 003859|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|glas||N05AH02|01.10.2014||R|2|0|0|0|G|0|AGT|0|0|0|100|XEU|2040|3884|lyfalmen|||2|100|0|8,3300|Actavis Group hf|Actavis Group hf|Klózapín||2040||2040|3884||1 003880|N05AH0205|Clozapine Actavis|töflur|100|mg|500|stk|1|glas||N05AH02|01.06.2015||R|2|0|0|0|G|0|AGT|0|0|0|100|XEU|36555|47950|lyfalmen|||2|500|0|166,6700|Actavis Group hf|Actavis Group hf|Klózapín||35901||35901|47950||1 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|ţpakki||N06AB06|01.11.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1017|2025|lyfalmen|V0151|1647|2|28|0|28,0000|Actavis Group hf|Actavis hf|Sertralín||689||689|2025||1 003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|ţpakki||M01AB05|01.03.1984||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|541|1821|lyfalmen|||1|20|0|10,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||541||541|1821||1 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|ţpakki||N06AB06|01.11.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2389|2560|lyfalmen|V0322|2329|2|98|0|98,0000|Actavis Group hf|Actavis hf|Sertralín||1078||1078|2560||1 003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.03.1984||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|1960|3774|lyfalmen|V0469|1902|1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||1960||1960|3774||1 004002|L04AD0101|Sandimmun|irţ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|17445|23557|lyfsjukr|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||17445||17445|23557||1 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|7295|11117|lyfalmen|||1|250|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||7295||7295|11117||1 004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|100|0|2,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ|||||||1 004050|R03AK0601|Seretide|innúđal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|4518|7295|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||4518||4518|7295||1 004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|ţpakki||N06AB06|01.05.2003||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|546|1828|lyfalmen|||1|7|0|3,5000|Icepharma hf|Pfizer ApS|Sertralín||546||546|1828||1 004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|ţpakki||N05CD01|01.12.2000||R|1|0|0|0|0|0|MAB|0|0|1|100|SEK|1032|2497|lyfalmen|||1|30|0|15,0000|Vistor hf|Meda AB|Flúrazepam||1032||1032|2497||1 004184|L03AC0101|Proleukin|stl/irs|||1|hgl|1|pakki||L03AC01|01.10.2013||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|30058|39244|lyfsjukr|||1|1|0|5,5000|Vistor hf|Novartis Healthcare A/S|Aldesleukín||30058||30058|39244||1 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|ţpakki|hart hylki|N05AE04|01.03.2003||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5044|8019|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Ziprasidon||5044||5044|8019||1 004282|R03AK0601|Seretide|innúđal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|7638|11589|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||7638||7638|11589||1 004293|R03AK0601|Seretide|innúđal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|10598|15663|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||10598||10598|15663||1 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|0|0|0|0|0|1|IPI|0|0|0|100|DKK|19415|26007|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer Limited|Voricónazól||19415||19415|26007||1 004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|ţpakki||A04AA01|01.01.2009||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|5984|5340|lyfalmen|V0381|3815|1|10|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||3098||3098|5340||1 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|7092|13625|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||7092||7092|13625||1 004455|N02AX0208|Zytram|forđatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|2993|5196|lyfalmen|||1|56|0|14,0000|Icepharma hf|Norpharma |Tramadól||2993||2993|5196||2 004478|N02AX0208|Zytram|forđatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|3991|6570|lyfalmen|V0226|2653|1|56|0|18,6667|Icepharma hf|Norpharma |Tramadól||3991||3991|6570||2 004500|N02AX0208|Zytram|forđatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|7504|11405|lyfalmen|V0228|4898|1|56|0|37,3333|Icepharma hf|Norpharma |Tramadól||7504||7504|11405||2 004502|J07BC0101|Engerix-B|stl|20|mcg/ml|0,5|ml|1|dćla|einnota dćla|J07BC01|01.01.1990||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|2394|4371|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsađir mótefnavakar||2394||2394|4371||1 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|ţpakki||A10BB12|01.06.2005||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|2765|2542|lyfalmen|V0494|2542|1|90|0|180,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríđ||1065||1065|2542||1 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2556|2666|lyfalmen|V0318|2666|2|100|0|100,0000|Actavis Group hf|Actavis hf|Cítalópram||1155||1155|2666||1 004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1744|3477|lyfalmen|||2|25|0||Actavis Group hf|Actavis Group hf|Metrónídazól||1744||1744|3477||1 004613|J07BC0101|Engerix-B|stl|20|mcg/ml|1|ml|1|áfspr||J07BC01|01.01.1990||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|3535|5942|lyfalmen|||1|1|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsađir mótefnavakar||3535||3535|5942||1 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|4843|5164|lyfalmen|V0320|3623|2|100|0|200,0000|Actavis Group hf|Actavis hf|Cítalópram||2970||2970|5164||1 004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001|30.06.2015|R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|776|1782|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis hf|Cítalópram||513||513|1782||1 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1921|2560|lyfalmen|V0317|2560|2|100|0|50,0000|Actavis Group hf|Actavis hf|Cítalópram||1078||1078|2560||1 004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|926|1782|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis hf|Cítalópram||513||513|1782|31.8.2015|1 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|1|0|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||0|100|0|16,6700|Vistor hf|Medic Team|Magnesíum hýdroxíđ|||||1803||1 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|0|0|0|1|0|1|BIO|0|0|0|100|DKK|34461|44720|lyfsjukr|||1|4,69|0|7,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||34461||34461|44720||3 004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001|30.06.2015|R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1778|3524|lyfalmen|||2|56|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||1778||1778|3524||1 004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|0|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||0|150|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Dextrómetorfan|||||||1 004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|Clikstar/JuniorStar pennar|A10AE04|01.06.2004||R|0|0|0|0|G|0|SDE|0|0|0|100|NOK|8203|12367|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||8203||8203|12367||1 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|ţpakki||P01AB01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|774|2142|lyfalmen|||2|24|0|3,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||774||774|2142||1 004874|N05AH0308|Lazapix|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.09.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|14905|2392|lyfalmen|V0282|2392|2|56|0|56,0000|Portfarma ehf|Portfarma|Olanzapín||956||956|2392||1 004880|J01FA1001|Zitromax|irs|500|mg|10|ml|1|hgl||J01FA10|01.05.2003||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4992|7137|lyfsjukr|||1|10|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||4992||4992|7137||1 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|344|1550|lyfalmen|||2|8|0|2,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||344||344|1550||1 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|678|2010|lyfalmen|||2|14|0|3,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||678||678|2010||1 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|1144|2651|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||1144||1144|2651||1 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|36|0|2,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 005085|J07AJ5205|Boostrix|stl|||0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|1940|3747|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum međ öđrum toxóíđum||1940||1940|3747||1 005089|J07AL0103|Pneumovax|stl|||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|3231|5523|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar||3231||3231|5523||2 005096|J07AJ5205|Boostrix|stl|||0,5|ml|10|áf.spr|áfyllt, dreifa|J07AJ52|01.09.2014||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|19399|27078|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum međ öđrum toxóíđum||||19399|27078||1 005108|G04CA0201|Omnic|forđahlk|0,4|mg|90|stk|1|ţpakki||G04CA02|01.08.1998||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|8099|6753|lyfalmen|V0148|3443|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4124||4124|6753||1 005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|ţpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|3052|5277|lyfalmen|V0353|4600|2|30|0|3,7500|Actavis Group hf|Actavis hf|Díkloxacillín||3052||3052|5277||1 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|ţpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|2352|4314|lyfalmen|||2|20|0|5,0000|Actavis Group hf|Actavis hf|Díkloxacillín||2352||2352|4314||1 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|ţpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|2641|4711|lyfalmen|V0337|4449|2|30|0|7,5000|Actavis Group hf|Actavis hf|Díkloxacillín||2641||2641|4711||1 005241|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|18345|25745|lyfalmen|V0356|25469|1|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||18345||18345|25745||1 005303|N02CC0303|Zomig Nasal|nefúđi|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|0|0|0|0|G|0|ASZ|0|0|0|100|SEK|2896|5062|lyfalmen|||1|10|0|4,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||2896||2896|5062||1 005330|D08AG0201|Betadine|húđlausn|100|mg/ml|500|ml|1|fl|sprittlausn|D08AG02|01.09.1982||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||||2 005336|R01AA0704|Otrivin ukonserveret|nefúđi|0,5|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.07.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.04.1996||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|51479|67653|lyfalmen|V0451|63642|1|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||51479||51479|67653||1 005390|R03BB0101|Atrovent|innúđal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|1649|3346|lyfalmen|||1|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíđ||1649||1649|3346||1 005576|R05CA0301|Tussol|mixtúra|||150|ml|1|glas||R05CA03|01.10.2001||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Slímlosandi lyf nema slímţynnir (mucolytica)- guaifenesin|||||||1 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|5616|8806|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíđ||5616||5616|8806||1 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|5903|9201|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíđ||5903||5903|9201||1 005606|J07AH0703|NeisVac-C|stl|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|0|0|0|0|0|0|PIS|0|0|0|100|USD|4537|7321|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer ApS|Hreinsuđ meningókokka C, poly­sakkaríđ mótefnavakar||4537||4537|7321||2 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|ţpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|1722|3446|lyfalmen|||1|30|0|15,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||1722||1722|3446||2 005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|ţpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|3444|5817|lyfalmen|V0020|1578|1|60|0|30,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||3444||3444|5817||2 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|ţpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|5419|8535|lyfalmen|V0020|4735|1|180|0|90,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||5419||5419|8535||2 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|ţpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|3959|6525|lyfalmen|V0020|2368|1|90|0|45,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||3959||3959|6525||2 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6123|8587|lyfalmen|V0324|2854|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5457||5457|8587||1 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|16578|28574|vetorma|||0|5|0||Vistor hf|Merial (MSD)|Ivermectinum||16578||16578|28574||1 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|9736|13339|lyfalmen|V0325|2643|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||8909||8909|13339||1 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|2536|4567|lyfalmen|||1|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2536||2536|4567||2 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|15073|19554|lyfalmen|V0326|4609|1|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||13450||13450|19554||1 005910|C09CA0301|Diovan|filmhtfl|80|mg|28|stk|1|ţpakki||C09CA03|01.01.2001||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|3289|5603|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan||3289||3289|5603||1 005963|J01CR0204|Amoxin comp|filmhtfl|875|mg|14|stk|1|ţpakki|875+125 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|ROY|0|0|1|100|IKR|1816|1968|lyfalmen|V0169|1968|2|14|0|12,2500|Medical ehf|ratiopharm Oy|Amoxicillín og ensímblokkar||648||648|1968||2 006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|76857|97449|lyfsjukr|||1|1,5|0|0,7500|Vistor hf|Takeda Pharma A/S|Náttúrulegir fosfólípíđar||76857||76857|97449||1 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5321|8400|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5321||5321|8400||1 006079|J02AX0403|Cancidas|irţ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|92428|116815|lyfsjukr|||1|1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||92428||92428|116815||1 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5095|8089|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5095||5095|8089||1 006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|144389|181439|lyfsjukr|||1|3|0|1,5000|Vistor hf|Takeda Pharma A/S|Náttúrulegir fosfólípíđar||144389||144389|181439||1 006115|J02AX0403|Cancidas|irţ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|70613|89683|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||70613||70613|89683||1 006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1995||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|2215|4125|lyfalmen|||1|30|0|7,5000|Vistor hf|Recip AB|Flúkloxacillín||2215||2215|4125||1 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|3284|6401|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim|||||3284|6401||1 006547|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|áf.spr||B01AX05|01.07.2012||R|0|0|0|0|G|0|TAA|0|0|0|100|GBP|7159|10930|lyfalmen|||1|5|0|10,0000|Navamedic A/S|Aspen Pharma Trading Limited|Fondaparinux||7159||7159|10930||1 006637|D05AX5201|Daivobet|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2013||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|12124|17876|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||12124||12124|17876||1 006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 006732|A16AB0401|Fabrazyme|irţ|5|mg/ml|35|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|1|0|1|GEA|0|1|0|100|DKK|458827|572512|lyfsjukr|||1|35|0|7,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||458827||458827|572512||1 006785|G03AD0101|NorLevo|töflur|750|mcg|2|stk|1|ţpakki||G03AD01|01.01.2005||L|0|0|0|0|0|0|LAR|0|0|0|100|IKR|||lyflausa|||0|2|0|1,0000|Vistor hf|Laboratoire HRA Pharma|Levonorgestrel|||||||1 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|ţpakki||C09CA01|01.05.2002||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|13492|19607|lyfalmen|V0099|3784|1|98|0|196,0000|Vistor hf|M.S.D.|Lósartan||13492||13492|19607||1 007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|ţpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|3681|6143|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||3681||3681|6143||1 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|11836|17367|lyfalmen|V0117|7462|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||11836||11836|17367||1 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|17480|24651|lyfalmen|V0118|12183|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||17480||17480|24651||1 007165|C09AA0105|Captopril Actavis|töflur|50|mg|100|stk|1|ţpakki||C09AA01|01.05.2013||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1901|3693|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Kaptópríl||1901||1901|3693||1 007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|ţpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7128|10887|lyfalmen|V0194|9355|1|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||7128||7128|10887||1 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|ţpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|21196|29351|lyfalmen|V0195|24802|1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||21196||21196|29351||1 007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.04.2002||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.04.2002||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|89216|112820|lyfsjukr|||1|3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||89216||89216|112820||1 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|ţpakki||J01XX08|01.12.2001||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|228453|285992|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||228453||228453|285992||1 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|2976|5172|lyfalmen|V0374|4176|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Tímólól í blöndum||2976||2976|5172||1 007448|B05XC04|Cernevit|sts|||5|ml|10|hgl||B05XC|01.05.2002||R|0|0|0|0|0|1|CPS|0|0|0|100|SEK|7441|10639|lyfsjukr|||1|50|0||Icepharma hf|Clintec parenteral SA|Vítamín||7441||7441|10639||2 007449|V03AB3401|Fomepizole OPi|irţ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|0|0|0|0|0|1|OPO|0|0|0|100|XEU|103809|130969|lyfsjukr|||1|100|0||Swedish Orphan International AB|OPi Orphan Pharma international (S)|Fómepízól||103809||103809|130969||3 007462|N01AB0801|Sevorane|innönd.l|||250|ml|1|plastf||N01AB08|01.03.2002||R|0|0|0|0|0|1|ABV|0|0|0|100|DKK|21517|28621|lyfsjukr|||1|250|0||Vistor hf|AbbVie Ltd.|Sevóflúran||21517||21517|28621||1 007494|QP52AA0101|Droncit vet.|hlaup|9|%|6,67|g|1|dćla|til inntöku|QP52AA01|01.04.2002||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1814|3127|vetorma|||0|6,67|0||Icepharma hf|Bayer Animal Health GmbH|||1814||1814|3127||2 007505|G04BD0702|Detrusitol Retard|forđahlk|2|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|5754|8996|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tólteródín||5754||5754|8996||1 007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|0|0|0|0|0|1|BRS|0|0|0|100|DKK|4139|5918|lyfsjukr|||1|1200|0|4,0000|Vistor hf|Bristol-Myers Squibb|Paracetamól||4139||4139|5918||1 007601|A16AB0301|Replagal|irţ|1|mg/ml|3,5|ml|1|hgl|lausn|A16AB03|01.09.2014||R|0|0|0|1|0|1|SHG|0|1|0|100|XEU|228548|286110|lyfsjukr|||1|3,5|0|3,5000|Shire Human Genetics Therapies AB|Shire Human Genetic Therapies AB|Agalsídasi alfa||||228548|286110||3 007760|G04BD0702|Detrusitol Retard|forđahlk|4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|4532|7314|lyfalmen|V0618|5893|1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tólteródín||4532||4532|7314||1 007769|G04BD0702|Detrusitol Retard|forđahlk|4|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|16286|23141|lyfalmen|V0589|8221|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Tólteródín||16286||16286|23141||1 007778|N05AX0802|Rison|filmhtfl|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1691|2453|lyfalmen|V0290|2384|2|60|0|6,0000|Actavis Group hf|Actavis hf|Risperídón||1000||1000|2453||1 007852|G02BB0101|NuvaRing|sk-hring|||3|stk|1|pakki|međ forđaverkun|G02BB01|01.11.2002||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|3687|6151|lyfalmen|||1|3|0|84,0000|Vistor hf|N.V. Organon|Skeiđarinnleg međ progestógeni og östrógeni||3687||3687|6151||1 007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|||50|ml|50|pokar|leysir f.stungulyf|V07AB|01.08.2005||L|0|0|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||0|2500|0||Icepharma hf|Baxter Medical AB|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|0|0|0|0|0|0|ALA|0|0|0|100|USD|1442|3061|lyfalmen|||1|5|0||Vistor hf|Alcon Laboratories Ltd.|Ólópatadín||1442||1442|3061||1 007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|0|0|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||||1 007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|ţpakki||H02AB01|01.09.1998||R|0|0|0|0|0|0|LOL|0|0|1|100|IKR|729|2080|lyfalmen|||0|30|1|10,0000|Lyfjaver ehf|Lyfjaver- óskráđ|Betametasón||729||729|2080||3 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|ţpakki||A10BA02|01.01.2002||R|1|0|0|0|G|0|MCK|0|0|0|100|SEK|350|1558|lyfalmen|||1|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||350||350|1558|31.8.2015|2 008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|ţpakki||N02CC04|01.03.2003|31.07.2015|R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|5112|8112|lyfalmen|||1|6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||5112||5112|8112||1 008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|0|0|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||||1 008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1385|2983|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón||1385||1385|2983||1 008243|D07AC0101|Betnovat|húđlausn|1|mg/g|30|ml|1|plglas|í hársvörđ|D07AC01|01.01.1985||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|521|1793|lyfalmen|||1|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||521||521|1793||1 008301|N02AX0209|Tramol-L|forđatfl|100|mg|20|stk|1|ţpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|EHF|0|0|1|100|XEU|824|2210|lyfalmen|||2|20|0|6,6700|Actavis Group PTC hf|Actavis ehf|Tramadól||824||824|2210||1 008326|D07AC0101|Betnovat|húđlausn|1|mg/g|100|ml|1|plglas|í hársvörđ|D07AC01|01.07.1988||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|1217|2751|lyfalmen|||1|100|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1217||1217|2751||1 008338|N02AX0209|Tramol-L|forđatfl|100|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|EHF|0|0|1|100|XEU|2660|4738|lyfalmen|V0226|4738|2|100|0|33,3300|Actavis Group PTC hf|Actavis ehf|Tramadól||2660||2660|4738||1 008360|N02AX0209|Tramol-L|forđatfl|150|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|EHF|0|0|1|100|XEU|4225|6892|lyfalmen|V0227|6892|2|100|0|50,0000|Actavis Group PTC hf|Actavis ehf|Tramadól||4225||4225|6892||1 008368|N02AX0209|Tramol-L|forđatfl|200|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|EHF|0|0|1|100|XEU|5950|8746|lyfalmen|V0228|8746|2|100|0|66,6700|Actavis Group PTC hf|Actavis ehf|Tramadól||5572||5572|8746||1 008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|0|0|0|1|0|1|GEZ|0|0|0|100|DKK|134606|169272|lyfsjukr|||1|2|0||Vistor hf|Genzyme BV|Thýrótrópín||134606||134606|169272||1 008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|ţpakki||H03AA01|01.05.2002||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|470|1723|lyfalmen|V0696|1723|1|100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||470||470|1723||2 008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|ţpakki||H03AA01|01.05.2002||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|617|1917|lyfalmen|V0697|1917|1|100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||611||611|1917||2 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|5348|9218|vetorma|||0|1000|0||Icepharma hf|Chanelle Pharmaceuticals |||5348||5348|9218||2 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|9965|19076|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals |||9965||9965|19076||2 008519|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|100|stk|1|ţpakki||R06AE07|01.09.2012||L|1|0|0|0|G|0|RGM|0|0|1|100|XEU|||lyfalmen|V0575|2234|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Cetirizín|||||2234||2 008545|G03FB0506|NovoFem|filmhtfl|||84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2662|4740|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2662||2662|4740||1 008673|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|10|stk|1|ţpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Medical ehf|ratiopharm GmbH|Cetirizín|||||||2 008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|95275|120355|lyfsjukr|||1|2|0|20,7700|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||95275||95275|120355||2 008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|98837|124786|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||98837||98837|124786||2 008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburđur, lausn|D10AF01|01.01.1994||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1784|3532|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1784||1784|3532||1 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|ţpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|6523|10055|lyfalmen|V0145|9451|1|4|0|8,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||6523|10055||2 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|ţpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|12934|18901|lyfalmen|V0145|18901|1|8|0|16,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||12934|18901||2 008959|R01AA0706|Naso-ratiopharm|nefúđi|0,5|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|LYFIS ehf|ratiopharm GmbH|Xýlómetazólín|||||||2 009078|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|30|stk|1|ţpakki||N06AG02|01.02.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|1619|2846|lyfalmen|V0064|2741|2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Móklóbemíđ||1286||1286|2846||2 009099|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|60|stk|1|ţpakki||N06AG02|01.03.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4424|5481|lyfalmen|V0064|5481|2|60|0|60,0000|Medical ehf|ratiopharm GmbH|Móklóbemíđ||3200||3200|5481||2 009113|B05DB0005|Balance|kviđ.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|7317|10461|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7317||7317|10461||2 009117|N06AG0202|Moclobemid ratiopharm|filmhtfl|150|mg|100|stk|1|ţpakki||N06AG02|01.02.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|3984|4848|lyfalmen|V0063|4848|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Móklóbemíđ||2740||2740|4848||2 009189|N02BA0111|ASA-ratiopharm|töflur|500|mg|50|stk|1|ţpakki||N02BA01|01.09.2014||L|0|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||2|50|0|8,3333|Medical ehf|ratiopharm GmbH|Acetýlsalicýlsýra|||||||2 009213|B05DB0005|Balance|kviđ.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|7317|10461|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7317||7317|10461||2 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|0|0|0|0|0|0|IPI|0|0|1|100|DKK|13171|19201|lyfalmen|||1|10|0|10,0000|Icepharma hf|Pfizer Limited|Parekoxíb||13171||13171|19201||1 009216|B05DB0005|Balance|kviđ.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|7317|10461|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7317||7317|10461||2 009270|R01AA0706|Naso-ratiopharm|nefúđi|1|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|LYFIS ehf|ratiopharm GmbH|Xýlómetazólín|||||||2 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|ţpakki||J02AC03|01.11.2002||R|1|0|0|0|0|1|IPI|0|0|0|100|DKK|48046|61616|lyfsjukr|||1|30|0|3,7500|Icepharma hf|Pfizer Limited|Voricónazól||48046||48046|61616||1 009282|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|0|0|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||0|400|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||2133||2 009285|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.07.2003||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|4799|7682|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||4799||4799|7682||1 009340|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||0|400|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||2948||2 009409|G03CA0316|Vivelle Dot|forđapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1051|2523|lyfalmen|||1|8|0|21,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1051||1051|2523||1 009443|G03CA0316|Vivelle Dot|forđapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1159|2672|lyfalmen|||1|8|0|28,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1159||1159|2672||1 009465|G03CA0316|Vivelle Dot|forđapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1341|2922|lyfalmen|||1|8|0|42,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1341||1341|2922||1 009489|G03CA0316|Vivelle Dot|forđapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1679|3387|lyfalmen|||1|8|0|56,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1679||1679|3387||1 009525|B05DB0005|Balance|kviđ.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6153|8797|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6153||6153|8797||2 009560|B05DB0005|Balance|kviđ.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6847|9789|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6847||6847|9789||2 009591|B05DB0005|Balance|kviđ.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6153|8797|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6153||6153|8797||2 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|ţpakki||J02AC03|01.11.2002||R|1|0|0|0|0|1|IPI|0|0|0|100|DKK|174003|218271|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer Limited|Voricónazól||174003||174003|218271||1 009649|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.07.2003||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|4649|7475|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||4649||4649|7475||1 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|1|0|0|1|0|1|GSL|0|0|0|100|DKK|52069|66619|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Tenófóvír dísóproxíl||52069||52069|66619||2 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8720|13079|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||8720||8720|13079||1 009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|9225|13774|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||9225||9225|13774||1 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8123|12257|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||8123||8123|12257||1 009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|9225|13774|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||9225||9225|13774||1 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|7956|12027|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||7956||7956|12027||1 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8115|12246|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||8115||8115|12246||1 009993|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|3|g|1|spr||QP52AF02|01.01.2013||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1141|1967|vetorma|||0|3|0||Icepharma hf|Zoetis Finland OY|||1141||1141|1967||2 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|2001|3830|lyfalmen|V0329|1765|1|30|0|15,0000|Vistor hf|N.V. Organon|Mirtazapín||2001||2001|3830||1 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|1|0|0|0|0|1|ROA|0|0|0|100|DKK|186749|234123|lyfsjukr|||1|60|0|30,0000|Icepharma hf|Roche A.S.|Valgancíklóvír||186749||186749|234123||2 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|6298|9004|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||6298||6298|9004||1 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|11827|17355|lyfalmen|V0331|2590|1|96|0|96,0000|Vistor hf|N.V. Organon|Mirtazapín||11827||11827|17355||1 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|16675|23633|lyfalmen|||1|96|0|144,0000|Vistor hf|N.V. Organon|Mirtazapín||16675||16675|23633||1 010290|N06DX0101|Ebixa|mixtúra|5|mg/sk|50|g|1|fl|dćluskammtur|N06DX01|01.08.2010||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|13181|19213|lyfalmen|||1|50|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||13181|19213||1 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|ţpakki||N06DX01|01.10.2002||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|21368|29568|lyfalmen|V0605|6042|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||21368||21368|29568||1 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|ţpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|10398|15388|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||10398||10398|15388||1 010446|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|ţpakki||A07EC02|01.01.2003||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|5685|8901|lyfalmen|||1|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||5685|8901||2 010534|B05BA0108|Vaminolac|irl|||100|ml|10|fl||B05BA01|01.03.2004||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|8488|12135|lyfsjukr|||1|1000|0||Icepharma hf|Fresenius Kabi|Amínósýrur||8488||8488|12135||2 010573|S01AE0501|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AE05|01.08.2002||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|1160|2673|lyfalmen|||1|5|0||Icepharma hf|Santen Oy|Levófloxacín||1160||1160|2673||2 010705|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2 010716|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.02.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2373|2848|lyfalmen|V0006|1990|2|56|0|56,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||1287||1287|2848||2 010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.12.2002||R|1|0|0|0|0|0|APC|0|0|0|100|NOK|11337|4922|lyfalmen|V0207|2310|1|12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||2794||2794|4922||1 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|ţpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|311364|389110|lyfsjukr|||1|56|0|14,0000|Vistor hf|Actelion Registration Ltd.|Bósentan||311364||311364|389110||3 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|ţpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|311364|389110|lyfsjukr|||1|56|0|28,0000|Vistor hf|Actelion Registration Ltd.|Bósentan||311364||311364|389110||3 010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|0|0|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||||1 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|42277|54441|lyfsjukr|||2|10|0||Icepharma hf|Baxter Medical AB|Bleómýcín||42277||42277|54441||2 010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|0|0|0|0|0|1|REP|0|0|0|100|SEK|2636|3769|lyfsjukr|||1|10|0|5,0000|Vistor hf|Recip AB|Kloxacillín||2636||2636|3769||1 010947|C08CA0203|Felodipin ratiopharm|forđatfl|5|mg|100|stk|1|ţpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|2700|3554|lyfalmen|V0058|3554|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Felódipín||1800||1800|3554||2 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|ţpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|18659|26142|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||18659||18659|26142||1 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|ţpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|18442|25867|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||18442||18442|25867||1 010980|C08CA0203|Felodipin ratiopharm|forđatfl|10|mg|100|stk|1|ţpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3200|4930|lyfalmen|V0059|4930|2|100|0|200,0000|Medical ehf|ratiopharm GmbH|Felódipín||2800||2800|4930||2 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|ţpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|31770|42725|lyfalmen|V0683|28574|1|56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||31770||31770|42725||1 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|ţpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|31554|42451|lyfalmen|V0684|28412|1|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||31554||31554|42451||1 011163|A07EA0601|Entocort|forđahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|15411|22034|lyfalmen|||1|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||15411||15411|22034||1 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|ţpakki||M01AH05|01.10.2002||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|4168|6813|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||4168||4168|6813||1 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|ţpakki||M01AH05|01.10.2002||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|4331|7038|lyfalmen|||1|28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||4331||4331|7038||1 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|18751|24791|lyfalmen|V0327|4048|1|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||17591||17591|24791||1 011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|ţpakki||M01AH05|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|1105|2597|lyfalmen|||1|7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||1105||1105|2597||1 011336|N05AH0309|Kozylex|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|0|0|0|0|G|0|POF|0|0|0|100|IKR|7436|6582|lyfalmen|V0457|6582|2|28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||4000||4000|6582||1 011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|856|2255|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis hf|Lósartan||856||856|2255||1 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2266|3255|lyfalmen|V0069|2943|2|98|0|98,0000|Actavis Group hf|Actavis hf|Lósartan||1583||1583|3255||1 011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|6034|9382|lyfalmen|V0357|8480|1|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||6034||6034|9382||1 011489|N06BA0402|Concerta|forđatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|5715|8491|lyfalmen|V0691|7815|1|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||5387||5387|8491||1 011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|1|0|0|1|PER|0|0|0|100|DKK|2135|3052|lyfsjukr|||1|50|0||Icepharma hf|Pfizer ApS|Esketamín||2135||2135|3052||1 011555|N06BA0402|Concerta|forđatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|7446|9013|lyfalmen|V0624|8337|1|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||5766||5766|9013||1 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|1785|3508|vetalmen|||0|25|0||Icepharma hf|Chanelle Pharmaceuticals |||1785||1785|3508||2 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|1|0|0|1|PER|0|0|0|100|DKK|4353|6224|lyfsjukr|||1|20|0||Icepharma hf|Pfizer ApS|Esketamín||4353||4353|6224||1 011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|skammtar|1|fl|međ skammtadćlu|G03CA03|01.03.2000||R|0|0|0|0|G|0|OYL|0|0|0|100|DKK|1128|2629|lyfalmen|||2|64|0||Vistor hf|Oy Leiras Finland Ab|Estradíól||1128||1128|2629||1 011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|59375|75706|lyfsjukr|||1|168|0|33,6000|Icepharma hf|Roche A.S.|Ribavirin||59375||59375|75706||2 011718|QJ01CE0101|Geepenil, vet.|sts|24|g|1|hgl|1|pakki|+ leysir, lausn|QJ01CE01|01.09.2012||R|0|0|0|0|0|0|OCO|0|0|0|100|SEK|2440|4796|vetalmen|||0|1|0||Icepharma hf|Orion Corporation (I)|Benzylpenicillín sodíum||2440||2440|4796||2 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|ţpakki||N06AB06|01.10.2005||R|1|0|0|0|0|0|ACA|0|0|0|100|IKR|1796|2124|lyfalmen|V0152|2124|2|28|0|56,0000|Actavis Group hf|Actavis hf|Sertralín||761||761|2124||1 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|ţpakki||N06AB06|01.10.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|4738|3909|lyfalmen|V0323|3611|2|98|0|196,0000|Actavis Group hf|Actavis hf|Sertralín||2058||2058|3909||1 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|3826|5470|lyfsjukr|||1|20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||3826||3826|5470||1 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|2117|3027|lyfsjukr|||1|20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2117||2117|3027||1 011985|N06DX0101|Ebixa|filmhtfl|10|mg|28|stk|1|ţpakki||N06DX01|01.06.2009||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|7382|11237|lyfalmen|V0604|2802|1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||7382|11237||1 012030|J05AG0301|Stocrin|filmhtfl|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|26046|34254|lyfsjukr|||1|30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||26046||26046|34254||1 012113|J02AC0104|Fluconazol ratiopharm|hylki|50|mg|7|stk|1|ţpakki||J02AC01|01.10.2012||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|1215|1723|lyfalmen|V0551|1723|2|7|0|1,7500|Medical ehf|ratiopharm GmbH|Flúkónazól||470||470|1723||2 012243|G04CB0201|Avodart|hylki|0,5|mg|30|stk|1|ţpakki|hylki mjúk|G04CB02|01.03.2012||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|4309|7007|lyfalmen|||1|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ||4309||4309|7007||1 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|ţpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|6276|9715|lyfalmen|||1|4|0|4,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||6276||6276|9715||2 012278|N07BA0106|Nicotinell|forđapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|7|0|3,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012326|N06BA0402|Concerta|forđatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|9286|10052|lyfalmen|V0622|9322|1|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||6521||6521|10052||1 012347|J02AC0104|Fluconazol ratiopharm|hylki|50|mg|28|stk|1|ţpakki||J02AC01|01.10.2012||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|3652|3023|lyfalmen|||2|28|0|7,0000|Medical ehf|ratiopharm GmbH|Flúkónazól||1414||1414|3023|31.8.2015|2 012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.01.2015||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012716|N07BA0106|Nicotinell|forđapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|7|0|7,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012799|N07BA0106|Nicotinell|forđapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|7|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012864|M01AE0113|Ibuxin|filmhtfl|200|mg|20|stk|1|ţpakki||M01AE01|01.09.2014||L|1|0|0|0|0|0|ROY|0|0|1|100|IKR|||lyflausa|||2|20|0|3,3333|Medical ehf|ratiopharm Oy|Íbúprófen|||||||2 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|718|2065|lyfalmen|||1|80|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||718||718|2065||1 012921|G03AA1301|Evra|forđapl|||9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|4059|6663|lyfalmen|||1|9|0||Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og ethinylestradíól||4059||4059|6663||1 012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|0|0|0|0|G|0|LBI|0|0|0|100|DKK|5766|9013|lyfalmen|||1|30|0|30,0000|Icepharma hf|Laboratoires Besins International|Testósterón||5766||5766|9013||2 012966|N03AX1208|Gabapentin ratiopharm|hylki|300|mg|100|stk|1|ţpakki||N03AX12|01.03.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|2585|3697|lyfalmen|V0250|3656|2|100|0|16,6667|Medical ehf|ratiopharm GmbH|Gabapentín||1904||1904|3697||2 012988|N03AX1208|Gabapentin ratiopharm|hylki|400|mg|100|stk|1|ţpakki||N03AX12|01.03.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|3384|4237|lyfalmen|V0251|4186|2|100|0|22,2200|Medical ehf|ratiopharm GmbH|Gabapentín||2296||2296|4237||2 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|0|1|0|0|0|HES|0|0|0|100|DKK|5442|8567|lyfalmen|||1|30|0|20,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||5442||5442|8567||1 013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|6438|12385|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||6438||6438|12385||2 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|0|1|0|0|0|HES|0|0|0|100|DKK|8803|13193|lyfalmen|||1|30|0|40,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||8803||8803|13193||1 013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1621|3186|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||1621||1621|3186||2 013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|0|0|0|0|0|1|ZLB|0|0|0|100|SEK|6084|8698|lyfsjukr|||1|2|0||Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||6084||6084|8698||2 013302|C02CA0405|Cardosin Retard|forđatfl|4|mg|100|stk|1|ţpakki||C02CA04|01.09.2009||R|1|0|0|0|G|0|ANO|0|0|0|100|XEU|2561|4601|lyfalmen|V0042|4601|2|100|0|100,0000|Actavis Group PTC hf|Actavis Nordic A/S|Doxazósín||2561||2561|4601||1 013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4228|8192|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||4228||4228|8192||2 013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|9867|18890|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||9867||9867|18890||2 013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1035|2034|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||1035||1035|2034||2 013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|1|0|1|BAL|0|1|0|100|SEK|123162|155039|lyfsjukr|||1|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuţáttur VIII||||123162|155039||3 013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|ţpakki||L01XE02|01.03.2010||R|0|0|0|1|0|1|AZD|0|1|0|100|SEK|316899|344972|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca A/S DK|Gefitiníb||275876||275876|344972||1 013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|80505|101986|lyfsjukr|||1|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||80505|101986||3 013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|1216|2750|lyfalmen|||1|5|0|1,6700|Icepharma hf|Norpharma|Oxýcódon||1216||1216|2750||2 013593|A01AA3001|Xerodent|munnstfl|||90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|90|0||Actavis Group hf|Actavis Group hf|Blöndur|||||1610||1 013615|M01AE0113|Ibuxin|filmhtfl|400|mg|100|stk|1|ţpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|706|1620|lyfalmen|V0562|1620|2|100|0|33,3300|Medical ehf|ratiopharm Oy|Íbúprófen||395||395|1620||2 013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|2324|4275|lyfalmen|||1|10|0|3,3300|Icepharma hf|Norpharma|Oxýcódon||2324||2324|4275||2 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|354|1564|lyfalmen|||1|30|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||354||354|1564||1 013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|ţpakki||C09DA03|01.04.2005||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|4339|7049|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan og ţvagrćsilyf||4339||4339|7049||1 013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|ţpakki|500+125 mg|J01CR02|01.01.2003||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|1215|2749|lyfalmen|V0168|2618|1|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1215||1215|2749||1 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5690|8908|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||5690||5690|8908||1 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2243|4164|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2243||2243|4164||1 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4275|6960|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||4275||4275|6960||1 013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|ţpakki||L01XE01|01.06.2012||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|153436|192691|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||153436||153436|192691||1 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|ţpakki||L01XE01|01.05.2004||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|312084|390005|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||312084||312084|390005||1 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2218|4129|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2218||2218|4129||1 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|6954|9942|lyfsjukr|||1|50|0|13,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||6954||6954|9942||1 014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|0|0|0|0|0|0|UCB|0|0|0|100|DKK|16768|23750|lyfalmen|||1|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||16768||16768|23750||1 014094|H05AA0202|Forsteo|stl|250|mcg/ml|2,4|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|52311|68705|lyfalmen|||1|2,4|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíđ||52311||52311|68705||2 014147|J01CA0417|Amoxicillin Sandoz|mixtduft|100|mg/ml|60|ml|1|glas||J01CA04|01.08.2015||R|0|0|0|0|0|0|SHS|0|0|1|100|DKK|2335|4290|lyfalmen|||2|60|0|6,0000|Artasan ehf|Sandoz A/S|Amoxicillín||2335||2335|4290||1 014158|J01CA0417|Amoxicillin Sandoz|mixtduft|100|mg/ml|100|ml|1|glas||J01CA04|01.08.2015||R|0|0|0|0|0|0|SHS|0|0|1|100|DKK|2955|5144|lyfalmen|||2|100|0|10,0000|Artasan ehf|Sandoz A/S|Amoxicillín||2955||2955|5144||1 014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|180|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.08.2009||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|18103|25439|lyfalmen|V0357|25439|1|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||18103||18103|25439||1 014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1504|3146|lyfalmen|V0676|3146|1|30|0||Icepharma hf|Bayer AB|Azelainsýra||1504||1504|3146||2 014365|M01AE0113|Ibuxin|filmhtfl|600|mg|30|stk|1|ţpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|339|1543|lyfalmen|V0563|1543|2|30|0|15,0000|Medical ehf|ratiopharm Oy|Íbúprófen||339||339|1543||2 014415|P01AB0106|Flagyl|mixtúra|40|mg/ml|100|ml|1|fl||P01AB01|01.08.2009||R|0|0|0|0|0|0|PCO|0|0|1|100|NOK|2029|3869|lyfalmen|||0|100|1||Distica|Distica - óskráđ lyf|Metrónídazól||2029||2029|3869||1 014435|QM01AE0303|Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|0|0|0|0|0|0|VET|0|0|0|100|XEU|2122|4171|vetalmen|||0|45|0||Dýraheilsa ehf|Vetcare Ltd.|||||2122|4171||2 014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|76462|96957|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Adefovír||||76462|96957||2 014541|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|24|dćlur|1|pakki||QA02BX12|01.04.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|XEU|5275|10178|vetalmen|||0|24|0||Icepharma hf|Zoetis Finland OY|||5275||5275|10178||2 014597|M01AE0113|Ibuxin|filmhtfl|600|mg|100|stk|1|ţpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|856|1714|lyfalmen|V0564|1714|2|100|0|50,0000|Medical ehf|ratiopharm Oy|Íbúprófen||463||463|1714||2 014679|N02AA0501|Oxycontin|forđatfl|5|mg|28|stk|1|ţpakki||N02AA05|01.12.2005||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|1169|2685|lyfalmen|V0596|1853|1|28|0|1,8600|Icepharma hf|Norpharma |Oxýcódon||1169||1169|2685||2 014696|C03EA0111|Miloride|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.02.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1026|2238|lyfalmen|V0558|2109|2|100|0|100,0000|Icepharma hf|Mylan AB|Hýdróklórtíazíđ og kalíumsparandi lyf||844||844|2238||2 014795|C03EA0112|Miloride mite|töflur|27,5|mg|100|stk|1|glas|2,5+25 mg|C03EA01|01.11.2009||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1198|2169|lyfalmen|V0559|2169|2|100|0|100,0000|Icepharma hf|Mylan AB|Hýdróklórtíazíđ og kalíumsparandi lyf||794||794|2169||2 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|17844|25111|lyfalmen|||1|60|0|10,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||17844||17844|25111||1 014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||||1 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|53844|70644|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||53844||53844|70644||1 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|35840|47872|lyfalmen|||1|60|0|20,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||35840||35840|47872||1 015037|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|1|0|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||0|90|0|30,5400|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||||2 015301|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|1|0|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||0|270|0|91,6200|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||||2 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2527|3950|lyfalmen|V0673|3691|2|100|0|100,0000|Actavis Group hf|Actavis hf|Mirtazapín||2088||2088|3950||1 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|7398|11259|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||7398||7398|11259||1 015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|ţpakki||N06AX11|01.07.2003||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|1024|2465|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Mirtazapín||1009||1009|2465||1 015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|0|0|0|0|0|0|LOL|0|0|1|100|IKR|2760|4875|lyfalmen|||0|100|1|33,3333|Lyfjaver ehf|Lyfjaver- óskráđ|Betametasón||2760||2760|4875||3 015419|G03CA0316|Vivelle Dot|forđapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1008|2464|lyfalmen|||1|8|0|14,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1008||1008|2464||1 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|ţpakki||N02CC01|01.10.2005||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|2111|2728|lyfalmen|V0234|1910|1|6|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1200||1200|2728||1 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|ţpakki||N02CC01|01.10.2005||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|3016|2728|lyfalmen|V0233|2188|1|12|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1200||1200|2728||1 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|8690|13037|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||8690||8690|13037||1 015532|L01CX0101|Yondelis|irţ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|1|0|1|PAM|0|0|0|100|DKK|293958|367461|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||293958||293958|367461||3 015598|L01CX0101|Yondelis|irţ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|1|0|1|PAM|0|0|0|100|DKK|84463|106908|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||84463||84463|106908||3 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|4911|7836|lyfalmen|||1|30|0|3,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4911||4911|7836||1 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|12487|18336|lyfalmen|||1|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||12487||12487|18336||1 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|4911|7836|lyfalmen|||1|30|0|10,0000|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4911||4911|7836||1 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|13498|19614|lyfalmen|||1|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13498||13498|19614||1 015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|ţpakki||J05AE08|01.04.2005|31.08.2015|R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|65277|83046|lyfsjukr|||1|60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||65277||65277|83046||1 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|4911|7836|lyfalmen|||1|30|0|6,6700|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4911||4911|7836||1 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|12355|18169|lyfalmen|||1|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||12355||12355|18169||1 015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|65146|82883|lyfsjukr|||1|60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||65146||65146|82883||1 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|ţpakki||L04AA06|01.11.2004||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|20343|28272|lyfalmen|||1|120|0|10,8000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||20343||20343|28272||1 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|ţpakki||L04AA06|01.11.2004||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|40688|54004|lyfalmen|||1|120|0|21,6000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||40688||40688|54004||1 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2962|5105|vetorma|||0|2,4|0||Icepharma hf|Bayer Animal Health GmbH|||2962||2962|5105||2 015855|QP54AB5206|Advocate yfirstćrđar hundar|bl.lausn|125|mg|4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4866|8387|vetorma|||0|12|0||Icepharma hf|Bayer Animal Health GmbH|||4866||4866|8387||2 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2210|3809|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||2210||2210|3809||2 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3082|5312|vetorma|||0|3|0||Icepharma hf|Bayer Animal Health GmbH|||3082||3082|5312||2 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4655|8023|vetorma|||0|7,5|0||Icepharma hf|Bayer Animal Health GmbH|||4655||4655|8023||2 015910|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|100|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||0|100|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||||2 015912|D11AH0101|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AH01|01.03.2009||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1860|3636|lyfalmen|||1|10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||||1860|3636||1 015923|D11AH0101|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AH01|01.10.2007||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|2089|3952|lyfalmen|||1|10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||2089||2089|3952||1 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1711|3431|lyfalmen|||2|10|0|3,3300|Icepharma hf|Martindale Pharmaceuticals|Morfín||1711||1711|3431||2 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2964|5109|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||2964||2964|5109||2 015956|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|60|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||0|60|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||||2 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|ţpakki||N06AB05|01.12.2006||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|2184|4082|lyfalmen|||1|28|0|14,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||2184||2184|4082||1 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1272|2827|lyfalmen|||2|10|0|1,2500|Icepharma hf|Martindale Pharmaceuticals|Petidín||1272||1272|2827||2 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1348|2932|lyfalmen|||2|20|0|2,5000|Icepharma hf|Martindale Pharmaceuticals|Petidín||1348||1348|2932||2 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2529|4557|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Pregabalín||2529||2529|4557||1 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|6592|10150|lyfalmen|V0686|8784|1|56|0|14,0000|Icepharma hf|Pfizer ApS|Pregabalín||6592||6592|10150||1 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|9994|14832|lyfalmen|V0687|13464|1|56|0|28,0000|Icepharma hf|Pfizer ApS|Pregabalín||9994||9994|14832||1 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1670|3375|lyfalmen|||1|14|0|3,5000|Icepharma hf|Pfizer ApS|Pregabalín||1670||1670|3375||1 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|14526|20914|lyfalmen|V0689|19351|1|56|0|56,0000|Icepharma hf|Pfizer ApS|Pregabalín||14526||14526|20914||1 016337|C08CA0302|Lomir Retard|forđahlk|5|mg|100|stk|1|ţpakki||C08CA03|01.04.1992||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|7615|11558|lyfalmen|||1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S|Ísradipín||7615||7615|11558||1 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|0|0|0|0|0|1|IPI|0|0|0|100|DKK|89039|112600|lyfsjukr|||1|70|0|7,0000|Icepharma hf|Pfizer Limited|Voricónazól||89039||89039|112600||1 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|3483|4980|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Cýtarabín||3483||3483|4980||1 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|ţpakki||N03AX16|01.01.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2601|4656|lyfalmen|V0685|4077|1|56|0|4,6667|Icepharma hf|Pfizer ApS|Pregabalín||2601||2601|4656||1 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016527|J01CE0206|Apocillin|mixt.kyr|50|mg/ml|200|ml|1|glerfl||J01CE02|01.06.2015||R|0|0|0|0|0|0|AGP|0|0|1|100|XEU|1217|2751|lyfalmen|||2|200|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Fenoxýmetýlpenicillín||1217||1217|2751||1 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|ţpakki||N05AX12|01.02.2006||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|16264|23113|lyfalmen|||1|28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||16264||16264|23113||1 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016622|A06AG1101|Microlax|innhl|||5|ml|50|túpa||A06AG11|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||7420||1 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|ţpakki||N05AX12|01.02.2006||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|31770|42725|lyfalmen|V0682|28574|1|56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||31770||31770|42725||1 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1026|2128|lyfalmen|V0169|1687|2|12|0|10,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||764||764|2128||1 016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|134263|168846|lyfsjukr|||1|2,4|0|120,0000|Icepharma hf|Roche|Epóetín||134263||134263|168846||2 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|0|1|0|0|0|HES|0|0|0|100|DKK|6949|10641|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||6949||6949|10641||1 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forđatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|2838|4983|lyfalmen|V0240|4983|3|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||2838||2838|4983||3 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forđatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|5239|8287|lyfalmen|V0433|8287|3|200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||5239||5239|8287||3 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|47610|62759|lyfalmen|||1|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||47610||47610|62759||1 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|70142|91258|lyfalmen|||1|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||70142||70142|91258||1 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|26077|35524|lyfalmen|||1|28|0|14,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||26077||26077|35524||1 016930|A16AB0401|Fabrazyme|irţ|5|mg/ml|5|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|1|0|1|GEA|0|1|0|100|DKK|74670|94729|lyfsjukr|||1|5|0|1,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||74670||74670|94729||1 016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|ţpakki||A02BC03|01.11.2009||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1654|3353|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||1654|3353||1 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|1|0|0|1|0|1|GSL|0|0|0|100|DKK|36661|46998|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Emtrícítabín||36293||36293|46998||2 016979|N02AE0103|Norspan|forđapl|5|mcg/klst|4|stk|1|ţpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|PRO|0|0|0|100|DKK|2918|5093|lyfalmen|||1|4|0|16,6700|Icepharma hf|Norpharma A/S|Búprenorfín||2918||2918|5093||2 016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|60|dćlur|1|pakki||QA02BX12|01.12.2006||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|17430|33239|vetalmen|||0|60|0||Icepharma hf|Zoetis Finland OY|||17430||17430|33239||2 017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|1419|3029|lyfalmen|||1|3|0|21,4286|Icepharma hf|Pfizer ApS|Medroxýprógesterón||1419||1419|3029||1 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|0|0|0|1|0|1|SKY|0|1|0|100|DKK|245041|306622|lyfsjukr|||1|5|0||Icepharma hf|SkyPharma PLC|Cýtarabín||245041||245041|306622||2 017182|N05CF0106|Zopiclone Actavis|filmhtfl|5|mg|500|stk|1|plglas||N05CF01|01.10.2012||R|2|0|0|0|0|0|APC|0|0|0|100|XEU|6275|9713|lyfalmen|||2|500|0|333,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zópíklón||6275||6275|9713||1 017193|N05CF0106|Zopiclone Actavis|filmhtfl|7,5|mg|500|stk|1|glas||N05CF01|01.05.2013||R|2|0|0|0|0|0|APC|0|0|0|100|SEK|5577|8753|lyfalmen|||2|500|0|500,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zópíklón||5577||5577|8753||1 017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|133695|168139|lyfsjukr|||1|1|0||Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||133695||133695|168139||1 017203|M05BA0601|Bondronat|irţ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|31709|41297|lyfsjukr|||1|6|0|1,0000|Icepharma hf|Roche|Íbandrónsýra||31709||31709|41297||2 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|104456|131774|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||104456||104456|131774||2 017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|ţpakki||M05BA06|01.08.2004||R|1|0|0|1|0|0|ROC|0|0|0|100|DKK|44449|58761|lyfalmen|||1|28|0|280,0000|Icepharma hf|Roche|Íbandrónsýra||44449||44449|58761||2 017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|ţpakki||M05BA06|01.08.2004||R|1|0|0|1|0|0|ROC|0|0|0|100|DKK|138031|177124|lyfalmen|||1|84|0|840,0000|Icepharma hf|Roche|Íbandrónsýra||138031||138031|177124||2 017266|N02AE0103|Norspan|forđapl|10|mcg/klst|4|stk|1|ţpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|PRO|0|0|0|100|DKK|5248|8300|lyfalmen|||1|4|0|33,3300|Icepharma hf|Norpharma A/S|Búprenorfín||5248||5248|8300||2 017326|N02AE0103|Norspan|forđapl|20|mcg/klst|4|stk|1|ţpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|PRO|0|0|0|100|DKK|9645|14352|lyfalmen|||1|4|0|66,6600|Icepharma hf|Norpharma A/S|Búprenorfín||9645||9645|14352||2 017331|A04AD1201|Emend|hylki|||3|stk|1|ţpakki|samsett pakkning|A04AD12|01.04.2004||R|1|0|0|0|0|1|MSD|0|0|0|100|DKK|8213|11742|lyfsjukr|||1|3|0|3,0000|Vistor hf|M.S.D.|Aprepitant||8213||8213|11742||1 017365|J01CR0201|Amoksiklav|filmhtfl|375|mg|20|stk|1|ţpakki|250+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|950|2384|lyfalmen|||2|20|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||950||950|2384||1 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|1|0|0|0|G|0|REP|0|0|1|100|SEK|2600|4655|lyfalmen|||1|30|0|150,0000|Vistor hf|Recip AB|Prednisón||2600||2600|4655||1 017556|J01CR0201|Amoksiklav|filmhtfl|625|mg|20|stk|1|ţpakki|500+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1459|2665|lyfalmen|V0168|2618|2|20|0|10,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1154||1154|2665||1 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|6221|11973|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||6221||6221|11973||1 017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|ţpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|9655|14365|lyfalmen|V0197|11812|1|30|0|30,0000|Icepharma hf|Pfizer ApS|Eplerenón||9655||9655|14365||1 017809|N06DA0401|Reminyl|forđahlk|24|mg|84|stk|1|ţpakki||N06DA04|01.08.2005||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|37683|50203|lyfalmen|||1|84|0|126,0000|Vistor hf|Janssen-Cilag AB|Galantamín||37683||37683|50203||1 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|ţpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|8843|13248|lyfalmen|V0107|5473|1|30|0|15,0000|Icepharma hf|Pfizer ApS|Eplerenón||8843||8843|13248||1 018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|0|0|0|0|0|0|PIS|0|0|0|100|SEK|3498|5891|lyfalmen|V0698|5891|1|0,25|0||Icepharma hf|Pfizer ApS|Heilabólguveira óvirk, borin međ blóđmaur||3498||3498|5891||2 018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|0|0|0|0|0|0|PIS|0|0|0|100|SEK|3769|6264|lyfalmen|V0699|6264|1|0,5|0||Icepharma hf|Pfizer ApS|Heilabólguveira óvirk, borin međ blóđmaur||3769||3769|6264||2 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|ţpakki||N03AX09|01.11.2004||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|1030|1707|lyfalmen|V0243|1367|1|42|0|3,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||458||458|1707||1 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|ţpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|6761|10382|lyfalmen|||1|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||6761||6761|10382||1 018663|J01DD0401|Rocephalin|sts|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|12704|17660|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Ceftríaxón||12704||12704|17660||2 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|ţpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|17189|24283|lyfalmen|V0441|21322|1|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||17189||17189|24283||1 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|ţpakki||H02AB06|01.06.2004||R|1|0|0|0|G|0|MKA|0|0|1|100|SEK|840|2232|lyfalmen|V0414|2080|1|100|0|50,0000|Icepharma hf|Merck KgaA|Prednisólón||840||840|2232||2 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|ţpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|5445|8571|lyfalmen|V0438|7046|1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5445||5445|8571||1 018689|J01EA0108|Idotrim|filmhtfl|100|mg|100|stk|1|glas||J01EA01|01.08.2015||R|1|0|0|0|0|0|COR|0|0|1|100|DKK|1637|3317|lyfalmen|||2|100|0|25,0000|Vistor hf|Orion Corporation|Trímetóprím||1628||1628|3317||1 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|ţpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|14152|20441|lyfalmen|V0440|17822|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||14152||14152|20441||1 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|ţpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|31365|42212|lyfalmen|V0111|22107|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Eplerenón||31365||31365|42212||1 018726|J06BA0209|Nanogam|irl|50|mg/ml|20|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SSB|0|1|0|100|XEU|8324|11901|lyfsjukr|||1|20|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Immúnóglóbúlín, normal, manna, gefin í ćđ||8324||8324|11901||2 018770|J01EA0108|Idotrim|filmhtfl|160|mg|14|stk|1|glas||J01EA01|01.08.2015||R|1|0|0|0|0|0|COR|0|0|1|100|DKK|328|1524|lyfalmen|||2|14|0|5,6000|Vistor hf|Orion Corporation|Trímetóprím||325||325|1524||1 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|0|0|0|1|0|1|TEP|0|0|0|100|NOK|87240|110362|lyfsjukr|||1|28|0|28,0000|Vistor hf|Teva Pharmaceuticals Limited UK|Glatíramer acetat||87240||87240|110362||1 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|65530|83361|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|Viiv Healthcare UK Ltd|Fosamprenavír||65530||65530|83361||1 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|NOK|1028|2020|vetalmen|||0|100|0||Icepharma hf|Kela Laboratoria NV|||1028||1028|2020||2 018995|N02AB0301|Durogesic|forđapl|75|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|8868|13282|lyfalmen|V0221|7256|1|5|0|22,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||8868||8868|13282||1 019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|6212|8881|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||6212||6212|8881||2 019094|N02AB0301|Durogesic|forđapl|50|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|6338|9800|lyfalmen|V0220|5647|1|5|0|15,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||6338||6338|9800||1 019098|J06BA0209|Nanogam|irl|50|mg/ml|400|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SSB|0|1|0|100|XEU|166471|208903|lyfsjukr|||1|400|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Immúnóglóbúlín, normal, manna, gefin í ćđ||166471||166471|208903||2 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|18882|25344|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||18882||18882|25344||2 019108|N02AB0301|Durogesic|forđapl|25|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|3514|5913|lyfalmen|V0219|3353|1|5|0|7,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||3514||3514|5913||1 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|22583|29947|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||22583||22583|29947||2 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|20305|27114|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||20305||20305|27114||2 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|27326|35846|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||27326||27326|35846||2 019150|J06BA0209|Nanogam|irl|50|mg/ml|200|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SSB|0|1|0|100|XEU|83236|105382|lyfsjukr|||1|200|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Immúnóglóbúlín, normal, manna, gefin í ćđ||83236||83236|105382||2 019167|N02AB0301|Durogesic|forđapl|100|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|6934|10620|lyfalmen|V0223|7880|1|5|0|30,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||6934||6934|10620||1 019175|C09CA0601|Atacand|töflur|32|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|10347|15318|lyfalmen|||1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||10347||10347|15318||1 019214|J06BA0209|Nanogam|irl|50|mg/ml|100|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SSB|0|1|0|100|XEU|41617|53620|lyfsjukr|||1|100|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Immúnóglóbúlín, normal, manna, gefin í ćđ||41617||41617|53620||2 019221|J06BA0209|Nanogam|irl|50|mg/ml|50|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SSB|0|1|0|100|XEU|20809|27741|lyfsjukr|||1|50|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Immúnóglóbúlín, normal, manna, gefin í ćđ||20809||20809|27741||2 019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|ţykkni, lausn|B01AE06|01.05.2005||R|0|0|0|1|0|1|THE|0|0|0|100|XEU|690453|860590|lyfsjukr|||1|10|0|10,0000|The Medicines Company UK Ltd.|The Medicines Company UK Ltd.|Bívalirúdín||690453||690453|860590||1 019308|QG03XB9001|Alizin, vet|stl|30|mg/ml|10|ml|1|hgl|fyrir hunda (tíkur)|QG03XB90|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|3911|7590|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Aglepristonum||3911||3911|7590||1 019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019372|C03CA0110|Impugan|töflur|20|mg|100|stk|1|glas||C03CA01|01.02.2014||R|1|0|0|0|G|0|AGT|0|0|0|100|SEK|372|1537|lyfalmen|V0633|1537|2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Fúrósemíđ||335||335|1537||1 019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|dćlur||QJ51CE09|01.04.2010||R|0|0|0|0|0|0|VET|0|0|0|100|DKK|30282|57622|vetalmen|||0|1000|0||Dýraheilsa ehf|Vetcare Ltd.|Benzylpenicillínprokaín||30282||30282|57622||2 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|6351|9818|lyfalmen|||1|56|0|18,6700|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6351||6351|9818||2 019445|L01XC0701|Avastin|irţ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|43657|56157|lyfsjukr|||1|4|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||43657||43657|56157||2 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|6351|9818|lyfalmen|||1|56|0|37,3300|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6351||6351|9818||2 019621|C09AA0504|Ramipril ratiopharm|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1099|1902|lyfalmen|V0496|1902|2|100|0|200,0000|Medical ehf|ratiopharm GmbH|Ramipríl||600||600|1902||2 019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019669|C09AA0504|Ramipril ratiopharm|töflur|2,5|mg|100|stk|1|ţpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|980|1902|lyfalmen|V0648|1902|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Ramipríl||600||600|1902||2 019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019682|C09AA0504|Ramipril ratiopharm|töflur|10|mg|100|stk|1|ţpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1543|2866|lyfalmen|V0649|2866|2|100|0|400,0000|Medical ehf|ratiopharm GmbH|Ramipríl||1300||1300|2866||2 019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|3454|4938|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||3454||3454|4938||2 019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|15174|20732|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||15174||15174|20732||2 019781|L01XC0701|Avastin|irţ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|166987|209545|lyfsjukr|||1|16|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||166987||166987|209545||2 019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|966|2063|lyfalmen|V0159|2060|2|20|0|10,0000|Icepharma hf|Mylan AB|Amoxicillín||717||717|2063||2 019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019797|L01BA0401|Alimta|irţ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|0|0|0|1|0|1|ELD|0|1|0|100|XEU|157949|198304|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||157949||157949|198304||2 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|11986|17574|lyfalmen|||1|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11986||11986|17574||2 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|11986|17574|lyfalmen|||1|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11986||11986|17574||2 019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005|31.07.2015|R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|41927|55571|lyfalmen|||1|1,08|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||41927|55571||1 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|11986|17574|lyfalmen|||1|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11986||11986|17574||2 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|11986|17574|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11986||11986|17574||2 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|11986|17574|lyfalmen|||1|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11986||11986|17574||2 019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|0|0|0|1|0|1|BIO|0|0|0|100|DKK|728583|908013|lyfsjukr|||1|6|0|8,9300|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Palifermín||728583||728583|908013||3 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|ţpakki||N04BC04|01.12.2006||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|433|1672|lyfalmen|||1|12|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||||433|1672||1 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|ţpakki|600+300 mg|J05AR02|01.05.2004||R|1|0|0|1|0|1|GGL|0|0|0|100|GBP|71530|90823|lyfsjukr|||1|30|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín og abacavír||71530||71530|90823||1 019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1199|2526|lyfalmen|V0160|2500|2|30|0|15,0000|Icepharma hf|Mylan AB|Amoxicillín||1053||1053|2526||2 020016|B03AA0704|Duroferon|forđatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|1|0|0|0|0|0|AHN|0|0|1|100|IKR|||lyflausa|||0|100|0|50,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Ferrósúlfat|||||||1 020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 020156|C08DB0109|Dilmin|töflur|60|mg|100|stk|1|ţpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|2601|4656|lyfalmen|||2|100|0|25,0000|Medical ehf|ratiopharm GmbH|Diltíazem||2601||2601|4656||2 020227|J07CA0204|Boostrix Polio|stl|||0,5|ml|1|áf.spr|dreifa|J07CA02|01.09.2014||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|2895|5061|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Barnaveiki, kíghósti, mćnusótt, stífkrampi||||2895|5061||1 020238|G04CA0203|Omnic Ocas|forđatfl|0,4|mg|30|stk|1|ţpakki||G04CA02|01.04.2006||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|2708|4804|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||2708||2708|4804||1 020244|J07CA0204|Boostrix Polio|stl|||0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|28953|39162|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, kíghósti, mćnusótt, stífkrampi||28953||28953|39162||1 020276|A06AB0203|Dulcolax (Lyfjaver)|eţ-stíll|10|mg|50|stk|1|ţpakki||A06AB02|01.07.2005||R|0|0|0|0|0|0|LVR|0|0|0|100|NOK|2186|4085|lyfalmen|||3|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2186||2186|4085||3 020282|L01XX2301|Lysodren|töflur|500|mg|100|stk|1|glas||L01XX23|01.04.2015||R|0|0|0|1|0|1|LHR|0|0|0|100|XEU|90374|114260|lyfsjukr|||1|100|0||Laboratoire HRA Pharma|Laboratoire HRA Pharma|Mitotanum||90374||90374|114260||0 020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|50|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 020305|C08DB0109|Dilmin|forđatfl|90|mg|100|stk|1|ţpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|2949|4271|lyfalmen|||2|100|0|37,5000|Medical ehf|ratiopharm GmbH|Diltíazem||2321||2321|4271||2 020338|G04CA0203|Omnic Ocas|forđatfl|0,4|mg|90|stk|1|ţpakki||G04CA02|01.04.2006||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|6322|9778|lyfalmen|||1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||6322||6322|9778||1 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|47154|62182|lyfalmen|||1|2|0|155,7500|Vistor hf|Astellas Pharma A/S|Leuprórelín||47154||47154|62182||1 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|ţpakki||N04BC04|01.06.2006||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|5272|4783|lyfalmen|V0530|4604|1|84|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||2693||2693|4783||1 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|ţpakki||N04BC04|01.12.2006||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|11966|5565|lyfalmen|||1|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||3261||3261|5565||1 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|21922|30269|lyfalmen|||1|2|0|51,9400|Vistor hf|Astellas Pharma A/S|Leuprórelín||21922||21922|30269||1 020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|543|1824|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||543||543|1824||1 020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1683|3393|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1683||1683|3393||1 020685|C08DB0109|Dilmin|forđatfl|120|mg|100|stk|1|ţpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|11730|6542|lyfalmen|V0599|6542|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Diltíazem||3971||3971|6542||2 020711|G03AD0102|Postinor|töflur|1500|mcg|1|stk|1|ţpakki||G03AD01|01.01.2007||L|0|0|0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Icepharma hf|Medimpex UK Limited|Levonorgestrel|||||||2 020770|QP54AA5101|Eqvalan Duo|pasta|||7,74|g|1|sk-dćl||QP54AA51|01.10.2006||R|0|0|0|0|0|0|MES|0|0|0|100|XEU|2064|3558|vetorma|||0|7,74|0||Vistor hf|Merial SAS|Ivermectinum í blöndum||2064||2064|3558||1 020861|QP52AF0203|Nematel Vet.|pasta|439|mg/g|52|g|1|spr||QP52AF02|01.08.2011||R|0|0|0|0|0|0|VEB|0|0|0|100|XEU|2413|4159|vetorma|||0|52|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||2413||2413|4159||2 020924|J01FA1003|Zithromax (Lyf og heilsa)|töflur|500|mg|3|stk|1|ţpakki||J01FA10|01.09.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|1593|3269|lyfalmen|V0174|2683|3|3|0|5,0000|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||1593||1593|3269||2 020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|1|0|0|0|0|0|LLS|0|0|0|100|DKK|2710|4806|lyfalmen|||1|30|0|37,5000|Icepharma hf|Les Laboratoires Servier|Perindópríl||2710||2710|4806||2 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|0|0|0|0|0|0|GAN|0|0|0|100|SEK|2156|4044|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen||2156||2156|4044||2 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|ţpakki||M01AB05|01.03.2005||R|1|0|0|0|G|0|ACA|0|0|1|100|IKR|581|1591|lyfalmen|V0188|1489|2|30|0|15,0000|Actavis Group hf|Actavis hf|Díklófenak||374||374|1591||1 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|0|0|0|0|G|0|GEM|0|0|0|100|XEU|1358|2945|lyfalmen|||1|10|0||Actavis Group hf|Gerhard Mann|Dexpantenól||1358||1358|2945||1 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|ţpakki||M01AB05|01.03.2005||R|1|0|0|0|G|0|ACA|0|0|1|100|IKR|1287|2150|lyfalmen|V0189|2125|2|100|0|50,0000|Actavis Group hf|Actavis hf|Díklófenak||780||780|2150||1 021341|R03AK0603|Seretide Diskus (Lyfjaver)|innönddu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg, discus|R03AK06|01.05.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|GBP|9716|14449|lyfalmen|V0437|13731|3|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og fluticason||9716||9716|14449||3 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.09.1998||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|15876|22622|lyfalmen|V0490|2285|1|98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||15876||15876|22622||1 021365|R03AK0603|Seretide Diskus (Lyfjaver)|innönddu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg, discus|R03AK06|01.05.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|GBP|7410|11275|lyfalmen|V0436|10728|3|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og fluticason||7410||7410|11275||3 021417|R01AD0504|Rhinocort (Lyf og heilsa)|nefúđi|64|mcg/sk|120|skammtar|1|fl||R01AD05|15.12.2004||R|0|0|0|0|G|0|HOL|0|0|1|100|SEK|1456|3080|lyfalmen|||3|120|0|38,4000|Lyf og heilsa|Lyf og heilsa|Búdesóníđ||1456||1456|3080|31.7.2015|2 021428|A06AB0201|Dulcolax|eţ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|0|0|0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Vistor hf|Boehringer Ingelheim|Bisakódýl|||||||1 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|1464|2093|lyfsjukr|||2|100|0||Icepharma hf|Fresenius Kabi|Própófól||1464||1464|2093||2 021593|H01BA0201|Minirin|frţ.tfl|60|mcg|30|stk|1|ţpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|3990|6568|lyfalmen|||1|30|0|4,5000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||3990||3990|6568||1 021604|H01BA0201|Minirin|frţ.tfl|60|mcg|100|stk|1|ţpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|12384|18205|lyfalmen|||1|100|0|15,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||12384||12384|18205||1 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|ţpakki||C10AA07|01.01.2006||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|12550|18415|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||12550||12550|18415||1 021614|H01BA0201|Minirin|frţ.tfl|120|mcg|30|stk|1|ţpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|6583|10137|lyfalmen|||1|30|0|9,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||6583||6583|10137||1 021625|A07EC0203|Pentasa Sachets|forđakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|13988|20234|lyfalmen|||1|60|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||13988||13988|20234||1 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|14643|20072|lyfsjukr|||2|1000|0||Icepharma hf|Fresenius Kabi|Própófól||14643||14643|20072||2 021641|H01BA0201|Minirin|frţ.tfl|120|mcg|100|stk|1|ţpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|20881|28952|lyfalmen|||1|100|0|30,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||20881||20881|28952||1 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|16840|22804|lyfsjukr|||2|500|0||Icepharma hf|Fresenius Kabi|Própófól||16840||16840|22804||2 021659|V01AA0304|Alutard SQ, derm. pter.|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|22540|31051|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||22540||22540|31051||1 021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|ţpakki||C10AA07|01.01.2006||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|3865|6396|lyfalmen|V0171|5243|1|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||3865||3865|6396||1 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|8420|12038|lyfsjukr|||2|500|0||Icepharma hf|Fresenius Kabi|Própófól||8420||8420|12038||2 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4249|6075|lyfsjukr|||1|50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||4249||4249|6075||1 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18045|25365|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||18045||18045|25365||1 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|ţpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|3761|6253|lyfalmen|V0692|4706|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||3761||3761|6253||2 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|ţpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|5938|9249|lyfalmen|V0693|6717|1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5938||5938|9249||2 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|ţpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|18106|25442|lyfalmen|V0694|21710|1|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||18106||18106|25442||2 021999|L01XX3501|Xagrid|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.10.2012||R|0|0|0|1|0|1|SHI|0|0|0|100|DKK|71214|90430|lyfsjukr|||1|100|0||Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Anagrelidum||71214||71214|90430||3 022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999|30.06.2015|R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18061|25386|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||18061||18061|25386||1 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|76690|97241|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||76690||76690|97241||2 022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|107315|135330|lyfsjukr|||1|1200|0||Icepharma hf|Baxter Medical AB|Albúmín||107315||107315|135330||2 022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||0|200|0|45,4500|Actavis Group hf|Actavis Group hf|Natríumflúoríđ|||||||1 022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|Clikstar/JuniorStar pennar|A10AB06|01.07.2010||R|0|0|0|0|G|0|SAA|0|0|0|100|NOK|4266|6948|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||4266||4266|6948||1 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|267904|335058|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||267904||267904|335058||2 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|281775|352309|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||281775||281775|352309||2 022218|QP52AA5102|Drontal Comp.vet.|töflur|||24|stk|1|ţpakki||QP52AA51|01.01.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|11715|20192|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||11715||11715|20192||2 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|0|0|0|1|0|0|ALL|0|0|0|100|SEK|21385|29590|lyfalmen|||1|1|0||Vistor hf|Allergan|Clostridium botulinum toxín-A||21385||21385|29590||1 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2103|3625|vetorma|||0|2,24|0||Icepharma hf|Bayer Animal Health GmbH|||2103||2103|3625||2 022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|ţpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1202|2731|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Amlódipín||1202||1202|2731||1 022281|QP52AA5102|Drontal Comp.vet.|töflur|||2|stk|1|ţpakki||QP52AA51|01.10.1991||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1329|2291|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||1329||1329|2291||2 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|3522|2694|lyfalmen|V0056|1990|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Amlódipín||1175||1175|2694||1 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|6244|3641|lyfalmen|V0057|1992|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Amlódipín||1863||1863|3641||1 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1991|3432|vetorma|||0|1,4|0||Icepharma hf|Bayer Animal Health GmbH|||1991||1991|3432||2 022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|566|1855|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||566||566|1855||1 022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1702|3419|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1702||1702|3419||1 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1289|2222|vetorma|||0|0,7|0||Icepharma hf|Bayer Animal Health GmbH|||1289||1289|2222||2 022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|ţpakki||C09DA03|01.11.2003||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|4338|7047|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan og ţvagrćsilyf||4338||4338|7047||1 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2129|3102|lyfalmen|V0321|3102|2|100|0|100,0000|Actavis Group hf|Actavis hf|Paroxetín||1472||1472|3102||1 022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|ţpakki||N06AB05|01.08.2013||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1554|2414|lyfalmen|V0321|1861|2|60|0|60,0000|Actavis Group hf|Actavis hf|Paroxetín||972||972|2414||1 022757|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|60|sk-hyl||S01XA20|01.07.2012||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||4622||2 022783|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|10|áf.spr||B01AX05|01.10.2011||R|0|0|0|0|G|0|TAA|0|0|0|100|GBP|28486|38571|lyfalmen|||1|8|0|40,0000|Navamedic A/S|Aspen Pharma Trading Limited|Fondaparinux||28486||28486|38571||1 022815|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|áf.spr||B01AX05|01.10.2011||R|0|0|0|0|G|0|TAA|0|0|0|100|GBP|14171|20465|lyfalmen|||1|4|0|20,0000|Navamedic A/S|Aspen Pharma Trading Limited|Fondaparinux||14171||14171|20465|31.8.2015|1 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|15|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||2849||2 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|ţpakki||D10BA01|01.02.2006||R|0|1|0|1|G|0|ACA|0|0|0|30|IKR|1407|2940|lyfalmen|||2|30|0|10,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1354||1354|2940||1 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.02.2006||R|0|1|0|1|G|0|ACA|0|0|0|30|IKR|2450|3402|lyfalmen|V0125|2603|2|30|0|20,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1690||1690|3402||1 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|74189|94130|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Tenófóvír dísóproxíl og emtrícítabín||74189||74189|94130||2 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|23854|32713|lyfalmen|||1|90|0|20,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||23854||23854|32713||3 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|37243|49647|lyfalmen|||1|90|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||37243||37243|49647||3 023114|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.09.2014||R|0|1|0|1|G|0|RAT|0|0|0|30|IKR|3000|2866|lyfalmen|V0125|2603|2|30|0|20,0000|LYFIS ehf|ratiopharm GmbH|Ísótretínóín||1300||1300|2866||2 023124|G04BD1001|Emselex|forđatfl|7,5|mg|98|stk|1|ţpakki||G04BD10|01.07.2005||R|1|0|0|0|G|0|LUX|0|0|0|100|DKK|18452|25880|lyfalmen|||1|98|0|98,0000|POA Pharma Scandinavia AB|Merus Labs Luxco S.ŕ R.L.|Darífenacín||18452||18452|25880||1 023125|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|60|stk|1|ţpakki||D10BA01|01.09.2014||R|0|1|0|1|G|0|RAT|0|0|0|30|IKR|6500|5206|lyfalmen|V0125|5206|2|60|0|40,0000|LYFIS ehf|ratiopharm GmbH|Ísótretínóín||3000||3000|5206||2 023154|N03AX1208|Gabapentin ratiopharm|filmhtfl|800|mg|100|stk|1|ţpakki||N03AX12|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|14000|20249|lyfalmen|V0256|20249|2|100|0|44,4400|Medical ehf|ratiopharm GmbH|Gabapentín||14000||14000|20249||2 023162|N03AX1208|Gabapentin ratiopharm|filmhtfl|600|mg|100|stk|1|ţpakki||N03AX12|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|7500|11399|lyfalmen|V0254|11399|2|100|0|33,3300|Medical ehf|ratiopharm GmbH|Gabapentín||7500||7500|11399||2 023193|G04BD1001|Emselex|forđatfl|15|mg|98|stk|1|ţpakki||G04BD10|01.07.2005||R|1|0|0|0|G|0|LUX|0|0|0|100|DKK|19051|26638|lyfalmen|||1|98|0|196,0000|POA Pharma Scandinavia AB|Merus Labs Luxco S.ŕ R.L.|Darífenacín||19051||19051|26638||1 023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2362|3656|lyfalmen|V0250|3656|2|100|0|16,6667|Icepharma hf|Mylan AB|Gabapentín||1874||1874|3656||2 023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3160|4186|lyfalmen|V0251|4186|2|100|0|22,2200|Icepharma hf|Mylan AB|Gabapentín||2259||2259|4186||2 023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|0|0|0|0|0|0|DED|0|0|1|100|XEU|18198|25559|lyfalmen|||1|34|0||Vistor hf|Dentsply DeTrey GmbH|Blöndur||18198||18198|25559||1 023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007|31.07.2015|R|0|0|0|1|0|1|BII|0|0|0|100|DKK|119794|150850|lyfsjukr|||1|120|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tipranavír||119794||119794|150850||1 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2007||R|1|0|0|0|G|0|SBM|0|0|0|100|NOK|16498|23409|lyfalmen|V0029|6587|1|100|0|100,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||16498||16498|23409||1 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2897|5064|lyfalmen|||1|12|0|30,0000|Icepharma hf|Santen Oy|Tímólól||2897||2897|5064||2 023608|N01AB0802|Sevofluran Baxter|innönd.l|100|%|250|ml|6|fl||N01AB08|01.04.2012||R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|127143|146954|lyfsjukr|||2|1500|0||Icepharma hf|Baxter|Sevóflúran||116661||116661|146954||2 023641|C09AA0211|Enalapril Krka|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|900|2315|lyfalmen|V0066|2314|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||900||900|2315||2 023649|C09AA0211|Enalapril Krka|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1050|2522|lyfalmen|V0449|2520|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||1050||1050|2522||2 023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|1|0|0|1|0|1|ROC|0|0|0|100|DKK|52546|67213|lyfsjukr|||1|120|0|33,3300|Icepharma hf|Roche|Saquínavír||52546||52546|67213||2 023738|C09AA0211|Enalapril Krka|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|700|2040|lyfalmen|V0448|1910|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||700||700|2040||2 023847|N06AX1106|Mirtazapin Krka|filmhtfl|45|mg|100|stk|1|ţpakki||N06AX11|01.04.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|4900|5894|lyfalmen|||2|100|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||3500||3500|5894||2 023897|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|100|stk|1|ţpakki||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2429|3691|lyfalmen|V0673|3691|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||1900||1900|3691||2 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|ţpakki||G04BE03|01.08.2006||R|0|1|0|1|0|1|IPI|0|0|0|100|DKK|68944|87607|lyfsjukr|||1|90|0|36,0000|Icepharma hf|Pfizer Limited|Síldenafíl||68944||68944|87607||1 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|2720|4820|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2720||2720|4820||1 024056|N02AB0301|Durogesic|forđapl|12|mcg/klst|5|stk|1|ţpakki||N02AB03|01.02.2006||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|2141|4023|lyfalmen|V0222|3755|1|5|0|3,6000|Vistor hf|Janssen-Cilag AB|Fentanýl||2141||2141|4023||1 024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|1|0|0|0|G|0|TPG|0|0|0|100|DKK|17974|25276|lyfalmen|||1|30|0|30,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||17974||17974|25276||1 024185|N05AH0309|Kozylex|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|0|0|0|0|G|0|POF|0|0|0|100|IKR|14561|12776|lyfalmen|V0456|12776|2|28|0|28,0000|Portfarma ehf|Portfarma|Olanzapín||8500||8500|12776||2 024198|C07AB0213|Metoprololsuccinat Hexal|forđatfl|50|mg|100|stk|1|plglas|47,5 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|1595|2472|lyfalmen|V0048|2472|2|100|0|31,6600|Artasan ehf|Hexal A/S|Metóprólól||1014||1014|2472||1 024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|ţpakki||N04BD02|01.10.2005||R|1|0|0|0|G|0|TPG|0|0|0|100|DKK|59282|77522|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||59282||59282|77522||1 024231|C07AB0213|Metoprololsuccinat Hexal|forđatfl|100|mg|100|stk|1|plglas|95 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|2140|3462|lyfalmen|V0049|3462|2|100|0|63,3300|Artasan ehf|Hexal A/S|Metóprólól||1733||1733|3462||1 024253|C07AB0213|Metoprololsuccinat Hexal|forđatfl|200|mg|100|stk|1|plglas|190 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|4307|5903|lyfalmen|V0054|5903|2|100|0|126,6600|Artasan ehf|Hexal A/S|Metóprólól||3507||3507|5903||1 024307|V01AA1105|Alutard SQ, hundahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|22540|31051|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||22540||22540|31051||1 024478|V04CL0016|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7096|10843|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7096||7096|10843||1 024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|378|1597|lyfalmen|||1|100|0|2,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||378||378|1597||1 024482|V04CL0017|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7096|10843|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7096||7096|10843||1 024504|V04CL0003|Soluprick SQ ALK106 - Rauđölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|11956|17533|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||11956||11956|17533||1 024526|V04CL0006|Soluprick SQ ALK113 - Hesliviđur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|11976|17560|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||11976||11976|17560||1 024565|V04CL0009|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|12098|17844|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12098||12098|17844||1 024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5116|8118|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||5116||5116|8118||1 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|0|1|0|1|0|0|NEL|0|0|0|100|DKK|65002|84757|lyfalmen|||1|100|0|1,2500|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||65002||65002|84757||1 024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|12098|17844|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12098||12098|17844||1 024603|V04CL0001|Soluprick Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1457|3082|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||1457||1457|3082||1 024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5116|8118|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||5116||5116|8118||1 024644|V04CL0015|Soluprick SQ ALK552 - Hrossavćrur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7096|10843|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7096||7096|10843||1 024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7096|10843|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7096||7096|10843||1 024681|V04CL0002|Soluprick Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1457|3082|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||1457||1457|3082||1 024901|C07AB0212|Metoprolin|töflur|100|mg|100|stk|1|ţpakki||C07AB02|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|2162|3141|lyfalmen|V0106|3141|2|100|0|66,6660|Medical ehf|ratiopharm GmbH|Metóprólól||1500||1500|3141||2 025041|C09AA0211|Enalapril Krka|töflur|20|mg|250|stk|1|glas||C09AA02|01.12.2013||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3115|5364|lyfalmen|||2|250|0|500,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||3115||3115|5364||2 025046|C09AA0211|Enalapril Krka|töflur|10|mg|250|stk|1|glas||C09AA02|01.12.2013||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2770|4889|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2770||2770|4889||2 025052|C09AA0211|Enalapril Krka|töflur|5|mg|250|stk|1|glas||C09AA02|01.12.2013||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2000|3829|lyfalmen|V0450|3829|2|250|0|125,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2000||2000|3829||2 025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húđ|D07AB02|01.04.1994||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|577|1871|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||577||577|1871||1 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18045|25365|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||18045||18045|25365||1 025239|C07AB0212|Metoprolin|töflur|50|mg|100|stk|1|ţpakki||C07AB02|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1480|2177|lyfalmen|V0051|2177|2|100|0|33,3333|Medical ehf|ratiopharm GmbH|Metóprólól||800||800|2177||2 025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999|30.06.2015|R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18061|25386|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||18061||18061|25386||1 025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|ţpakki||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|74017|93916|lyfsjukr|||1|30|0|60,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||74017||74017|93916||1 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|ţpakki||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|69135|87845|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||69135||69135|87845||1 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|8942|17135|vetalmen|||0|20|0||Vistor hf|Boehringer Ingelheim|||8942||8942|17135||1 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|ţpakki|frostţurrkađar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|15478|22119|lyfalmen|||1|30|0||Vistor hf|ALK-Abello A/S|grasfrjó||15478||15478|22119||1 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|ţpakki||M05BA06|01.01.2006||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|4896|7815|lyfalmen|V0205|1257|1|1|0|30,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||4896||4896|7815||2 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|ţpakki||M05BA06|01.01.2006||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|13122|19139|lyfalmen|V0205|3770|1|3|0|90,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||13122||13122|19139||2 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|ţpakki|frostţurrkađar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|49719|65427|lyfalmen|||1|100|0||Vistor hf|ALK-Abello A/S|grasfrjó||49719||49719|65427||1 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|6436|9202|lyfsjukr|||1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Lídókaín||6436||6436|9202||1 025841|V01AA1106|Alutard SQ, kattahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|22540|31051|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||22540||22540|31051||1 025895|N02AA0505|Oxycodone ratiopharm|forđatfl|10|mg|28|stk|1|ţpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|1437|2312|lyfalmen|V0597|2312|2|28|0|3,7300|Medical ehf|ratiopharm GmbH|Oxýcódon||898||898|2312||2 025906|N02AA0505|Oxycodone ratiopharm|forđatfl|10|mg|98|stk|1|ţpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|3671|4911|lyfalmen|V0598|4911|2|98|0|13,0700|Medical ehf|ratiopharm GmbH|Oxýcódon||2786||2786|4911||2 025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|ţpakki|hart|L04AX02|01.09.2011||R|0|1|0|1|0|1|CEE|0|1|0|100|XEU|48259|61881|lyfsjukr|||1|28|0|14,0000|Celgene Europe ltd|Celgene Europe ltd|Thalidómíde||||48259|61881||2 025927|N06AX2601|Brintellix|filmhtfl|20|mg|98|stk|1|ţpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|41843|55465|lyfalmen|||1|98|0|196,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||41843||41843|55465||1 025941|R03DC0302|Montelukast Portfarma|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.01.2012|31.07.2015|R|1|0|0|0|G|0|POF|0|0|0|100|XEU|12570|3990|lyfalmen|||2|98|0|39,2000|Portfarma ehf|Portfarma|Montelúkast||2117||2117|3990||1 025963|R03DC0302|Montelukast Portfarma|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.01.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|4235|6096|lyfalmen|V0491|6096|2|98|0|49,0000|Portfarma ehf|Portfarma|Montelúkast||3647||3647|6096||1 025986|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.11.2011|31.07.2015|R|1|0|0|0|G|0|POF|0|0|0|100|XEU|12858|2380|lyfalmen|||2|98|0|98,0000|Portfarma ehf|Portfarma|Montelúkast||947||947|2380||1 025997|A07DA0302|Loperamid Portfarma|töflur|2|mg|20|stk|1|ţpakki||A07DA03|01.09.2015||L|1|0|0|0|0|0|POF|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Portfarma ehf|Portfarma|Lóperamíđ|||||||1 026000|QS02CA0301|Easotic|eyrnadr|||10|ml|1|fl|dreifa|QS02CA03|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|1824|3585|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Hýdrókortisón,miconazol,gentamicin||1824||1824|3585||1 026019|A07DA0302|Loperamid Portfarma|töflur|2|mg|100|stk|1|ţpakki||A07DA03|01.09.2015||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|820|2205|lyfalmen|V0447|2205|2|100|0|20,0000|Portfarma ehf|Portfarma|Lóperamíđ||820||820|2205||1 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|8667|14938|vetorma|||0|2,5|0||Vistor hf|Merial (MSD)|Ivermectinum||8667||8667|14938||1 026086|N05AH0309|Kozylex|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|IKR|23430|13464|lyfalmen|V0475|13464|2|28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||9000||9000|13464||1 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18045|25365|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||18045||18045|25365||1 026101|L01CA0501|Javlor|irţ|25|mg/ml|2|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|39801|51361|lyfsjukr|||1|2|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||39801||39801|51361||1 026114|L01CA0501|Javlor|irţ|25|mg/ml|10|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|199006|249368|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||199006||199006|249368||1 026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|1696|3411|lyfalmen|||1|14|0|2,3300|Vistor hf|U.C.B|Lacosamíđ||||1696|3411||1 026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|6425|9920|lyfalmen|||1|56|0|9,3300|Vistor hf|U.C.B|Lacosamíđ||||6425|9920||1 026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|3350|5687|lyfalmen|||1|14|0|4,6700|Vistor hf|U.C.B|Lacosamíđ||||3350|5687||1 026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|13268|19323|lyfalmen|||1|56|0|18,6700|Vistor hf|U.C.B|Lacosamíđ||||13268|19323||1 026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|19882|27689|lyfalmen|||1|56|0|28,0000|Vistor hf|U.C.B|Lacosamíđ||||19882|27689||1 026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|26497|36055|lyfalmen|||1|56|0|37,3300|Vistor hf|U.C.B|Lacosamíđ||||26497|36055||1 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|1265|2817|lyfalmen|||2|100|0|25,0000|Vistor hf|Recip AB|Nítrófúrantóín||1265||1265|2817||1 026698|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|14|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2 026943|C09CA0106|Losatrix|filmhtfl|100|mg|100|stk|1|ţpakki||C09CA01|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4765|3861|lyfalmen|V0099|3861|2|100|0|200,0000|Medical ehf|ratiopharm GmbH|Lósartan||2023||2023|3861||2 026946|J01CA0412|Amoxicillin Mylan (Lyf og heilsa)|hylki|500|mg|30|stk|1|glas||J01CA04|01.07.2011||R|0|0|0|0|0|0|HOL|0|0|1|100|SEK|1034|2500|lyfalmen|V0160|2500|3|30|0|15,0000|Lyf og heilsa|Lyf og heilsa|Amoxicillín||1034||1034|2500||2 026957|J01CA0412|Amoxicillin Mylan (Lyf og heilsa)|hylki|500|mg|20|stk|1|glas||J01CA04|01.05.2011||R|0|0|0|0|0|0|DAC|0|0|1|100|SEK|715|2060|lyfalmen|V0159|2060|3|20|0|10,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||715||715|2060||2 027051|A10BX1201|Jardiance|filmhtfl|10|mg|90|stk|1|ţpakki||A10BX12|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|19187|26810|lyfalmen|||1|90|0||Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||19187||19187|26810||1 027058|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|100|stk|1|ţpakki||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2043|3003|lyfalmen|V0672|3003|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||1400||1400|3003||2 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|376|1594|lyfalmen|||2|50|0|1,2500|Vistor hf|Recip AB|Nítrófúrantóín||376||376|1594||1 027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|2562|4603|lyfalmen|||1|5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||2562||2562|4603||1 027235|G03HA0104|Cyproteron Mylan|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|5650|8853|lyfalmen|||2|50|0|25,0000|Icepharma hf|Mylan AB|Cýpróterón||5650||5650|8853||2 027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|ţpakki||N06DA02|01.05.2009||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|15526|7456|lyfalmen|V0341|7456|2|100|0|66,6600|Actavis Group hf|Actavis hf|Dónepezíl||4635||4635|7456||1 027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|ţpakki||N06DA02|01.05.2009||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|17824|7456|lyfalmen|V0342|7456|2|100|0|133,3300|Actavis Group hf|Actavis hf|Dónepezíl||4635||4635|7456||1 027505|B05BB0121|Plasmalyte|irl|||1000|ml|10|pokar|lausn|B05BB01|01.05.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2485|3553|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2485||2485|3553||2 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|ţpakki||N03AX15|01.03.2007||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|6390|9872|lyfalmen|||1|56|0|7,0000|Vistor hf|Eisai Ltd|Zonisamíđ||6390||6390|9872||1 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|1|0|0|0|G|0|TDA|0|0|0|100|DKK|563|1851|lyfalmen|||2|100|0|33,3300|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||563||563|1851||1 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|1|0|0|0|G|0|TDA|0|0|0|100|DKK|648|1968|lyfalmen|||2|100|0|66,6667|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||648||648|1968||1 027733|N05AH0409|Quetiapin Orion|filmhtfl|25|mg|100|stk|1|ţpakki||N05AH04|01.10.2012||R|1|0|0|0|G|0|OPF|0|0|0|100|IKR|2109|2109|lyfalmen|V0284|2109|2|100|0|6,2500|Portfarma ehf|Orion Corporation|Quetíapín||750||750|2109||1 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|ţpakki||N05AX12|01.01.2007||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|19136|26745|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||19136||19136|26745||1 027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|22052|29287|lyfsjukr|||1|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||22052|29287||2 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|ţpakki||N05AX12|01.01.2007||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|22117|30516|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||22117||22117|30516||1 027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|30120|39321|lyfsjukr|||1|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||30120||30120|39321||2 027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|44507|57214|lyfsjukr|||1|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||44507|57214||2 028045|G03AB0801|Qlaira|töflur|||84|stk|1|ţpakki|3x28 stk|G03AB08|01.11.2009||R|0|0|0|0|0|0|BAP|0|0|0|100|DKK|4008|6593|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Kaflaskipt lyf, prógestógen og östrógen||4008||4008|6593||2 028110|A10BD0701|Janumet|filmhtfl|900|mg|196|stk|1|ţpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|21194|29348|lyfalmen|V0387|29348|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||21194||21194|29348||1 028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|ţpakki|50/1000mg|A10BD07|01.01.2010||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|18940|26497|lyfalmen|V0386|26497|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||18940||18940|26497||1 028124|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|ţpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3154|4374|lyfalmen|V0364|3448|2|100|0|100,0000|Icepharma hf|Mylan AB|Fexófenadín||2396||2396|4374||2 028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|47227|60597|lyfsjukr|||1|1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||47227||47227|60597||1 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ ađsk. nál|J07AP03|01.05.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2459|4461|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsađir mótefnavakar||2459||2459|4461||2 028333|J07CA0602|Pentavac|sts|||0,5|ml|10|hgl|+ 10 áf. spr.|J07CA06|01.02.2013||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|38230|50895|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||38230||38230|50895||2 028351|J07BL0101|Stamaril|sts|||0,5|ml|10|hgl|+ 10 áf.spr. međ leysi|J07BL01|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|39512|52517|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluđ veira||||39512|52517||2 028360|J07BG0101|Rabies - Imovax|sts|||1|ml|1|hgl||J07BG01|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|SEK|8913|13344|lyfalmen|||1|1|0||Icepharma hf|Sanofi Pasteur MSD|Hundaćđi, dauđ veira||8913||8913|13344||2 028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas||M03BX01|01.10.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1650|3347|lyfalmen|V0202|3347|2|50|0|25,0000|Icepharma hf|Mylan AB|Baklófen||1650||1650|3347||2 028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1850|3623|lyfalmen|V0428|3061|2|50|0|50,0000|Icepharma hf|Mylan AB|Naproxen||1850||1850|3623||2 028575|N03AX0901|Lamictal|dreifit.|5|mg|56|stk|1|ţpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|1278|2835|lyfalmen|||1|56|0|0,9334|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||1278|2835||1 028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|ţpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|5812|3884|lyfalmen|V0245|3483|1|98|0|32,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||2040||2040|3884||1 028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|ţpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|10358|8729|lyfalmen|V0232|7799|1|98|0|65,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||5560||5560|8729||1 028599|N04BC0503|Pramipexole Portfarma|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.02.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|745|2093|lyfalmen|V0266|2093|2|30|0|1,0600|Portfarma ehf|Portfarma|Pramipexól||739||739|2093||1 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|0|0|0|0|0|0|OCO|1|0|0|100|DKK|7421|14250|vetalmen|||0|10|0||Icepharma hf|Orion Corporation (I)|||7421||7421|14250||2 028610|N04BC0503|Pramipexole Portfarma|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.02.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|3609|4981|lyfalmen|V0267|4981|2|100|0|7,2000|Portfarma ehf|Portfarma|Pramipexól||2837||2837|4981||1 028739|C08CA0502|Adalat Oros|forđatfl|30|mg|28|stk|1|ţpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BGB|0|0|0|100|DKK|1583|3255|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer Pharma AG|Nífedipín||||1583|3255||2 028907|J02AC0103|Fluconazole Portfarma|hylki|50|mg|7|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|1362|1723|lyfalmen|V0551|1723|2|7|0|1,7500|Portfarma ehf|Portfarma|Flúkónazól||470||470|1723||1 028918|J02AC0103|Fluconazole Portfarma|hylki|50|mg|30|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|4998|3155|lyfalmen|V0552|3155|2|30|0|7,5000|Portfarma ehf|Portfarma|Flúkónazól||1510||1510|3155||1 028929|J02AC0103|Fluconazole Portfarma|hylki|150|mg|1|stk|1|ţpakki||J02AC01|01.05.2010||L|1|0|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||2|1|0|0,7500|Portfarma ehf|Portfarma|Flúkónazól|||||||1 028940|J02AC0103|Fluconazole Portfarma|hylki|150|mg|2|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|523|1796|lyfalmen|V0555|1796|2|2|0|1,5000|Portfarma ehf|Portfarma|Flúkónazól||523||523|1796||1 028953|J02AC0103|Fluconazole Portfarma|hylki|150|mg|4|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|2031|1861|lyfalmen|V0556|1861|2|4|0|3,0000|Portfarma ehf|Portfarma|Flúkónazól||570||570|1861||1 029066|R01AD0801|Flixonase|nefúđi|50|mcg/sk|120|skammtar|1|stauk||R01AD08|01.04.1992||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|1121|2453|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||1000||1000|2453||1 029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|ţpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|LLS|0|0|0|100|DKK|7084|10827|lyfalmen|||1|28|0|28,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||7084||7084|10827||2 029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|ţpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|LLS|0|0|0|100|DKK|17727|24963|lyfalmen|||1|84|0|84,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||17727||17727|24963||2 029198|R06AX2201|Kestine|filmhtfl|20|mg|30|stk|1|ţpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|2703|4797|lyfalmen|||1|30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||2703||2703|4797||1 029276|J04BA0202|Dapsone|töflur|50|mg|28|stk|1|ţpakki||J04BA02|01.04.2013||R|0|0|0|1|G|0|AUK|0|0|0|100|XEU|1189|2713|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis UK Ltd.|Dapsón||1189||1189|2713||1 029287|C03DB0105|Amiloride|töflur|5|mg|28|stk|1|ţpakki||C03DB01|01.04.2009||R|0|0|0|0|G|0|AUK|0|0|0|100|GBP|361|1573|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Amiloridhýdróklóríđ||361||361|1573||1 029381|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.04.2014||L|1|0|0|0|0|0|SIV|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Vistor hf|Bayer AB|Lóratadín|||||||1 029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|0|0|0|1|0|1|EIS|0|1|0|100|SEK|56727|72413|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Eribulin||56727||56727|72413||1 029517|L01BB0503|Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|18387|24728|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||18387||18387|24728||1 029528|L01CA0402 |Vinorelbin Actavis|irţ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|4001|5720|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||4001||4001|5720||1 029706|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|ţpakki|32+12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|11893|17446|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||11893|17446||1 029729|C09DA0601|Atacand Plus|töflur|57|mg|98|stk|1|ţpakki|32+25 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|11538|16957|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||11538|16957||1 029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|ţpakki|međ br.losunarhrađa|J01AA02|01.12.2011||R|1|0|0|0|0|0|GAN|0|0|1|100|SEK|5623|8816|lyfalmen|||1|56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||5623||5623|8816||2 029811|B02BX0401|Nplate|sts|250|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEB|0|1|0|100|DKK|88897|112423|lyfsjukr|||1|1|0|8,3300|Vistor hf|Amgen Europe B.V.|Romiplóstím||88897||88897|112423||1 029822|B02BX0401|Nplate|sts|500|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEU|0|1|0|100|DKK|177793|222985|lyfsjukr|||1|1|0|16,6600|Vistor hf|Amgen Europe B.V.|Romiplóstím||177793||177793|222985||1 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 030170|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.07.2014||R|0|0|0|0|0|0|IPI|0|0|0|100|DKK|7664|11625|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Limited|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar (cojugated)||7664||7664|11625||1 030546|N03AX1108|Topiramat Bluefish|filmhtfl|25|mg|60|stk|1|ţpakki||N03AX11|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1950|1748|lyfalmen|V0247|1748|2|60|0|5,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||488||488|1748||2 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|8625|12948|lyfalmen|V0277|8495|1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S|Klózapín||8625||8625|12948||1 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|G|0|HES|0|0|0|100|IKR|2886|5049|lyfalmen|V0276|3137|1|100|0|8,3333|Vistor hf|Novartis Healthcare A/S|Klózapín||2886||2886|5049||1 030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|15094|26016|vetorma|||0|40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||||15094|26016||2 030940|C07AB0210|Metoprolol Mylan|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1223|2636|lyfalmen|V0051|2177|2|100|0|33,3333|Icepharma hf|Mylan AB|Metóprólól||1133||1133|2636||2 031039|C07AB0210|Metoprolol Mylan|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1755|3277|lyfalmen|V0106|3141|2|100|0|66,6667|Icepharma hf|Mylan AB|Metóprólól||1599||1599|3277||2 031070|A04AD0101|Scopoderm|forđapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||L|0|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S|Skópólamín|||||2661||1 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|2724|4826|lyfalmen|||1|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||2724||2724|4826||2 031201|L01BA0109|Metoject|stl|50|mg/ml|0,25|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2566|4608|lyfalmen|||1|0,25|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2566||2566|4608||2 031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|1814|3573|lyfalmen|||1|100|0|33,3333|Vistor hf|Recip AB|Ísósorbíđ dínítrat||1814||1814|3573||1 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5428|8547|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5428||5428|8547||1 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|20623|27509|lyfsjukr|||1|5|0|0,4200|Vistor hf|Ferring Lćgemidler A/S|Terlípressín||20623||20623|27509||1 031971|C07AA0705|Sotalol Mylan|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1771|3514|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Sótalól||1771||1771|3514||2 032399|C09CA0106|Losatrix|filmhtfl|25|mg|98|stk|1|ţpakki||C09CA01|01.08.2015||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|2877|3829|lyfalmen|||2|98|0|49,0000|Medical ehf|ratiopharm GmbH|Lósartan||2000||2000|3829||2 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|0|0|0|0|G|0|OTS|0|0|0|100|DKK|19730|27497|lyfalmen|||1|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||19730||19730|27497||1 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|0|0|0|0|0|0|MEF|1|0|0|100|XEU|13669|23560|vetorma|||0|200|0||Vistor hf|Merial (MSD)|Ivermectinum||13669||13669|23560||1 032706|C03EA0113|Diuramin|töflur|55|mg|100|stk|1|ţpakki|5+50 mg|C03EA01|01.05.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1198|2109|lyfalmen|V0558|2109|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Hýdróklórtíazíđ og kalíumsparandi lyf||750||750|2109||2 033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|G|0|FER|0|0|0|100|DKK|19998|27835|lyfalmen|||1|1|0|29,6300|Vistor hf|Ferring|Degarelix||||19998|27835||1 033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|G|0|FER|0|0|0|100|DKK|39885|52989|lyfalmen|||1|2|0|88,8900|Vistor hf|Ferring|Degarelix||||39885|52989||1 033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|1147|1977|vetorma|||0|7,49|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||1147||1147|1977||2 033195|N02AA5501|Targin|forđatfl|15|mg|28|stk|1|ţpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|2882|5043|lyfalmen|||1|28|0|3,7400|Icepharma hf|Norpharma|Oxycodonum í blöndum||2882||2882|5043||2 033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|8590|16467|vetalmen|||0|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríđ||||8590|16467||2 033206|N02AA5501|Targin|forđatfl|15|mg|98|stk|1|ţpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|9821|14594|lyfalmen|||1|98|0|13,0700|Icepharma hf|Norpharma|Oxycodonum í blöndum||9821||9821|14594||2 033218|N02AA5501|Targin|forđatfl|30|mg|28|stk|1|ţpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|5767|9014|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxycodonum í blöndum||5767||5767|9014||2 033229|N02AA5501|Targin|forđatfl|30|mg|98|stk|1|ţpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|17024|24074|lyfalmen|||1|98|0|26,1400|Icepharma hf|Norpharma|Oxycodonum í blöndum||17024||17024|24074||2 033251|S01CA0102|Tobradex|augndr|||5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|0|0|0|0|G|0|CLA|0|0|1|100|USD|1393|2994|lyfalmen|||1|5|0||Vistor hf|Alcon Nordic A/S|Dexametasón||1393||1393|2994||1 033357|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|100|stk|1|ţpakki||M01AB05|01.08.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|1881|2125|lyfalmen|V0189|2125|2|100|0|50,0000|Medical ehf|ratiopharm Oy|Díklófenak||762||762|2125||2 033498|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|30|stk|1|ţpakki||M01AB05|01.08.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|823|1489|lyfalmen|V0188|1489|2|30|0|15,0000|Medical ehf|ratiopharm Oy|Díklófenak||300||300|1489||2 033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.04.2011||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|17595|13848|lyfalmen|V0185|13848|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Letrózól||9279||9279|13848||2 033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|85899|108694|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||85899||85899|108694||1 034033|QJ01MA9001|Baytril vet.|töflur|50|mg|10|stk|1|ţpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2320|4560|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||2320|4560||2 034124|C09BA0202|Enalapril comp ratiopharm|töflur|32,5|mg|100|stk|1|ţpakki|20+12,5 mg|C09BA02|01.12.2013||R|1|0|0|0|G|0|ROY|0|0|0|100|XEU|1837|2395|lyfalmen|V0098|2395|2|100|0|100,0000|Medical ehf|ratiopharm Oy|Enalapríl og ţvagrćsilyf||958||958|2395||2 034157|J07AM5104|Diftavax|stl|||0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|0|0|0|0|0|0|SPM|0|0|1|100|XEU|700|2040|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Stífkrampatoxóíđ í blöndum međ barnaveikistoxóíđum||700||700|2040||2 034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|15653|21328|lyfsjukr|||1|25|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||15653||15653|21328||2 034468|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|ţpakki||B01AC22|01.12.2009||R|0|1|0|0|G|0|ELD|0|0|0|100|XEU|7790|11798|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||7790|11798||2 034479|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|ţpakki||B01AC22|01.12.2009||R|0|1|0|0|G|0|ELD|0|0|0|100|XEU|7790|11798|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||7790|11798||2 034494|N05CM1801|Dexdor|irţ|100|mcg/ml|10|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|63135|80382|lyfsjukr|||1|40|0|4,0000|Vistor hf|Orion Corporation|Dexmedetómid||63135||63135|80382||1 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|1559|3222|lyfalmen|V0367|3222|1|6|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||1559||1559|3222||1 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|2607|4665|lyfalmen|||1|12|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||2607||2607|4665||1 034988|L03AB0702|Rebif|stl|44|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|107599|135683|lyfsjukr|||1|2|0|40,9300|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||107599||107599|135683||2 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|6985|9987|lyfsjukr|||1|25|0||Vistor hf|LEO Pharma A/S|Prótamín||6985||6985|9987||1 035113|B05XA0501|Addex-Magnesium|irţ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2101|3004|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Magnesíum súlfat||2101||2101|3004||2 035134|B01AF0201|Eliquis|filmhtfl|5|mg|14|stk|1|ţpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|2336|4292|lyfalmen|||1|14|0|14,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||2336|4292||1 035153|N02AB0306|Instanyl|nefúđi|50|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014||R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|9013|13482|lyfalmen|||1|6|0|0,5000|Vistor hf|Takeda Pharma A/S|Fentanýl||9013||9013|13482||1 035212|A07EC0202|Pentasa|forđatfl|500|mg|300|stk|1|ţpakki||A07EC02|01.04.1992||R|1|0|0|0|G|0|FER|0|0|0|100|DKK|14651|21073|lyfalmen|||1|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||14651||14651|21073||1 035494|C07AB0211|Metoprolol ratiopharm|forđatfl|23,75|mg|100|stk|1|ţpakki||C07AB02|01.05.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|1259|2809|lyfalmen|V0050|2421|2|100|0|15,8300|Medical ehf|ratiopharm GmbH|Metóprólól||1259||1259|2809||2 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|ţpakki||N03AX09|01.11.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1844|2001|lyfalmen|V0244|2001|2|56|0|9,3300|Actavis Group hf|Actavis hf|Lamótrigín||672||672|2001||1 035528|C07AB0211|Metoprolol ratiopharm|forđatfl|47,5|mg|100|stk|1|ţpakki||C07AB02|01.06.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|1251|2798|lyfalmen|V0048|2472|2|100|0|31,6600|Medical ehf|ratiopharm GmbH|Metóprólól||1251||1251|2798||2 035563|C07AB0211|Metoprolol ratiopharm|forđatfl|95|mg|100|stk|1|ţpakki||C07AB02|01.05.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|2234|3825|lyfalmen|V0049|3462|2|100|0|63,3300|Medical ehf|ratiopharm GmbH|Metóprólól||1997||1997|3825||2 035568|C09CA0601|Atacand|töflur|16|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8068|12181|lyfalmen|V0080|5758|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||8068||8068|12181||1 035597|C07AB0211|Metoprolol ratiopharm|forđatfl|190|mg|100|stk|1|ţpakki||C07AB02|01.06.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|4881|6303|lyfalmen|V0054|5903|2|100|0|126,6600|Medical ehf|ratiopharm GmbH|Metóprólól||3797||3797|6303||2 035755|M01AE0102|Ibufen|filmhtfl|400|mg|100|stk|1|ţpakki||M01AE01|01.12.2014||R|1|0|0|0|G|0|AGP|0|0|1|100|XEU|705|1926|lyfalmen|V0562|1620|2|100|0|33,3333|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen||617||617|1926||1 036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|1|1|0|0|0|0|GZE|0|0|0|100|NOK|23771|30148|lyfalmen|V0680|27369|1|180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||21826||21826|30148||1 036108|L03AB0702|Rebif|stl|22|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|107599|135683|lyfsjukr|||1|2|0|20,4700|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||107599||107599|135683||2 036228|C09CA0601|Atacand|töflur|8|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7171|10946|lyfalmen|V0081|4960|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||7171||7171|10946||1 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|ţpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|718|2065|lyfalmen|||1|20|0|8,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||718||718|2065||1 036502|N06DA0301|Exelon|forđapl|13,3|mg/sólh|30|pokar|1|pakki||N06DA03|01.02.2014||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|19251|26891|lyfalmen|||1|30|0|42,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||19251||19251|26891||1 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1263|2815|lyfalmen|||1|60|0|3,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1263||1263|2815||1 036529|QI09AB1302|Ingelvac MycoFLEX|stl|||50|ml|1|glas|handa svínum|QI09AB13|01.12.2013||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|4165|7179|vetorma|||1|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Óvirkar bakteríur í bóluefnum||4165||4165|7179||1 036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|0|0|0|0|0|0|AHN|0|0|0|100|IKR|||lyflausa|||0|30|0|6,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Silíkonsambönd|||||||1 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|2492|4506|lyfalmen|||1|125|0|6,2500|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||2492||2492|4506||1 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|ţpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|756|2117|lyfalmen|||1|30|0|12,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||756||756|2117||1 037287|N04BC0404|Requip Depot|forđatfl|2|mg|84|stk|1|ţpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|10332|8377|lyfalmen|V0532|6102|1|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||5304||5304|8377||1 037305|N04BC0404|Requip Depot|forđatfl|4|mg|84|stk|1|ţpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|20991|11998|lyfalmen|V0533|10298|1|84|0|56,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||7935||7935|11998||1 037323|N04BC0404|Requip Depot|forđatfl|8|mg|84|stk|1|ţpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|37281|22752|lyfalmen|V0534|20434|1|84|0|112,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||15979||15979|22752||1 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2652|4727|lyfalmen|V0434|4727|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2652||2652|4727||2 037584|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|30|stk|1|ţpakki||N06AB06|01.02.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|967|1765|lyfalmen|V0151|1765|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||500||500|1765||2 037595|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|100|stk|1|ţpakki||N06AB06|01.02.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2311|2453|lyfalmen|V0322|2377|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||1000||1000|2453||2 037607|N06AB0604|Sertralin Bluefish|filmhtfl|100|mg|100|stk|1|ţpakki||N06AB06|01.02.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|4353|3829|lyfalmen|V0323|3685|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||2000||2000|3829||2 037846|A12BA0101|Kaleorid|forđatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|G|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|100|0|25,0000|Vistor hf|LEO Pharma A/S|Kalíumklóríđ|||||2277||1 037853|A12BA0101|Kaleorid|forđatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|G|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|250|0|62,5000|Vistor hf|LEO Pharma A/S|Kalíumklóríđ|||||3592||1 037895|C09CA0601|Atacand|töflur|4|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7307|11134|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||7307|11134||1 038123|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|6231|11992|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||6231||6231|11992||2 038305|N06AX1611|Duofaxin|forđatfl|150|mg|98|stk|1|ţpakki||N06AX16|01.07.2015||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|2845|4568|lyfalmen|V0335|3078|2|98|0|147,0000|Vistor hf|MediLink A/S|Venlafaxín||2537||2537|4568||1 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|ţpakki||N06AB05|01.04.1993||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|2667|3266|lyfalmen|V0321|3102|1|100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1591||1591|3266||1 038494|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA01|01.02.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1347|2128|lyfalmen|V0110|2128|2|100|0|133,3333|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||764||764|2128||2 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|0|0|0|0|0|0|SON|0|0|1|100|DKK|963|2402|lyfalmen|||1|50|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||963||963|2402||2 038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|144246|181262|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||144246||144246|181262||1 039141|B01AF0101|Xarelto|filmhtfl|15|mg|42|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|13446|19549|lyfalmen|||1|42|0|63,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||13446|19549||2 039147|N04BC0701|Apomorfin PharmSwed|irl|5|mg/ml|20|ml|5|hgl|lausn|N04BC07|01.03.2013||R|0|0|0|1|0|1|PSS|0|0|0|100|SEK|29543|38603|lyfsjukr|||1|100|0|25,0000|Williams & Halls efh|PharmSwed|Apómorfín||29543||29543|38603||2 039395|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|50|stk|1|ţpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|14342|11997|lyfalmen|||2|50|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||7934||7934|11997||2 039430|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|m.nál, dreifa|J07AL52|01.04.2012||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|6969|10668|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||6969||6969|10668||1 039631|C01BD0701|Multaq|filmhtfl|400|mg|20|stk|1|ţpakki||C01BD07|01.08.2010||R|1|1|0|1|0|0|SGA|0|0|0|100|NOK|3630|6073|lyfalmen|||1|20|0|10,0000|Vistor hf|Sanofi-aventis groupe|Dronedarón||||3630|6073||1 039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|ţpakki||C01BD07|01.08.2010||R|1|1|0|1|0|0|SGA|0|0|0|100|NOK|16786|23773|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis groupe|Dronedarón||||16786|23773||1 039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|ţpakki||N06AX03|01.06.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3157|5405|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Míanserín||3145||3145|5405||2 039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|ţpakki||C07AB03|01.04.1992||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|394|1573|lyfalmen|V0541|1438|2|98|0|32,6667|Icepharma hf|Mylan AB|Atenólól||361||361|1573||2 039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|ţpakki||C07AB03|01.01.1991||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|567|1619|lyfalmen|V0542|1584|2|98|0|65,3333|Icepharma hf|Mylan AB|Atenólól||394||394|1619||2 039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|993|2443|lyfalmen|||1|15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||993||993|2443||1 039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|1742|3474|lyfalmen|||1|22,5|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1742||1742|3474||1 039837|N02BE0107|Paratabs|filmhtfl|500|mg|30|stk|1|ţpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|1170|1673|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||1170||1170|1673||2 039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|1630|2128|lyfalmen|V0110|2085|2|98|0|130,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||764||764|2128||1 039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|ţpakki||J05AB11|01.01.2010||R|1|0|0|0|G|0|AGP|0|0|1|100|GBP|8461|5545|lyfalmen|V0182|5343|2|42|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||3247||3247|5545||1 039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|2932|4192|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||2932||2932|4192||2 039968|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|ţpakki||J05AB11|01.01.2010||R|1|0|0|0|G|0|AGP|0|0|1|100|GBP|2033|2055|lyfalmen|V0033|2040|2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||711||711|2055||1 040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|5849|8362|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||5849||5849|8362||2 040313|N02AB0306|Instanyl|nefúđi|200|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014||R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|9107|13611|lyfalmen|||1|6|0|2,0000|Vistor hf|Takeda Pharma A/S|Fentanýl||9107||9107|13611||1 040421|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dćlu|1|stk|24|spr||QJ51CF02|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|5222|10078|vetalmen|||0|24|0||Icepharma hf|Zoetis Finland OY|||5222||5222|10078||2 040426|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|30|stk|1|ţpakki||R06AX27|01.05.2012||R|1|0|0|0|G|0|APC|0|0|1|100|XEU|1223|2633|lyfalmen|V0366|2244|2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||1131||1131|2633||1 040475|C09DA0603|Candesartan/Hydrochlorothiazide Aspen|töflur|28,5|mg|100|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.04.2014||R|1|0|0|0|0|0|ART|0|0|0|100|XEU|3530|4951|lyfalmen|||2|100|0|100,0000|Artasan ehf|Navamedic ASA|Candesartan og ţvagrćsilyf||2815||2815|4951|31.8.2015|1 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|0|0|0|0|G|0|SAC|0|0|0|100|IKR|||lyfalmen|||0|15|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Gervitár og ađrar óvirkar samsetningar|||||1825||1 040620|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|ţpakki||QJ01CA04|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4434|8583|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||4434||4434|8583||2 040708|G02AD0601|Misodel|sk-innl|200|mcg|5|stk|1|askja||G02AD06|01.09.2014||R|0|0|0|1|0|1|FEL|0|0|0|100|DKK|83591|105824|lyfsjukr|||1|5|0||Vistor hf|Ferring Lćgemidler A/S|Misóprostól||||83591|105824||1 040735|J01FA1005|Azithromycin Actavis|filmhtfl|500|mg|3|stk|1|ţpakki||J01FA10|01.12.2012||R|1|0|0|0|0|0|APC|0|0|1|100|XEU|1167|2683|lyfalmen|V0174|2683|2|3|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Azitrómýcín||1167||1167|2683||1 040742|C08CA0203|Felodipin ratiopharm|forđatfl|2,5|mg|100|stk|1|ţpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3128|5382|lyfalmen|V0201|5382|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Felódipín||3128||3128|5382||2 040891|N06AB1007|Escitalopram Bluefish|filmhtfl|20|mg|28|stk|1|ţpakki||N06AB10|01.08.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|2060|3912|lyfalmen|V0328|3912|2|28|0|56,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||2060||2060|3912||2 041086|C01EB1701|Procoralan|filmhtfl|5|mg|56|stk|1|ţpakki||C01EB17|01.04.2014||R|1|0|0|1|0|0|LLS|0|0|0|100|DKK|9003|13468|lyfalmen|||1|56|0|28,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||9003||9003|13468||2 041105|C01EB1701|Procoralan|filmhtfl|7,5|mg|56|stk|1|ţpakki||C01EB17|01.04.2014||R|1|0|0|1|0|0|LLS|0|0|0|100|DKK|9003|13468|lyfalmen|||1|56|0|42,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||9003||9003|13468||2 041490|N06AB0404|Citalopram Bluefish|filmhtfl|20|mg|100|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2521|2177|lyfalmen|||2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||800||800|2177|30.6.2015|2 041704|QG03XA9101|Improvac|stl|300|mcg|20|ml|12|fl||QG03XA91|01.08.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|13087|22557|vetorma|||0|240|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||13087||13087|22557||2 041716|QG03XA9101|Improvac|stl|300|mcg|100|ml|10|glös||QG03XA91|01.10.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|53892|92888|vetorma|||0|1000|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||53892||53892|92888||2 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|3335|5748|vetorma|||0|100|0||Vistor hf|Intervet International BV|||3335||3335|5748||1 041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|ţpakki||N06AX03|01.06.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1043|2512|lyfalmen|||2|90|0|15,0000|Icepharma hf|Mylan AB|Míanserín||||1043|2512||2 041938|A02BC0508|Esomeprazol Actavis|sţ-hylki|40|mg|28|stk|1|ţpakki|hart|A02BC05|01.03.2012|31.08.2015|R|1|0|0|0|0|0|APC|0|0|0|100|XEU|2093|2442|lyfalmen|||2|28|0|37,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||992||992|2442||1 041942|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|300|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|7000|9335|lyfalmen|||2|300|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||6000||6000|9335||2 041951|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|250|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|9000|9335|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||6000||6000|9335||2 041996|A06AG1101|Microlax|innhl|||5|ml|4|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||||1 042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|1341|2922|lyfalmen|||1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Metóprólól||1341||1341|2922||1 042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|7518|10749|lyfsjukr|||1|500|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||7518||7518|10749||1 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2368|3386|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2368||2368|3386||2 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3738|5344|lyfsjukr|||1|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||3738||3738|5344||2 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2031|2904|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2031||2031|2904||2 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2685|3839|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2685||2685|3839||2 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|1961|2804|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||1961||1961|2804||2 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2221|3175|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||2221||2221|3175||2 042549|J07BF0301|Imovax Polio|stl|||0,5|ml|1|áf.spr|međ nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2137|4018|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||2137||2137|4018||2 042551|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|||1000|ml|10|plpok||B05BB02|01.04.2009||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3064|4381|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||3064||3064|4381||2 042556|J07BF0301|Imovax Polio|stl|||0,5|ml|20|áf.spr|međ nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|13806|20004|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||13806||13806|20004||2 042573|QM01AH9201|Trocoxil|tuggutfl|20|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1865|3665|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||1865||1865|3665||2 042584|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2500|4914|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||2500||2500|4914||2 042595|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5001|9658|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||5001||5001|9658||2 042607|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5750|11079|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||5750||5750|11079||2 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2257|3227|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2257||2257|3227||2 042669|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|4000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2 042775|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.10.2012||R|1|0|0|0|0|0|FMV|0|0|0|100|GBP|4179|6828|lyfalmen|||3|500|0||Icepharma hf|Icepharma hf|Senna||4179||4179|6828||2 043232|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|30|stk|1|ţpakki||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|504|1770|lyfalmen|||2|30|0|30,0000|Icepharma hf|Mylan AB|Flúnítrazepam||504||504|1770||2 043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|2795|3996|lyfsjukr|||1|100|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||2795||2795|3996||1 043345|N03AX1405|Matever|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|17617|5442|lyfalmen|V0516|5442|2|100|0|66,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||3172||3172|5442||1 043379|R03AC1201|Serevent|innúđal|25|mcg/sk|120|skammtar|1|stauk|HFA 134a|R03AC12|01.04.2007||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|4490|7256|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||4490||4490|7256||1 043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|5016|7171|lyfsjukr|||1|100|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||5016||5016|7171||1 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|ţpakki||N05CD05|01.12.1983||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|526|1800|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||526||526|1800||1 043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|ţpakki||G03CA04|01.07.1989||R|0|0|0|0|G|0|PTL|0|0|0|100|XEU|1189|2713|lyfalmen|V0659|2650|1|30|0|30,0000|Navamedic AB|Aspen Pharma Trading Limited|Estríól||1189||1189|2713||1 043919|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||3053||2 043935|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||3053||2 043988|B03AA0705|Ferrous Sulphate|töflur|200|mg|100|stk|1|glas|sykurhúđađar|B03AA07|01.09.2009||L|1|0|0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||0|100|0|32,5000|Actavis Group hf|Actavis UK Ltd.|Ferrósúlfat|||||||1 044360|B03AC0004|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.05.2006||R|0|0|0|0|G|0|LVR|0|0|1|100|CHF|13778|19968|lyfalmen|V0637|19968|3|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járn, stungulyf||13778||13778|19968||3 044580|L01XE1001|Afinitor|töflur|5|mg|30|stk|1|ţpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|355271|443718|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||355271|443718||1 044591|L01XE1001|Afinitor|töflur|10|mg|30|stk|1|ţpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|451306|563158|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||451306|563158||1 044732|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|ţpakki||L01AA01|01.06.2014||R|0|0|0|0|G|0|BAM|0|0|0|100|SEK|5421|8538|lyfalmen|V0156|8538|1|100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||5421||5421|8538||2 044739|N04BC0502|Sifrol|forđatfl|0,52|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|15976|22748|lyfalmen|V0635|18075|1|100|0|20,8000|Vistor hf|Boehringer Ingelheim International|Pramipexól||15976||15976|22748||1 044752|N04BC0502|Sifrol|forđatfl|2,1|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|46606|61489|lyfalmen|V0636|36623|1|100|0|84,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||46606||46606|61489||1 044763|N04BC0502|Sifrol|forđatfl|0,52|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|2497|4513|lyfalmen|||1|10|0|2,0800|Vistor hf|Boehringer Ingelheim International|Pramipexól||2497||2497|4513||1 044888|QN05CM9001|Domosedan, vet.|munnh.hl|7,6|mg/ml|3|ml|1|áf.spr|munnsk.dćla|QN05CM90|01.01.2012||R|0|0|0|0|0|0|OCO|0|0|0|100|DKK|1945|3823|vetalmen|||0|3|0||Icepharma hf|Orion Corporation (I)|||1945||1945|3823||2 045332|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|50|l|12|hylki|undir ţrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|600|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 045385|J07BF0301|Imovax Polio|stl|||0,5|ml|10|áf.spr|međ nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|6902|10576|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||6902||6902|10576||2 045475|A10BX1201|Jardiance|filmhtfl|25|mg|30|stk|1|ţpakki||A10BX12|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|6499|10022|lyfalmen|||1|30|0||Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||6499||6499|10022||1 045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|1050|1795|lyfalmen|V0109|1759|2|98|0|65,3400|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||522||522|1795||1 045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|868|1665|lyfalmen|V0108|1632|2|98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||428||428|1665||1 045634|N02AA5907|Pinex Comp Forte|eţ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.01.2011||R|0|0|0|0|0|0|AGT|0|0|1|100|XEU|387|1609|lyfalmen|||2|10|0|3,3333|Actavis Group hf|Actavis Group hf|Kódein í blöndum nema međ geđlyfjum||387||387|1609||1 045765|C03CA0110|Impugan|dropar|10|mg/ml|30|ml|1|glas||C03CA01|01.06.2013||R|0|0|0|0|G|0|AGT|0|0|0|100|SEK|1927|3729|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis Group hf|Fúrósemíđ||1927||1927|3729||1 046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|19717|37578|vetalmen|||0|10|0||Icepharma hf|Zoetis Belgium S.A.|||19717||19717|37578||2 046248|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|30|sk-hyl|30 (6x5)|S01EE01|01.03.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|1443|3062|lyfalmen|||1|6|0|30,0000|Vistor hf|Laboratories THEA|Latanóprost||1443||1443|3062||1 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|ţpakki||C09AA05|01.03.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|796|2030|lyfalmen|V0648|1902|2|100|0|100,0000|Actavis Group hf|Actavis hf|Ramipríl||693||693|2030||1 046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|0|0|0|0|G|0|VIS|0|0|1|100|DKK|3666|6122|lyfalmen|V0382|6122|1|10|0|1,2500|Icepharma hf|Vian SA|Ondansetrón||3666||3666|6122||2 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|616|1844|lyfalmen|V0021|1722|2|90|0|45,0000|Actavis Group hf|Actavis hf|Glímepíríđ||558||558|1844||1 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|748|2106|lyfalmen|V0022|2054|2|90|0|90,0000|Actavis Group hf|Actavis hf|Glímepíríđ||748||748|2106||1 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|958|2395|lyfalmen|V0023|2322|2|90|0|135,0000|Actavis Group hf|Actavis hf|Glímepíríđ||958||958|2395||1 046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|0|0|0|0|G|0|VIS|0|0|1|100|DKK|6105|9479|lyfalmen|||1|20|0|2,5000|Icepharma hf|Vian SA|Ondansetrón||6105||6105|9479||2 046724|R01AD0802|Nasofan|nefúđi|50|mcg/sk|150|skammtar|1|glas||R01AD08|01.12.2013||R|0|0|0|0|G|0|TSB|0|0|1|100|IKR|1350|2934|lyfalmen|||2|150|0|37,5000|Medical ehf|Teva Sweden AB|Flútíkasón||1350||1350|2934|30.6.2015|2 046745|N04BC0405|Ropinirol Portfarma|filmhtfl|0,5|mg|84|stk|1|ţpakki||N04BC04|01.02.2012||R|0|0|0|0|G|0|POF|0|0|0|100|GBP|5559|4604|lyfalmen|V0530|4604|2|84|0|7,0000|Portfarma ehf|Portfarma|Rópíníról||2563||2563|4604||1 046812|M05BA0603|Ibandronic acid Portfarma|filmhtfl|150|mg|3|stk|1|ţpakki||M05BA06|01.02.2012||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|5525|3770|lyfalmen|V0205|3770|2|3|0|90,0000|Portfarma ehf|Portfarma|Íbandrónsýra||1957||1957|3770||1 046823|N05AH0308|Lazapix|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|3407|3802|lyfalmen|V0279|3802|2|28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||1980||1980|3802||1 046845|N06AB0605|Sertraline Portfarma|filmhtfl|50|mg|100|stk|1|ţpakki||N06AB06|01.08.2014||R|1|0|0|0|G|0|PEH|0|0|0|100|IKR|2240|2377|lyfalmen|V0322|2377|2|100|0|100,0000|Portfarma ehf|Portfarma ehf|Sertralín||945||945|2377||1 046867|N06AB0605|Sertraline Portfarma|filmhtfl|100|mg|100|stk|1|ţpakki||N06AB06|01.08.2014||R|1|0|0|0|G|0|PEH|0|0|0|100|IKR|4495|3685|lyfalmen|V0323|3685|2|100|0|200,0000|Portfarma ehf|Portfarma ehf|Sertralín||1895||1895|3685||1 047147|J01CF0104|Dicloxacillin Bluefish|hylki|250|mg|30|stk|1|ţpakki||J01CF01|01.08.2015||R|0|0|0|0|0|0|BLP|0|0|1|100|IKR|3000|4600|lyfalmen|V0353|4600|2|30|0|3,7500|LYFIS ehf|Bluefish Pharmaceuticals AB|Díkloxacillín||2560||2560|4600||2 047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|894|2307|lyfalmen|||2|100|0|25,0000|Icepharma hf|Mylan AB|Sótalól||894||894|2307||2 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|13388|18511|lyfsjukr|||1|10|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||13388||13388|18511||5 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|47555|61005|lyfsjukr|||1|50|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||47555||47555|61005||5 047986|L02BB0305|Bicalutamide Portfarma|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.02.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|11780|7799|lyfalmen|V0420|4947|2|30|0|30,0000|Portfarma ehf|Portfarma|Bíkalútamíđ||4884||4884|7799||1 047998|L02BB0305|Bicalutamide Portfarma|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.02.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|14146|9276|lyfalmen|V0421|7087|2|30|0|90,0000|Portfarma ehf|Portfarma|Bíkalútamíđ||5957||5957|9276||1 048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4519|6461|lyfsjukr|||1|250|0||Icepharma hf|Baxter Medical AB|Albúmín||4519||4519|6461||2 048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|8321|11897|lyfsjukr|||1|5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||8321||8321|11897||2 048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7332|10483|lyfsjukr|||1|100|0||Icepharma hf|Baxter Medical AB|Albúmín||7332||7332|10483||2 048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|ţpakki||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|2523|3448|lyfalmen|V0324|2854|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1723||1723|3448||1 048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|2344|4303|lyfalmen|V0319|2893|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2344||2344|4303||1 048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|7275|3657|lyfalmen|V0325|2643|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1875||1875|3657||1 048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|7147|5123|lyfalmen|V0326|4609|2|100|0|150,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2940||2940|5123||1 048155|N06AB1004|Esopram|töflur|20|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|3666|6122|lyfalmen|V0328|3912|2|28|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||3666||3666|6122||1 048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|14292|6173|lyfalmen|V0327|4048|2|100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||3703||3703|6173||1 048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|1|0|0|0|G|0|MAB|0|0|0|100|SEK|1099|2589|lyfalmen|||1|100|0||Vistor hf|Meda AB|Klídín og geđlyf||1099||1099|2589||1 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|ţpakki|100+12,5 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|11853|17391|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||11853||11853|17391||1 048447|G03AA0901|Marvelon|töflur|||63|stk|1|ţpakki|150/30 mcg|G03AA09|01.07.1986||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1673|3379|lyfalmen|||1|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og ethinylestradíól||1673||1673|3379||1 048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|ţpakki||L04AA06|01.03.1999||R|0|0|0|1|G|0|ROC|0|0|0|100|DKK|54671|71690|lyfalmen|V0187|13725|1|150|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||54671||54671|71690||2 048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|0|0|0|1|0|1|GZE|0|1|0|100|NOK|777022|968258|lyfsjukr|||1|1,2|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||777022||777022|968258||1 048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|1|0|0|0|0|0|GSH|0|0|1|100|DKK|449|1694|lyfalmen|V0230|1612|1|100|0|16,6667|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||449||449|1694||1 048770|B05ZB0001|Hemosol BO|blóđ.sk|||5000|ml|2|pokar||B05ZB|01.04.2013||R|0|0|0|1|0|1|GBL|0|0|0|100|SEK|3962|5665|lyfsjukr|||1|10000|0||Vistor hf|Gambro Lundia AB|Blóđsölt og stuđpúđalausn||3962||3962|5665||1 049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|ţpakki||A02BA02|01.10.1987||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1869|3649|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Ranitidín||1869||1869|3649||1 049033|C08DB0108|Cardil|forđatfl|120|mg|60|stk|1|glas||C08DB01|01.05.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|4202|4515|lyfalmen|V0599|3925|2|60|0|30,0000|Vistor hf|Orion Corporation|Diltíazem||2498||2498|4515||1 049091|S01EE0101|Xalatan|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.08.2013||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|5802|9062|lyfalmen|V0376|4904|1|7,5|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||||5802|9062||1 049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|0|0|0|0|0|0|RRL|0|0|0|100|DKK|15533|22188|lyfalmen|||1|3|0|0,5000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||15533||15533|22188||2 049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|1602|3281|lyfalmen|V0122|3281|1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||1602||1602|3281||1 049549|N03AX2201|Fycompa|filmhtfl|2|mg|7|stk|1|ţpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|5404|8514|lyfalmen|V0663|8514|1|7|0|1,7500|Vistor hf|Eisai Europe Ltd.|Perampanel||5404||5404|8514||1 049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|0|0|0|0|0|0|GAN|0|0|1|100|CHF|4386|7113|lyfalmen|V0655|4655|1|5|0||Icepharma hf|Galderma Nordic AB|Amorolfín||4386||4386|7113||2 049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA01|01.07.2006||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1154|1971|lyfalmen|V0109|1759|2|98|0|65,3400|Portfarma ehf|Portfarma|Simvastatín||650||650|1971||1 049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA01|01.07.2006||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1827|2418|lyfalmen|V0110|2128|2|100|0|133,3333|Portfarma ehf|Portfarma|Simvastatín||975||975|2418||1 049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.04.1993||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|7642|4937|lyfalmen|V0123|3881|1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Terbínafín||2805||2805|4937||1 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.04.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1009|2109|lyfalmen|V0496|1902|2|100|0|200,0000|Actavis Group hf|Actavis hf|Ramipríl||750||750|2109||1 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|NHE|0|0|1|100|DKK|||lyflausa|||0|30|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|ţpakki||C09AA05|01.08.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1309|2878|lyfalmen|V0649|2866|2|100|0|400,0000|Actavis Group hf|Actavis hf|Ramipríl||1309||1309|2878||1 049834|N02BE0113|Pinex Junior|eţ-stíll|125|mg|10|stk|1|ţpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|10|0|0,4167|Actavis Group hf|Actavis Group hf|Paracetamól|||||1419||1 049845|N02BE0113|Pinex Junior|eţ-stíll|250|mg|10|stk|1|ţpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|10|0|0,8333|Actavis Group hf|Actavis Group hf|Paracetamól|||||1419||1 049856|N02BE0114|Pinex|eţ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.01.2012||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|10|0|1,6667|Actavis Group hf|Actavis Group hf|Paracetamól|||||1517||1 049894|N02BG1001|Sativex|munnhúđi|52|mg|10|ml|3|úđagl|27 mg + 25 mg|N02BG10|01.07.2013||R|0|0|1|1|0|0|GWP|0|0|0|100|DKK|75979|98640|lyfalmen|||1|30|0|37,1400|Vistor hf|GW Pharma Ltd.|Cannabinoids||75979||75979|98640||1 049902|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|171578|215255|lyfsjukr|||1|200|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||171578||171578|215255||2 049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|ţpakki||L04AA06|01.03.1999||R|0|0|0|1|G|0|ROC|0|0|0|100|DKK|57511|75282|lyfalmen|V0470|71565|1|300|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||57511||57511|75282||2 049913|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|8579|12266|lyfsjukr|||1|10|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||8579||8579|12266||2 049925|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|21448|28535|lyfsjukr|||1|25|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||21448||21448|28535||2 049936|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|42894|55208|lyfsjukr|||1|50|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||42894||42894|55208||2 049947|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|85630|108360|lyfsjukr|||1|100|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||85630||85630|108360||2 050010|G04CB0104|Finasterid LYFIS|filmhtfl|5|mg|98|stk|1|ţpakki||G04CB01|01.12.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|3083|3829|lyfalmen|||2|98|0|98,0000|LYFIS ehf|LYFIS ehf|Fínasteríđ||2000||2000|3829|30.6.2015|2 050292|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|V0150|2574|0|100|0|20,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||2574||1 050306|G04CA0104|Alfuzosin hydrochlorid ratiopharm|forđatfl|10|mg|90|stk|1|ţpakki||G04CA01|01.12.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|3479|5865|lyfalmen|||2|90|0|120,0000|LYFIS ehf|ratiopharm GmbH|Alfúzósín||3479||3479|5865||2 050346|L04AD0104|Ciqorin|hylki|100|mg|50|stk|1|ţpakki||L04AD01|01.04.2014||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|25500|29735|lyfalmen|||2|50|0|20,0000|Medical ehf|Teva Pharma B.V.|Ciklospórín||21500||21500|29735||2 050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|ţpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|65505|83330|lyfsjukr|||1|7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||65505|83330||1 050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1 050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|ţpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2943|5127|lyfalmen|||1|14|0|10,5000|Icepharma hf|Pfizer ApS|Pregabalín||2943||2943|5127||1 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|ţpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|12413|18242|lyfalmen|V0688|17180|1|56|0|42,0000|Icepharma hf|Pfizer ApS|Pregabalín||12413||12413|18242||1 050660|C02CA0402|Carduran Retard|forđatfl|4|mg|100|stk|1|ţpakki||C02CA04|01.01.2007||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|5135|5002|lyfalmen|V0042|4601|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Doxazósín||2852||2852|5002||1 050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|4615|5371|lyfalmen|V0002|5371|2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||3120||3120|5371||1 050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|4435|3554|lyfalmen|V0006|3554|2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1800||1800|3554||1 050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|7275|4415|lyfalmen|V0001|3050|2|100|0|200,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2426||2426|4415||1 051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995|31.07.2015|R|1|0|0|0|G|0|DEA|0|0|0|100|XEU|1603|3283|lyfalmen|||1|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1603||1603|3283||1 051109|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|50|l|1|hylki|undir ţrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|50|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|G|0|DEA|0|0|0|100|XEU|1621|3307|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1621||1621|3307||1 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|ţpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1252|2244|lyfalmen|V0363|2244|2|30|0|45,0000|Icepharma hf|Mylan AB|Fexófenadín||848||848|2244||2 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|ţpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3403|4446|lyfalmen|V0365|4446|2|100|0|150,0000|Icepharma hf|Mylan AB|Fexófenadín||2448||2448|4446||2 051550|N03AX1401|Keppra|irţ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|0|0|0|0|0|1|UCB|0|0|0|100|DKK|20504|27361|lyfsjukr|||1|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||20504||20504|27361||1 051732|C08CA0104|Amlódipín Portfarma|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.12.2006||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|1472|1990|lyfalmen|V0056|1990|2|100|0|100,0000|Portfarma ehf|Portfarma|Amlódipín||664||664|1990||1 051750|C08CA0104|Amlódipín Portfarma|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.12.2006||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|2471|2433|lyfalmen|V0057|1992|2|100|0|200,0000|Portfarma ehf|Portfarma|Amlódipín||986||986|2433||1 051761|R03AC0302|Bricanyl Turbuhaler|innönddu|0,5|mg/sk|100|skammtar|1|stauk||R03AC03|01.07.2012||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|810|2191|lyfalmen|||1|100|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||810||810|2191||1 052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|ţpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|188|1335|lyfalmen|V0047|1335|2|20|0|5,0000|Icepharma hf|Mylan AB|Alprazólam||188||188|1335||2 052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|ţpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|442|1685|lyfalmen|V0305|982|2|50|0|12,5000|Icepharma hf|Mylan AB|Alprazólam||442||442|1685||2 052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|285689|357177|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||285689||285689|357177||1 052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|ţpakki||N05BA12|01.07.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|313|1493|lyfalmen|V0439|1493|2|20|0|10,0000|Icepharma hf|Mylan AB|Alprazólam||303||303|1493||2 052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|ţpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|772|2118|lyfalmen|||2|50|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||757||757|2118||2 052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|644|1963|lyfalmen|V0305|1963|2|100|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||644||644|1963||2 052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|577311|719873|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||577311||577311|719873||1 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|541266|675043|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||541266||541266|675043||1 052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|0|0|0|0|G|0|ALL|0|0|0|100|SEK|3312|5635|lyfalmen|||1|3|0|30,0000|Vistor hf|Allergan|Tímólól í blöndum||3312||3312|5635||1 052478|D06BB0305|Zovirax (Lyf og heilsa)|krem|50|mg/g|2|g|1|túpa|+sk.dćla|D06BB03|01.03.2007||L|0|0|0|0|0|0|HOL|0|0|1|100|IKR|||lyflausa|||0|2|0||Lyf og heilsa|Lyf og heilsa|Acíklóvír||||||30.6.2015|2 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|32998|42900|lyfsjukr|||1|8212|0||Icepharma hf|Fresenius Kabi|Blöndur||32998||32998|42900||2 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|26827|35225|lyfsjukr|||1|7698|0||Icepharma hf|Fresenius Kabi|Blöndur||26827||26827|35225||2 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|27283|35792|lyfsjukr|||1|7680|0||Icepharma hf|Fresenius Kabi|Blöndur||27283||27283|35792||2 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|23922|31612|lyfsjukr|||1|7200|0||Icepharma hf|Fresenius Kabi|Blöndur||23922||23922|31612||2 052737|N05AX1205|Aripiprazol Krka|töflur|5|mg|56|stk|1|ţpakki||N05AX12|01.03.2015||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|20582|28574|lyfalmen|V0682|28574|2|56|0|18,6670|LYFIS ehf|Krka Sverige AB|Aripiprazól||20582||20582|28574||2 052838|A10BX0701|Victoza|stl|6|mg/ml|3|ml|2|lyfjap|lausn,áfylltur lyfjapenni|A10BX07|01.01.2012||R|0|0|0|0|0|0|NAS|0|0|0|100|DKK|13997|20245|lyfalmen|||1|6|0|30,0000|Vistor hf|Novo-Nordisk A/S|Liraglútíđ||13997||13997|20245||1 052997|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|30|stk|1|ţpakki||N05CF02|01.03.2014||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|427|1514|lyfalmen|V0060|1514|2|30|0|30,0000|Icepharma hf|Mylan AB|Zolpidem||318||318|1514||2 053006|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|100|stk|1|ţpakki||N05CF02|01.11.2006||R|2|0|0|0|0|0|MYL|0|0|0|100|SEK|2091|3621|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Zolpidem||1849||1849|3621||2 053025|G03HB0102|Diane mite|töflur|||63|stk|1|ţpakki||G03HB01|01.07.1989|30.06.2015|R|0|0|0|0|0|0|BAP|0|0|0|100|DKK|2046|3892|lyfalmen|||1|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Cýpróterón og östrógen||2046||2046|3892||2 053055|C01BA0302|Durbis Retard|forđatfl|250|mg|100|stk|1|ţpakki||C01BA03|01.05.1983||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|4389|7117|lyfalmen|||1|100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíđ||4389||4389|7117||1 053155|N02AA5501|Targin|forđatfl|60|mg|28|stk|1|ţpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|11330|16671|lyfalmen|||1|28|0|14,9400|Icepharma hf|Norpharma|Oxycodonum í blöndum||11330||11330|16671||2 053166|N02AA5501|Targin|forđatfl|60|mg|98|stk|1|ţpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|33744|45221|lyfalmen|||1|98|0|52,2700|Icepharma hf|Norpharma|Oxycodonum í blöndum||33744||33744|45221||2 053200|N02AA5501|Targin|forđatfl|7,5|mg|98|stk|1|ţpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|5649|8852|lyfalmen|||1|98|0|6,5400|Icepharma hf|Norpharma|Oxycodonum í blöndum||5649||5649|8852||2 053211|N02AA5501|Targin|forđatfl|7,5|mg|28|stk|1|ţpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|1656|3350|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxycodonum í blöndum||1652||1652|3350||2 053231|J07BB0201|Fluarix|stl|||0,5|ml|10|áf.spr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|6775|10401|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsađir mótefnavakar||6775||6775|10401||1 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|0|1|0|1|G|0|SDE|0|0|0|100|NOK|28210|38222|lyfalmen|V0453|36286|1|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíđ||28210||28210|38222||1 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|17311|24437|lyfalmen|||2|10|0|50,0000|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||17311||17311|24437||2 053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|1449|3071|lyfalmen|||1|1,33|0|0,6650|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||1449||1449|3071||1 053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburđur, lausn|D10AF01|01.07.1985||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1080|2563|lyfalmen|||1|30|0||Icepharma hf|Pfizer ApS|Klindamýcín||1080||1080|2563||1 054054|R03DC0303|Montelukast Actavis|filmhtfl|10|mg|100|stk|1|ţpakki||R03DC03|01.11.2011||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|7326|2498|lyfalmen|V0490|2332|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Montelúkast||1033||1033|2498||1 054213|J07AG0101|Act-Hib|sts|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|3683|6146|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Haemophilus influenzae B||3683||3683|6146||2 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|2|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1 054278|D01AE1502|Lamisil Once|húđlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|4|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1 054321|J01CA0801|Selexid|filmhtfl|400|mg|15|stk|1|ţpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|2239|4158|lyfalmen|||1|15|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||2239||2239|4158||1 054332|J01CA0801|Selexid|filmhtfl|400|mg|20|stk|1|ţpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|3070|5302|lyfalmen|||1|20|0|13,3300|Vistor hf|LEO Pharma A/S|Pívmecillínam||3070||3070|5302||1 054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|39744|51290|lyfsjukr|||1|56|0|22,4000|Icepharma hf|Roche A.S.|Ribavirin||39744||39744|51290||2 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|2|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1 054524|N05BB0101|Atarax|filmhtfl|25|mg|100|stk|1|ţpakki||N05BB01|01.06.2014||R|1|0|0|0|0|0|UCN|0|0|1|100|DKK|1407|3013|lyfalmen|||1|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1407||1407|3013||1 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|0|0|0|0|0|0|UCN|0|0|0|100|SEK|961|2399|lyfalmen|||1|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||961||961|2399||1 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|ţpakki||N06AB03|01.10.2006||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|1595|3272|lyfalmen|V0061|3272|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||1595||1595|3272||1 054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|0|0|1|0|0|0|SOG|1|0|0|100|DKK|4493|8695|vetalmen|||0|10|0||Icepharma hf|Sogeval UK Limited|Buprenorphinhýdróklóríđ||||4493|8695||2 054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|7276|12541|vetorma|||0|20|0||Icepharma hf|Zoetis Finland OY|Medroxyprogesteronum||7276||7276|12541||2 054974|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|1|innö.t||R03BB05|01.01.2013||R|0|0|0|0|G|0|ZEN|0|0|0|100|SEK|5101|8097|lyfalmen|||1|60|0|30,0000|Vistor hf|AstraZeneca AB|Aclídínumbrómíđ||5101||5101|8097||1 055073|L04AA0606|Myfenax|hylki|250|mg|100|stk|1|ţpakki||L04AA06|01.11.2013||R|1|0|0|1|G|0|TEV|0|0|0|100|XEU|19183|23855|lyfalmen|V0470|23855|2|100|0|12,5000|Medical ehf|Teva Pharma B.V.|Mýcófenólsýra||16851||16851|23855||2 055084|L04AA0606|Myfenax|filmhtfl|500|mg|50|stk|1|ţpakki||L04AA06|01.11.2013||R|1|0|0|1|G|0|TEV|0|0|0|100|XEU|6763|4575|lyfalmen|V0187|4575|2|50|0|12,5000|Medical ehf|Teva Pharma B.V.|Mýcófenólsýra||2542||2542|4575||2 055164|S01AE0701|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AE07|01.08.2010||R|0|0|0|0|0|0|CLA|0|0|1|100|USD|1927|3729|lyfalmen|||1|5|0||Vistor hf|Alcon Nordic A/S|Moxífloxacín||||1927|3729||1 055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|686|2021|lyfalmen|||1|20|0|5,0000|Vistor hf|Recip AB|Erýtrómýcín||686||686|2021||1 055257|G03AA0903|Benidette|töflur|||63|stk|1|ţpakki|150/20 mcg|G03AA09|01.04.2013||R|0|0|0|0|0|0|AAB|0|0|0|100|XEU|1257|2555|lyfalmen|V0065|1915|2|63|0|84,0000|Actavis Group PTC ehf|Actavis BV|Desógestrel og ethinylestradíól||1074||1074|2555||1 055277|N02AA0101|Contalgin|forđatfl|60|mg|100|stk|1|ţpakki||N02AA01|01.10.1995||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|8716|13073|lyfalmen|||1|100|0|60,0000|Icepharma hf|Pfizer ApS|Morfín||8716||8716|13073||1 055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.06.2011||R|0|0|0|0|G|0|APC|0|0|0|100|IKR|1765|2453|lyfalmen|V0467|2453|2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1000||1000|2453||1 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|36|0|1,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2834|3058|lyfalmen|V0112|2728|2|100|0|50,0000|Actavis Group hf|Actavis hf|Atorvastatín||1440||1440|3058||1 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|4425|3726|lyfalmen|V0113|3210|2|100|0|100,0000|Actavis Group hf|Actavis hf|Atorvastatín||1925||1925|3726||1 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|5897|3726|lyfalmen|V0114|3210|2|100|0|200,0000|Actavis Group hf|Actavis hf|Atorvastatín||1925||1925|3726||1 056308|N07XX0701|Fampyra|forđatfl|10|mg|28|stk|1|ţpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|30380|40967|lyfalmen|||1|28|0|14,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||30380||30380|40967||2 056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|0|0|0|0|0|0|CES|1|0|0|100|XEU|25557|44050|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||25557||25557|44050||2 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|1116|2612|lyfalmen|||1|40|0|10,0000|Vistor hf|Recip AB|Erýtrómýcín||1116||1116|2612||1 056664|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|100|stk|1|glas|Til vélskömmtunar|N06AX16|01.10.2011||R|2|0|0|0|G|0|AGP|0|0|0|100|XEU|3524|3497|lyfalmen|||2|100|0|75,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1759||1759|3497||1 056675|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|100|stk|1|glas|Til vélskömmtunar|N06AX16|01.10.2011||R|2|0|0|0|G|0|AGP|0|0|0|100|XEU|3524|3497|lyfalmen|||2|100|0|150,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1759||1759|3497||1 056763|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|2594|4647|lyfalmen|||1|15|0||Vistor hf|Meda AB|Pímekrólímus||2594||2594|4647||1 056915|L04AA2301|Tysabri|irţ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|0|1|0|1|0|1|BIB|0|1|0|100|XEU|203766|255288|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Biogen Idec Ltd|Natalizumab||203766||203766|255288||2 057042|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8736|13101|lyfalmen|V0095|5032|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||8736||8736|13101||1 057304|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN05|01.08.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|4|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|7137|10204|lyfsjukr|||1|5|0|1,4300|Vistor hf|Novartis Healthcare A/S|Oktreótíđ||7137||7137|10204||1 057335|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3501|5005|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||3501||3501|5005||2 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|3568|5101|lyfsjukr|||1|5|0|0,7100|Vistor hf|Novartis Healthcare A/S|Oktreótíđ||3568||3568|5101||1 057401|N06DA0404|Galantamine Portfarma|forđahlk|16|mg|84|stk|1|ţpakki||N06DA04|01.12.2011||R|1|0|0|0|G|0|POF|0|0|0|100|SEK|20474|28438|lyfalmen|||2|84|0|84,0000|Portfarma ehf|Portfarma|Galantamín||20474||20474|28438||1 057422|B05XA3102|Tracel|irţ|||10|ml|20|plastl||B05XA31|01.01.1987||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4623|6610|lyfsjukr|||1|200|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ öđrum efnum||4623||4623|6610||2 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|2513|3593|lyfsjukr|||1|5|0|0,3600|Vistor hf|Novartis Healthcare A/S|Oktreótíđ||2513||2513|3593||1 057492|L01XC1001|Arzerra|irţ|20|mg/ml|50|ml|1|hgl|1000 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|1|0|1|NEL|0|0|0|100|GBP|334580|417984|lyfsjukr|||1|50|0||Vistor hf|Novartis Europharm Ltd|Ofatúmúmabi||334580||334580|417984||1 057556|L02BX0301|Zytiga|töflur|250|mg|120|stk|1|glas||L02BX03|01.12.2011||R|0|0|0|1|0|1|JAS|0|1|0|100|SEK|424430|529732|lyfsjukr|||1|120|0|30,0000|Vistor hf|Janssen-Cilag AB|Abírateron||424430||424430|529732||1 057867|N06DX0107|Zalatine|filmhtfl|20|mg|98|stk|1|ţpakki||N06DX01|01.03.2014||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|22034|12414|lyfalmen|V0607|12392|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||8237||8237|12414||2 058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|ţpakki||N07BA03|01.03.2009||R|1|0|0|0|0|0|IPI|0|0|1|100|DKK|19067|26658|lyfalmen|||1|112|0|56,0000|Icepharma hf|Pfizer Limited|Vareniclin||||19067|26658||1 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|403|1631|lyfalmen|||1|5|0|1,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||403||403|1631||1 058272|L01XE1101|Votrient|filmhtfl|200|mg|30|stk|1|glas||L01XE11|01.02.2011||R|1|0|0|1|0|1|NEL|0|1|0|100|GBP|142826|179496|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Pazópaníb||142826||142826|179496||1 058283|QI01AD0401|Avipro Thymovac|frţlyf|||500|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|153544|264648|vetorma|||0|5000|0||Icepharma hf|Lohmann Animal Health|||||153544|264648||2 058294|QI01AD0401|Avipro Thymovac|frţlyf|||1000|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|233248|402026|vetorma|||0|10000|0||Icepharma hf|Lohmann Animal Health|||||233248|402026||2 058300|N02AA0506|Oxikodon Depot Actavis|forđatfl|40|mg|98|stk|1|ţpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|9476|14119|lyfalmen|V0587|14118|2|98|0|52,2700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||9476||9476|14119||1 058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|903|2319|lyfalmen|||1|100|0|2,5000|Vistor hf|Recip AB|Trímetóprím||903||903|2319||1 058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|89958|113743|lyfsjukr|||1|210|0|21,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||89958||89958|113743||1 058609|N05AX1302|Xeplion|stl|50|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|36636|48879|lyfalmen|||1|1|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||36636||36636|48879||1 058622|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5146|7357|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||5146||5146|7357||2 058735|C03CA0105|Lasix Retard|forđahlk|30|mg|100|stk|1|ţpakki||C03CA01|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|991|2440|lyfalmen|||1|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíđ||991||991|2440||1 058768|C03CA0105|Lasix Retard|forđahlk|60|mg|100|stk|1|ţpakki||C03CA01|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1683|3393|lyfalmen|||1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíđ||1683||1683|3393||1 059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|ţpakki||A02BC01|01.05.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|2374|2848|lyfalmen|V0006|1990|2|56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1287||1287|2848||1 059224|A04AA0501|Aloxi|stl|250|mcg|5|ml|1|hgl|lausn|A04AA05|01.04.2013||R|0|0|0|0|0|0|HBP|0|0|1|100|DKK|10439|15445|lyfalmen|||1|5|0|1,0000|Swedish Orphan Biovitrum AB|Helsinn Birex Pharmaceuticals Ltd.|Palonosetrón||10439||10439|15445||3 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|89160|115312|lyfalmen|||1|2|0|311,1900|Vistor hf|Astellas Pharma A/S|Leuprórelín||89160||89160|115312||1 059659|J07CA0601|Infanrix-Polio + Hib|sts|||0,5|ml|10|spr||J07CA06|01.01.2007||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|36592|48824|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||36592||36592|48824||1 059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|ţpakki||N03AF04|01.03.2010||R|1|0|0|0|G|0|BPC|0|0|0|100|SEK|35779|41894|lyfalmen|||1|30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||31113||31113|41894||1 059795|C10AA0506|Atorvaratio|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA05|01.07.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|5500|3210|lyfalmen|V0114|3210|2|100|0|200,0000|Medical ehf|Teva Sweden AB|Atorvastatín||1550||1550|3210||2 059803|C08CA0502|Adalat Oros|forđatfl|30|mg|98|stk|1|ţpakki||C08CA05|01.04.2013||R|1|0|0|0|G|0|BAP|0|0|0|100|DKK|5174|8198|lyfalmen|||1|98|0|98,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||5174|8198||2 059882|L04AD0203|Modigraf|mixt.kyr|0,2|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|0|1|0|0|ASP|0|0|0|100|XEU|8466|12729|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||8466||8466|12729||1 059938|L04AD0203|Modigraf|mixt.kyr|1|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|0|1|0|0|ASP|0|0|0|100|XEU|42333|56085|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||42333||42333|56085||1 060114|N02AB0305|Fentanyl ratiopharm|forđapl|25|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|2569|3353|lyfalmen|V0219|3353|2|5|0|7,5000|Medical ehf|ratiopharm GmbH|Fentanýl||1654||1654|3353||2 060123|N02AB0305|Fentanyl ratiopharm|forđapl|50|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|4080|5647|lyfalmen|V0220|5647|2|5|0|15,0000|Medical ehf|ratiopharm GmbH|Fentanýl||3321||3321|5647||2 060132|N02AB0305|Fentanyl ratiopharm|forđapl|75|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|5290|7256|lyfalmen|V0221|7256|2|5|0|22,5000|Medical ehf|ratiopharm GmbH|Fentanýl||4490||4490|7256||2 060141|N02AB0305|Fentanyl ratiopharm|forđapl|100|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|6168|7880|lyfalmen|V0223|7880|2|5|0|30,0000|Medical ehf|ratiopharm GmbH|Fentanýl||4943||4943|7880||2 060337|QC01CE9001|Vetmedin vet.|tuggutfl|10|mg|50|stk|1|glas|fyrir hunda|QC01CE90|01.07.2015||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|7233|13893|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||7233||7233|13893||1 060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|0|1|0|1|0|0|NEL|0|0|0|100|DKK|321585|409283|lyfalmen|||1|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||321585||321585|409283||1 060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|0|1|0|1|0|0|NEL|0|0|0|100|DKK|178085|227784|lyfalmen|||1|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||178085||178085|227784||1 061112|L04AA3101|AUBAGIO|filmhtfl|14|mg|28|stk|1|ţpakki||L04AA31|01.09.2014||R|1|1|0|1|0|1|SGA|0|1|0|100|NOK|137215|172517|lyfsjukr|||1|28|0|28,0000|Vistor hf|Sanofi-aventis groupe|Teriflúnomíđ||||137215|172517||1 061227|L01XE0103|Mylaukim|filmhtfl|100|mg|60|stk|1|ţpakki||L01XE01|01.09.2014||R|0|0|0|1|0|1|WEH|0|1|0|100|XEU|100136|126401|lyfsjukr|||2|60|0||Williams & Halls efh|Williams & Halls ehf|Imatiníb||100136||100136|126401||2 061414|QA04AD9001|Cerenia|töflur|60|mg|4|stk|1|ţpakki||QA04AD90|01.02.2009||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2597|5098|vetalmen|||0|4|0||Icepharma hf|Zoetis Belgium S.A.|||||2597|5098||2 061442|QA04AD9001|Cerenia|töflur|24|mg|4|stk|1|ţpakki||QA04AD90|01.02.2009||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1361|2675|vetalmen|||0|4|0||Icepharma hf|Zoetis Belgium S.A.|||||1361|2675||2 061451|QA04AD9001|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|8037|15418|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|||||8037|15418||2 061460|G03CX0102|Livial (Lyf og heilsa)|töflur|2,5|mg|84|stk|1|ţpakki||G03CX01|01.04.2010||R|0|0|0|0|G|0|HOL|0|0|0|100|DKK|6601|9018|lyfalmen|V0133|7766|3|84|0|84,0000|Lyf og heilsa|Lyf og heilsa|Tíbólón||5770||5770|9018||2 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|ţpakki||G03CX01|01.07.1998||R|0|0|0|0|G|0|ORG|0|0|0|100|DKK|5770|9018|lyfalmen|V0133|7766|1|84|0|84,0000|Vistor hf|N.V. Organon|Tíbólón||5770||5770|9018||1 061580|QP52AF0201|Banminth, vet.|pasta|439|mg/g|26|g|1|spr||QP52AF02|01.04.1992||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1608|2772|vetorma|||0|26|0||Icepharma hf|Zoetis Finland OY|||1608||1608|2772||2 061937|L04AD0101|Sandimmun|irţ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|3916|5599|lyfsjukr|||1|10|0|2,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||3916||3916|5599||1 061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|14980|20491|lyfsjukr|||1|1|0|1,2500|Vistor hf|Novartis Europharm Ltd|Daptomýcín||14980||14980|20491||1 061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|20847|27788|lyfsjukr|||1|1|0|1,7900|Vistor hf|Novartis Europharm Ltd|Daptomýcín||20847||20847|27788||1 062117|N05BA1204|Tafil Retard|forđatfl|0,5|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|434|1674|lyfalmen|V0307|1540|1|30|0|15,0000|Icepharma hf|Pfizer ApS|Alprazólam||434||434|1674||1 062202|N06DX0102|Memantine Merz|filmhtfl|10|mg|30|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|6327|3097|lyfalmen|V0604|3002|2|30|0|15,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||1468||1468|3097||1 062341|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|150|stk|1|ţpakki||L04AA06|01.08.2010||R|0|0|0|1|G|0|AGP|0|0|0|100|XEU|15257|14199|lyfalmen|V0187|13725|2|150|0|37,5000|Actavis Group hf|Actavis Group PTC ehf|Mýcófenólsýra||9534||9534|14199||1 062387|N04BC0502|Sifrol|forđatfl|0,26|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|1558|3221|lyfalmen|V0634|1689|1|10|0|1,0400|Vistor hf|Boehringer Ingelheim International|Pramipexól||1558||1558|3221||1 062575|J05AX1501|Sovaldi|filmhtfl|400|mg|28|stk|1|glas||J05AX15|01.09.2015||R|0|0|0|1|0|1|GIL|0|0|0|100|XEU|2018251|2511999|lyfsjukr|||1|28|0|28,0000|Gilead Sience Sweden AB|Gilead Science International Limited|Sofosbuvir||||2018251|2511999||1 062614|QG03XA9101|Improvac|stl|300|mcg|100|ml|10|glös||QG03XA91|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|53892|92888|vetorma|||0|1000|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||53892||53892|92888||2 062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|ţpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 062729|N05BA1204|Tafil Retard|forđatfl|0,5|mg|60|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|875|2281|lyfalmen|V0308|2014|1|60|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||875||875|2281||1 062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|1|0|0|0|G|0|AGT|0|0|1|100|XEU|1899|3690|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Cyanocobalamin||1899||1899|3690||1 062745|QP53AF0102|Sebacil vet.|húđlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|17011|29320|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|||17011||17011|29320||2 062987|J07BM0201|Cervarix|stl|||0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|14875|18140|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerđ 16, 18)||12332||12332|18140||1 062996|J07BM0201|Cervarix|stl|||0,5|ml|10|áf.spr|dreifa|J07BM02|01.03.2014||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|148759|190692|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerđ 16, 18)||148759||148759|190692||1 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|ţpakki||J05AB09|01.10.1995||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|3977|6550|lyfalmen|||1|10|0|1,6667|Vistor hf|Novartis Healthcare A/S|Famcíclóvír||3977||3977|6550||1 063180|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|ţpakki||N05AH02|01.05.2015||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|1732|3137|lyfalmen|V0276|3137|2|100|0|8,3300|Actavis Group hf|Actavis Group hf|Klózapín||1497||1497|3137||1 063255|N05AH0205|Clozapine Actavis|töflur|100|mg|100|stk|1|ţpakki||N05AH02|01.07.2014||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|6838|8495|lyfalmen|V0277|8495|2|100|0|33,3333|Actavis Group hf|Actavis Group hf|Klózapín||5390||5390|8495||1 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|0|0|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||0|500|0|49,7761|Vistor hf|Medic Team|Laktúlósa|||||2947||1 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.11.2006||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|2058|3909|lyfalmen|V0123|3881|2|28|0|28,0000|Actavis Group hf|Actavis hf|Terbínafín||2058||2058|3909||1 063715|R06AX2702|Aerius (Lyf og heilsa)|töflur|5|mg|100|stk|1|ţpakki||R06AX27|01.07.2011||R|1|0|0|0|G|0|HOL|0|0|1|100|XEU|3934|6370|lyfalmen|V0458|3551|3|100|0|100,0000|Lyf og heilsa|Lyf og heilsa|Deslóratadín||3846||3846|6370||2 063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|0|0|0|0|0|1|OCT|0|0|0|100|DKK|7351|10510|lyfsjukr|||1|2|0||Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||7351||7351|10510||1 063923|QP54AB5207|Equest Pramox vet|hlaup|||11,8|g|1|sk-dćl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|0|0|0|0|0|0|ZFO|0|0|0|100|XEU|2399|4135|vetorma|||0|11,8|0||Vistor hf|Zoetis Finland Oy|||2399||2399|4135||2 063926|L04AC0701|RoActemra|stl|162|mg|4|áf.spr|1|pakki||L04AC07|01.12.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|138677|174335|lyfsjukr|||1|4|0|32,4000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||138677||138677|174335||2 063941|N05BA1204|Tafil Retard|forđatfl|1|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|919|2341|lyfalmen|V0309|1949|1|30|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||919||919|2341||1 063958|N05BA1204|Tafil Retard|forđatfl|1|mg|60|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1925|3726|lyfalmen|V0310|2904|1|60|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||1925||1925|3726||1 064023|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.07.2014||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|80505|101986|lyfsjukr|||1|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||80505|101986||3 064034|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.07.2014||R|0|0|0|1|0|1|BAL|0|1|0|100|SEK|123162|155039|lyfsjukr|||1|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuţáttur VIII||||123162|155039||3 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|887138|1105211|lyfsjukr|||1|20|0|11,6300|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||887138|1105211||2 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|410697|512652|lyfsjukr|||1|20|0|4,6500|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||410697|512652||2 064170|N05BA1204|Tafil Retard|forđatfl|2|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2022|3859|lyfalmen|V0311|2904|1|30|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2022||2022|3859||1 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|4106976|5109788|lyfsjukr|||1|20|0|46,5100|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||4106976|5109788||2 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|1612978|2007953|lyfsjukr|||1|20|0|23,2600|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||1612978|2007953||2 064270|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|2123|3657|lyfalmen|V0009|3454|2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||1875||1875|3657||2 064281|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|6574|6622|lyfalmen|V0029|6587|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||4029||4029|6622||2 064402|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.06.2013||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1118|2197|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1118||1118|2197||1 064732|A03BB0101|Buscopan|húđuđtfl|10|mg|100|stk|1|ţpakki||A03BB01|01.03.2012||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|1985|3808|lyfalmen|||1|100|0|16,6700|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||1985||1985|3808||1 064733|J07BB0203|Vaxigrip|stl|||0,5|ml|1|áfspr||J07BB02|01.10.1985||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|950|2098|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsađir mótefnavakar||742||742|2098||2 064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|0|0|0|1|0|1|OCT|0|0|0|100|DKK|46557|59764|lyfsjukr|||1|1|0|1,4300|Vistor hf|Octapharma AB|Storkuţćttir lX,ll,Vll,X||46557||46557|59764||1 064840|A03FA0102|Afipran|töflur|10|mg|50|stk|1|glas||A03FA01|01.03.2013||R|1|0|0|0|G|0|TAS|0|0|1|100|DKK|785|2157|lyfalmen|||2|50|0|6,6700|Vistor hf|Takeda Nycomed AS|Metóklópramíđ||785||785|2157||1 064939|G04BD0804|Solifenacin Actavis|filmhtfl|10|mg|90|stk|1|ţpakki||G04BD08|01.03.2015||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|17093|21323|lyfalmen|V0441|21322|2|90|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Sólífenacín||14849||14849|21323||1 064956|A03FA0102|Afipran|stl|5|mg/ml|2|ml|10|lykjur|lausn|A03FA01|01.03.2013||R|0|0|0|0|G|0|TAS|0|0|1|100|DKK|451|1697|lyfalmen|||2|20|0|3,3300|Vistor hf|Takeda Nycomed AS|Metóklópramíđ||451||451|1697||1 065032|D10AF5101|Duac|hlaup|||25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|0|0|0|0|0|0|SLL|0|0|0|100|DKK|1846|3617|lyfalmen|||1|25|0||Vistor hf|Stiefel Laboratories (Ireland) Ltd.|Klindamýcín í blöndum||1846||1846|3617|30.6.2015|1 065076|QM01AE0302|Ketodine vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.01.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|5553|10706|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||5553||5553|10706||2 065314|G01AF0201|Canesten|sk-tfl|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 065332|G01AF0201|Canesten|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 065339|A07EA0604|Cortiment|freyđit|9|mg|30|stk|1|ţpakki||A07EA06|01.09.2015||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|14934|21431|lyfalmen|||1|30|0|30,0000|Vistor hf|Ferring Lćgemidler A/S|Búdesóníđ||14934||14934|21431||1 065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|10931|15455|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||10931||10931|15455||2 065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.06.2011||R|0|0|0|1|G|0|LVR|0|0|0|100|SEK|51479|63642|lyfalmen|V0451|63642|3|1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||48308||48308|63642||3 065729|N07BA0142|Nicorette Invisi|forđapl|15|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065740|N07BA0142|Nicorette Invisi|forđapl|15|mg/16kls|7|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065751|J01CR0204|Amoxin comp|mixtduft|80|mg/ml|70|ml|1|glas|80+11,4 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|954|1968|lyfalmen|V0163|1968|2|70|0|5,6000|Medical ehf|ratiopharm GmbH|Amoxicillín og ensímblokkar||648||648|1968||2 065752|N07BA0142|Nicorette Invisi|forđapl|10|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065775|N07BA0142|Nicorette Invisi|forđapl|25|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065786|N07BA0142|Nicorette Invisi|forđapl|25|mg/16kls|7|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|3453|4937|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Jóhexól||3453||3453|4937||2 065934|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|28|stk|1|ţpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|AGP|0|0|0|100|SEK|556|1842|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||556||556|1842||1 065945|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|98|stk|1|ţpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|AGP|0|0|0|100|SEK|1679|3387|lyfalmen|||2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||1679||1679|3387||1 065956|C08CA1301|Lerkanidipin Actavis|filmhtfl|20|mg|98|stk|1|ţpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|AGP|0|0|0|100|SEK|3122|5373|lyfalmen|||2|98|0|196,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||3122||3122|5373||1 066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|0|0|0|0|0|0|DOR|1|0|0|100|DKK|4244|8222|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|||4244||4244|8222||2 066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|5903|9201|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíđ||5903||5903|9201||1 066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05AA07|01.05.2008||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|29316|38321|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||29316||29316|38321||2 066399|N07BA0106|Nicotinell|forđapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|21|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 066407|N07BA0106|Nicotinell|forđapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|21|0|21,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|0|0|0|0|0|0|GOG|0|0|1|100|DKK|890|2301|lyfalmen|||1|51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||890||890|2301||2 066423|N07BA0106|Nicotinell|forđapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|21|0|31,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 066593|A02BC0111|Omeprazol Pensa|sţ-hylki|20|mg|100|stk|1|glas|2x50 stk|A02BC01|01.12.2012||R|1|0|0|0|G|0|PEN|0|0|0|100|IKR|2100|3829|lyfalmen|V0006|3554|2|100|0|100,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól||2000||2000|3829||3 066751|C01BD0103|Cordarone (Lyf og heilsa)|töflur|100|mg|30|stk|1|ţpakki||C01BD01|01.11.2006||R|1|0|0|0|G|0|HOL|0|0|0|100|NOK|951|2385|lyfalmen|V0036|2385|3|30|0|15,0000|Lyf og heilsa|Lyf og heilsa|Amíódarón||951||951|2385||2 066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|ţpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1 066897|L01CD0104|Paclitaxel Actavis|irţ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|3692|5279|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Paklítaxel||3692||3692|5279||1 067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|8322|11898|lyfsjukr|||1|5000|0||Icepharma hf|Fresenius Kabi|Kolvetni||8322||8322|11898||2 067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|14199|12776|lyfalmen|V0419|12776|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúkónazól||8500||8500|12776||1 067877|B05BA0314|Glucos Baxter Viaflo|irl|100|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2461|3519|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||||2461|3519||2 068358|L01XC1001|Arzerra|irţ|20|mg/ml|5|ml|3|hgl|100 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|1|0|1|NEL|0|0|0|100|GBP|115429|145421|lyfsjukr|||1|15|0||Vistor hf|Novartis Europharm Ltd|Ofatúmúmabi||115429||115429|145421||1 068381|B02BX0501|Revolade|filmhtfl|25|mg|14|stk|1|ţpakki||B02BX05|01.04.2011||R|1|1|0|1|0|1|NEL|0|1|0|100|GBP|82105|103976|lyfsjukr|||1|14|0|7,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||82105||82105|103976||1 068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|ţpakki||C01BC04|01.04.1987||R|1|0|0|1|G|0|MEB|0|0|0|100|SEK|1446|3067|lyfalmen|||1|20|0|10,0000|Vistor hf|Meda AB (V)|Flekaíníđ||1446||1446|3067||1 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|ţpakki||C01BC04|01.04.1987||R|1|0|0|1|G|0|MEB|0|0|0|100|SEK|4936|7870|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB (V)|Flekaíníđ||4936||4936|7870||1 068698|N06DA0206|Donepezil Medical|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.04.2012|30.06.2015|R|1|0|0|0|G|0|MED|0|0|0|100|XEU|17485|10115|lyfalmen|||2|98|0|130,6700|Medical ehf|Medical ehf|Dónepezíl||6567||6567|10115||2 068811|L01BA0109|Metoject|stl|50|mg/ml|0,55|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3180|5453|lyfalmen|||1|0,55|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3180||3180|5453||2 068896|B05XA0303|Natriumklorid B.Braun|irţ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|2378|3400|lyfsjukr|||2|400|0||Actavis Group hf|Braun|Natríumklóríđ||2378||2378|3400||1 068905|B05XA0103|Kaliumklorid B.Braun|irţ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|2223|3178|lyfsjukr|||2|400|0||Actavis Group hf|Braun|Kalíumklóríđ||2223||2223|3178||1 068923|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||3200||1 068933|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||3383||1 068951|V07AB0009|Sterilt Vann B. Braun|leysir|||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||3155||1 068960|V07AB0009|Sterilt Vann B. Braun|leysir|||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||3334||1 069106|H01BA0201|Minirin|frţ.tfl|240|mcg|30|stk|1|ţpakki||H01BA02|01.08.2012||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|13366|19447|lyfalmen|||1|30|0|18,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||13366||13366|19447||1 069115|H01BA0201|Minirin|frţ.tfl|240|mcg|100|stk|1|ţpakki||H01BA02|01.08.2012||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|42188|55901|lyfalmen|||1|100|0|60,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||42188||42188|55901||1 069347|C02KX0501|Adempas|filmhtfl|1|mg|84|stk|1|ţpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BGB|0|1|0|100|DKK|380546|475153|lyfsjukr|||1|84|0||Icepharma hf|Bayer Pharma AG|Riociguatum||380546||380546|475153||2 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|15|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1 070113|B01AC0601|Hjartamagnyl|sţ-tfl|75|mg|500|stk|1|glas||B01AC06|01.10.2012||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|500|0|500,0000|Actavis Group hf|Actavis Group hf|Asetýlsalicýlsýra|||||||1 070142|G04BD0704|Tolterodin Actavis|forđahlk|4|mg|100|stk|1|ţpakki||G04BD07|01.01.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|5191|8221|lyfalmen|V0589|8221|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tólteródín||5191||5191|8221||1 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|međ skammtasprautu|N05AX08|01.01.1997||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|10988|16200|lyfalmen|||1|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||10988||10988|16200||1 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|57641|73549|lyfsjukr|||1|1|0|8,3300|Vistor hf|Eisai Ltd|Ziconotíđ||57641||57641|73549||1 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|291519|364428|lyfsjukr|||1|5|0|41,6500|Vistor hf|Eisai Ltd|Ziconotíđ||291519||291519|364428||1 071458|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 071468|N03AX1108|Topiramat Bluefish|filmhtfl|25|mg|60|stk|1|ţpakki||N03AX11|01.04.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1950|1748|lyfalmen|V0247|1748|2|60|0|5,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||488||488|1748||2 071479|N03AX1108|Topiramat Bluefish|filmhtfl|50|mg|60|stk|1|ţpakki||N03AX11|01.08.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|3008|3361|lyfalmen|V0248|3361|2|60|0|10,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||1660||1660|3361||2 071490|N03AX1108|Topiramat Bluefish|filmhtfl|100|mg|60|stk|1|ţpakki||N03AX11|01.04.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|5900|3766|lyfalmen|V0249|3766|2|60|0|20,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||1954||1954|3766||2 071501|N03AX1108|Topiramat Bluefish|filmhtfl|200|mg|60|stk|1|ţpakki||N03AX11|01.12.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|12711|17537|lyfalmen|V0252|17537|2|60|0|40,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||11959||11959|17537||2 071591|N05AH0405|Seroquel Prolong|forđatfl|150|mg|30|stk|1|ţpakki||N05AH04|01.10.2011||R|1|0|0|0|0|0|ASA|0|0|0|100|SEK|7579|11508|lyfalmen|||1|30|0|11,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||7579|11508||1 071611|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|10282|4908|lyfalmen|V0144|4908|3|12|0|24,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||2784||2784|4908||2 071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|ţpakki||L01BB05|01.09.2011||R|0|0|0|1|0|1|GZE|0|0|0|100|NOK|74441|94444|lyfsjukr|||1|20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||74441||74441|94444||1 071998|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|ţpakki||H03AA01|01.06.2015||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|617|1926|lyfalmen|V0697|1917|1|100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||617||617|1926||2 072021|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|ţpakki||H03AA01|01.06.2015||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|470|1723|lyfalmen|V0696|1723|1|100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||470||470|1723||2 072044|B01AC0402|Grepid|töflur|75|mg|30|stk|1|ţpakki||B01AC04|01.01.2010||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|1978|3701|lyfalmen|V0009|3701|2|30|0|30,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||1907||1907|3701||1 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|0|0|0|0|0|0|ORF|1|0|0|100|DKK|6630|12749|vetalmen|||0|5|0||Vistor hf|Orion-Farmos|||6630||6630|12749||1 072233|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|300|stk|1|ţpakki||N07BA01|01.02.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|ţpakki||B01AC04|01.12.2009||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|6574|6587|lyfalmen|V0029|6587|2|100|0|100,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||4004||4004|6587||1 072641|V04CX0001|Lung test gas CO (HE) Aga|lyfjagas|0,28|%|20|l|1|hylki|undir ţrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|180305|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|180305||5 072654|V04CX0002|Lung test gas CO (C2H2/CH4) Aga|lyfjagas|0,3|%|20|l|1|hylki|undir ţrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|180305|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|180305||5 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|547|782|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Súfentaníl||547||547|782||1 072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|0|0|0|0|0|0|BRI|0|0|0|100|SEK|14906|21395|lyfalmen|||1|1,2|0|20,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Exenatíđ||14906||14906|21395||1 072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|0|0|0|0|0|0|BRI|0|0|0|100|SEK|14906|21395|lyfalmen|||1|2,4|0|40,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Exenatíđ||14906||14906|21395||1 073027|J05AG0401|Intelence|töflur|200|mg|60|stk|1|glas||J05AG04|01.04.2012||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|57611|73512|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||57611||57611|73512||1 073030|N05AH0410|Quetiapin Actavis|filmhtfl|200|mg|100|stk|1|ţpakki||N05AH04|01.08.2013||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|8388|7946|lyfalmen|V0286|7840|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||4991||4991|7946||1 073276|C02KX0401|Opsumit|filmhtfl|10|mg|30|stk|1|ţpakki||C02KX04|01.09.2014||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|359019|448379|lyfsjukr|||1|30|0|30,0000|Vistor hf|Actelion Registration Ltd.|Macitentan||||359019|448379||1 073313|L01XE1601|Xalkori|hylki|200|mg|60|stk|1|ţpakki||L01XE16|01.05.2013||R|1|1|0|1|0|1|IPI|0|0|0|100|DKK|635034|791664|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Limited|Crizotiníb||635034||635034|791664||2 073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|4037|6633|lyfalmen|||1|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ og tamsúlósínhýdroklóríđ||4037||4037|6633||1 073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.09.2011||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|17595|13848|lyfalmen|V0185|13848|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Letrózól||9279||9279|13848||1 073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|288|1473|lyfalmen|V0047|1335|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Alprazólam||288||288|1473||1 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|905|2322|lyfalmen|V0305|1963|1|100|0|25,0000|Icepharma hf|Pfizer ApS|Alprazólam||905||905|2322||1 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|487|1747|lyfalmen|V0439|1493|1|20|0|10,0000|Icepharma hf|Pfizer ApS|Alprazólam||487||487|1747||1 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1323|2897|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Alprazólam||1323||1323|2897||1 073933|C09AA0211|Enalapril Krka|töflur|2,5|mg|100|stk|1|ţpakki||C09AA02|01.04.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1479|2351|lyfalmen|||2|100|0|25,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||926||926|2351||2 073935|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|3519|6065|vetorma|||0|1|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||3519||3519|6065||2 073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|ţpakki||L04AX01|01.12.2010||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|1132|2634|lyfalmen|||1|50|0|8,3333|Artasan ehf|Aspen Pharma Trading Limited|Azatíóprín||1132||1132|2634||1 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|1|0|0|0|0|0|NEL|0|0|0|100|DKK|3007|5215|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||3007||3007|5215||1 074083|B03BB0106|Folic Acid (Lyf og heilsa)|töflur|5|mg|28|stk|1|ţpakki||B03BB01|01.03.2011|31.07.2015|R|1|0|0|0|G|0|HOL|0|0|1|100|GBP|442|1685|lyfalmen|||3|28|0|350,0000|Lyf og heilsa|Lyf og heilsa|Fólínsýra||442||442|1685||2 074348|N03AX2201|Fycompa|filmhtfl|8|mg|28|stk|1|ţpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|21614|29879|lyfalmen|V0666|29879|1|28|0|28,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||21614||21614|29879||1 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|670|1999|lyfalmen|||2|25|0|12,5000|Actavis Group hf|Actavis Group hf|Díazepam||670||670|1999||1 074477|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|30|stk|1|ţpakki||N02BE01|01.10.2013||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|Medical ehf|ratiopharm GmbH|Paracetamól|||||||2 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|626|1938|lyfalmen|||2|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||626||626|1938||1 074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|975|2418|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Díazepam||975||975|2418||1 074617|QI06AA0402|Fel-O-Vax PCT vet.|stl|||1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|21252|36630|vetorma|||0|25|0||Icepharma hf|Pfizer Oy Animal Health|||21252||21252|36630||2 074667|N06AA0905|Amitriptyline|filmhtfl|10|mg|98|stk|1|ţpakki||N06AA09|01.03.2011||R|1|0|0|0|G|0|AUK|0|0|0|100|GBP|455|1703|lyfalmen|||2|98|0|13,0700|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||455||455|1703||1 074679|N06AA0905|Amitriptyline|filmhtfl|25|mg|98|stk|1|ţpakki||N06AA09|01.02.2011||R|1|0|0|0|G|0|AUK|0|0|0|100|GBP|787|2160|lyfalmen|||2|98|0|32,6600|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||787||787|2160||1 074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|1060|2535|lyfalmen|||1|60|0|12,0000|Artasan ehf|Aspen Pharma Trading Limited|Digoxín||1060||1060|2535||1 074782|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.09.2010||R|1|0|0|0|G|0|APP|0|0|0|100|GBP|565|1854|lyfalmen|||1|100|0|100,0000|Artasan ehf|Aspen Pharma Trading Limited|Digoxín||565||565|1854||1 075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|ţpakki||L04AX01|01.08.2011||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|2615|4676|lyfalmen|||1|100|0|33,3333|Artasan ehf|Aspen Pharma Trading Limited|Azatíóprín||2615||2615|4676||1 075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|4614|7427|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4614||4614|7427||1 075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|13840|20047|lyfalmen|||1|90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||13840||13840|20047||1 075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|4614|7427|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4614||4614|7427||1 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|ţpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1488|2504|lyfalmen|V0363|2244|1|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1037||1037|2504||1 075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|13840|20047|lyfalmen|||1|90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||13840||13840|20047||1 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|ţpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|2|0|1|0|0|0|AGP|0|0|1|100|IKR|3144|5404|lyfalmen|||2|300|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||3144||3144|5404||1 075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|2|0|1|0|0|0|AGP|0|0|1|100|IKR|4555|7346|lyfalmen|||2|300|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema međ geđlyfjum||4555||4555|7346||1 075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||R|0|0|0|0|0|0|NBV|0|0|0|100|DKK|2334|4289|lyfalmen|||1|4|0||Norgine BV|Norgine BV|Hćgđalyf međ osmótíska verkun||||2334|4289||1 075451|G04CB0103|Finasteride Portfarma|filmhtfl|5|mg|98|stk|1|ţpakki||G04CB01|01.05.2011||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|3879|4699|lyfalmen|V0445|4699|2|98|0|98,0000|Portfarma ehf|Portfarma|Fínasteríđ||2632||2632|4699||1 075470|L01CD0201|Taxotere|irţ|20|mg|1|ml|1|hgl|lausn|L01CD02|01.06.2010||R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|24667|32539|lyfsjukr|||1|1|0||Vistor hf|Aventis Pharma SA|Docetaxel||24667||24667|32539||1 075482|L01CD0201|Taxotere|irţ|80|mg|4|ml|1|hgl|lausn|L01CD02|01.06.2010||R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|67248|85498|lyfsjukr|||1|4|0||Vistor hf|Aventis Pharma SA|Docetaxel||67248||67248|85498||1 075777|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|ţpakki||QG03DA02|01.03.2011||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|995|1956|vetalmen|||0|20|0||Vistor hf|Dechra Veterinary Products A/S|Medroxyprogesteronum||995||995|1956||1 075865|G04BD0803|Solifenacin Portfarma|filmhtfl|5|mg|90|stk|1|ţpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|PEH|0|0|0|100|XEU|12081|17822|lyfalmen|V0440|17822|2|90|0|90,0000|Portfarma ehf|Portfarma ehf|Sólífenacín||12081||12081|17822||1 075869|B05DB0005|Balance|kviđ.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5261|7522|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5261||5261|7522||2 075888|B05DB0005|Balance|kviđ.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5261|7522|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5261||5261|7522||2 075906|B05DB0005|Balance|kviđ.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5728|8189|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5728||5728|8189||2 075936|P01BC0104|Quinine Sulphate Actavis|filmhtfl|200|mg|28|stk|1|ţpakki||P01BC01|01.07.2010||R|1|0|0|0|0|0|AUK|0|0|0|100|GBP|564|1853|lyfalmen|||2|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Kínín||564||564|1853||1 075947|J01EE0107|Trimezol|töflur|480|mg|20|stk|1|ţpakki|80+400 mg|J01EE01|01.12.2009||R|0|0|0|0|0|0|AEA|0|0|1|100|XEU|601|1904|lyfalmen|||2|20|0|5,0000|Actavis hf|Actavis EAD|Súlfametoxazól og trímetóprím||601||601|1904||1 076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|ţpakki||A10BH01|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|6041|9391|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Sítagliptín||6041||6041|9391||1 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|ţpakki||A10BH01|01.11.2007||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|18508|25951|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Sítagliptín||||18508|25951||1 076043|A10BH0101|Januvia|filmhtfl|25|mg|98|stk|1|ţpakki||A10BH01|01.02.2013||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|18602|26070|lyfalmen|||1|98|0|24,5000|Vistor hf|M.S.D.|Sítagliptín||18602||18602|26070||1 076052|A10BH0101|Januvia|filmhtfl|50|mg|98|stk|1|ţpakki||A10BH01|01.10.2012||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|18602|26070|lyfalmen|||1|98|0|49,0000|Vistor hf|M.S.D.|Sítagliptín||18602||18602|26070||1 076237|G04BE0309|Vizarsin|filmhtfl|50|mg|4|stk|1|ţpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|1605|2147|lyfalmen|V0143|1466|2|4|0|4,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||778||778|2147||2 076248|G04BE0309|Vizarsin|filmhtfl|50|mg|8|stk|1|ţpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|2971|3182|lyfalmen|V0143|2932|2|8|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1530||1530|3182||2 076259|G04BE0309|Vizarsin|filmhtfl|50|mg|12|stk|1|ţpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|3742|4402|lyfalmen|V0143|4398|2|12|0|12,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||2416||2416|4402||2 076270|G04BE0309|Vizarsin|filmhtfl|100|mg|4|stk|1|ţpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|1667|2348|lyfalmen|V0144|1636|2|4|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||924||924|2348||2 076282|G04BE0309|Vizarsin|filmhtfl|100|mg|8|stk|1|ţpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|3208|3513|lyfalmen|V0144|3272|2|8|0|16,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1770||1770|3513||2 076293|G04BE0309|Vizarsin|filmhtfl|100|mg|12|stk|1|ţpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|7023|4912|lyfalmen|V0144|4908|2|12|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||2787||2787|4912||2 076361|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir ţrýstingi/LIV|V03AN01|01.12.2009||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5 076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|ţpakki||N05AX08|01.07.2007||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|445|1689|lyfalmen|V0045|1689|2|20|0|2,0000|Portfarma ehf|Portfarma|Risperídón||445||445|1689||1 076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|ţpakki||N05AX08|01.07.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1691|2384|lyfalmen|V0290|2384|2|60|0|6,0000|Portfarma ehf|Portfarma|Risperídón||950||950|2384||1 076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|ţpakki||N05AX08|01.07.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1946|2315|lyfalmen|V0291|2315|2|60|0|12,0000|Portfarma ehf|Portfarma|Risperídón||900||900|2315||1 076403|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.06.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|1541|3197|lyfalmen|||1|5|0||Vistor hf|Laboratories THEA|Ketotifen||1541||1541|3197||1 076628|N05AX0806|Risperidon Krka|filmhtfl|0,5|mg|60|stk|1|ţpakki||N05AX08|01.08.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1500|2453|lyfalmen|V0290|2384|2|60|0|6,0000|LYFIS ehf|Krka Sverige AB|Risperídón||1000||1000|2453||2 076667|B02BD0207|ReFacto AF|sts|3000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PZE|0|1|0|100|DKK|254719|318659|lyfsjukr|||1|1|0|6,0000|Icepharma hf|Pfizer Ltd.|Storkuţáttur VIII||254719||254719|318659||1 076680|B02BD0207|ReFacto AF|sts|2000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PZE|0|1|0|100|DKK|169813|213060|lyfsjukr|||1|1|0|4,0000|Icepharma hf|Pfizer Ltd.|Storkuţáttur VIII||169813||169813|213060||1 076691|B02BD0207|ReFacto AF|sts|1000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PZE|0|1|0|100|DKK|85037|107622|lyfsjukr|||1|1|0|2,0000|Icepharma hf|Pfizer Ltd.|Storkuţáttur VIII||85037||85037|107622||1 076702|B02BD0207|ReFacto AF|sts|500|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PZE|0|1|0|100|DKK|42769|55053|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Pfizer Ltd.|Storkuţáttur VIII||42769||42769|55053||1 076781|N02AA0506|Oxikodon Depot Actavis|forđatfl|10|mg|98|stk|1|glas||N02AA05|01.09.2015||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|2884|4911|lyfalmen|V0598|4911|2|98|0|13,0700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||2786||2786|4911||1 076871|G01AF0202|Canesten (Lyf og heilsa)|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.12.2009||L|0|0|0|0|0|0|HOL|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Lyf og heilsa|Lyf og heilsa|Klótrímazól|||||||2 076876|M01AE0219|Alpoxen|töflur|500|mg|25|stk|1|ţpakki||M01AE02|01.05.2014||R|0|0|0|0|G|0|AGP|0|0|1|100|SEK|440|1682|lyfalmen|||2|25|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen||440||440|1682||1 077213|A02BC0509|Esomeprazole Alvogen|sţ-tfl|40|mg|30|stk|1|ţpakki||A02BC05|01.09.2015||R|1|0|0|0|0|0|IPC|0|0|0|100|IKR|2559|2550|lyfalmen|V0005|2550|2|30|0|40,0000|Portfarma ehf|Alvogen IPco S.á.r.l.|Esómeprazól||1071||1071|2550||1 077324|B02BD0102|Cofact|sts|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.02.2015||R|0|0|0|1|0|1|QUI|0|0|0|100|XEU|50437|64590|lyfsjukr|||1|1|0|1,4300|Williams & Halls efh|Sanquin|Storkuţćttir lX,ll,Vll,X||50437||50437|64590||2 077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1985||R|1|0|0|0|0|0|AGP|0|0|1|100|IKR|367|1581|lyfalmen|||2|30|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||367||367|1581||1 077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1985||R|1|0|0|0|0|0|AGP|0|0|1|100|IKR|1042|2511|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis Group PTC ehf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||1042||1042|2511||1 077606|N06BA0405|Medikinet|töflur|5|mg|30|stk|1|ţpakki||N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|872|2277|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||872||872|2277||2 077615|N06BA0405|Medikinet|töflur|10|mg|30|stk|1|ţpakki||N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|1025|2384|lyfalmen|V0671|2384|2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||950||950|2384||2 077624|N06BA0405|Medikinet|töflur|20|mg|30|stk|1|ţpakki||N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|1700|3416|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||1700||1700|3416||2 077633|N06BA0406|Medikinet CR|hylki|10|mg|30|stk|1|ţpakki|međ breyttan losunarhrađa|N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|3300|5618|lyfalmen|||2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||3300||3300|5618||2 077642|N06BA0406|Medikinet CR|hylki|20|mg|30|stk|1|ţpakki|međ breyttan losunarhrađa|N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|5000|7958|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||5000||5000|7958||2 077652|N06BA0406|Medikinet CR|hylki|30|mg|30|stk|1|ţpakki|međ breyttan losunarhrađa|N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|6300|9748|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||6300||6300|9748||2 077661|N06BA0406|Medikinet CR|hylki|40|mg|30|stk|1|ţpakki|međ breyttan losunarhrađa|N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|8120|12253|lyfalmen|||2|30|0|40,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||8120||8120|12253||2 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|876|2282|lyfalmen|||1|10|0|0,8333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||876||876|2282||1 078193|D01AC0102|Canesten (Lyf og heilsa)|krem|1|%|20|g|1|túpa||D01AC01|01.12.2009||L|0|0|0|0|0|0|HOL|0|0|1|100|IKR|||lyflausa|||0|20|0||Lyf og heilsa|Lyf og heilsa|Klótrímazól|||||||2 078307|J02AC0103|Fluconazole Portfarma|hylki|200|mg|28|stk|1|ţpakki||J02AC01|01.12.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|11524|12776|lyfalmen|V0419|11924|2|28|0|28,0000|Portfarma ehf|Portfarma|Flúkónazól||8500||8500|12776||1 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|466|1718|lyfalmen|||1|20|0|2,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||466||466|1718||1 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|709|2052|lyfalmen|||1|40|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||709||709|2052||1 078688|N01BB0204|Lidokain FarmaPlus|stl|10|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.04.2012||R|0|0|0|0|0|0|FPL|0|0|1|100|XEU|1317|2889|lyfalmen|V0560|2889|2|100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||1317||1317|2889||2 078699|N01BB0204|Lidokain FarmaPlus|stl|20|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.04.2012||R|0|0|0|0|0|0|FPL|0|0|1|100|XEU|1883|3668|lyfalmen|V0561|3668|2|100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||1883||1883|3668||2 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|ţpakki||C09CA01|01.01.1995||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|8384|5920|lyfalmen|V0069|2943|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan||3519||3519|5920||1 079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|ţpakki||J05AH02|01.11.2002||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|3385|5735|lyfalmen|||1|10|0|5,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3385||3385|5735||2 079269|N05AB0302|Trilafon Dekanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|17357|24495|lyfalmen|V0639|24495|1|10|0|154,5714|Vistor hf|Orion Corporation|Perfenazín||17357||17357|24495||1 079358|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 079381|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|ţpakki||N06AB03|01.05.2010||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|3602|6034|lyfalmen|V0315|6034|2|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||3602||3602|6034||1 079597|L02BG0305|Anastrozole Teva|filmhtfl|1|mg|100|stk|1|ţpakki||L02BG03|01.05.2014||R|0|0|0|0|G|0|TSB|0|0|0|100|IKR|9500|6031|lyfalmen|V0184|5366|2|100|0|100,0000|Medical ehf|Teva Sweden AB|Anastrózól||3600||3600|6031||2 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|0|0|0|0|0|1|BRS|0|0|0|100|DKK|1949|2787|lyfsjukr|||1|5|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||1949||1949|2787||1 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|ţpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|393|1617|lyfalmen|V0176|1617|2|10|0|2,5000|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1617||1 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|ţpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|638|1954|lyfalmen|V0418|1954|2|20|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|1954||1 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|ţpakki||J01MA02|01.05.2008||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|647|1967|lyfalmen|V0177|1967|2|10|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|1967||1 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|ţpakki||J01MA02|01.01.1994||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|1168|2684|lyfalmen|V0411|2684|2|20|0|10,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||1168||1168|2684||1 080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|IKR|4985|9628|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|||4985||4985|9628||2 080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|3779|7340|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||3779|7340||2 080256|A10BB0903|Gliclazide LYFIS|töflur|30|mg|90|stk|1|ţpakki||A10BB09|01.10.2014||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|4000|5756|lyfalmen|V0020|2368|2|90|0|45,0000|LYFIS ehf|LYFIS ehf|Glíklazíđ||3400||3400|5756||2 080331|L02BB0306|Bicalutamid LYFIS|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.06.2012||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|14146|10344|lyfalmen|V0421|7087|2|30|0|90,0000|LYFIS ehf|LYFIS ehf|Bíkalútamíđ||6733||6733|10344||2 080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|1|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|ţpakki|230+20 mg|QP52AA51|01.11.2011||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|10241|17651|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||10241||10241|17651||2 080470|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|30|stk|1|ţpakki||L02BG04|01.03.2012||R|0|0|0|0|G|0|RAT|0|0|0|100|XEU|9126|6453|lyfalmen|||2|30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Letrózól||3906||3906|6453||2 080482|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.03.2012||R|0|0|0|0|G|0|RAT|0|0|0|100|XEU|17595|13848|lyfalmen|V0185|13848|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Letrózól||9279||9279|13848||2 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|2114|3986|lyfalmen|||1|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2114||2114|3986||1 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|glas|m/br. losunarhrađa|N06AX12|01.07.2007||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|6577|10129|lyfalmen|||1|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||6577||6577|10129||1 080538|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|1574|2202|lyfalmen|V0143|1466|2|4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||818||818|2202||1 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|glas|m/br. losunarhrađa|N06AX12|01.07.2007||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|3415|5777|lyfalmen|||1|30|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||3415||3415|5777||1 080550|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|3738|4521|lyfalmen|V0143|4398|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2503||2503|4521||1 080561|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|1589|2376|lyfalmen|V0144|1636|2|4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||944||944|2376||1 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|14068|19357|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||14068||14068|19357||1 080573|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|7016|5183|lyfalmen|V0144|4908|2|12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2984||2984|5183||1 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|27734|36353|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||27734||27734|36353||1 080987|G03XB0101|Mifepristone Linepharma|töflur|200|mg|1|stk|1|ţpakki||G03XB01|01.06.2015||R|0|0|0|1|0|1|LPF|0|0|0|100|XEU|3007|4295|lyfsjukr|||1|1|0|0,3300|Portfarma ehf|Linepharma France|Mifepriston||3004||3004|4295||1 081305|L01XE1601|Xalkori|hylki|250|mg|60|stk|1|ţpakki||L01XE16|01.05.2013||R|1|1|0|1|0|1|IPI|0|0|0|100|DKK|690253|860341|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Limited|Crizotiníb||690253||690253|860341||2 081490|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.07.2013||L|0|0|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6667|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||||1 081501|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.10.2013||L|0|0|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||||1 081525|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081534|V03AN0101|Conoxia|lyfjagas|100|%|20|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|20|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081543|V03AN0101|Conoxia|lyfjagas|100|%|50|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|50|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081552|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081561|V03AN0101|Conoxia|lyfjagas|100|%|50|l|12|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|600|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081589|V03AN0101|Conoxia|lyfjagas|100|%|1|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|1|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081613|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 081625|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081634|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081635|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 081645|N03AX1405|Matever|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|7571|4049|lyfalmen|V0515|4049|2|100|0|16,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||2160||2160|4049||1 081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|ţpakki||G03DA04|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|4334|7042|lyfalmen|||1|21|0|23,3300|Vistor hf|Ferring Lćgemidler A/S|Prógesterón||4334||4334|7042||1 081671|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1658|2370|lyfsjukr|||1|10|0|3,3333|Icepharma hf|Roche|Mídazólam||1658||1658|2370||2 081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|0|0|0|0|G|0|SAA|0|0|0|100|NOK|4638|7460|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||4638||4638|7460||1 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|0|0|0|0|G|0|SDE|0|0|0|100|NOK|6532|10067|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||6532||6532|10067||1 082021|L02BG0302|Anastrozol Actavis|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.2011||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|16060|8830|lyfalmen|V0184|5259|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Anastrózól||5633||5633|8830||1 082233|V03AN0101|Conoxia|lyfjagas|100|%|36|l|1|hylki|kćlt|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|36|0||Ísaga ehf|AGA AB|Súrefni|||||||5 082237|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.04.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|28435|37225|lyfsjukr|||1|60|0||Icepharma hf|Baxter Medical AB|Mesna||28435||28435|37225||2 082512|QI06AH0701|Leucofeligen FeLV/RCP|stl|||10|hgl|1|pakki|frostţurrkađ stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|8117|13990|vetorma|||0|10|0||Vistor hf|Virbac S.A|.||8117||8117|13990||1 082523|QI06AH0701|Leucofeligen FeLV/RCP|stl|||50|hgl|1|pakki|frostţurrkađ stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|37364|64401|vetorma|||0|50|0||Vistor hf|Virbac S.A|.||37364||37364|64401||1 082548|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|622|1932|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||622||622|1932||1 082675|N02BE0118|Paracetamol-ratiopharm|töflur|1000|mg|100|stk|1|ţpakki||N02BE01|01.10.2013||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|696|2019|lyfalmen|V0229|2019|2|100|0|33,3300|Medical ehf|ratiopharm GmbH|Paracetamól||685||685|2019||2 082685|R03BA0502|Flixotide Diskus|innönddu|250|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|3290|5605|lyfalmen|||1|60|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||3290||3290|5605||1 082719|R03BA0502|Flixotide Diskus|innönddu|500|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|5823|9091|lyfalmen|||1|60|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5823||5823|9091||1 082797|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|ţpakki||N02BE01|01.02.2012||L|0|0|0|0|0|0|GGK|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|GlaxoSmithKline ehf|GlaxoSmithKline Consumer Healthcare A/S|Paracetamól|||||||1 082883|R03BA0201|Pulmicort|innúđal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|3463|5843|lyfalmen|||1|40|0|3,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||3463||3463|5843||1 082933|R03BA0201|Pulmicort|innúđal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|3769|6264|lyfalmen|||1|40|0|6,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||3769||3769|6264||1 082940|C09CA0602|Candpress|töflur|16|mg|100|stk|1|ţpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|4341|5876|lyfalmen|V0080|5876|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||3487||3487|5876||1 082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|ţpakki||N06DA03|01.10.2008||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|12322|18127|lyfalmen|V0354|16626|1|56|0|9,3350|Vistor hf|Novartis Healthcare A/S|Rívastigmín||12322||12322|18127||1 083113|L02BG0301|Arimidex|filmhtfl|1|mg|28|stk|1|ţpakki||L02BG03|01.03.1998||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|16560|23487|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca AB|Anastrózól||16560||16560|23487||1 083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|ţpakki||N06DA03|01.10.2008||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|12869|18819|lyfalmen|V0344|15681|1|56|0|18,6700|Vistor hf|Novartis Healthcare A/S|Rívastigmín||12869||12869|18819||1 083154|R03BA0201|Pulmicort|innúđal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|5116|8118|lyfalmen|V0701|6582|1|40|0|13,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||5116||5116|8118||1 083413|QN05CM9102|Narcostart|stl|1|mg/ml|10|mg|1|hgl|fyrir hunda og ketti|QN05CM91|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|5805|11184|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Metetomidinum||5805||5805|11184||2 083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|ţpakki||N06DA03|01.01.1999||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|27925|37862|lyfalmen|V0346|33490|1|112|0|74,6667|Vistor hf|Novartis Healthcare A/S|Rívastigmín||27925||27925|37862||1 083644|N02BE0101|Panodil|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.02.2013||R|1|0|0|0|0|0|GSH|0|0|1|100|DKK|1228|2767|lyfalmen|V0231|2548|1|300|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||1228||1228|2767||1 084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|252|1423|lyfalmen|V0642|1423|2|10|0|2,5000|Vistor hf|Takeda Pharma A/S|Fúrósemíđ||252||252|1423||1 084192|N05BA1206|Alprazolam Krka|forđatfl|2|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|1908|2904|lyfalmen|V0311|2904|2|30|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1328||1328|2904||2 084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|486|1745|lyfalmen|V0643|1745|2|20|0|5,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíđ||486||486|1745||1 084456|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 084591|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.04.2012||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|64468|82040|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||64468||64468|82040||1 084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008|31.07.2015|R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|54801|70017|lyfsjukr|||1|0,3|0|37,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||54801||54801|70017||2 084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008|31.07.2015|R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|71442|90714|lyfsjukr|||1|0,3|0|50,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||71442||71442|90714||2 084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008|31.07.2015|R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|89303|112928|lyfsjukr|||1|0,3|0|62,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||89303||89303|112928||2 084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008|31.07.2015|R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|18268|24580|lyfsjukr|||1|0,3|0|12,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||18268||18268|24580||2 084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008|31.07.2015|R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|27401|35939|lyfsjukr|||1|0,3|0|18,7500|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||27401||27401|35939||2 084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008|31.07.2015|R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|36534|47298|lyfsjukr|||1|0,3|0|25,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||36534||36534|47298||2 084751|B03XA0301|Mircera|stl|30|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009|31.07.2015|R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|11146|15723|lyfsjukr|||1|0,3|0|7,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||11146|15723||2 084778|B03XA0301|Mircera|stl|120|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009|31.07.2015|R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|44316|56977|lyfsjukr|||1|0,3|0|30,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||44316|56977||2 084787|B03XA0301|Mircera|stl|360|mcg/spr|0,6|ml|1|áf.spr||B03XA03|01.05.2009|31.07.2015|R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|122346|154024|lyfsjukr|||1|0,6|0|90,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||122346|154024||2 084807|L01XE2301|Tafinlar|hylki|75|mg|28|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|GBP|242839|303884|lyfsjukr|||1|28|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||242839||242839|303884||1 084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|ţpakki||N03AF03|01.09.2007||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|825|2212|lyfalmen|V0660|2212|1|10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíđ||825||825|2212||1 084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|ţpakki||N03AF03|01.09.2007||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|9794|14557|lyfalmen|V0661|14557|1|60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||9794||9794|14557||1 084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|ţpakki||N03AF03|01.09.2007||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|31872|42854|lyfalmen|V0662|42854|1|100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||31872||31872|42854||1 084924|J05AG0301|Stocrin|filmhtfl|200|mg|90|stk|1|glas||J05AG03|01.10.2013||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|40921|52754|lyfsjukr|||1|90|0|30,0000|Vistor hf|M.S.D.|Efavirenz||40921||40921|52754||1 085068|N02AA0101|Contalgin|forđatfl|100|mg|100|stk|1|ţpakki||N02AA01|01.10.1985||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|11931|17498|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Morfín||11931||11931|17498|30.6.2015|1 085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|0|0|0|1|G|0|GAN|0|0|0|100|NOK|34430|46089|lyfalmen|||1|2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||34430||34430|46089||2 085205|S01AE0501|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AE05|01.03.2008||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|2460|4462|lyfalmen|||1|15|0||Icepharma hf|Santen Oy|Levófloxacín||2460||2460|4462||2 085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|ţpakki||N06DA03|01.01.1999||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|27925|37862|lyfalmen|V0345|33490|1|112|0|56,0000|Vistor hf|Novartis Healthcare A/S|Rívastigmín||27925||27925|37862||1 085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|756|2117|lyfalmen|||1|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||756||756|2117||1 085488|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4745|6784|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4745||4745|6784||2 085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|16790|23778|lyfalmen|V0412|21669|1|375|0|12,5000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||||16790|23778||1 085551|G03GA0202|Menopur|sts|||75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|32254|43337|lyfalmen|V0412|43337|1|750|0|25,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||||32254|43337||1 085574|B01AF0201|Eliquis|filmhtfl|5|mg|100|stk|1|ţpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|16278|22029|lyfalmen|V0652|22029|1|100|0|100,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||15407||15407|22029||1 085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|ţpakki||G04BE08|01.12.2010||R|0|0|0|1|0|1|ELD|0|0|0|100|XEU|85177|107796|lyfsjukr|||1|56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||85177||85177|107796||2 085771|N07XX0202|Riluzol Actavis|filmhtfl|50|mg|56|stk|1|ţpakki||N07XX02|01.11.2012||R|1|0|0|1|G|0|AGP|0|0|0|100|SEK|19006|26581|lyfalmen|V0579|26581|2|56|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Rílúzól||19006||19006|26581||1 085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|0|0|0|0|0|0|AEB|0|0|0|100|DKK|37307|49728|lyfalmen|||1|1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||37307||37307|49728||1 085830|L01XA0211|Carboplatin Actavis|irţ|10|mg/ml|60|ml|1|hgl||L01XA02|01.05.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|3986|5699|lyfsjukr|||2|60|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Karbóplatín||3986||3986|5699||1 085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|G|0|API|0|0|0|100|SEK|2583|4632|lyfalmen|V0465|3861|1|3|0|30,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||2583||2583|4632||1 085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|G|0|API|0|0|0|100|SEK|7633|11582|lyfalmen|V0465|11582|1|9|0|90,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||7633||7633|11582||1 085860|N05CF0101|Imovane|filmhtfl|5|mg|30|stk|1|ţpakki||N05CF01|01.12.2013||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|368|1583|lyfalmen|||1|30|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||368||368|1583||1 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|ţpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1723|3448|lyfalmen|V0364|3448|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1723||1723|3448||1 086018|N02CC0404|Rizatriptan Actavis|munndr.t|10|mg|6|stk|1|ţpakki||N02CC04|01.09.2013|31.07.2015|R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|3548|1857|lyfalmen|||2|6|0|6,0000|Actavis Group hf|Actavis Group PTC ehf|Rizatriptan||567||567|1857||1 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|ţpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|4380|5067|lyfalmen|V0365|4446|1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||2899||2899|5067||1 086142|N07XX0701|Fampyra|forđatfl|10|mg|56|stk|1|ţpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|60760|79391|lyfalmen|||1|56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||60760||60760|79391||2 086191|N03AX2201|Fycompa|filmhtfl|8|mg|28|stk|1|ţpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|21614|29879|lyfalmen|V0666|29879|1|28|0|28,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||21614||21614|29879||1 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|9121|13040|lyfsjukr|||1|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||9121||9121|13040||1 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|9901|14156|lyfsjukr|||1|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||9901||9901|14156||1 086324|A02BC0501|Nexium|sţ-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2013||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|12525|18384|lyfalmen|V0012|5267|1|100|0|133,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||12525||12525|18384||1 086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|27544|37380|lyfalmen|||1|600|0|20,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||||27544|37380||1 086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|49867|65614|lyfalmen|||1|1200|0|40,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||||49867|65614||1 086434|L04AA2401|Orencia|stl/irţ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|48696|62424|lyfsjukr|||1|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Abatacept||48696||48696|62424||1 086530|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.08.2012||R|0|0|0|0|0|0|BOY|0|0|0|100|DKK|15756|22470|lyfalmen|||1|1|0||Icepharma hf|Bayer OY|Plast lyfjalykkja (IUD) međ prógestógen||||15756|22470||2 086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|46709|59953|lyfsjukr|||1|100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||46709||46709|59953||2 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|ţpakki|mjúk hylki|A03AX13|01.12.2008||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd|||||||1 087233|N05CF0201|Stilnoct|töflur|10|mg|30|stk|1|ţpakki||N05CF02|01.08.2012||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|342|1547|lyfalmen|V0060|1514|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||342||342|1547||1 087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|ţpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VII|0|0|0|100|DKK|115565|145591|lyfsjukr|||1|60|0|15,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||115565||115565|145591||1 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|ţpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|231|1394|lyfalmen|V0312|401|1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||231||231|1394||1 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|ţpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|203|1356|lyfalmen|V0312|1204|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||203||203|1356||1 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|ţpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|1714|3435|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||1714||1714|3435||1 087332|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|0|G|0|APC|0|0|0|100|XEU|46669|18581|lyfalmen|||2|250|0|166,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||12681||12681|18581||1 087354|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|0|G|0|APC|0|0|0|100|XEU|46669|18581|lyfalmen|||2|250|0|333,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||12681||12681|18581||1 087445|A02BX1301|Gaviscon|mixtúra|||500|ml|1|glas||A02BX13|01.08.1984||L|0|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|500|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||3700||1 087727|D07AC1301|Elocon|húđlausn|0,1|%|100|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1946|3755|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1946||1946|3755||1 087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|ţpakki||G03GB02|01.07.1986||R|0|0|0|0|G|0|MEC|0|0|0|100|SEK|865|2267|lyfalmen|||1|5|0|27,7778|Icepharma hf|Merck AB|Klómífen||865||865|2267||2 087788|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.11.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|2123|3529|lyfalmen|V0009|3454|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||1782||1782|3529||1 087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|ţpakki|50/144/150|QP52AA51|01.07.2010||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|29461|50779|vetorma|||0|104|0||Icepharma hf|Chanelle Pharmaceuticals|||29461||29461|50779||2 087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|ţpakki||A02BX13|01.10.1993||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||0|20|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||||1 087969|QD07AC0001|Cortavance|húđúđi|0,584|mg/ml|76|ml|1|fl|lausn|QD07AC|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|3541|6888|vetalmen|||0|76|0||Vistor hf|Virbac S.A|Hýdrókortisón aceponat||3541||3541|6888||1 088026|QG03DA0402|Prid delta|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.02.2012||R|0|0|0|0|0|0|CES|1|0|0|100|SEK|24560|42332|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||24560||24560|42332||2 088235|G03AA1204|Yasmin 28|filmhtfl|||84|stk|1|ţpakki|3+0,03 mg|G03AA12|01.10.2013||R|0|0|0|0|0|0|BYP|0|0|0|100|DKK|2926|5104|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||2926||2926|5104||2 088261|R01AD1201|Avamys|nefúđi|27,5|mcg/sk|120|skammtar|1|glas||R01AD12|01.04.2008||R|0|0|0|0|G|0|GGL|0|0|1|100|GBP|1383|2980|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Flútíkasón fúróat||1383||1383|2980||1 088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|ţpakki||M01AX01|01.04.1995||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|1339|2919|lyfalmen|||1|20|0|20,0000|Vistor hf|Meda AB|Nabúmeton||1339||1339|2919||1 088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|ţpakki||M01AX01|01.04.1995||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|5168|8190|lyfalmen|||1|100|0|100,0000|Vistor hf|Meda AB|Nabúmeton||5168||5168|8190||1 088445|N05AX1205|Aripiprazol Krka|töflur|15|mg|56|stk|1|ţpakki||N05AX12|01.03.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|20454|28412|lyfalmen|V0684|28412|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||20454||20454|28412||2 088558|N06AX2601|Brintellix|filmhtfl|15|mg|28|stk|1|ţpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|8992|13453|lyfalmen|||1|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||8992||8992|13453||1 088612|N06DA0207|Donepezil Bluefish|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.04.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|12153|7456|lyfalmen|V0342|7307|2|98|0|130,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Dónepezíl||4635||4635|7456||2 088696|D05AX5201|Daivobet|hlaup|||30|g|1|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|4539|7324|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||4539||4539|7324||1 088697|N06AX1611|Duofaxin|forđatfl|75|mg|98|stk|1|ţpakki||N06AX16|01.07.2015||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|2731|4426|lyfalmen|V0334|3078|2|98|0|73,5000|Vistor hf|MediLink A/S|Venlafaxín||2434||2434|4426||1 088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|7495|11392|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||7495||7495|11392||1 088714|D05AX5201|Daivobet|hlaup|||60|g|2|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|13838|20044|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||13838||13838|20044||1 088737|J05AE0301|Norvir|filmhtfl|100|mg|30|stk|1|glas||J05AE03|01.06.2014|30.06.2015|R|0|0|0|1|0|1|ABV|0|0|0|100|DKK|5398|7718|lyfsjukr|||1|30|0|2,5000|Vistor hf|AbbVie Ltd.|Ritonavír||5398||5398|7718||1 088814|L02BB0304|Bicalutamid Actavis|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.12.2008||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|14146|10389|lyfalmen|V0421|7087|2|30|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíđ||6766||6766|10389||1 088882|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|60|dćlur|1|pakki||QA02BX12|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|17430|33239|vetalmen|||0|60|0||Icepharma hf|Zoetis Finland OY|||17430||17430|33239||2 088964|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.08.2010||R|0|0|0|0|G|0|POF|0|0|0|100|DKK|2781|4904|lyfalmen|V0376|4904|2|7,5|0|75,0000|Portfarma ehf|Portfarma|Latanóprost||2781||2781|4904||1 088975|G03AA1005|Harmonet|töflur|||63|stk|1|ţpakki|20+75 mcg|G03AA10|01.10.2011||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1381|2977|lyfalmen|||1|63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og ethinylestradíól||1381||1381|2977||1 089077|J07BD5204|M-M-RVAXPRO|sts|||10|hgl|1|pakki|+ lausn í áf.sp|J07BD52|01.02.2013||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|21931|30280|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||21931||21931|30280||2 089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|ţpakki||A02BX13|01.01.1989||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|120|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||5800||1 089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|ţpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VII|0|0|0|100|DKK|115565|145591|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||115565||115565|145591||1 089156|A03AA0406|Mebeverin dura|filmhtfl|135|mg|100|stk|1|ţpakki||A03AA04|01.07.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3512|5910|lyfalmen|||2|100|0|45,0000|Icepharma hf|Mylan AB|Mebeverín||3512||3512|5910||2 089190|H01AC0101|Genotropin|sts|5|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|20396|27227|lyfsjukr|||1|1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||20396||20396|27227||1 089212|H01AC0101|Genotropin|sts|12|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|48950|62740|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||48950||48950|62740||1 089281|R06AX1305|Loratadin LYFIS|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.05.2012||L|1|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|LYFIS ehf|LYFIS ehf|Lóratadín||||||31.7.2015|2 089304|R06AX1305|Loratadin LYFIS|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.05.2012||L|1|0|0|0|G|0|LYF|0|0|1|100|XEU|||lyfalmen|V0362|2040|2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||2040||2 089801|B03AC0001|Monofer|irl|100|mg/ml|1|ml|5|hgl||B03AC|01.10.2012||R|0|0|0|0|G|0|PAC|0|0|1|100|DKK|23139|31808|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||23139||23139|31808||1 089936|B03AC0001|Monofer|irl|100|mg/ml|10|ml|2|hgl||B03AC|01.10.2012||R|0|0|0|0|G|0|PAC|0|0|1|100|DKK|92556|119607|lyfalmen|||1|20|0|20,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||92556||92556|119607||1 090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|ţpakki||J01DB01|01.07.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|1510|3155|lyfalmen|||1|20|0|5,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||1510||1510|3155||2 090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|ţpakki||J01DB01|01.05.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|3020|5233|lyfalmen|||1|40|0|10,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||3020||3020|5233||2 090320|J01DB0101|Keflex|mixt.kyr|50|mg/ml|100|ml|1|fl|dreifa|J01DB01|01.03.2012||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|708|2051|lyfalmen|||1|100|0|2,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||708||708|2051||2 090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|0|0|0|0|0|1|PAD|0|0|0|100|DKK|5427|7759|lyfsjukr|||1|10|0|3,3333|Icepharma hf|PharmaCoDane ApS|Cefazólín||5427||5427|7759||2 090547|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.10.2014||R|0|1|0|1|G|0|BIO|0|0|0|100|DKK|121616|156362|lyfalmen|||1|1|0|1,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Clostridíum||121616||121616|156362||3 090662|R01AD1101|Nasacort|nefúđi|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|1411|3018|lyfalmen|||1|16,5|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1411||1411|3018||1 090784|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|ţpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|825|2212|lyfalmen|V0660|2212|1|10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíđ||825||825|2212||1 090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|0|0|0|1|0|1|CLA|0|0|0|100|USD|16782|22732|lyfsjukr|||1|60|0||Vistor hf|Alcon Nordic A/S|Flúorescein||||16782|22732||1 091266|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2440|3489|lyfsjukr|||1|2,5|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||2440||2440|3489||1 091277|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4221|6035|lyfsjukr|||1|5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||4221||4221|6035||1 091289|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|12389|17268|lyfsjukr|||1|17,5|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||12389||12389|17268||1 091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas||N06BA04|01.03.2011||R|1|0|1|0|0|0|HES|0|0|0|100|DKK|3694|6161|lyfalmen|||1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||3694||3694|6161||1 091493|A10BH0501|Trajenta|filmhtfl|5|mg|30|stk|1|ţpakki||A10BH05|01.12.2012||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|6121|9501|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||6121||6121|9501||1 091627|J01CR0501|Piperacillin/Tazobactam Actavis|irs|2,5|g|1|hgl|1|pakki|2 g/ 0,5 g|J01CR05|01.08.2014||R|0|1|0|0|0|1|APC|0|0|0|100|SEK|1097|1568|lyfsjukr|||2|1|0|0,1400|Actavis Group PTC ehf|Actavis Group PTC ehf|Piperacillín og ensimblokkar||1097||1097|1568||1 091662|L01DB0105|Doxorubicin Actavis|sts|50|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|6865|9815|lyfsjukr|||2|1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||6865|9815||1 091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|pakki|lausn|S01BA01|01.05.2011||R|0|0|0|0|G|0|CHA|0|0|1|100|DKK|3699|6168|lyfalmen|||1|30|0||Vistor hf|CCS Healthcare AB|Dexametasón||3699||3699|6168||1 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|999|1722|lyfalmen|V0021|1722|1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríđ||469||469|1722||1 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1728|2054|lyfalmen|V0022|2054|1|90|0|90,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríđ||710||710|2054||1 091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|583|1879|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Própranólól||583||583|1879||1 092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|ţpakki||QJ01CA04|01.10.1987||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|8542|16376|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||8542||8542|16376||2 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|ţpakki||B01AC04|01.12.1999||R|1|0|0|0|G|0|SBM|0|0|0|100|NOK|4679|7516|lyfalmen|V0009|3454|1|28|0|28,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||4679||4679|7516||1 092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 092554|N06DX0105|Memantine Mylan|filmhtfl|20|mg|28|stk|1|ţpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|10763|5481|lyfalmen|V0606|5119|2|28|0|28,0000|Icepharma hf|Generics UK Ltd|Memantín||3200||3200|5481||2 092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2116|3989|lyfalmen|||1|18|0|7,2000|Vistor hf|Novo-Nordisk A/S|Estradíól||2116||2116|3989||1 092750|N05AH0203|Leponex (Lyf og heilsa)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|1|0|0|0|G|0|HOL|0|0|0|100|DKK|8624|12946|lyfalmen|V0277|8495|3|100|0|33,3333|Lyf og heilsa|Lyf og heilsa|Klózapín||8624||8624|12946||2 092879|M01AB0103|Indometacin Actavis|hylki|25|mg|28|stk|1|ţpakki||M01AB01|01.03.2010||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|632|1946|lyfalmen|||2|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||632||632|1946||1 092891|M01AB0103|Indometacin Actavis|hylki|50|mg|28|stk|1|ţpakki||M01AB01|01.03.2010||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|1200|2728|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||1200||1200|2728||1 092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.05.2010||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|3128|2789|lyfalmen|V0203|2789|2|12|0|84,0000|Williams & Halls efh|Williams & Halls ehf|Alendrónsýra||1244||1244|2789||2 092989|C03DA0403|Eplerenon Bluefish|filmhtfl|25|mg|30|stk|1|ţpakki||C03DA04|01.10.2014||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|7800|6169|lyfalmen|V0107|5473|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||3700||3700|6169||2 093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|928|2354|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxýcódon||928||928|2354||2 093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|2131|4009|lyfalmen|||1|28|0|3,7300|Icepharma hf|Norpharma|Oxýcódon||2131||2131|4009||2 093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|4143|6779|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxýcódon||4143||4143|6779||2 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|6961|10657|lyfalmen|||1|1|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||6961||6961|10657||1 093284|G04BD1201|Betmiga|forđatfl|50|mg|30|stk|1|ţpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|5512|8663|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||5512||5512|8663||1 093306|M03AX0105|Xeomin|sts|100|ein/hgl|1|hgl|1|pakki||M03AX01|01.08.2015||R|0|0|0|1|0|1|ERZ|0|0|0|100|XEU|23000|30466|lyfsjukr|||1|1|0||Williams & Halls efh|Merz Pharmaceuticals GmbH|Clostridium botulinum toxín-A||23000||23000|30466||2 093343|C09CA0301|Diovan|mixtúra|3|mg/ml|160|ml|1|fl|lausn|C09CA03|01.03.2012||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1366|2956|lyfalmen|||1|160|0|6,0000|Vistor hf|Novartis Healthcare A/S|Valsartan||1366||1366|2956||1 093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|24617|42430|vetorma|||0|100|0||Icepharma hf|Zoetis Finland OY|Medroxyprogesteronum||24617||24617|42430||2 093668|N01BB0203|Xylocain|húđúđi|100|mg/ml|50|ml|1|glas|+ sk-úđari|N01BB02|01.10.2014||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2330|4283|lyfalmen|V0656|4283|1|50|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2330||2330|4283||1 093725|C03BA0802|Metolazon Abcur|töflur|5|mg|100|stk|1|ţpakki||C03BA08|01.01.2014||R|0|0|0|0|G|0|ABC|0|0|0|100|SEK|34261|45875|lyfalmen|||2|100|0|100,0000|Icepharma hf|Abcur AB|Metólazón||34261||34261|45875||2 093747|C09AA0503|Ramipril Actavis (Lyf og heilsa)|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.11.2011||R|1|0|0|0|G|0|HOL|0|0|0|100|XEU|749|2107|lyfalmen|V0496|1902|3|100|0|200,0000|Lyf og heilsa|Lyf og heilsa|Ramipríl||749||749|2107||2 093757|N02AA0501|Oxycontin|forđatfl|80|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|8908|13337|lyfalmen|||1|28|0|29,8700|Icepharma hf|Norpharma |Oxýcódon||8908||8908|13337||2 093799|N02AA0501|Oxycontin|forđatfl|80|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|23089|31745|lyfalmen|V0588|21465|1|98|0|104,5300|Icepharma hf|Norpharma |Oxýcódon||23089||23089|31745||2 093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|363506|453960|lyfsjukr|||1|0,5|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||363506||363506|453960||1 093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|410382|512260|lyfsjukr|||1|1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||410382||410382|512260||1 094111|N02CC0501|Almogran|filmhtfl|12,5|mg|6|stk|1|ţpakki||N02CC05|01.07.2010||R|1|0|0|0|G|0|AAA|0|0|0|100|SEK|4469|7227|lyfalmen|V0236|6795|1|6|0|6,0000|Vistor hf|Almirall S.A.|Almótriptan||4469||4469|7227||1 094122|N02CC0501|Almogran|filmhtfl|12,5|mg|9|stk|1|ţpakki||N02CC05|01.07.2010||R|1|0|0|0|G|0|AAA|0|0|0|100|SEK|6623|10192|lyfalmen|V0236|10192|1|9|0|9,0000|Vistor hf|Almirall S.A.|Almótriptan||6623||6623|10192||1 094132|QM01AC0604|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|1659|3261|vetalmen|||0|15|0||Vistor hf|Boehringer Ingelheim|||1659||1659|3261||1 094441|J05AB0103|Aclovir|töflur|200|mg|25|stk|1|ţpakki||J05AB01|01.04.2013||R|1|0|0|0|G|0|RGM|0|0|1|100|XEU|987|2292|lyfalmen|V0044|2292|2|25|0|1,2500|Medical ehf|ratiopharm GmbH|Acíklóvír||883||883|2292||2 094495|N06AB1007|Escitalopram Bluefish|filmhtfl|5|mg|98|stk|1|ţpakki||N06AB10|01.08.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2500|2797|lyfalmen|V0324|2797|2|98|0|49,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||1250||1250|2797||2 094652|B01AC0602|Hjarta-Aspirín|sţ-tfl|75|mg|500|stk|1|glas||B01AC06|01.02.2014||L|1|0|0|0|0|0|LYF|0|0|0|100|IKR|||lyflausa|||0|500|0|500,0000|LYFIS ehf|LYFIS ehf|Asetýlsalicýlsýra|||||||2 094757|N04BC0406|Ropinirole Portfarma|forđatfl|8|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|28905|20434|lyfalmen|V0534|20434|2|84|0|112,0000|Portfarma ehf|Portfarma|Rópíníról||14146||14146|20434||1 094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|ţpakki|300+150+300 mg|J05AR04|01.08.2003||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|88918|112449|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín, lamívúdín og abacavír||88918||88918|112449||1 094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|0|1|0|0|0|0|APE|0|0|1|100|XEU|44168|58406|lyfalmen|||1|1|0||Vistor hf|Astellas Phama Europe B.V.|Capsaicin||||44168|58406||1 094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|6026|10386|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Bakteríubólefni gegn Escherichia coli + Clostridium||6026||6026|10386||2 095005|B02BC3001|TachoSil|vefjal.n|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.01.2014||R|0|0|0|1|0|1|TAG|0|0|0|100|DKK|37576|48594|lyfsjukr|||2|1|0||Vistor hf|Takeda Austria GmbH|Blöndur||37576||37576|48594||1 095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|1577|3247|lyfalmen|||0|100|1|50,0000|Distica|Distica - óskráđ lyf|Magnesíum hýdroxíđ||1577||1577|3247||1 095418|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|4708|3181|lyfalmen|V0143|2932|3|8|0|8,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||1529||1529|3181||2 095588|N07BB0101|Antabus|freyđit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|0|0|0|0|G|0|AGT|0|0|0|100|DKK|6860|10518|lyfalmen|||1|50|0|100,0000|Actavis Group hf|Actavis Group hf|Dísúlfíram||6860||6860|10518||1 095652|N05AX1301|Invega|forđatfl|3|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|15620|22298|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||15620||15620|22298||1 095680|N05AX1301|Invega|forđatfl|6|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|15620|22298|lyfalmen|||1|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||15620||15620|22298||1 095692|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|100|ml|1|hgl||J01MA02|01.12.2010||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|1788|2556|lyfsjukr|||2|100|0|0,4000|Portfarma ehf|Portfarma|Cíprófloxacín||1788||1788|2556||1 095704|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|200|ml|1|hgl||J01MA02|01.12.2010||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|2800|4003|lyfsjukr|||2|200|0|0,8000|Portfarma ehf|Portfarma|Cíprófloxacín||2800||2800|4003||1 095707|N05AX1301|Invega|forđatfl|9|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|15620|22298|lyfalmen|||1|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||15620||15620|22298||1 095715|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|2078|2971|lyfsjukr|||2|50|0|0,5000|Portfarma ehf|Portfarma|Flúkónazól||||2078|2971||1 095726|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|3248|4644|lyfsjukr|||2|100|0|1,0000|Portfarma ehf|Portfarma|Flúkónazól||||3248|4644||1 095748|N02AX0212|Tramadol Actavis|hylki|50|mg|100|stk|1|glas||N02AX02|01.09.2011||R|1|0|1|0|G|0|AGP|0|0|1|100|XEU|930|1539|lyfalmen|V0225|1539|2|100|0|16,6700|Actavis Group hf|Actavis Group PTC ehf|Tramadól||336||336|1539||1 095767|R03BA0203|Budesonide Teva|innúđal|0,5|mg/ml|2|ml|20|lykjur||R03BA02|01.07.2015||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|4482|6582|lyfalmen|V0701|6582|2|40|0|13,3400|Medical ehf|Teva Pharma B.V.|Búdesóníđ||4000||4000|6582||2 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|IKR|4156|8055|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||4156||4156|8055||2 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|IKR|5733|11047|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||5733||5733|11047||2 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|IKR|9534|18258|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||9534||9534|18258||2 096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl||J06BA01|01.10.2008||R|0|0|0|1|0|1|OCT|0|1|0|100|DKK|88417|111826|lyfsjukr|||1|100|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í ćđ||88417||88417|111826||1 096203|C09DA0107|Losartan HCT Bluefish|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.05.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2232|2380|lyfalmen|V0088|2380|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og ţvagrćsilyf||947||947|2380||2 096227|C09DA0107|Losartan HCT Bluefish|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.05.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2323|2677|lyfalmen|V0089|2677|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og ţvagrćsilyf||1163||1163|2677||2 096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|0|0|0|0|0|0|GGL|0|0|1|100|GBP|1986|3810|lyfalmen|||1|5|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retapamúlín||1986||1986|3810||1 096260|N06DA0301|Exelon|forđapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|14022|20277|lyfalmen|V0347|17726|1|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||14022||14022|20277||1 096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|639130|796759|lyfsjukr|||1|21|0|10,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||639130||639130|796759||2 096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|677511|844494|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||677511||677511|844494||2 096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|682358|850522|lyfsjukr|||1|21|0|31,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||682358||682358|850522||2 096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|743839|926987|lyfsjukr|||1|21|0|52,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||743839||743839|926987||2 096679|N06DA0301|Exelon|forđapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|14960|21463|lyfalmen|V0349|19091|1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||14960||14960|21463||1 096685|C03BA1102|Natrilix Retard|forđatfl|1,5|mg|30|stk|1|ţpakki||C03BA11|01.03.1999||R|1|0|0|0|G|0|SEV|0|0|0|100|DKK|1221|2757|lyfalmen|||1|30|0|18,0000|Icepharma hf|Servier|Indapamíđ||1221||1221|2757||2 096768|L02AE0102|Suprecur|nefúđi|0,15|mg/sk|10|g|2|fl|lausn|L02AE01|01.01.2012||R|0|0|0|1|G|0|SNO|0|0|0|100|NOK|11901|17457|lyfalmen|||1|20|0|16,6700|Vistor hf|Sanofi-aventis Norge AS|Búserelín||11901||11901|17457||1 097033|B05AA0706|Tetraspan|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05AA07|01.04.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|25100|33077|lyfsjukr|||2|10000|0||Actavis Group hf|Braun|Hýdróxyetýl sterkja||25100||25100|33077||1 097061|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.10.2012||R|0|0|0|0|0|0|ELA|0|0|0|100|DKK|68214|117574|vetorma|||1|1000|0||Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||68214||68214|117574||2 097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|0|0|0|0|0|0|AUW|1|0|0|100|XEU|7529|14455|vetalmen|||0|10|0||Icepharma hf|ALVETRA u. WERFFTt GmbH|Bútorfanóltartrat||||7529|14455||2 097269|J01FF0103|Dalacin (Lyf og heilsa)|hylki|300|mg|20|stk|1|ţpakki||J01FF01|01.06.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|2024|3862|lyfalmen|V0461|3862|3|20|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klindamýcín||2024||2024|3862||2 097498|N06AX1602|Efexor Depot|forđahlk|37,5|mg|7|stk|1|ţpakki||N06AX16|01.12.2012||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|535|1813|lyfalmen|V0333|785|1|7|0|2,6300|Icepharma hf|Pfizer ApS|Venlafaxín||535||535|1813||1 097531|N06AX1602|Efexor Depot|forđahlk|75|mg|98|stk|1|ţpakki||N06AX16|01.07.2012||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10316|15275|lyfalmen|V0334|3078|1|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||10316||10316|15275||1 097577|N06AX1602|Efexor Depot|forđahlk|150|mg|98|stk|1|ţpakki||N06AX16|01.09.2011||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|19586|27314|lyfalmen|V0335|3078|1|98|0|147,0000|Icepharma hf|Pfizer ApS|Venlafaxín||||19586|27314||1 097599|N05BA0603|Temesta|töflur|1|mg|100|stk|1|ţpakki||N05BA06|01.02.2012||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|2253|4177|lyfalmen|||0|100|1|40,0000|Distica|Distica - óskráđ lyf|Lórazepam||2253||2253|4177||1 097662|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|ţpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5750|11079|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||5750||5750|11079||2 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|2480|2322|lyfalmen|V0023|2322|1|90|0|135,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríđ||905||905|2322||1 097887|N02CC0104|Sumacta|húđuđtfl|50|mg|12|stk|1|ţpakki||N02CC01|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|IKR|2738|2190|lyfalmen|V0233|2188|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||809||809|2190||1 097896|N02CC0104|Sumacta|húđuđtfl|100|mg|6|stk|1|ţpakki||N02CC01|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|IKR|1917|1910|lyfalmen|V0234|1910|2|6|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||606||606|1910||1 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|1023|1937|lyfalmen|V0329|1765|2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||625||625|1937||1 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|ţpakki||C09CA03|01.12.2007||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|3121|3719|lyfalmen|V0678|3416|2|98|0|98,0000|Actavis Group hf|Actavis hf|Valsartan||1920||1920|3719||1 098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|ţpakki||C09CA03|01.12.2007||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|5199|3719|lyfalmen|V0679|3691|2|98|0|196,0000|Actavis Group hf|Actavis hf|Valsartan||1920||1920|3719||1 098074|QM01AE9001|Quadrisol|hlaup|100|mg/ml|30|ml|3|spr|f. hesta|QM01AE90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5295|10216|vetalmen|||0|90|0||Icepharma hf|Zoetis Belgium S.A.|Vedaprófen||5295||5295|10216||2 098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|0|0|0|0|G|0|BIG|0|0|1|100|SEK|597|1898|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||597||597|1898||2 098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|0|0|0|0|G|0|BIG|0|0|1|100|SEK|597|1898|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||597||597|1898||2 098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|250|0||Icepharma hf|Bioglan AB|Klórhexidín|||||||2 098378|N03AX0904|Lamotrigin ratiopharm|dreifit.|25|mg|50|stk|1|ţpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|1063|1627|lyfalmen|V0243|1627|2|50|0|4,1600|Medical ehf|ratiopharm GmbH|Lamótrigín||400||400|1627||2 098387|N03AX0904|Lamotrigin ratiopharm|dreifit.|50|mg|50|stk|1|ţpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|1812|1902|lyfalmen|V0244|1787|2|50|0|8,3300|Medical ehf|ratiopharm GmbH|Lamótrigín||600||600|1902||2 098405|N03AX0904|Lamotrigin ratiopharm|dreifit.|100|mg|100|stk|1|ţpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|5116|3554|lyfalmen|V0245|3554|2|100|0|33,3300|Medical ehf|ratiopharm GmbH|Lamótrigín||1800||1800|3554||2 098423|N03AX0904|Lamotrigin ratiopharm|dreifit.|200|mg|100|stk|1|ţpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|9166|7958|lyfalmen|V0232|7958|2|100|0|66,6600|Medical ehf|ratiopharm GmbH|Lamótrigín||5000||5000|7958||2 098469|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|10|stk|1|ţpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|2815|3815|lyfalmen|V0381|3815|2|10|0|2,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||1990||1990|3815||2 098713|V03AB2502|Flumazenil B. Braun|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|5525|7899|lyfsjukr|||2|25|0||Actavis Group hf|Braun|Flúmazeníl||5525||5525|7899||1 098722|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|15033|21556|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerđ 6, 11, 16, 18)||15033||15033|21556||2 099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|0|0|0|1|0|1|ASZ|0|0|0|100|SEK|69581|88399|lyfsjukr|||1|10|0|60,2400|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||69581||69581|88399||1 099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2868|2160|lyfalmen|V0284|2109|2|100|0|6,2500|Icepharma hf|Mylan AB|Quetíapín||787||787|2160||2 099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|5979|4323|lyfalmen|V0285|4311|2|100|0|25,0000|Icepharma hf|Mylan AB|Quetíapín||2359||2359|4323||2 099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|9294|7840|lyfalmen|V0286|7840|2|100|0|50,0000|Icepharma hf|Mylan AB|Quetíapín||4914||4914|7840||2 099705|D08AG0201|Betadine|húđlausn|100|mg/ml|500|ml|1|brusar|vatnslausn|D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||||2 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||||2 099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|2731|2004|lyfalmen|V0247|1748|2|60|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||674||674|2004||1 099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|3777|3858|lyfalmen|V0248|3361|2|60|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||2021||2021|3858||1 099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|7671|4388|lyfalmen|V0249|3766|2|60|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||2406||2406|4388||1 099863|L01XE0401|Sutent|hylki|12,5|mg|28|stk|1|ţpakki||L01XE04|01.12.2012||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|162392|203830|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||162392||162392|203830||1 099872|L01XE0401|Sutent|hylki|25|mg|28|stk|1|ţpakki||L01XE04|01.03.2014||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|313008|391154|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||313008||313008|391154||1 099881|L01XE0401|Sutent|hylki|50|mg|28|stk|1|ţpakki||L01XE04|01.03.2014||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|625993|780420|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||625993||625993|780420||1 099902|H02AB0605|Prednisolone Actavis|töflur|5|mg|98|stk|1|ţpakki||H02AB06|01.01.2011||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|699|2038|lyfalmen|V0414|2038|2|98|0|49,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||699||699|2038||1 100211|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|25|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|6558|10571|veteldis|||0|25|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||6558||6558|10571||1 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|ţpakki||G04BE08|01.11.2008||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|10795|15935|lyfalmen|||1|28|0|14,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||10795|15935||2 100428|N06AX1103|Miron|filmhtfl|15|mg|100|stk|1|plglas||N06AX11|01.01.2012||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1868|3365|lyfalmen|V0672|3003|2|100|0|50,0000|Actavis Group hf|Actavis hf|Mirtazapín||1663||1663|3365||1 100807|N03AX1603|Pregabalin Krka|hylki|25|mg|56|stk|1|ţpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|2180|4077|lyfalmen|V0685|4077|2|56|0|4,6667|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2180||2180|4077||2 100884|J01AA0401|Lymecycline Actavis|hylki|300|mg|100|stk|1|ţpakki||J01AA04|01.07.2015||R|0|0|0|0|0|0|AGP|0|0|1|100|XEU|4570|7366|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Lymecycline||4570||4570|7366||1 101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|10644|12584|lyfalmen|V0254|11399|1|100|0|33,3300|Icepharma hf|Pfizer ApS|Gabapentín||8361||8361|12584||1 101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|16105|22912|lyfalmen|V0256|20249|1|100|0|44,4400|Icepharma hf|Pfizer ApS|Gabapentín||16105||16105|22912||1 101148|QI10AB0301|Alpha Ject 5-3|stl|||500|ml|1|poki||QI10AB03|01.09.2013||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|64440|103877|veteldis|||0|500|0||Vistor hf|Pharmaq AS|Aeromónas + moritella + vibrio||64440||64440|103877||1 101195|N06DX0105|Memantine Mylan|filmhtfl|10|mg|28|stk|1|ţpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|5763|3020|lyfalmen|V0604|2802|2|28|0|14,0000|Icepharma hf|Generics UK Ltd|Memantín||1412||1412|3020||2 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|1260|2165|lyfalmen|V0330|1765|2|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||791||791|2165||1 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|2589|2995|lyfalmen|V0331|2590|2|96|0|96,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1394||1394|2995||1 101756|C09DA0106|Lopress Comp|filmhtfl|62,5|mg|100|stk|1|glas|50+12,5 mg|C09DA01|01.11.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|2439|2469|lyfalmen|V0088|2429|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og ţvagrćsilyf||1012||1012|2469||1 101767|C09DA0106|Lopress Comp|filmhtfl|125|mg|100|stk|1|glas|100+25 mg|C09DA01|01.11.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|3097|2790|lyfalmen|V0089|2732|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og ţvagrćsilyf||1245||1245|2790||1 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|11557|22096|vetalmen|||0|250|0||Vistor hf|Boehringer Ingelheim|||11557||11557|22096||1 101893|G03DB0801|Visanne|töflur|2|mg|28|stk|1|ţpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|5728|8960|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AB|Díenógest||5728||5728|8960||2 101904|G03DB0801|Visanne|töflur|2|mg|84|stk|1|ţpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|16993|24035|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Díenógest||16993||16993|24035||2 102051|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|995|2446|lyfalmen|||1|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||995||995|2446||1 102062|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1549|3208|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1549||1549|3208||1 102121|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|5849|8362|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||5849||5849|8362||2 102173|N02BE0107|Paratabs|filmhtfl|500|mg|100|stk|1|ţpakki||N02BE01|01.03.2013||R|1|0|0|0|0|0|APC|0|0|1|100|XEU|389|1612|lyfalmen|V0230|1612|2|100|0|16,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól||389||389|1612||1 102404|R03DX0701|Daxas|filmhtfl|500|mcg|30|stk|1|ţpakki||R03DX07|01.10.2013||R|0|1|0|0|0|0|TAK|0|0|0|100|DKK|6746|10362|lyfalmen|||1|30|0|30,0000|Vistor hf|Takeda GmbH|Roflumílast||6746||6746|10362||1 102871|C01DA1401|Imdur|forđatfl|60|mg|98|stk|1|ţpakki||C01DA14|01.07.1989||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|3255|5557|lyfalmen|V0041|2657|1|98|0|147,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||3255||3255|5557||1 102952|G04BD0803|Solifenacin Portfarma|filmhtfl|10|mg|90|stk|1|ţpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|PEH|0|0|0|100|XEU|14848|21322|lyfalmen|V0441|21322|2|90|0|180,0000|Portfarma ehf|Portfarma ehf|Sólífenacín||14848||14848|21322||1 103050|N05CF0205|Zovand|filmhtfl|10|mg|30|stk|1|ţpakki||N05CF02|01.04.2015||R|1|0|0|0|0|0|WEH|0|0|1|100|IKR|321|1518|lyfalmen|V0060|1514|2|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Zolpidem||321||321|1518||2 103610|L01DB0105|Doxorubicin Actavis|irţ|2|mg/ml|25|ml|1|hgl|lausn|L01DB01|01.03.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|812|1161|lyfsjukr|||2|25|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||812||812|1161||1 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.02.2008||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2501|2739|lyfalmen|V0088|2380|2|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og ţvagrćsilyf||1208||1208|2739||1 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.02.2008||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|3172|3325|lyfalmen|V0089|2677|2|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og ţvagrćsilyf||1634||1634|3325||1 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|ţpakki||C09CA01|01.02.2008||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2416|3513|lyfalmen|V0069|2943|2|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan||1770||1770|3513||1 103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|ţpakki||J05AB11|01.02.2008||R|1|0|0|0|G|0|POF|0|0|1|100|GBP|1933|2055|lyfalmen|V0033|2040|2|10|0|1,6667|Portfarma ehf|Portfarma|Valacíklóvír||711||711|2055||1 103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|ţpakki||J05AB11|01.02.2008||R|1|0|0|0|G|0|POF|0|0|1|100|GBP|8059|5334|lyfalmen|V0182|5089|2|40|0|6,6700|Portfarma ehf|Portfarma|Valacíklóvír||3093||3093|5334||1 103678|N06AX1604|Venlafaxin (Portfarma)|forđahlk|75|mg|100|stk|1|ţpakki||N06AX16|01.12.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|4454|3554|lyfalmen|V0334|3141|2|100|0|75,0000|Portfarma ehf|Portfarma|Venlafaxín||1800||1800|3554||1 103687|N06AX1604|Venlafaxin (Portfarma)|forđahlk|150|mg|100|stk|1|ţpakki||N06AX16|01.12.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|7148|4380|lyfalmen|V0335|3141|2|100|0|150,0000|Portfarma ehf|Portfarma|Venlafaxín||2400||2400|4380||1 103791|M01AE0115|Alvofen Express|hylki|400|mg|10|stk|1|ţpakki||M01AE01|01.01.2015||L|1|0|0|0|0|0|IPC|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Portfarma ehf|Alvogen IPco S.á.r.l.|Íbúprófen|||||||1 103806|N02AB0305|Fentanyl ratiopharm|forđapl|12|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|1946|3755|lyfalmen|V0222|3755|2|5|0|3,6000|Medical ehf|ratiopharm GmbH|Fentanýl||1946||1946|3755||2 103813|B02BC3002|TISSEEL|vefjalím|||4|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|300413|375490|lyfsjukr|||1|40|0||Icepharma hf|Baxter AG|Blöndur||300413||300413|375490||2 103854|L01XE1701|INLYTA|filmhtfl|1|mg|56|stk|1|ţpakki||L01XE17|01.05.2013||R|1|0|0|1|0|1|PZE|0|1|0|100|DKK|114345|144073|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Ltd.|Axitinib||114345||114345|144073||1 103906|QD08AC5201|Malaseb vet.|hársápa|2|%|250|ml|1|glas|w/v|QD08AC52|01.10.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|3694|7179|vetalmen|||1|250|0||Vistor hf|Dechra Veterinary Products A/S|Bígvaníđ og amídín-Klórhexidín í blöndum||3694||3694|7179||1 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|0|0|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||1945||1 103952|A06AG0201|Toilax|innhl/tf|||1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Vistor hf|Orion Pharma|Bisakódýl|||||||1 104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|9341|13355|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||9341||9341|13355||2 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|2634|4702|lyfalmen|||1|2,5|0|10,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||2634||2634|4702||1 104489|H01BA0201|Minirin|nefúđi|0,1|mg/ml|5|ml|1|úđagl||H01BA02|01.09.2013||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|6315|9768|lyfalmen|||1|5|0|20,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||6315||6315|9768||1 104760|A07EC0202|Pentasa|eţ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|7282|11099|lyfalmen|||1|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||7282||7282|11099||1 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|3774|6271|lyfalmen|V0017|5602|1|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||3774||3774|6271||1 104851|A07EC0202|Pentasa|forđatfl|500|mg|100|stk|1|ţpakki||A07EC02|01.04.1992||R|1|0|0|0|G|0|FER|0|0|0|100|DKK|4889|7806|lyfalmen|||1|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||4889||4889|7806||1 104856|R03AK1101|Flutiform|innúđal|55|mcg/sk|120|skammtar|1|pakki|50+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|HAR|0|0|0|100|DKK|4228|6896|lyfalmen|||1|120|0|30,0000|Icepharma hf|Norpharma a/s (N)|Formóteról og flútikasón||4228||4228|6896||2 104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|102521|129367|lyfsjukr|||1|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||102521|129367||1 105306|A02BC0505|Nexium (Lyf og heilsa)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|23.09.2007||R|1|0|0|0|0|0|HOL|0|0|0|100|SEK|12524|18269|lyfalmen|V0012|5267|3|100|0|133,3300|Lyf og heilsa|Lyf og heilsa|Esómeprazól||12434||12434|18269|| 105315|G03AA0705|Microgynon (Lyf og heilsa)|töflur|||63|stk|1|ţpakki||G03AA07|01.05.2009||R|0|0|0|0|0|0|HOL|0|0|0|100|DKK|1200|2725|lyfalmen|V0545|1897|3|63|0|84,0000|Lyf og heilsa|Lyf og heilsa|Levónorgestrel og ethinylestradíól||1198||1198|2725||2 105363|C03DA0403|Eplerenon Bluefish|filmhtfl|25|mg|30|stk|1|ţpakki||C03DA04|01.05.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|7800|6169|lyfalmen|V0107|5473|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||3700||3700|6169||2 105597|C09XA0201|Rasilez|filmhtfl|150|mg|98|stk|1|ţpakki|2 x 49 töflur|C09XA02|01.01.2008||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|12521|18379|lyfalmen|||1|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||12521||12521|18379||1 105620|C09XA0201|Rasilez|filmhtfl|300|mg|98|stk|1|ţpakki|2 x 49 töflur|C09XA02|01.01.2008||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|14711|21148|lyfalmen|||1|98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||14711||14711|21148||1 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2116|3989|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||2116||2116|3989||1 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2502|4520|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||2502||2502|4520||1 106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|ţpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|1712|3433|lyfalmen|||1|10|0|2,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||1712||1712|3433||2 106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|ţpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|3279|5590|lyfalmen|||1|10|0|3,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3279||3279|5590||2 106182|G03AA1203|Yasminelle|filmhtfl|||63|stk|1|ţpakki|3+0,02 mg|G03AA12|01.04.2013||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|3275|5584|lyfalmen|V0191|4838|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||3275||3275|5584||2 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|20550|27418|lyfsjukr|||1|5|0|0,6250|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||20550||20550|27418||1 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|11365|15995|lyfsjukr|||1|5|0|0,3125|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||11365||11365|15995||1 106932|A10BG0303|Pioglitazone Teva Pharma|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.11.2012||R|1|1|0|0|G|0|TEV|0|0|0|100|XEU|6688|4015|lyfalmen|V0572|4014|2|98|0|49,0000|Medical ehf|Teva Pharma B.V.|Píóglítazón||2135||2135|4015||2 106978|C03DA0404|Kalspar|filmhtfl|25|mg|30|stk|1|ţpakki||C03DA04|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|3374|5720|lyfalmen|V0107|5473|2|30|0|15,0000|Williams & Halls efh|Williams & Halls ehf|Eplerenón||3374||3374|5720||2 107002|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|150308|188801|lyfsjukr|||1|3|0|1,5000|Vistor hf|Takeda Pharma A/S|Náttúrulegir fosfólípíđar||150308||150308|188801||1 107203|R06AX2201|Kestine|filmhtfl|10|mg|30|stk|1|ţpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1461|3087|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1461||1461|3087||1 107265|C03DA0403|Eplerenon Bluefish|filmhtfl|50|mg|30|stk|1|ţpakki||C03DA04|01.10.2014||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|9000|11812|lyfalmen|V0197|11812|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||7800||7800|11812||2 107464|G04BD0803|Solifenacin Portfarma|filmhtfl|5|mg|30|stk|1|ţpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|PEH|0|0|0|100|XEU|4337|7046|lyfalmen|V0438|7046|2|30|0|30,0000|Portfarma ehf|Portfarma ehf|Sólífenacín||4337||4337|7046|| 107575|N01AB0803|Sevoflurane Piramal|innö.guf|100|%|250|ml|1|fl||N01AB08|01.03.2015||R|0|0|0|0|0|1|PIR|0|0|0|100|XEU|19964|23722|lyfsjukr|||1|250|0||Williams & Halls efh|Piramal Healthcare UK Limited|Sevóflúran||17578||17578|23722||2 107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||R|0|0|0|0|0|0|CRO|0|0|0|100|XEU|1445|2491|vetorma|||0|6,42|0||Portfarma ehf|Cross Vetpharm Group Ltd.|Ivermectinum||1445||1445|2491|31.7.2015|1 107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|ţpakki||A02BA02|01.07.1986||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|861|2261|lyfalmen|||2|60|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||861||861|2261||1 107657|N05AX1205|Aripiprazol Krka|töflur|10|mg|56|stk|1|ţpakki||N05AX12|01.03.2015||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|20582|28574|lyfalmen|V0683|28574|2|56|0|37,3300|LYFIS ehf|Krka Sverige AB|Aripiprazól||20582||20582|28574||2 107935|QN01AX0304|Aniketam vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2015||R|0|0|1|0|0|0|VEB|1|0|0|100|IKR|8574|16437|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ketaminum||||8574|16437||2 108103|M05BA0804|Zoledronic acid medac|irl|4|mg/glasi|100|ml|1|glas|lausn|M05BA08|01.12.2013||R|0|0|0|1|0|1|WIL|0|0|0|100|XEU|13553|18716|lyfsjukr|||2|100|0|1,0000|Williams & Halls efh|medac Gesellschaft|Zoledronsýra||13553||13553|18716||2 108126|G04BD0402|Oxybutynin Mylan|töflur|5|mg|100|stk|1|ţpakki||G04BD04|01.05.2013||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|2249|4172|lyfalmen|||2|100|0|33,3300|Icepharma hf|Mylan AB|Oxýbútýnín||2249||2249|4172||2 108433|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.10.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|50872|65131|lyfsjukr|||1|4|0|26,6700|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||50872||50872|65131||1 108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|ţpakki||A10BH02|01.09.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|3064|5294|lyfalmen|||1|30|0|15,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||3064||3064|5294||1 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|ţpakki||A10BH02|01.09.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|9092|13591|lyfalmen|||1|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||9092||9092|13591||1 108697|A16AA0601|Cystadane|duft|1|g|180|g|1|glas||A16AA06|01.07.2013||R|0|0|0|1|0|0|OEU|0|0|0|100|XEU|69284|90172|lyfalmen|||1|180|0|30,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Betain anhydrous||69284||69284|90172||3 108852|R01AD0501|Rhinocort Aqua|nefúđi|64|mcg/sk|120|skammtar|1|fl||R01AD05|01.10.1988||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1419|3029|lyfalmen|||1|120|0|38,4000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1419||1419|3029||1 109212|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|glas||N03AX14|01.12.2014|30.06.2015|R|1|0|0|0|0|0|APC|0|0|0|100|XEU|17635|5675|lyfalmen|||2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3341||3341|5675||1 109357|A02BC0508|Esomeprazol Actavis|sţ-hylki|20|mg|28|stk|1|ţpakki|hart|A02BC05|01.03.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|1244|2198|lyfalmen|V0004|2198|2|28|0|18,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||815||815|2198||1 109421|V01AA0303|Alutard SQ, derm.farinae|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|22540|31051|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||22540||22540|31051||1 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18045|25365|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||18045||18045|25365||1 109569|N02AA0505|Oxycodone ratiopharm|forđatfl|20|mg|28|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|2805|3347|lyfalmen|V0584|3347|2|28|0|7,4700|Medical ehf|ratiopharm GmbH|Oxýcódon||1650||1650|3347||2 109578|N02AA0505|Oxycodone ratiopharm|forđatfl|20|mg|98|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|6973|8234|lyfalmen|V0585|8234|2|98|0|26,1300|Medical ehf|ratiopharm GmbH|Oxýcódon||5200||5200|8234||2 109588|N02AA0505|Oxycodone ratiopharm|forđatfl|40|mg|28|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|4718|6289|lyfalmen|V0586|6289|2|28|0|14,9300|Medical ehf|ratiopharm GmbH|Oxýcódon||3787||3787|6289||2 109597|N02AA0505|Oxycodone ratiopharm|forđatfl|40|mg|98|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|13624|14118|lyfalmen|V0587|14118|2|98|0|52,2700|Medical ehf|ratiopharm GmbH|Oxýcódon||9475||9475|14118||2 109615|N02AA0505|Oxycodone ratiopharm|forđatfl|80|mg|98|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|20915|21467|lyfalmen|V0588|21465|2|98|0|104,5300|Medical ehf|ratiopharm GmbH|Oxýcódon||14963||14963|21467||2 110033|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|30|stk|1|ţpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Medical ehf|ratiopharm GmbH|Cetirizín|||||||2 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|482|1740|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||482||482|1740||2 110094|G04BE0308|Sildenafil Portfarma|tuggutfl|100|mg|12|stk|1|ţpakki||G04BE03|01.09.2013||R|1|0|0|0|0|0|PEH|0|0|0|100|XEU|7029|4992|lyfalmen|||2|12|0|24,0000|Portfarma ehf|Portfarma ehf|Síldenafíl||2845||2845|4992|31.8.2015|1 110242|V03AN0101|Conoxia|lyfjagas|100|%|3|l|1|hylki|undir ţrýstingi/LIV|V03AN01|01.04.2008||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|3|0||Ísaga ehf|AGA AB|Súrefni|||||||5 110287|N05AX0806|Risperidon Krka|filmhtfl|1|mg|60|stk|1|ţpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1500|2315|lyfalmen|V0291|2315|2|60|0|12,0000|LYFIS ehf|Krka Sverige AB|Risperídón||900||900|2315||2 110306|N05AX0806|Risperidon Krka|filmhtfl|2|mg|60|stk|1|ţpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2700|3760|lyfalmen|V0292|3760|2|60|0|24,0000|LYFIS ehf|Krka Sverige AB|Risperídón||1950||1950|3760||2 110324|N05AX0806|Risperidon Krka|filmhtfl|3|mg|60|stk|1|ţpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|4210|5343|lyfalmen|V0296|5343|2|60|0|36,0000|LYFIS ehf|Krka Sverige AB|Risperídón||3100||3100|5343||2 110342|N05AX0806|Risperidon Krka|filmhtfl|4|mg|60|stk|1|ţpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|5000|6720|lyfalmen|V0297|6720|2|60|0|48,0000|LYFIS ehf|Krka Sverige AB|Risperídón||4100||4100|6720||2 110395|G03AA0902|Mercilon|töflur|||63|stk|1|ţpakki|150/20 mcg|G03AA09|01.07.1990||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1429|3043|lyfalmen|V0065|1915|1|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og ethinylestradíól||1429||1429|3043||1 110397|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5 110635|C08DA0104|Veraloc Retard|forđatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|3655|6107|lyfalmen|||1|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||3655||3655|6107||1 110750|J05AX0801|Isentress|filmhtfl|400|mg|60|stk|1|glas||J05AX08|01.04.2012||R|1|0|0|1|0|1|MLD|0|0|0|100|DKK|85635|108366|lyfsjukr|||1|60|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Raltegravír||85635||85635|108366||1 111295|G02BA0304|Levosert|leginnle|20|mcg/sólh|1|stk|1|poki||G02BA03|01.09.2015||R|0|0|0|0|0|0|EHF|0|0|0|100|XEU|15723|22428|lyfalmen|||2|1|0||Actavis Group PTC hf|Actavis ehf|Plast lyfjalykkja (IUD) međ prógestógen||15723||15723|22428||1 111479|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|4904|7015|lyfalmen|V0373|7015|2|15|0|75,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||4315||4315|7015||1 111678|A06AB5802|CitraFleet|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.12.2013||L|0|0|0|0|0|0|CAS|0|0|0|100|IKR|||lyflausa|||0|2|0||Vistor hf|Casen Recordati S.L.|Natríumpicosúlfat|||||||1 111795|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.09.2014||L|1|0|0|0|0|0|SIV|0|0|1|100|IKR|||lyflausa|||1|10|0|10,0000|Vistor hf|Bayer AB|Lóratadín|||||||1 111863|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.04.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3466|4955|lyfsjukr|||1|100|0||Icepharma hf|Baxter Medical AB|Mesna||3466||3466|4955||2 111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|1|0|0|0|0|0|GSH|0|0|1|100|DKK|696|2034|lyfalmen|V0229|2019|1|100|0|33,3300|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||696||696|2034||1 112022|G03AC0802|Implanon NXT|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2011||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|20195|28085|lyfalmen|||1|1|0|1000,0000|Vistor hf|N.V. Organon|Etónógestrel||20195||20195|28085||1 112056|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|3|innö.t||R03BB05|01.01.2013||R|0|0|0|0|G|0|ZEN|0|0|0|100|SEK|15302|21896|lyfalmen|||1|180|0|90,0000|Vistor hf|AstraZeneca AB|Aclídínumbrómíđ||15302||15302|21896||1 112191|C02KX0501|Adempas|filmhtfl|1|mg|42|stk|1|ţpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BGB|0|1|0|100|DKK|188911|236812|lyfsjukr|||1|42|0||Icepharma hf|Bayer Pharma AG|Riociguatum||188911||188911|236812||2 113058|N07BA0148|Nicovel Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Orifarm Generics A/S|Nikótín|||||||1 113143|N05AX1205|Aripiprazol Krka|töflur|30|mg|56|stk|1|ţpakki||N05AX12|01.03.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|40598|40486|lyfalmen|||2|56|0|112,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||30000||30000|40486||2 113247|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.03.2014|30.06.2015|R|0|1|0|1|G|0|BIO|0|0|0|100|DKK|122543|157534|lyfalmen|||1|1|0|1,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Clostridíum||122543||122543|157534||3 113251|D01AE1602|Amorolfin ratiopharm|lakk|5|%|5|ml|1|glas||D01AE16|01.09.2014||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyfalmen|V0655|4655|2|5|0||LYFIS ehf|ratiopharm Oy|Amorolfín|||||4655||2 113331|H02AB0205|Dexametason Abcur|töflur|1|mg|20|stk|1|ţpakki||H02AB02|01.11.2013||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|1714|3435|lyfalmen|||2|20|0|13,3300|Icepharma hf|Abcur AB|Dexametasón||1714||1714|3435||2 113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|ţpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|7199|10985|lyfalmen|V0024|9227|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||7199||7199|10985||1 113403|A10BD0801|Eucreas|filmhtfl|900|mg|180|stk|1|ţpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|19875|27680|lyfalmen|V0024|27680|1|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||19875||19875|27680||1 113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|ţpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|6484|10001|lyfalmen|V0025|8089|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||6484||6484|10001||1 113414|B05AA0114|Albuman|irl|40|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SSB|0|0|0|100|XEU|2156|3082|lyfsjukr|||1|100|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Albúmín||2156||2156|3082||2 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|áf.spr|einnota dćla|B01AB05|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|2779|4901|lyfalmen|||1|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||2779||2779|4901||1 113421|A10BD0801|Eucreas|filmhtfl|1050|mg|180|stk|1|ţpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|17177|24267|lyfalmen|V0025|24267|1|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||17177||17177|24267||1 113648|N06BA0404|Methylphenidate Sandoz|forđatfl|27|mg|30|stk|1|glas||N06BA04|01.03.2015||R|1|0|1|0|0|0|SHS|0|0|0|100|DKK|5463|8596|lyfalmen|V0681|8596|2|30|0|27,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||5463||5463|8596||1 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|áf.spr|einnota dćla|B01AB05|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|4773|7646|lyfalmen|||1|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||4773||4773|7646||1 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|ţpakki||L01XE08|01.06.2008||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|464804|579946|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||464804||464804|579946||1 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|582|1877|lyfalmen|||1|20|0|10,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||582||582|1877||1 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|737|2091|lyfalmen|||1|30|0|15,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||737||737|2091||1 113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1122|2621|lyfalmen|||1|40|0|20,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1122||1122|2621||1 114033|R03AC0210|Ventolin Diskus|innönddu|200|mcg/sk|60|skammtar|1|stk|Diskus tćki|R03AC02|01.03.1999||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|732|2084|lyfalmen|||1|60|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||732||732|2084||1 114072|A07DA0301|Imodium|filmhtfl|2|mg|16|stk|1|ţpakki||A07DA03|01.02.2014||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíđ|||||||1 114134|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|20891|27843|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||20891|27843||2 114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|32887|42762|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||||32887|42762||2 114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|ţpakki||M01AH05|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|3836|6356|lyfalmen|||1|28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||3836||3836|6356||1 114512|D06BB0401|Condyline|áburđur|5|mg/ml|3,5|ml|1|glas|til penslunar|D06BB04|01.11.2010||R|0|0|0|0|0|0|GAN|0|0|1|100|XEU|2059|3910|lyfalmen|||1|3,5|0||Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||2059||2059|3910||2 114531|L01AA0201|Leukeran|filmhtfl|2|mg|25|stk|1|glas||L01AA02|01.04.2013||R|0|0|0|0|G|0|APP|0|0|0|100|XEU|10300|15253|lyfalmen|||1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Chlorambucíl||10300||10300|15253|30.6.2015|1 114675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.12.2011||R|0|0|0|0|0|0|GAN|0|0|0|100|SEK|5423|8541|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíđ||5423||5423|8541||2 114755|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|90|stk|1|ţpakki||L02BB03|01.11.2014||R|0|0|0|0|G|0|MED|0|0|0|100|IKR|14000|14840|lyfalmen|V0420|14840|2|90|0|90,0000|Medical ehf|Medical ehf|Bíkalútamíđ||10000||10000|14840||2 114912|QP54AA0501|Stronghold|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|5644|9728|vetorma|||0|3|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5644||5644|9728||2 114941|N05AH0312|Zalasta|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|2313|2727|lyfalmen|V0278|2727|2|28|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1199||1199|2727||2 114952|N05AH0312|Zalasta|töflur|5|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|3025|4102|lyfalmen|V0279|3802|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||2198||2198|4102||2 114963|N05AH0312|Zalasta|töflur|7,5|mg|56|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|10497|15524|lyfalmen|V0280|5375|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||10497||10497|15524||2 114985|N05AH0312|Zalasta|töflur|10|mg|56|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|11046|16280|lyfalmen|V0282|2392|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||11046||11046|16280||2 114996|N05AH0312|Zalasta|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|7255|6582|lyfalmen|V0457|6582|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||4000||4000|6582||2 115007|N05AH0312|Zalasta|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|14207|13189|lyfalmen|V0456|12776|2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||8800||8800|13189||2 115018|N05AH0312|Zalasta|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|23237|13739|lyfalmen|V0475|13464|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||9200||9200|13739||2 115029|N05AH0312|Zalasta|munndr.t|20|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|35825|19911|lyfalmen|V0540|19911|2|28|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||13733||13733|19911||2 115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|1768|3510|lyfalmen|||1|10|0|3,4100|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1768||1768|3510||1 115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|8242|11784|lyfsjukr|||2|10|0||Actavis Group hf|Braun|Naloxón||8242||8242|11784||1 115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|ţpakki||J01CA04|01.10.1998||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1164|2564|lyfalmen|V0158|2453|2|20|0|15,0000|Icepharma hf|Mylan AB|Amoxicillín||1081||1081|2564||2 115309|N05AH0206|Clozapin Medical|töflur|25|mg|100|stk|1|ţpakki||N05AH02|01.06.2015||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|1955|3141|lyfalmen|V0276|3137|2|100|0|8,3300|Medical ehf|Medical ehf|Klózapín||1500||1500|3141||2 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|10607|15676|lyfalmen|||1|60|0|20,4600|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||10607||10607|15676||1 115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|1768|3510|lyfalmen|||1|10|0|5,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1768||1768|3510||1 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|9690|14414|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||9690||9690|14414||1 115554|B03AC0001|Monofer|irl|100|mg/ml|10|ml|1|hgl||B03AC|01.07.2013||R|0|0|0|0|G|0|PAC|0|0|1|100|DKK|48168|63465|lyfalmen|||1|10|0|10,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||48168||48168|63465||1 115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996|31.07.2015|R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|1775|3519|lyfalmen|||1|5|0|16,6667|Vistor hf|M.S.D.|Dorzólamíđ||1775||1775|3519||1 115931|R03AC1202|Serevent Diskus|innönddu|50|mcg/sk|60|skammtar|1|pakki||R03AC12|01.01.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|4082|6695|lyfalmen|||1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||4082||4082|6695||1 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|4100|5862|lyfsjukr|||1|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||4100||4100|5862||1 116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|2143|3064|lyfsjukr|||1|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2143||2143|3064||1 116198|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.03.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1153|1992|lyfalmen|V0056|1990|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|1992||2 116220|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.03.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1826|1992|lyfalmen|V0057|1992|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|1992||2 116244|D11AF01|Verucid|áburđur|||10|ml|1|glas||D11AF|01.11.1981||L|0|0|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||0|10|0||Icepharma hf|Galderma Nordic AB|Lyf viđ vörtum og líkţornum|||||||2 116449|N05AH0313|Olanzapin Sandoz|filmhtfl|5|mg|250|stk|1|glas||N05AH03|01.05.2013||R|2|0|0|0|G|0|SHS|0|0|0|100|DKK|18340|12897|lyfalmen|||2|250|0|125,0000|Artasan ehf|Sandoz A/S|Olanzapín||8588||8588|12897||1 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|ţpakki||M01AE01|01.12.2008||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group hf|Actavis hf|Íbúprófen|||||||1 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|ţpakki||M01AE01|01.05.2008||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Actavis Group hf|Actavis hf|Íbúprófen|||||||1 116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|ţpakki||M01AE01|01.07.2008||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|351|1543|lyfalmen|V0563|1543|2|30|0|15,0000|Actavis Group hf|Actavis hf|Íbúprófen||339||339|1543||1 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|glas||M01AE01|01.05.2008||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|845|2220|lyfalmen|V0564|1714|2|100|0|50,0000|Actavis Group hf|Actavis hf|Íbúprófen||831||831|2220||1 116694|G04BD1101|Toviaz|forđatfl|4|mg|84|stk|1|ţpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|14692|21124|lyfalmen|||1|84|0|84,0000|Icepharma hf|Pfizer Limited|Fesóteródín||14692||14692|21124||1 116697|C09CA0602|Candpress|töflur|8|mg|100|stk|1|ţpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|4973|5061|lyfalmen|V0081|5061|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||2895||2895|5061||1 116705|G04BD1101|Toviaz|forđatfl|4|mg|28|stk|1|ţpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|5603|8788|lyfalmen|||1|28|0|28,0000|Icepharma hf|Pfizer Limited|Fesóteródín||5603||5603|8788||1 116716|G04BD1101|Toviaz|forđatfl|8|mg|28|stk|1|ţpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|6017|9358|lyfalmen|||1|28|0|56,0000|Icepharma hf|Pfizer Limited|Fesóteródín||6017||6017|9358||1 116727|G04BD1101|Toviaz|forđatfl|8|mg|84|stk|1|ţpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|15750|22463|lyfalmen|||1|84|0|168,0000|Icepharma hf|Pfizer Limited|Fesóteródín||15750||15750|22463||1 116769|N06DX0108|Memantine Alvogen|munndr.t|20|mg|56|stk|1|ţpakki||N06DX01|01.05.2014||R|0|0|0|0|G|0|IPC|0|0|0|100|DKK|11489|8966|lyfalmen|||2|56|0|56,0000|Portfarma ehf|Alvogen IPco S.á.r.l.|Memantín||5732||5732|8966||1 116841|D07AC1302|Ovixan|húđlausn|0,1|%|30|ml|1|dropaí||D07AC13|01.08.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|657|1981|lyfalmen|||2|30|0||Vistor hf|Galenica AB|Mómetasón||||657|1981||1 117408|QA12AX0001|Calcimag vet. Kela|irl|||500|ml|12|plastf||QA12AX|01.04.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|XEU|9098|17431|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum í blöndum međ D-vítamíni/eđa öđrum efnum||9098||9098|17431||2 117424|M01AE0303|Orudis|forđahlk|100|mg|100|stk|1|glas||M01AE03|01.12.2014||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1504|3146|lyfalmen|||1|100|0|66,6700|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||1504||1504|3146||1 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|4210|6871|lyfalmen|V0435|6772|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4210||4210|6871||2 117550|N05AH0405|Seroquel Prolong|forđatfl|50|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|12895|16520|lyfalmen|||1|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||11220||11220|16520||1 117561|N05AH0405|Seroquel Prolong|forđatfl|200|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|G|0|ASZ|0|0|0|100|SEK|22791|27622|lyfalmen|V0273|24044|1|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||19829||19829|27622||1 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1492|3130|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1492||1492|3130||2 117573|N05AH0405|Seroquel Prolong|forđatfl|300|mg|10|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|3941|6501|lyfalmen|||1|10|0|7,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||3941|6501||1 117584|N05AH0405|Seroquel Prolong|forđatfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|G|0|ASZ|0|0|0|100|SEK|36577|42790|lyfalmen|V0272|34973|1|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||31822||31822|42790||1 117595|N05AH0405|Seroquel Prolong|forđatfl|400|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|G|0|ASZ|0|0|0|100|SEK|45582|60194|lyfalmen|V0261|48515|1|100|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||45582|60194||1 117676|L01DB0103|Caelyx|irţ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|0|0|0|1|0|1|JCI|0|1|0|100|SEK|51918|66431|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||51918||51918|66431||1 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|9026|15557|vetorma|||0|250|0||Icepharma hf|Bayer Animal Health GmbH|||9026||9026|15557||2 117929|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|NOK|5814|11201|vetalmen|||0|1200|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||5814||5814|11201||2 117937|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|XEU|10774|20611|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||10774||10774|20611||2 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.05.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|1684|3394|lyfalmen|V0278|2727|2|28|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1684||1684|3394||1 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|2761|4877|lyfalmen|V0279|3802|2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2761||2761|4877||1 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.03.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|9919|2780|lyfalmen|V0282|2392|2|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1238||1238|2780||1 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|1628|3317|lyfalmen|V0283|3317|2|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1628||1628|3317||1 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|9512|13599|lyfsjukr|||1|4|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||9512||9512|13599||5 118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|ţpakki||A02BA02|01.04.1994||L|1|0|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||0|30|0|15,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|16109|5375|lyfalmen|V0280|5375|2|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||3123||3123|5375||1 118525|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|45|ml|1|hgl||L01XA02|01.03.2015||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|5987|8560|lyfsjukr|||2|45|0||Alvogen HS|Hospira Nordic AB|Karbóplatín||5987||5987|8560||1 118575|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|ţpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5001|9658|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||5001||5001|9658||2 118612|A07EC0203|Pentasa Sachets|forđakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|20355|28287|lyfalmen|||1|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||20355||20355|28287||1 118658|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|2932|4192|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||2932||2932|4192||2 118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|ţpakki||C01AA05|01.12.2010||R|1|0|0|0|G|0|APP|0|0|0|100|XEU|455|1703|lyfalmen|||1|120|0|30,0000|Artasan ehf|Aspen Pharma Trading Limited|Digoxín||455||455|1703||1 118967|C03DA0405|Eplerenon Actavis|filmhtfl|25|mg|30|stk|1|ţpakki||C03DA04|01.09.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|6800|5991|lyfalmen|V0107|5473|2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Eplerenón||3571||3571|5991||1 119394|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.04.2013||R|1|0|0|0|G|0|APP|0|0|0|100|GBP|1499|3140|lyfalmen|||1|50|0|8,3333|Artasan ehf|Aspen Pharma Trading Limited|Labetalól||1499||1499|3140||1 119825|N05BA1206|Alprazolam Krka|forđatfl|1|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|896|1949|lyfalmen|V0309|1949|2|30|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||634||634|1949||2 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|ţpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|GGL|0|1|0|100|GBP|410022|511813|lyfsjukr|||1|30|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||410022||410022|511813||1 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|ţpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|GGL|0|1|0|100|GBP|366758|458004|lyfsjukr|||1|30|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||366758||366758|458004||1 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|0|0|0|0|G|0|SAC|0|0|0|100|USD|1077|2559|lyfalmen|||1|10|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Cýklópentólat||1077||1077|2559||1 120062|L01BA0401|Alimta|irţ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|0|0|0|1|0|1|LIL|0|1|0|100|XEU|39963|51563|lyfsjukr|||1|1|0||Icepharma hf|Lilly ICOS Limited|Pemetrexed||39963||39963|51563||2 120768|C10AA0703|Rosuvastatin Krka|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA07|01.03.2015||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|10373|12432|lyfalmen|V0118|12432|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||8250||8250|12432||2 120798|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|27223|35718|lyfsjukr|||1|1,5|0|15,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||27223||27223|35718||1 121104|L01XC1401|Kadcyla|irţ|160|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|420659|525042|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration Limited|Trastuzumab emtansine||420659||420659|525042||2 121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|4466|7223|lyfalmen|||1|28|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4466||4466|7223||1 121286|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|0|0|0|0|0|1|ORG|0|0|0|100|DKK|7131|10195|lyfsjukr|||1|50|0||Vistor hf|N.V. Organon|Rókúrón, brómíđ||7131||7131|10195||1 121302|N02BA5102|Treo|freyđit|||60|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|60|0|10,0000|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole|||||||1 121327|R03AC0204|Ventolin|innúđal|0,1|mg/sk|200|skammtar|1|stauk||R03AC02|01.12.1972||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|439|1681|lyfalmen|||1|200|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||439||439|1681||1 121550|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|98|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|3829|5278|lyfalmen|V0011|5119|2|98|0|65,3300|Portfarma ehf|Portfarma|Esómeprazól||3053||3053|5278||1 121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|ţpakki||B03BB01|01.01.2008||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|516|1787|lyfalmen|||2|28|0|350,0000|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||516||516|1787||1 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|ţpakki||N06AA04|01.03.1977||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1636|3328|lyfalmen|V0314|2805|1|100|0|25,0000|Vistor hf|Novartis Healthcare A/S|Klómípramín||1636||1636|3328||1 121691|H02AB0605|Prednisolone Actavis|töflur|1|mg|28|stk|1|ţpakki||H02AB06|01.01.2011||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|345|1551|lyfalmen|||2|28|0|2,8000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||345||345|1551||1 122301|R01AD0802|Nasofan|nefúđi|50|mcg/sk|60|skammtar|1|glas||R01AD08|01.05.2014||L|0|0|0|0|0|0|TSB|0|0|1|100|IKR|||lyflausa|||2|60|0|15,0000|Medical ehf|Teva Sweden AB|Flútíkasón||||||31.8.2015|2 122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|9429|16252|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||9429||9429|16252||1 122547|N07BC0202|Metadon Abcur|töflur|5|mg|20|stk|1|ţpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|611|1917|lyfalmen|||1|20|0|5,0000|Icepharma hf|Abcur AB|Metadón||611||611|1917||2 122577|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|10|stk|1|ţpakki||A04AA01|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|1|100|XEU|2815|3815|lyfalmen|||2|10|0|2,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||1990||1990|3815|31.7.2015|2 122588|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|50|stk|1|ţpakki||A04AA01|01.11.2012||R|1|0|0|0|G|0|BLP|0|0|1|100|XEU|9198|12065|lyfalmen|||2|50|0|12,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||7984||7984|12065|31.7.2015|2 122610|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|10|stk|1|ţpakki||A04AA01|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|1|100|XEU|3320|3712|lyfalmen|||2|10|0|5,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||1915||1915|3712|30.6.2015|2 122643|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|50|stk|1|ţpakki||A04AA01|01.11.2012||R|1|0|0|0|G|0|BLP|0|0|1|100|XEU|14342|11997|lyfalmen|||2|50|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||7934||7934|11997|30.6.2015|2 123216|N05BA0105|Stesolid|eţ-stíll|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|820|2205|lyfalmen|||2|10|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||820||820|2205||1 123224|N05BA0105|Stesolid|eţ-stíll|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1051|2523|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1051||1051|2523||1 123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|ţpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|ICE|0|0|0|100|USD|29555|50941|vetorma|||0|100|0||Icepharma hf|Icepharma hf|||29555||29555|50941||2 123456|R03DX0701|Daxas|filmhtfl|500|mcg|90|stk|1|ţpakki||R03DX07|01.10.2013||R|0|1|0|0|0|0|TAK|0|0|0|100|DKK|19862|27663|lyfalmen|||1|90|0|90,0000|Vistor hf|Takeda GmbH|Roflumílast||19862||19862|27663||1 123493|C10AA0506|Atorvaratio|filmhtfl|80|mg|100|stk|1|ţpakki||C10AA05|01.07.2014||R|1|0|0|0|0|0|TSB|0|0|0|100|IKR|7844|11873|lyfalmen|V0115|11873|2|100|0|400,0000|Medical ehf|Teva Sweden AB|Atorvastatín||7844||7844|11873||2 123641|QP51AJ0102|Baycox Sheep vet.|mixtúra|50|mg/ml|1000|ml|1|glas||QP51AJ01|01.03.2014||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|29606|51029|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|||29606||29606|51029||2 123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|228|1390|lyfalmen|||2|100|0|12,5000|Actavis Group hf|Actavis Group hf|Própranólól||||228|1390||1 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|ţpakki||N07XX02|01.05.1998||R|1|0|0|1|G|0|AVS|0|0|0|100|NOK|22730|31291|lyfalmen|V0579|26581|1|56|0|28,0000|Vistor hf|Aventis Pharma SA|Rílúzól||22730||22730|31291||1 124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|1695|3331|vetalmen|||0|42|0||Icepharma hf|Chanelle Pharmaceuticals|||||1695|3331||2 124119|B01AC0401|Plavix|töflur|300|mg|30|stk|1|ţpakki||B01AC04|01.09.2009||R|1|0|0|0|0|0|SBM|0|0|0|100|NOK|30125|40644|lyfalmen|||1|30|0|120,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||||30125|40644||1 124168|N07BC0202|Metadon Abcur|töflur|20|mg|100|stk|1|ţpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|9163|13688|lyfalmen|||1|100|0|100,0000|Icepharma hf|Abcur AB|Metadón||9163||9163|13688||2 124207|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|ţpakki||N02CC01|01.04.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1777|1910|lyfalmen|V0234|1910|2|6|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||606||606|1910||2 124251|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|ţpakki||N02CC01|01.04.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2539|2188|lyfalmen|V0233|2188|2|12|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||808||808|2188||2 124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|ţpakki||G02AB01|01.03.1980||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|929|2355|lyfalmen|||1|30|0|18,7500|Vistor hf|Novartis Healthcare A/S|Metýlergómetrín||929||929|2355||1 124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|ţpakki||C09AA02|01.01.1994||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|435|1675|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Enalapríl||435||435|1675||1 124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|10535|15577|lyfalmen|V0464|15577|1|7,5|0|75,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||10535||10535|15577||1 125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.01.1994||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|951|2314|lyfalmen|V0066|2314|2|100|0|100,0000|Actavis Group hf|Actavis hf|Enalapríl||899||899|2314||1 125125|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2013||R|0|0|0|1|G|0|APP|0|0|0|100|XEU|11815|17338|lyfalmen|||1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Melphalan||11815||11815|17338||1 125457|N05AH0411|Quetiapine Teva|filmhtfl|100|mg|100|stk|1|ţpakki||N05AH04|01.09.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|4400|4380|lyfalmen|V0285|4311|2|100|0|25,0000|Medical ehf|Teva Sweden AB|Quetíapín||2400||2400|4380||2 126540|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|0|0|0|0|0|1|EUS|0|0|0|100|XEU|23591|31201|lyfsjukr|||1|1|0|0,5417|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||23591||23591|31201||2 126649|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|0|0|0|0|0|1|EUS|0|0|0|100|XEU|7863|11242|lyfsjukr|||1|1|0|0,1354|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||7863||7863|11242||2 126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|31306|40796|lyfsjukr|||1|50|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||31306||31306|40796||2 126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|62611|79731|lyfsjukr|||1|100|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||62611||62611|79731||2 126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|125223|157602|lyfsjukr|||1|200|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||125223||125223|157602||2 126803|S01LA0501|Eylea|stl|40|mg/ml|1|hgl|1|pakki|lausn|S01LA05|01.10.2013||R|0|0|0|1|0|1|BGB|0|1|0|100|DKK|125990|158556|lyfsjukr|||1|1|0||Icepharma hf|Bayer Pharma AG|Aflibercept||125990||125990|158556||2 126926|B01AF0101|Xarelto|filmhtfl|15|mg|100|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|31879|42863|lyfalmen|||1|100|0|150,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||31879|42863||2 126949|S01BC1001|Nevanac|augndr|3|mg/ml|3|ml|1|glas||S01BC10|01.02.2014||R|0|0|0|0|G|0|ALA|0|0|1|100|USD|3482|5869|lyfalmen|||1|3|0||Vistor hf|Alcon Laboratories Ltd.|Nepafenak||||3482|5869||1 127362|A02BC0508|Esomeprazol Actavis|sţ-tfl|20|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|3871|5223|lyfalmen|V0011|5223|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3013||3013|5223||1 127383|R02AA0302|Strepsils med honning og citron|sogtfl|||36|stk|1|ţpakki||R02AA03|01.01.2009||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 127542|G04BE0307|Sildenafil Mylan|filmhtfl|100|mg|4|stk|1|ţpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|1639|2348|lyfalmen|V0144|1636|2|4|0|8,0000|Icepharma hf|Mylan AB|Síldenafíl||924||924|2348||2 127881|N07BA0149|Nicovel Mint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Orifarm Generics A/S|Nikótín|||||||1 128003|N05CF0205|Zovand|töflur|10|mg|100|stk|1|ţpakki||N05CF02|01.04.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|IKR|1644|2549|lyfalmen|V0313|2549|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Zolpidem||1070||1070|2549||2 128058|N05AH0301|Zyprexa|húđuđtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.03.1998||R|1|0|0|0|G|0|ELD|0|0|0|100|XEU|8109|5964|lyfalmen|V0279|3802|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||3551||3551|5964||2 128131|QG51AG0101|Sulfa-Streptocillin vet.|legstíl|||30|stk|1|ţpakki||QG51AG01|01.03.2009||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|13422|25635|vetalmen|||0|30|0||Vistor hf|Boehringer Ingelheim Danmark|Súlfónamíđar í blöndu međ öđrum lyfjum||13422||13422|25635||1 128146|N06DX0108|Memantine Alvogen|munndr.t|10|mg|56|stk|1|ţpakki||N06DX01|01.05.2014||R|0|0|0|0|G|0|IPC|0|0|0|100|DKK|4643|4471|lyfalmen|||2|56|0|28,0000|Portfarma ehf|Alvogen IPco S.á.r.l.|Memantín||2466||2466|4471||1 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|||100|stk|1|glas||C03AB01|01.05.1999||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|1144|2651|lyfalmen|||1|100|0|50,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||1144||1144|2651||1 128625|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2015||R|0|0|0|0|0|0|PIS|0|0|0|100|SEK|3769|6264|lyfalmen|V0699|6264|1|0,5|0||Icepharma hf|Pfizer ApS|Heilabólguveira óvirk, borin međ blóđmaur||3769||3769|6264||2 129024|A02BC0403|Rabeprazol Krka|sţ-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.03.2014||R|0|0|0|0|0|0|KRK|0|0|0|100|IKR|2500|2177|lyfalmen|V0003|1643|2|28|0|28,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||800||800|2177||2 129106|N05AH0301|Zyprexa|húđuđtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.03.1998||R|1|0|0|0|G|0|ELD|0|0|0|100|XEU|31775|21891|lyfalmen|V0282|2392|1|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||15298||15298|21891||2 129124|N02AA0506|Oxikodon Depot Actavis|forđatfl|80|mg|98|stk|1|ţpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|14961|21465|lyfalmen|V0588|21465|2|98|0|104,5300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||14961||14961|21465||1 129158|H02AB0605|Prednisolone Actavis|töflur|5|mg|28|stk|1|ţpakki||H02AB06|01.02.2011||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|251|1422|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||251||251|1422||1 129483|J01DH0202|Merinfec|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.08.2013|31.07.2015|R|0|0|0|0|0|1|AGP|0|0|0|100|XEU|17258|23324|lyfsjukr|||1|10|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Meropenem||||17258|23324||1 129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH|01.08.2005||L|1|0|0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen|||0|100|0||Vistor hf|Recip AB|Natríumhýdrógenkarbonat|||||3031||1 129817|R03BB0101|Atrovent|innúđal|0,25|mg/ml|60|plastl|1|pakki|í vél|R03BB01|01.04.1989||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|3108|5354|lyfalmen|||1|60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíđ||3108||3108|5354||1 129936|N06BA0406|Medikinet CR|hylki|50|mg|30|stk|1|ţpakki|međ breyttan losunarhrađa|N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|9929|14743|lyfalmen|||2|30|0|50,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||9929||9929|14743||2 130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|2028|3868|lyfalmen|||2|10|0|20,0000|Icepharma hf|Mylan AB|Adrenalín tartrat||2028||2028|3868||2 130397|QH01CA9301|Suprelorin|vefjalyf|4,7|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|16099|30714|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||16099||16099|30714||1 130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|3711|6184|lyfalmen|V0644|6184|2|125|0|31,2500|Vistor hf|Takeda Pharma A/S|Fúrósemíđ||3711||3711|6184||1 130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1585|3258|lyfalmen|||2|10|0|3,3400|Icepharma hf|Mylan AB|Atrópínsúlfat||1585||1585|3258||2 130596|N07BA0301|Champix|filmhtfl|||53|stk|1|ţpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|1|0|0|0|0|0|IPI|0|0|1|100|DKK|10560|15611|lyfalmen|||1|53|0|23,7500|Icepharma hf|Pfizer Limited|Vareniclin||||10560|15611||1 130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|50957|82143|veteldis|||0|500|0||Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||50957|82143||1 131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|0|100|SEK|2906|5076|lyfalmen|||2|10|0|10,0000|Icepharma hf|Mylan AB|Efedrínhýdróklóríđ||||2906|5076||2 131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|410|1641|lyfalmen|||2|100|0|33,3333|Vistor hf|Recip AB|Fenýtóín||410||410|1641||1 131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|645|1964|lyfalmen|||2|100|0|15,0000|Vistor hf|Recip AB|Fenemal||645||645|1964||1 131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|860|2260|lyfalmen|||2|100|0|50,0000|Vistor hf|Recip AB|Fenemal||860||860|2260||1 131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|952|2387|lyfalmen|||2|100|0|100,0000|Vistor hf|Recip AB|Fenemal||952||952|2387||1 131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|ţpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 131817|B01AF0101|Xarelto|filmhtfl|10|mg|10|stk|1|ţpakki||B01AF01|01.05.2009|30.06.2015|R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|3217|5504|lyfalmen|||1|10|0|10,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||3217|5504||2 131828|B01AF0101|Xarelto|filmhtfl|10|mg|30|stk|1|ţpakki||B01AF01|01.05.2009|30.06.2015|R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|9650|14359|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||9650|14359||2 131840|B01AF0101|Xarelto|filmhtfl|10|mg|100|stk|1|ţpakki||B01AF01|01.05.2009|30.06.2015|R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|31908|42899|lyfalmen|||1|100|0|100,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||31908|42899||2 132260|N06DA0404|Galantamine Portfarma|forđahlk|8|mg|28|stk|1|ţpakki||N06DA04|01.12.2011||R|1|0|0|0|G|0|POF|0|0|0|100|SEK|6937|10624|lyfalmen|||2|28|0|14,0000|Portfarma ehf|Portfarma|Galantamín||6937||6937|10624||1 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|ţpakki||C09DA03|01.10.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|4914|2973|lyfalmen|V0581|2728|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og ţvagrćsilyf||1378||1378|2973||1 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|ţpakki||C09DA03|01.10.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|3055|2973|lyfalmen|V0580|2728|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og ţvagrćsilyf||1378||1378|2973||1 132546|A06AX0401|Constella|hylki|290|mcg|28|stk|1|glas||A06AX04|01.05.2013||R|0|0|0|0|G|0|ALM|0|0|0|100|DKK|9348|13943|lyfalmen|||1|28|0|28,0000|Vistor hf|Almirall S.A.|Linaclotídum||9348||9348|13943||1 132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|1|0|1|0|G|0|REP|0|0|1|100|SEK|1288|2849|lyfalmen|||2|100|0|25,0000|Vistor hf|Recip AB|Kódein||1288||1288|2849||1 132663|N06BA0402|Concerta|forđatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|6050|9303|lyfalmen|V0681|8596|1|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||5977||5977|9303||1 132717|QN05CM9204|Nerfasin vet.|stl|100|mg/ml|50|ml|1|hgl|fyrir nautgripi og hesta|QN05CM92|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|8953|17156|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet B.V.|||8953||8953|17156||2 132748|N06AX1610|Venlafaxine Bluefish|forđahlk|150|mg|100|stk|1|ţpakki|hart|N06AX16|01.05.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|3141|lyfalmen|V0335|3141|2|100|0|150,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3141||2 132761|D08AG0201|Betadine|húđlausn|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|8|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||||2 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|0|0|0|0|0|0|SAC|0|0|0|100|USD|1228|2767|lyfalmen|||1|15|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Proxýmetakaín||1228||1228|2767||1 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|0|0|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||0|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||||1 132902|G03AB0402|Trinovum 28|töflur|||84|stk|1|ţpakki||G03AB04|01.01.1993||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|1109|2603|lyfalmen|||1|84|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og ethinylestradíól||1109||1109|2603||1 133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|23572|31177|lyfsjukr|||1|0,5|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||23572||23572|31177||1 133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|31342|40841|lyfsjukr|||1|1|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||31342||31342|40841||1 133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|42618|54865|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||42618|54865||1 133411|B06AC0101|Cinryze|sts|500|ae|2|hgl|1|pakki|+ leysir, lausn|B06AC01|01.03.2013||R|0|1|0|1|0|1|SPR|0|0|0|100|DKK|253984|317745|lyfsjukr|||1|2|0||Lyfjaver ehf|ViroPharma SPRL|C1 hemill||253984||253984|317745||3 133508|A06AD6501|Moxalole|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||||1 133530|A06AD6501|Moxalole|mixtduft|13,8|g|20|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Vistor hf|Meda AB (V)|Makrógól 3350|||||||1 133551|J05AG0101|Viramune|töflur|200|mg|14|stk|1|ţpakki||J05AG01|01.03.2013||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|7918|11321|lyfsjukr|||1|14|0|7,0000|Vistor hf|Boehringer Ingelheim International|Nevírapín||7918||7918|11321||1 133552|A06AD6501|Moxalole|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|SEK|||lyfalmen|V0592|6071|0|50|0|25,0000|Vistor hf|Meda AB (V)|Makrógól 3350|||||6071||1 133919|N06AX1105|Mirtazapine Bluefish|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.04.2014||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|998|1765|lyfalmen|V0329|1765|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||500||500|1765||2 133949|H01BB0201|Syntocinon|nefúđi|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.02.2015||R|0|0|0|0|G|0|STI|0|0|0|100|NOK|2931|5111|lyfalmen|||1|5|0|13,3333|Lyfjaver ehf|Sigma-Tau Industrie Farmaceutiche|Oxýtócín||2931||2931|5111||3 133974|N06AX1610|Venlafaxine Bluefish|forđahlk|37,5|mg|30|stk|1|ţpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|1661|3363|lyfalmen|V0333|3363|2|30|0|11,2500|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1661||1661|3363||2 134019|N06AX1610|Venlafaxine Bluefish|forđahlk|75|mg|100|stk|1|ţpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|3141|lyfalmen|V0334|3141|2|100|0|75,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3141||2 134085|N06AX1610|Venlafaxine Bluefish|forđahlk|150|mg|100|stk|1|ţpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|3141|lyfalmen|V0335|3141|2|100|0|150,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3141||2 134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3716|6191|lyfalmen|V0378|5470|1|9|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||3716||3716|6191||2 134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|11140|16409|lyfalmen|V0378|16409|1|27|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||11140||11140|16409||2 134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|0|0|0|1|0|1|AGT|0|0|0|100|XEU|2523|3607|lyfsjukr|||2|25|0||Actavis Group hf|Actavis Group hf|Epírúbicín||2523||2523|3607||1 134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|55669|71097|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||55669||55669|71097||1 134844|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.04.2014||L|1|0|0|0|G|0|SIV|0|0|1|100|DKK|||lyfalmen|V0362|2040|1|100|0|100,0000|Vistor hf|Bayer AB|Lóratadín|||||8649||1 134862|J05AR0601|Atripla|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|111747|140842|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||111747||111747|140842||2 134906|A02BC0307|Gasterix|sţ-hylki|30|mg|100|stk|1|glas||A02BC03|01.02.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4200|3416|lyfalmen|V0007|3416|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Lansóprazól||1700||1700|3416||2 134939|A02BC0307|Gasterix|sţ-hylki|15|mg|100|stk|1|glas||A02BC03|01.02.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|2560|3829|lyfalmen|||2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Lansóprazól||2000||2000|3829||2 135090|C02KX0501|Adempas|filmhtfl|1,5|mg|84|stk|1|ţpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BGB|0|1|0|100|DKK|380546|475153|lyfsjukr|||1|84|0||Icepharma hf|Bayer Pharma AG|Riociguatum||380546||380546|475153||2 135111|H01AC0101|Genotropin|sts|12|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.04.1992|31.08.2015|R|0|0|0|1|0|1|PER|0|1|0|100|DKK|49049|62863|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||49049||49049|62863||1 135319|C08DA0108|Verapamil Mylan|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|877|2283|lyfalmen|||2|100|0|33,3333|Icepharma hf|Mylan AB|Verapamíl||877||877|2283||2 135434|R03BA0502|Flixotide Diskus|innönddu|100|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|1490|3127|lyfalmen|||1|60|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||1490||1490|3127||1 135559|L01CD0202|Docetaxel Actavis|irţ|20|mg/ml|4|ml|1|hgl|lausn|L01CD02|01.04.2013||R|0|0|0|1|0|1|AVB|0|0|0|100|XEU|4976|7114|lyfsjukr|||2|4|0||Actavis Group PTC ehf|Actavis BV|Docetaxel||4976||4976|7114||1 136168|G03AB0401|Trinovum|töflur|||63|stk|1|ţpakki||G03AB04|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|1109|2603|lyfalmen|||1|63|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og ethinylestradíól||1109||1109|2603||1 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|1|0|0|0|0|0|REP|0|0|0|100|SEK|6015|9355|lyfalmen|||1|100|0|100,0000|Vistor hf|Recip AB|Ísóníazíđ||6015||6015|9355||1 136281|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.03.2012||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|64468|82040|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||64468||64468|82040||1 136653|N06AX2601|Brintellix|filmhtfl|5|mg|28|stk|1|ţpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|2996|5200|lyfalmen|||1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||2996||2996|5200||1 136658|N05BA1206|Alprazolam Krka|forđatfl|0,5|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|426|1540|lyfalmen|V0307|1540|2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||337||337|1540||2 136964|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|5|ml|1|hgl||L01CD01|01.10.2005||R|0|0|0|1|0|1|VOG|0|0|0|100|XEU|2177|3113|lyfsjukr|||2|5|0||Alvogen HS|Hospira UK Ltd.|Paklítaxel||2177||2177|3113||1 136975|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|0|0|0|1|0|1|VOG|0|0|0|100|XEU|6816|9745|lyfsjukr|||2|16,7|0||Alvogen HS|Hospira UK Ltd.|Paklítaxel||6816||6816|9745||1 136987|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|0|0|0|1|0|1|VOG|0|0|0|100|XEU|5023|7181|lyfsjukr|||2|25|0||Alvogen HS|Hospira UK Ltd.|Paklítaxel||5023||5023|7181||1 136998|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|0|0|0|1|0|1|VOG|0|0|0|100|XEU|7831|11196|lyfsjukr|||2|50|0||Alvogen HS|Hospira UK Ltd.|Paklítaxel||7831||7831|11196||1 137110|L01XA0302|Oxaliplatin Hospira|irţ|5|mg/ml|20|ml|1|hgl||L01XA03|01.06.2011||R|0|0|0|1|0|1|VOG|0|0|0|100|XEU|5505|7871|lyfsjukr|||2|20|0||Alvogen HS|Hospira UK Ltd.|Oxalíplatín||5505||5505|7871||1 137635|N05AH0413|Quetiapin ratiopharm|forđatfl|400|mg|100|stk|1|ţpakki||N05AH04|01.05.2015||R|1|0|0|0|G|0|TEV|0|0|0|100|IKR|39000|49340|lyfalmen|V0261|48515|2|100|0|100,0000|Medical ehf|Teva Pharma B.V.|Quetíapín||37000||37000|49340||2 137809|M05BA0302|Pamidronatdinatrium Hospira|irţ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|VOG|0|0|0|100|XEU|20034|26777|lyfsjukr|||2|25|0|1,2500|Alvogen HS|Hospira UK Ltd.|Pamídrónsýra||20034||20034|26777||1 137820|M05BA0302|Pamidronatdinatrium Hospira|irţ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|0|0|0|0|0|1|VOG|0|0|0|100|XEU|5824|8327|lyfsjukr|||2|10|0|0,5000|Alvogen HS|Hospira UK Ltd.|Pamídrónsýra||5824||5824|8327||1 137831|M05BA0302|Pamidronatdinatrium Hospira|irţ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|VOG|0|0|0|100|XEU|5087|7273|lyfsjukr|||2|10|0|1,0000|Alvogen HS|Hospira UK Ltd.|Pamídrónsýra||5087||5087|7273||1 137842|M05BA0302|Pamidronatdinatrium Hospira|irţ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|VOG|0|0|0|100|XEU|5749|8219|lyfsjukr|||2|10|0|1,5000|Alvogen HS|Hospira UK Ltd.|Pamídrónsýra||5749||5749|8219||1 137992|J01XA0106|Vancomycin Hospira|irs|500|mg/hgl|1|hgl|1|pakki||J01XA01|01.04.1997||R|0|0|0|0|0|1|ENH|0|0|0|100|XEU|690|987|lyfsjukr|||2|1|0|0,2500|Alvogen HS|Hospita Enterprises B.V. (I)|Vankómýcín||690||690|987||1 138073|J01XA0106|Vancomycin Hospira|irs|1|g/hgl|1|hgl|1|pakki||J01XA01|01.04.1997||R|0|0|0|0|0|1|ENH|0|0|0|100|XEU|972|1390|lyfsjukr|||2|1|0|0,5000|Alvogen HS|Hospita Enterprises B.V. (I)|Vankómýcín||972||972|1390||1 138302|N03AX1603|Pregabalin Krka|hylki|300|mg|56|stk|1|ţpakki||N03AX16|01.04.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|13290|19351|lyfalmen|V0689|19351|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||13290||13290|19351||2 138318|L01BA0109|Metoject|stl|50|mg/ml|0,35|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2818|4955|lyfalmen|||1|0,35|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2818||2818|4955||2 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1590|3265|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól||1590||1590|3265||2 138603|N07BB0501|Selincro|filmhtfl|18|mg|28|stk|1|ţpakki||N07BB05|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|15907|22661|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||15907||15907|22661||1 139050|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíđ 20 mg|S01ED51|01.01.2012||R|0|0|0|0|G|0|APC|0|0|0|100|XEU|4376|7015|lyfalmen|V0373|7015|2|15|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||4315||4315|7015||1 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|ţpakki||R06AA04|01.08.1981||L|1|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|100|0|50,0000|Artasan ehf|Novartis Healthcare A/S|Klemastín|||||4882||1 140141|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.04.2009|31.08.2015|R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|313961|392340|lyfsjukr|||1|50|0||Vistor hf|Merck Sharp & Dohme Limited|Sugammadex||313961||313961|392340||1 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|1342|2923|lyfalmen|V0266|2093|1|30|0|1,0600|Vistor hf|Boehringer Ingelheim International |Pramipexól||1342||1342|2923||1 140330|N02AA0506|Oxikodon Depot Actavis|forđatfl|80|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|14961|21465|lyfalmen|V0588|21465|2|98|0|104,5300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||14961||14961|21465||1 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|0|0|0|0|0|1|LBK|0|0|0|100|DKK|10301|14672|lyfsjukr|||1|10|0|16,6700|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||10301||10301|14672||1 140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|0|0|0|0|0|1|SIG|0|0|0|100|DKK|588|841|lyfsjukr|||1|5|0|3,3333|Swedish Orphan Biovitrum A/S|Sigma-Tau Industrie Farmaceutiche|Oxýtócín||588||588|841||3 140729|QN01AX0001|Finquel, vet|duft|100|%|1000|g|1|fl|bađlausn handa fiskum|QN01AX|01.01.2012||R|0|0|0|0|0|0|SRR|0|0|0|100|NOK|73818|140218|vetalmen|||0|1000|0||Scan Aqua AS|Scan Aqua AS|Tricaine mesylate||73818||73818|140218||1 140954|N07BA0103|Nicorette|nefúđi|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|áfspr||H02AB04|01.04.1994||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|1123|2622|lyfalmen|V0413|2392|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1123||1123|2622||1 141063|S01BC1001|Nevanac|augndr|1|mg/ml|5|ml|1|dropaí||S01BC10|01.08.2013||R|0|0|0|0|G|0|ALA|0|0|1|100|USD|3482|5869|lyfalmen|||1|5|0||Vistor hf|Alcon Laboratories Ltd.|Nepafenak||||3482|5869||1 141129|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|1170|1673|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||1170||1170|1673||2 141153|R01AB0601|Otrivin Comp|nefúđi|1,1|mg/ml|10|ml|1|glas|0,5+0,6 mg/ml|R01AB06|01.05.2013||L|0|0|0|0|0|0|NAA|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S|Xýlómetazóín og Ípratrópíum|||||||1 141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3630|5190|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3630||3630|5190||2 141438|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|15078|21613|lyfalmen|||1|0,5|0|4,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||15078|21613||2 141569|H02AB0908|Plenadren|töflur|5|mg|50|stk|1|glas|međ breyttan losunarhrađa|H02AB09|01.01.2013||R|1|0|0|0|G|0|SPR|0|0|1|100|DKK|40401|53641|lyfalmen|||1|50|0|8,3300|Lyfjaver ehf|ViroPharma SPRL|Hýdrókortisón||40401||40401|53641||2 141684|G03AA1205|Yaz|filmhtfl|||84|stk|1|ţpakki|0,02mg/3mg|G03AA12|01.02.2009||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|3735|6217|lyfalmen|V0193|5016|1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||||3735|6217||2 141751|J01EE0106|Co-Trimoxazole|töflur|480|mg|28|stk|1|glas|80+400 mg|J01EE01|01.02.2009||R|0|0|0|0|0|0|AEA|0|0|1|100|XEU|601|1904|lyfalmen|||2|28|0|7,0000|Actavis hf|Actavis EAD|Súlfametoxazól og trímetóprím||601||601|1904||1 141856|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|0|KAB|0|0|0|100|IKR|||lyfalmen|||0|200|0||Icepharma hf|Fresenius Kabi AB|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||3053||2 141872|R03DC0304|Montelukast Teva|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.02.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|12417|3496|lyfalmen|V0492|3496|2|98|0|39,2000|Medical ehf|Teva Pharma B.V.|Montelúkast||1758||1758|3496||2 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|7951|12020|lyfalmen|V0267|4981|1|100|0|7,2000|Vistor hf|Boehringer Ingelheim International|Pramipexól||7951||7951|12020||1 142034|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.07.2012||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1709|3343|lyfalmen|V0127|3115|2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||1647||1647|3343||2 142123|R07AX0101|INOmax|innö.gas|800|ppm|2|l|1|gashyl||R07AX01|01.09.2014||R|0|1|0|1|0|1|LIN|0|0|0|100|XEU|21564|28680|lyfsjukr|||1|2|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíđ||||21564|28680||5 142266|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|10|stk|1|ţpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|3320|3712|lyfalmen|V0384|3712|2|10|0|5,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||1915||1915|3712||2 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|ţpakki||C01BD01|01.04.1987||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|780|2150|lyfalmen|||1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||780||780|2150||1 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|2498|4515|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB (V)|Metenamín||2498||2498|4515||1 142615|C07AG0205|Carveratio|töflur|6,25|mg|100|stk|1|ţpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|1750|3485|lyfalmen|||2|100|0|16,6700|Medical ehf|ratiopharm GmbH|Carvedílól||1750||1750|3485||2 143139|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||100|ml|50|hgl|fyrir stungulyf|V07AB|01.11.2012||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||0|5000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||16398||2 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|1334|2912|lyfalmen|||1|1|0|6,2500|Icepharma hf|Pfizer ApS|Metýlprednisólón||1334||1334|2912||1 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2095|2995|lyfsjukr|||1|1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2095||2095|2995||1 143511|J07BC2002|Twinrix Paediatric|stl|||0,5|ml|1|dćla|einnota dćla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|4189|6842|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||4189||4189|6842||1 143526|C07AB0309|Atenolol Actavis|filmhtfl|50|mg|100|stk|1|ţpakki||C07AB03|01.10.2012||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|543|1616|lyfalmen|V0542|1616|2|100|0|66,6700|Actavis Group hf|Actavis Group PTC ehf|Atenólól||392||392|1616||1 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|0|0|0|0|0|0|SAC|0|0|0|100|USD|1014|2472|lyfalmen|||1|15|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Trópíkamíđ||1014||1014|2472||1 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|ţpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|1263|2815|lyfalmen|V0173|2349|1|2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1263||1263|2815||1 143609|A10BD0701|Janumet|filmhtfl|900|mg|56|stk|1|ţpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|6104|9478|lyfalmen|V0387|8385|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||6104||6104|9478||1 143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|ţpakki||N02CX02|01.04.1974||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|1227|2765|lyfalmen|||1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Klónidín||1227||1227|2765||1 143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|ţpakki|50/1000mg|A10BD07|01.03.2009||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|6172|9571|lyfalmen|V0386|7571|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||6172||6172|9571||1 143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|543|1824|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||543||543|1824||1 143787|N06AX1611|Duofaxin|forđatfl|225|mg|28|stk|1|ţpakki||N06AX16|01.07.2015||R|1|0|0|0|0|0|MEV|0|0|0|100|DKK|1502|3001|lyfalmen|||2|28|0|63,0000|Vistor hf|MediLink A/S|Venlafaxín||1398||1398|3001||1 143800|N05AN0101|Litarex|forđatfl|6|mmól|100|stk|1|glas||N05AN01|01.04.1974||R|1|0|0|0|G|0|AGT|0|0|0|100|DKK|2513|4535|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis Group hf|Litíum||2513||2513|4535||1 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|ţpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|1594|3270|lyfalmen|V0174|2683|1|3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1594||1594|3270||1 144030|N04BA0207|Sinemet depot mite|forđatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|1929|3731|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1929||1929|3731||1 144035|N05AH0501|Sycrest|tungur.t|10|mg|60|stk|1|ţpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|21213|29372|lyfalmen|||1|60|0|30,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||21213||21213|29372||1 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|64376|81926|lyfsjukr|||1|1,5|0|22,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||64376||64376|81926||1 144242|C10AA0106|Simvastatin Bluefish|filmhtfl|80|mg|100|stk|1|ţpakki||C10AA01|01.05.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|5000|3815|lyfalmen|||2|100|0|266,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||1990||1990|3815||2 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|42924|55245|lyfsjukr|||1|1,5|0|15,0000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||42924||42924|55245||1 144498|N02AA0506|Oxikodon Depot Actavis|forđatfl|40|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|9476|14119|lyfalmen|V0587|14118|2|98|0|52,2700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||9476||9476|14119||1 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|21462|28553|lyfsjukr|||1|1,5|0|7,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||21462||21462|28553||1 144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|568|1858|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||568||568|1858||1 145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|0|1|0|1|0|1|CEO|0|1|0|100|DKK|72538|92077|lyfsjukr|||1|1|0|26,6700|Vistor hf|Centocor B.V.|Infliximab||72538||72538|92077||1 145440|QG04CX9001|Ypozane|töflur|1,875|mg|7|stk|1|ţpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|1662|3266|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||1662||1662|3266||1 145451|QG04CX9001|Ypozane|töflur|3,75|mg|7|stk|1|ţpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|2521|4953|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||2521||2521|4953||1 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|ţpakki||P02CX01|01.12.1972||L|1|0|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||0|8|0|1,1400|Vistor hf|Recip AB|Pýrvín|||||||1 145616|QG04CX9001|Ypozane|töflur|7,5|mg|7|stk|1|ţpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|3880|7532|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||3880||3880|7532||1 145627|QG04CX9001|Ypozane|töflur|15|mg|7|stk|1|ţpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|5410|10434|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||5410||5410|10434||1 145648|B05BB0121|Plasmalyte|irl|||500|ml|20|pokar|lausn|B05BB01|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|9678|13837|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||9678||9678|13837||2 145784|B03AC0005|Ferinject|irl|50|mg/ml|2|ml|1|hgl||B03AC|01.06.2014||R|0|0|0|0|G|0|VIF|0|0|1|100|CHF|5454|8583|lyfalmen|||1|2|0|1,0000|Vistor hf|Vifor France SA|Járn, stungulyf||5454||5454|8583||1 145806|B03AC0005|Ferinject|irl|50|mg/ml|10|ml|1|hgl||B03AC|01.06.2014||R|0|0|0|0|G|0|VIF|0|0|1|100|CHF|28815|38987|lyfalmen|||1|10|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||28815||28815|38987||1 146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|1|0|1|GGL|0|1|0|100|GBP|33483|43503|lyfsjukr|||1|1|0|4,8000|GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||||33483|43503||1 146207|L01XX1903|Irinotecan Hospira|irţ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.03.2009||R|0|0|0|1|0|1|VOG|0|0|0|100|XEU|2812|4020|lyfsjukr|||2|2|0||Alvogen HS|Hospira UK Ltd.|Írinótekan||2812||2812|4020||1 146218|L01XX1903|Irinotecan Hospira|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.03.2009||R|0|0|0|1|0|1|VOG|0|0|0|100|XEU|5713|8168|lyfsjukr|||2|5|0||Alvogen HS|Hospira UK Ltd.|Írinótekan||5713||5713|8168||1 146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|ţpakki|hart|N06BA09|01.01.2010||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|16534|23454|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||16534||16534|23454||2 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|ţpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|690|2026|lyfalmen|||1|10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||690||690|2026||1 146692|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|15|ml|1|hgl||L01XA02|01.03.2015||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|2186|3125|lyfsjukr|||2|15|0||Alvogen HS|Hospira Nordic AB|Karbóplatín||2186||2186|3125||1 147241|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.03.2009||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|2332|3334|lyfsjukr|||2|5|0||Alvogen HS|Hospira Nordic AB|Cýtarabín||2332||2332|3334||1 147252|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.03.2009||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|1445|2066|lyfsjukr|||2|10|0||Alvogen HS|Hospira Nordic AB|Cýtarabín||1445||1445|2066||1 147263|L01BC0102|Arabine|stl/irl|100|mg/ml|20|ml|1|hgl||L01BC01|01.09.2015||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|2970|4246|lyfsjukr|||2|20|0||Alvogen HS|Hospira Nordic AB|Cýtarabín||||2970|4246||1 147426|N06BA0404|Methylphenidate Sandoz|forđatfl|18|mg|30|stk|1|glas||N06BA04|01.04.2015||R|1|0|1|0|0|0|SHS|0|0|0|100|DKK|4896|7815|lyfalmen|V0691|7815|2|30|0|18,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||4896||4896|7815||1 147578|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||20|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|0|KAB|0|0|0|100|IKR|||lyfalmen|||0|400|0||Icepharma hf|Fresenius Kabi AB|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||2948||2 148213|R05CB1301|Pulmozyme|innúđal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|0|0|0|0|0|0|ROA|0|0|1|100|DKK|104430|134625|lyfalmen|||1|75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||104430||104430|134625||2 148263|J01CA0802|Penomax|filmhtfl|200|mg|20|stk|1|ţpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|1117|2345|lyfalmen|V0577|2345|2|20|0|6,6667|Portfarma ehf|Orion Corporation|Pívmecillínam||922||922|2345||1 148274|J01CA0802|Penomax|filmhtfl|200|mg|30|stk|1|ţpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|1662|3364|lyfalmen|||2|30|0|10,0000|Portfarma ehf|Orion Corporation|Pívmecillínam||1662||1662|3364||1 148285|J01CA0802|Penomax|filmhtfl|200|mg|100|stk|1|glas||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|5712|8558|lyfalmen|||2|100|0|33,3300|Portfarma ehf|Orion Corporation|Pívmecillínam||5436||5436|8558||1 148363|D11AH0401|Toctino|hylki|10|mg|30|stk|1|ţpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLI|0|0|0|100|DKK|69599|90571|lyfalmen|||1|30|0|15,0000|GlaxoSmithKline ehf|Stiefel Laboratories (Ireland) Ltd.|Alítretínóín||69599||69599|90571||1 148374|D11AH0401|Toctino|hylki|30|mg|30|stk|1|ţpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLI|0|0|0|100|DKK|69599|90571|lyfalmen|||1|30|0|45,0000|GlaxoSmithKline ehf|Stiefel Laboratories (Ireland) Ltd.|Alítretínóín||69599||69599|90571||1 148411|C03CA0110|Impugan|töflur|40|mg|100|stk|1|glas||C03CA01|01.08.2013||R|1|0|0|0|G|0|AGT|0|0|0|100|SEK|400|1529|lyfalmen|V0601|1529|2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Fúrósemíđ||329||329|1529||1 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|ţpakki||N04AA02|01.11.2005||R|1|0|0|0|G|0|LFS|0|0|0|100|DKK|789|2162|lyfalmen|||1|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||789||789|2162||1 148642|N01AX6301|Livopan|lyfjagas|||5|l|1|hylki|50% + 50%|N01AX63|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|62097|79091|lyfsjukr|||1|5|0||Ísaga ehf|AGA AB|Tvínituroxíđ og súrefni||62097||62097|79091||5 148741|L01CA0207|Vincristine Hospira|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|6067|8674|lyfsjukr|||2|5|0||Alvogen HS|Hospira Nordic AB|Vínkristín||6067||6067|8674||1 148752|L01CA0207|Vincristine Hospira|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|12719|17679|lyfsjukr|||2|10|0||Alvogen HS|Hospira Nordic AB|Vínkristín||12719||12719|17679||1 148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|27209|35700|lyfsjukr|||1|1|0||Alvogen HS|Hospira Nordic AB|Raltítrexed||27209||27209|35700||1 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|0|0|0|0|0|0|BAN|1|0|0|100|DKK|3363|6551|vetalmen|||0|25|0||Icepharma hf|Bayer Animal Health GmbH|||3363||3363|6551||2 149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|ţpakki||N05AG02|01.03.2004||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|3123|5375|lyfalmen|||0|75|1|18,7500|Distica|Distica - óskráđ lyf|Pímózíđ||3123||3123|5375||1 149375|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.03.2010||R|0|0|0|0|G|0|POF|0|0|0|100|DKK|966|2406|lyfalmen|V0376|1635|2|2,5|0|25,0000|Portfarma ehf|Portfarma|Latanóprost||966||966|2406||1 149525|QA04AD9001|Cerenia|töflur|60|mg|4|stk|1|ţpakki||QA04AD90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2597|5098|vetalmen|||0|4|0||Icepharma hf|Zoetis Belgium S.A.|||||2597|5098||2 150162|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.01.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|4576|7375|lyfalmen|||1|24|0||Vistor hf|Laboratories THEA|Ketotifen||4576||4576|7375||1 150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|41007|52861|lyfsjukr|||1|1,6|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||41007|52861||1 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|6080|9445|lyfalmen|||1|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||6080||6080|9445||1 151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|930|2356|lyfalmen|||1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||930||930|2356||1 151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|ţpakki||N06DX01|01.11.2008||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|14764|21216|lyfalmen|V0606|5119|1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||14764|21216||1 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|ţpakki||N06DX01|01.11.2008||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|45586|57452|lyfalmen|V0607|12392|1|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||43414||43414|57452||1 151532|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|392|1616|lyfalmen|V0633|1537|2|100|0|50,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíđ||392||392|1616||1 151627|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|pakki|lausn,áf.lyfjap.+ spr.nál|G03GA08|01.04.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|4357|7073|lyfalmen|||1|0,5|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||||4357|7073||2 151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|ţpakki|međ br. losunarhrađa|G04CA02|01.05.2006||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|4661|3543|lyfalmen|V0148|3443|2|90|0|90,0000|Icepharma hf|Mylan AB|Tamsúlósín||1792||1792|3543||2 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|ţpakki||N06AA12|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1458|3083|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Doxepín||1458||1458|3083||1 151975|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.02.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|4359|3554|lyfalmen|V0006|3554|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||1800||1800|3554||2 152197|C07AB0213|Metoprololsuccinat Hexal|forđatfl|25|mg|100|stk|1|plglas|23,75 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|1082|2421|lyfalmen|V0050|2421|2|100|0|15,8300|Artasan ehf|Hexal A/S|Metóprólól||977||977|2421||1 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|1768|2528|lyfsjukr|||1|5|0|0,4500|Vistor hf|Novartis Healthcare A/S|Baklófen||1768||1768|2528||1 152318|D01BA0204|Terbinafine (Lyf og heilsa)|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.12.2010||R|1|0|0|0|0|0|HOL|0|0|0|100|XEU|2057|3881|lyfalmen|V0123|3881|3|28|0|28,0000|Lyf og heilsa|Lyf og heilsa|Terbínafín||2038||2038|3881||2 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||0|25|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1 152397|R03BA0202|Pulmicort Turbuhaler|innönddu|100|mcg/sk|200|skammtar|1|stauk||R03BA02|01.04.1991||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|2826|4966|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||2826||2826|4966||1 152413|R03BA0202|Pulmicort Turbuhaler|innönddu|200|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|4536|7320|lyfalmen|||1|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4536||4536|7320||1 152421|R03BA0202|Pulmicort Turbuhaler|innönddu|400|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|G|0|ASZ|0|0|0|100|SEK|8292|12489|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníđ||8292||8292|12489||1 152635|B01AC0601|Hjartamagnyl|sţ-tfl|75|mg|100|stk|1|glas||B01AC06|01.06.2012||L|1|0|0|0|0|0|AGP|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||||1 152653|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|10|stk|1|ţpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|1427|2040|lyfalmen|V0033|2040|2|10|0|1,6667|LYFIS ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||700||700|2040||2 152663|N04BC0504|Oprymea (Lyfis)|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|17477|24647|lyfalmen|||3|100|0|28,0000|LYFIS ehf|LYFIS ehf|Pramipexól||17477||17477|24647||2 152675|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|42|stk|1|ţpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|5140|5343|lyfalmen|V0182|5343|2|42|0|7,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||3100||3100|5343||2 152687|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|90|stk|1|ţpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|12712|10711|lyfalmen|||2|90|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||7000||7000|10711||2 152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|ţpakki|hart|J02AC02|01.01.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|1062|2538|lyfalmen|||1|4|0|2,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||1062||1062|2538||1 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|ţpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis hf|Cetirizín|||||||1 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1555|3217|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín í blöndum||1555||1555|3217||1 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|ţpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis hf|Cetirizín|||||||1 153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|30756|40112|lyfsjukr|||1|1,2|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||30756|40112||1 153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1964|3780|lyfalmen|V0561|3668|1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1964||1964|3780||1 153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1374|2967|lyfalmen|V0560|2889|1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1374||1374|2967||1 153288|R06AE0704|Histasin|filmhtfl|10|mg|100|stk|1|ţpakki||R06AE07|01.01.1998||L|1|0|0|0|G|0|ACA|0|0|1|100|XEU|||lyfalmen|V0575|2234|2|100|0|100,0000|Actavis Group hf|Actavis hf|Cetirizín|||||3709||1 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|0|0|0|0|0|1|GSL|0|0|0|100|DKK|198880|249211|lyfsjukr|||1|10|0|14,2857|Gilead Nordic|Gilead Science International Ltd|Amfóterícín||198880||198880|249211||2 153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|506|1773|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis Group hf|Própranólól||||506|1773||1 153507|L02BG0602|Exemestan- Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||L02BG06|01.08.2011||R|0|0|0|0|G|0|APC|0|0|0|100|XEU|28194|38202|lyfalmen|V0452|38202|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Exemestan||28194||28194|38202||1 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|ţpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|3450|5825|lyfalmen|||1|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||3450||3450|5825||1 153553|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|598|1899|lyfalmen|||2|24|0|8,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||598||598|1899||1 153564|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|976|2420|lyfalmen|||2|24|0|20,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||976||976|2420|31.8.2015|1 153903|N03AX1108|Topiramat Bluefish|filmhtfl|100|mg|60|stk|1|ţpakki||N03AX11|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|5900|3766|lyfalmen|V0249|3766|2|60|0|20,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||1954||1954|3766||2 154014|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|30|stk|1|ţpakki||R06AX27|01.09.2013||R|1|0|0|0|G|0|TEV|0|0|1|100|XEU|1131|2244|lyfalmen|V0366|2244|2|30|0|30,0000|Medical ehf|Teva Pharma B.V.|Deslóratadín||848||848|2244||2 154480|R06AX2201|Kestine|filmhtfl|20|mg|100|stk|1|ţpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|8735|13099|lyfalmen|||1|100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||8735||8735|13099||1 154558|N03AX2201|Fycompa|filmhtfl|12|mg|28|stk|1|ţpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|21614|29879|lyfalmen|V0668|29879|1|28|0|42,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||21614||21614|29879||1 154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|ţpakki|0,2+50 mg|M01AB55|01.04.1993||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|980|2425|lyfalmen|||1|20|0|10,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||980||980|2425||1 154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|18826|25274|lyfsjukr|||1|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||18826||18826|25274||2 154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|21510|28612|lyfsjukr|||1|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||21510||21510|28612||2 154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|26908|35326|lyfsjukr|||1|7880|0||Icepharma hf|Fresenius Kabi|Blöndur||26908||26908|35326||2 154651|B05BA1021|SmofKabiven|irl|2700|kcal|2463|ml|3|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|24550|32393|lyfsjukr|||1|7389|0||Icepharma hf|Fresenius Kabi|Blöndur||24550||24550|32393||2 154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|24885|32810|lyfsjukr|||1|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||24885||24885|32810||2 154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|30160|39371|lyfsjukr|||1|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||30160||30160|39371||2 154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|16050|21822|lyfsjukr|||1|4824|0||Icepharma hf|Fresenius Kabi|Blöndur||16050||16050|21822||2 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|ţpakki|0,2+50 mg|M01AB55|01.04.1993||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|3056|5283|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3056||3056|5283||1 154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|23718|31359|lyfsjukr|||1|7616|0||Icepharma hf|Fresenius Kabi|Blöndur||23718||23718|31359||2 154728|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|28|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|1416|3025|lyfalmen|V0336|2333|2|28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1416||1416|3025||1 154739|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|98|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|4025|3138|lyfalmen|V0334|3078|2|98|0|73,5000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1498||1498|3138||1 154761|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|98|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|6460|3138|lyfalmen|V0335|3078|2|98|0|147,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1498||1498|3138||1 154952|L04AX0501|Esbriet|hylki|267|mg|252|stk|1|ţpakki|hart|L04AX05|01.07.2012||R|1|1|0|1|0|0|RRL|0|0|0|100|DKK|353735|449946|lyfalmen|||1|252|0|28,0300|Icepharma hf|Roche Registration Limited|Pírfenidon||353735||353735|449946||2 155033|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|30|stk|1|ţpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|5299|3002|lyfalmen|V0604|3002|2|30|0|15,0000|Medical ehf|ratiopharm GmbH|Memantín||1399||1399|3002||2 155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|0|0|0|0|G|0|APP|0|0|0|100|XEU|10091|14966|lyfalmen|||1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Chlorambucíl||10091||10091|14966||1 155219|N03AX1106|Topiramate Portfarma|filmhtfl|25|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|2058|2004|lyfalmen|V0247|1748|2|60|0|5,0000|Portfarma ehf|Portfarma|Tópíramat||674||674|2004||1 155230|N03AX1106|Topiramate Portfarma|filmhtfl|50|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|3468|3839|lyfalmen|V0248|3361|2|60|0|10,0000|Portfarma ehf|Portfarma|Tópíramat||2007||2007|3839||1 155241|N03AX1106|Topiramate Portfarma|filmhtfl|100|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|6234|4388|lyfalmen|V0249|3766|2|60|0|20,0000|Portfarma ehf|Portfarma|Tópíramat||2406||2406|4388||1 155246|C10BA0501|Atozet|filmhtfl|30|mg|90|stk|1|ţpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|16416|23305|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||16416||16416|23305||1 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1411|3018|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1411||1411|3018||1 155410|A02BC0403|Rabeprazol Krka|sţ-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.03.2014||R|0|0|0|0|0|0|KRK|0|0|0|100|IKR|1500|2177|lyfalmen|V0466|1781|2|28|0|14,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||800||800|2177||2 155415|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|11259|6985|lyfalmen|V0253|6256|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||4293||4293|6985||1 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|604|1908|lyfalmen|||1|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||604||604|1908||1 155478|G03AC0902|Gestrina|filmhtfl|75|mcg|84|stk|1|ţpakki|3x28 stk|G03AC09|01.01.2013||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|1556|3079|lyfalmen|V0590|3079|2|84|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Desógestrel||1455||1455|3079||1 155494|M01AE0113|Ibuxin|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.09.2014||L|1|0|0|0|0|0|ROY|0|0|1|100|IKR|||lyflausa|||2|30|0|10,0000|Medical ehf|ratiopharm Oy|Íbúprófen|||||||2 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|ţpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|5642|8842|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||5642||5642|8842||1 156195|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|100|stk|1|ţpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|16000|20249|lyfalmen|V0383|20249|2|100|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||14000||14000|20249||2 156439|L04AC1001|Cosentyx|stl|150|mg|2|áf.spr|1|ţpakki||L04AC10|01.07.2015||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|151869|163396|lyfsjukr|||1|2|0||Vistor hf|Novartis Europharm Ltd|Secukinumab||129881||129881|163396||1 156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|5014|7978|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5014||5014|7978||2 156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|5613|8802|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5613||5613|8802||2 156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|ţpakki||J01XE01|01.08.2010||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|377|1595|lyfalmen|||2|15|0|3,7500|Vistor hf|Recip AB|Nítrófúrantóín||377||377|1595||1 156563|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|2186|3125|lyfsjukr|||2|15|0||Alvogen HS|Hospira Nordic AB|Karbóplatín||2186||2186|3125||1 156574|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|1281|1831|lyfsjukr|||2|5|0||Alvogen HS|Hospira Nordic AB|Karbóplatín||1281||1281|1831||1 156585|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|5987|8560|lyfsjukr|||2|45|0||Alvogen HS|Hospira Nordic AB|Karbóplatín||5987||5987|8560||1 156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|ţpakki||A08AB01|01.07.1999||R|1|0|0|0|0|0|ROC|0|0|0|100|DKK|9094|13593|lyfalmen|||1|84|0|28,0000|Icepharma hf|Roche|Orlístat||9094||9094|13593||2 156597|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|8019|11465|lyfsjukr|||2|60|0||Alvogen HS|Hospira Nordic AB|Karbóplatín||8019||8019|11465||1 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|ţpakki||P02CA01|01.12.1982||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|756|2117|lyfalmen|||1|6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||756||756|2117||1 156723|QN01AX0303|Ketador vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2013||R|0|0|1|0|0|0|RPG|1|0|0|100|XEU|10928|20903|vetalmen|||0|50|0||Icepharma hf|Richter Pharma AG|Ketaminum||10928||10928|20903||2 157015|QP54AB5207|Equest Pramox vet|hlaup|||14,4|g|1|sk-dćl|19,5mg/g+121,7mg/g|QP54AB52|01.08.2014||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|2640|4550|vetorma|||0|14,4|0||Icepharma hf|Zoetis Finland OY|||2640||2640|4550||2 157047|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|ţpakki||N03AF01|01.01.2010||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1414|3023|lyfalmen|V0239|3023|1|100|0|20,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1414||1414|3023||1 157869|D11AX1601|Vaniqa|krem|11,5|%|30|g|1|túpa||D11AX16|01.01.2013||R|0|0|0|0|0|0|ALM|0|0|0|100|DKK|6228|9649|lyfalmen|||1|30|0||Vistor hf|Almirall S.A.|Eflórníthin||6228||6228|9649||1 158098|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|6|lykjur||C01BD01|01.08.2013||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|982|1404|lyfsjukr|||1|18|0|4,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||||982|1404||1 158163|N05AH0405|Seroquel Prolong|forđatfl|50|mg|10|stk|1|ţpakki||N05AH04|01.10.2011||R|1|0|0|0|0|0|ASA|0|0|0|100|SEK|1371|2963|lyfalmen|V0695|2813|1|10|0|1,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||1371|2963||1 158185|N05AH0405|Seroquel Prolong|forđatfl|150|mg|100|stk|1|ţpakki||N05AH04|01.10.2011||R|1|0|0|0|0|0|ASA|0|0|0|100|SEK|25263|34495|lyfalmen|||1|100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||25263|34495||1 158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|ţpakki||N03AF01|01.12.1972||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|882|2290|lyfalmen|V0239|1512|1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||882||882|2290||1 158431|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|94551|119455|lyfsjukr|||1|1|0|0,0200|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||94551|119455||1 158442|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|175956|220700|lyfsjukr|||1|1|0|0,0400|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||175956|220700||1 158453|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|472757|589837|lyfsjukr|||1|1|0|0,1000|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||472757|589837||1 158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|1|0|1|APG|0|0|0|100|XEU|42315|54488|lyfsjukr|||1|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||42315|54488||1 158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|1|0|1|APG|0|0|0|100|XEU|55696|71130|lyfsjukr|||1|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||55696||55696|71130||1 158725|M01AB0516|Diklofenak Mylan|sţ-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.12.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|896|1956|lyfalmen|V0469|1902|2|100|0|50,0000|Icepharma hf|Mylan AB|Díklófenak||639||639|1956||2 159107|N02AB0303|Fentanyl Actavis|forđapl|25|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|1960|3353|lyfalmen|V0219|3353|2|5|0|7,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||1654||1654|3353||1 159118|N02AB0303|Fentanyl Actavis|forđapl|50|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|3361|5647|lyfalmen|V0220|5647|2|5|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||3321||3321|5647||1 159130|N02AB0303|Fentanyl Actavis|forđapl|75|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|4826|7259|lyfalmen|V0221|7256|2|5|0|22,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||4492||4492|7259||1 159141|N02AB0303|Fentanyl Actavis|forđapl|100|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|5394|7880|lyfalmen|V0223|7880|2|5|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||4943||4943|7880||1 159295|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|172,5|mg|98|stk|1|ţpakki|160/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3218|2728|lyfalmen|V0581|2728|2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og ţvagrćsilyf||1200||1200|2728||2 159341|L02BB0306|Bicalutamid LYFIS|filmhtfl|150|mg|90|stk|1|ţpakki||L02BB03|01.06.2015||R|0|0|0|0|G|0|LYF|0|0|0|100|IKR|27000|21261|lyfalmen|V0421|21261|2|90|0|270,0000|LYFIS ehf|LYFIS ehf|Bíkalútamíđ||14800||14800|21261||2 159672|R05CB0105|Acetylcystein Mylan|freyđit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|G|0|MYL|0|0|1|100|SEK|459|1708|lyfalmen|||2|25|0|10,0000|Icepharma hf|Mylan AB|Acetýlcýstein||459||459|1708||2 159683|R05CB0105|Acetylcystein Mylan|freyđit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|G|0|MYL|0|0|1|100|SEK|1392|2992|lyfalmen|||2|100|0|40,0000|Icepharma hf|Mylan AB|Acetýlcýstein||1392||1392|2992||2 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|0|0|0|0|0|1|APC|0|0|0|100|DKK|127233|160102|lyfsjukr|||1|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||127233||127233|160102||1 159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|3910|7589|vetalmen|||0|50|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||3910||3910|7589||2 160164|M01AE0219|Alpoxen|töflur|250|mg|20|stk|1|ţpakki||M01AE02|01.05.2014||L|0|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||2|20|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen|||||||1 160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.05.2011||R|0|0|0|0|G|0|APC|0|0|0|100|IKR|5300|2453|lyfalmen|V0010|2067|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1000||1000|2453||1 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|6992|4222|lyfsjukr|||2|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||2953||2953|4222||1 160343|G03AA1206|Cleodette|filmhtfl|||63|stk|1|ţpakki|3+0,02 mg|G03AA12|01.07.2014||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|2733|4838|lyfalmen|V0191|4838|2|63|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Dróspírenón og ethinylestradíól||2733||2733|4838||1 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|ţpakki||N05AB04|01.06.1981||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|787|2160|lyfalmen|||1|100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||787||787|2160||1 160852|R01AX0301|Atrovent|nefúđi|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.09.2009||R|0|0|0|0|G|0|BOI|0|0|1|100|DKK|1116|2612|lyfalmen|||1|15|0|15,7500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíđ||1116||1116|2612||1 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|552|1836|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||552||552|1836||1 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|856|1224|lyfsjukr|||1|1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||856||856|1224||1 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|1465|3093|lyfalmen|||1|5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||1465||1465|3093||1 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|563|1851|lyfalmen|||1|1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||563||563|1851||1 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|ţpakki||L02BG06|01.06.2001||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|56007|73380|lyfalmen|V0452|38202|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||56007||56007|73380||1 161870|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|ţpakki|8+2 mg|N07BC51|01.08.2011||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|11413|16055|lyfsjukr|||1|28|0|28,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||11413||11413|16055||1 162080|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|136117|171151|lyfsjukr|||1|7,5|0|75,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||136117||136117|171151||1 162261|H01CB0501|Signifor|stl|0,6|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|506975|643764|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|PAsireótiđ disapartate||506975||506975|643764||1 162276|A10BB0904|Zodediab|töflur|30|mg|180|stk|1|ţpakki||A10BB09|01.03.2015||R|1|0|0|0|G|0|IPC|0|0|0|100|IKR|2658|4735|lyfalmen|V0020|4735|2|180|0|90,0000|Portfarma ehf|Alvogen IPco S.á.r.l.|Glíklazíđ||2658||2658|4735||1 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1783|3530|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1783||1783|3530||1 162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|0|0|0|0|0|0|LEV|1|0|0|100|XEU|5063|9776|vetalmen|||0|5|0||Le Vet B.V.|Le Vet B.V.|||||5063|9776||2 162808|C01DA1404|Fem-Mono Retard|forđatfl|60|mg|100|stk|1|ţpakki||C01DA14|01.10.2013||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2508|2711|lyfalmen|V0041|2711|2|100|0|150,0000|Icepharma hf|Mylan AB|Ísósorbíđ mónónítrat||1188||1188|2711||2 162841|A10BA0203|Metformin Bluefish|filmhtfl|500|mg|100|stk|1|ţpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|445|1682|lyfalmen|V0500|1656|2|100|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||440||440|1682||2 162852|A10BA0203|Metformin Bluefish|filmhtfl|850|mg|100|stk|1|ţpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|745|2102|lyfalmen|||2|100|0|42,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||745||745|2102||2 162863|A10BA0203|Metformin Bluefish|filmhtfl|1000|mg|60|stk|1|ţpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|918|1902|lyfalmen|V0502|1705|2|60|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||600||600|1902||2 162874|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|743|1665|lyfalmen|V0108|1665|2|100|0|33,3400|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||428||428|1665||2 162885|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|836|1795|lyfalmen|V0109|1795|2|100|0|66,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||522||522|1795||2 162896|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1347|2128|lyfalmen|V0110|2128|2|100|0|133,3333|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||764||764|2128||2 162903|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíđ 20 mg|S01ED51|01.01.2012|30.06.2015|R|0|0|0|0|G|0|APC|0|0|0|100|XEU|1528|3115|lyfalmen|||2|5|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||1481||1481|3115||1 162933|R03BA0501|Flixotide|innúđal|50|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|1626|3314|lyfalmen|||1|120|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||1626||1626|3314||1 163036|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|ţpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|9794|14557|lyfalmen|V0661|14557|1|60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||9794||9794|14557||1 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|ţpakki||N06BA04|01.12.1972||R|1|0|1|0|0|0|HES|0|0|0|100|DKK|1179|2699|lyfalmen|V0671|2384|1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||1179||1179|2699||1 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|ţpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|1327|2903|lyfalmen|||1|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1327||1327|2903||1 163354|C10BA0501|Atozet|filmhtfl|30|mg|30|stk|1|ţpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|5868|9153|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||5868||5868|9153||1 163389|G03AD0102|Postinor|töflur|1500|mcg|1|stk|1|ţpakki||G03AD01|01.09.2015||L|0|0|0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Icepharma hf|Medimpex UK Limited|Levonorgestrel|||||||2 163429|C01CA0601|Fenylefrin Abcur|stl|0,1|mg/ml|5|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|11626|16319|lyfsjukr|||2|50|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||11626||11626|16319||2 163493|R03BA0501|Flixotide|innúđal|125|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|2837|4981|lyfalmen|||1|120|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2837||2837|4981||1 163494|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|ţpakki||L01XE05|01.06.2013||R|0|0|0|1|0|1|BYP|0|1|0|100|DKK|487330|607962|lyfsjukr|||1|112|0||Icepharma hf|Bayer Pharma AG|Sorafeníb||487330||487330|607962||2 163667|M01AE0113|Ibuxin|filmhtfl|800|mg|30|stk|1|ţpakki||M01AE01|01.03.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|651|1714|lyfalmen|||2|30|0|20,0000|Medical ehf|ratiopharm Oy|Íbúprófen||463||463|1714||2 163675|M01AE0113|Ibuxin|filmhtfl|800|mg|100|stk|1|ţpakki||M01AE01|01.03.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|1563|2610|lyfalmen|||2|100|0|66,6700|Medical ehf|ratiopharm Oy|Íbúprófen||1114||1114|2610||2 163709|V03AE0101|Resonium|duft|||454|g|1|stauk||V03AE01|01.01.2000||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|9543|14211|lyfalmen|||0|454|1|10,0800|Distica|Distica - óskráđ lyf|Pólýstýren súlfónat||9543||9543|14211||1 164125|R01AA0707|Otrivin Junior ukonserveret|nefúđi|0,5|mg/ml|10|ml|1|glas||R01AA07|01.02.2014||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3682|5264|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||3682||3682|5264||2 164324|L01BB0202|Xaluprine|mixtúra|20|mg/ml|100|ml|1|glas||L01BB02|01.05.2015||R|0|0|0|1|0|1|VON|0|0|0|100|DKK|36710|47517|lyfsjukr|||1|100|0||Williams & Halls efh|Nova Laboratories Limited|Merkaptópúrín||36710||36710|47517||2 164592|QN03AX9001|Pexion|töflur|400|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|8932|17116|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||8932||8932|17116||1 164724|QA07XA9101|VetZin|forbl|1000|mg/g|25|kg|1|poki|forblanda f, lyfjabl. fóđur|QA07XA91|01.03.2014||R|0|0|0|0|0|0|VEP|0|0|0|100|DKK|40935|77832|vetalmen|||0|25|0||Orion Pharma A/S Animal Health|Vepidan Aps|Zink Oxide||40935||40935|77832||2 164807|N04BD0105|Selegilin Mylan|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2614|4674|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Selegilín||||2614|4674||2 164818|N04BD0105|Selegilin Mylan|töflur|10|mg|100|stk|1|glas||N04BD01|01.05.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|8617|12937|lyfalmen|||2|100|0|200,0000|Icepharma hf|Mylan AB|Selegilín||8617||8617|12937||2 164827|C02KX0501|Adempas|filmhtfl|2,5|mg|84|stk|1|ţpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BGB|0|1|0|100|DKK|380546|475153|lyfsjukr|||1|84|0||Icepharma hf|Bayer Pharma AG|Riociguatum||380546||380546|475153||2 164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1063|2539|lyfalmen|||2|100|0|10,0000|Icepharma hf|Mylan AB|Klómípramín||1063||1063|2539||2 164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1256|2805|lyfalmen|V0314|2805|2|100|0|25,0000|Icepharma hf|Mylan AB|Klómípramín||1256||1256|2805||2 164871|A07EC0204|Asacol|eţ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|0|0|0|0|G|0|TIL|0|0|0|100|SEK|5480|8619|lyfalmen|V0014|8619|1|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||5480|8619||2 165019|C05AA0102|Proctosedyl|eţ-smyr|||30|g|1|túpa||C05AA01|01.03.1981||L|0|0|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||0|30|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||||1 165175|N05BA0205|Risolid|filmhtfl|10|mg|100|stk|1|glas||N05BA02|01.03.2012||R|1|0|0|0|0|0|AGT|0|0|0|100|XEU|1221|2757|lyfalmen|||2|100|0|33,3300|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||1221||1221|2757||1 165306|QN05CM9101|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM91|01.05.2009||R|0|0|0|0|0|0|LAS|1|0|0|100|XEU|6441|12390|vetalmen|||0|10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|Metetomidinum||6441||6441|12390||2 165449|C08CA0202|Plendil|forđatfl|10|mg|98|stk|1|ţpakki||C08CA02|01.10.1995||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|4423|7164|lyfalmen|V0059|4831|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||4423||4423|7164||1 165507|L01XX1904|Irinotecan Actavis|irţ|20|mg/ml|25|ml|1|hgl|lausn|L01XX19|01.04.2013||R|0|0|0|1|0|1|AGT|0|0|0|100|XEU|6943|9927|lyfsjukr|||2|25|0||Actavis Group hf|Actavis Group hf|Írinótekan||6943||6943|9927||1 165548|C08CA0202|Plendil|forđatfl|5|mg|98|stk|1|ţpakki||C08CA02|01.10.1995||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2854|5005|lyfalmen|V0058|3483|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||2854||2854|5005||1 165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|168301|211179|lyfsjukr|||1|7,5|0|90,0000|Icepharma hf|E. Merck AB|Sómatrópín||168301||168301|211179||2 165662|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|28697|37551|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||28697||28697|37551||2 165670|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|41784|53828|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||41784||41784|53828||2 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|ţpakki||R06AE05|01.12.1972||R|1|0|0|0|G|0|UCN|0|0|1|100|SEK|612|1919|lyfalmen|||1|100|0|50,0000|Vistor hf|UCB Nordic A/S|Meklózín||612||612|1919||1 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|ţpakki||R06AE05|01.12.1972||R|1|0|0|0|G|0|UCN|0|0|1|100|SEK|177|1320|lyfalmen|||1|25|0|12,5000|Vistor hf|UCB Nordic A/S|Meklózín||177||177|1320||1 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|ţpakki||R06AE05|01.12.1972||L|1|0|0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa|||0|10|0|5,0000|Vistor hf|UCB Nordic A/S|Meklózín|||||||1 165799|C02KX0501|Adempas|filmhtfl|2|mg|42|stk|1|ţpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BGB|0|1|0|100|DKK|188911|236812|lyfsjukr|||1|42|0||Icepharma hf|Bayer Pharma AG|Riociguatum||188911||188911|236812||2 165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3890|5562|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||3890||3890|5562||2 165878|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|55743|71189|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||55743||55743|71189||2 166008|QJ51RC2202|Nafpenzal vet.|spenalyf|||3|g|20|spr||QJ51RC22|01.02.2010||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4352|8427|vetalmen|||0|60|0||Vistor hf|Intervet International BV|||||4352|8427||1 166120|A16AX0701|Kuvan|lausnart|100|mg|120|stk|1|glas||A16AX07|01.04.2013||R|0|0|0|1|0|0|MSE|0|0|0|100|SEK|405889|515910|lyfalmen|||1|120|0||Icepharma hf|Merck Serono Europe Ltd|Saprópterín||405889||405889|515910||2 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|ţpakki||P01BA02|01.12.1972||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1463|3090|lyfalmen|||1|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||1463||1463|3090||1 166165|H01CA0201|Synarela|nefúđi|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|0|0|0|1|G|0|PER|0|0|0|100|DKK|14134|20419|lyfalmen|||1|8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||14134||14134|20419||1 166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1937|3742|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Naproxen||1937||1937|3742||2 166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3666|6122|lyfalmen|V0428|6122|2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||3666||3666|6122||2 166858|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.09.2011|30.06.2015|R|0|1|0|1|G|0|BIO|0|0|0|100|DKK|122543|157534|lyfalmen|||1|1|0|1,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Clostridíum||122543||122543|157534||3 166869|N02BA0110|Aspirin Actavis|töflur|300|mg|100|stk|1|glas||N02BA01|01.11.2010||L|1|0|0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||0|100|0|10,0000|Actavis Group hf|Actavis UK Ltd.|Acetýlsalicýlsýra|||||||1 167319|N06AX1608|Venlafaxin Actavis|forđahlk|37,5|mg|7|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|418|1652|lyfalmen|V0333|785|2|7|0|2,6300|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||418||418|1652||1 167905|A02BC0508|Esomeprazol Actavis|sţ-tfl|40|mg|28|stk|1|ţpakki||A02BC05|01.01.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|1671|2439|lyfalmen|V0005|2380|2|28|0|37,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||990||990|2439||1 168038|J05AR0901|Stribild|filmhtfl|745|mg|30|stk|1|glas|150+150+200+245 mg|J05AR09|01.11.2013||R|0|1|0|1|0|1|GSL|0|0|0|100|DKK|164785|206806|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Science International Ltd|Emtrícítabín,tenófóvír disóproxíl,elvítegravír og cobícístat||164785||164785|206806||2 168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|ţpakki||M04AA01|01.06.2009||R|1|0|0|0|G|0|AUK|0|0|0|100|GBP|585|1882|lyfalmen|V0119|1627|2|100|0|25,0000|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||585|1882||1 168309|A02BC0306|Lanser|sţ-hylki|30|mg|98|stk|1|ţpakki||A02BC03|01.08.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|4452|3650|lyfalmen|V0007|3348|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lansóprazól||1870||1870|3650||1 168589|N02CC0402|Maxalt Smelt|frţ.tfl|10|mg|6|stk|1|ţpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|4166|6810|lyfalmen|V0621|1756|1|6|0|6,0000|Vistor hf|M.S.D.|Rizatriptan||4166||4166|6810||1 168618|L01BA0109|Metoject|stl|50|mg/ml|0,15|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2158|4047|lyfalmen|||1|0,15|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2158||2158|4047||2 168629|L01BA0109|Metoject|stl|50|mg/ml|0,2|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2311|4257|lyfalmen|||1|0,2|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2311||2311|4257||2 168640|L01BA0109|Metoject|stl|50|mg/ml|0,3|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2539|4571|lyfalmen|||1|0,3|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2539||2539|4571||2 168651|L01BA0109|Metoject|stl|50|mg/ml|0,4|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2870|5027|lyfalmen|||1|0,4|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2870||2870|5027||2 168662|L01BA0109|Metoject|stl|50|mg/ml|0,5|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3023|5237|lyfalmen|||1|0,5|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3023||3023|5237||2 168740|N03AF0105|Tegretol Retard|forđatfl|200|mg|200|stk|1|ţpakki||N03AF01|01.07.1988||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2839|4984|lyfalmen|V0240|4983|1|200|0|40,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||2839||2839|4984||1 168971|N03AF0105|Tegretol Retard|forđatfl|400|mg|200|stk|1|ţpakki||N03AF01|01.07.1988||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|5240|8289|lyfalmen|V0433|8287|1|200|0|80,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||5240||5240|8289||1 168997|L01CA0401|Navelbine|irţ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|1|0|1|PFP|0|0|0|100|SEK|27023|35469|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||27023||27023|35469||1 169175|N03AX1603|Pregabalin Krka|hylki|225|mg|56|stk|1|ţpakki||N03AX16|01.04.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|11700|17180|lyfalmen|V0688|17180|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||11700||11700|17180||2 169433|L01CA0401|Navelbine|irţ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|1|0|1|PFP|0|0|0|100|SEK|135114|169904|lyfsjukr|||1|50|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||135114||135114|169904||1 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|19188|25724|lyfsjukr|||1|5|0|5,0000|Icepharma hf|Roche A.S.|Gancíklóvír||19188||19188|25724||2 169664|J07BK0101|Varilrix|sts|||0,5|ml|1|hgl|ţurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|5879|9168|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hlaupabóla, veikluđ veira||5879||5879|9168||1 169729|D10BA0105|Isotretinoin Portfarma|hylki|10|mg|30|stk|1|ţpakki||D10BA01|01.10.2009|31.07.2015|R|0|1|0|1|G|0|POF|0|0|0|30|IKR|1407|2936|lyfalmen|||2|30|0|10,0000|Portfarma ehf|Portfarma|Ísótretínóín||1351||1351|2936||1 169740|D10BA0105|Isotretinoin Portfarma|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.10.2009||R|0|1|0|1|G|0|POF|0|0|0|30|IKR|2450|2852|lyfalmen|V0125|2603|2|30|0|20,0000|Portfarma ehf|Portfarma|Ísótretínóín||1290||1290|2852||1 169751|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|20|stk|1|ţpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|1168|2684|lyfalmen|V0411|2684|2|20|0|10,0000|Portfarma ehf|Portfarma|Cíprófloxacín||1168||1168|2684||1 169762|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|10|stk|1|ţpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|647|1967|lyfalmen|V0177|1967|2|10|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||647||647|1967||1 169773|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|20|stk|1|ţpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|638|1954|lyfalmen|V0418|1954|2|20|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||638||638|1954||1 169784|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|10|stk|1|ţpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|393|1617|lyfalmen|V0176|1617|2|10|0|2,5000|Portfarma ehf|Portfarma|Cíprófloxacín||393||393|1617||1 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2576|4622|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2576||2576|4622||1 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2773|4893|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2773||2773|4893||1 170062|L04AC0701|RoActemra|irţ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|18456|24814|lyfsjukr|||1|4|0|4,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||18456|24814||2 170085|L04AC0701|RoActemra|irţ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|45702|58700|lyfsjukr|||1|10|0|10,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||45702|58700||2 170092|J07BC2001|Twinrix Adult|stl|||1|ml|1|dćla|einnota dćla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|6173|9573|lyfalmen|||1|1|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||6173||6173|9573||1 170107|L04AC0701|RoActemra|irţ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|91404|115541|lyfsjukr|||1|20|0|20,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||91404||91404|115541||2 170489|G04BD0705|Tolterodine Sandoz|forđahlk|4|mg|28|stk|1|plglas||G04BD07|01.08.2013||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|3214|5500|lyfalmen|V0618|5500|1|28|0|28,0000|Artasan ehf|Sandoz A/S|Tólteródín||||3214|5500||1 170505|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|ţpakki||J04AB02|01.07.2012||R|1|0|0|0|G|0|SAD|0|0|0|100|DKK|12565|18434|lyfalmen|||1|100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||12565||12565|18434||2 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2108|3978|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín í blöndum||2108||2108|3978||1 170628|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|10651|15107|lyfsjukr|||2|1600|0|6,6700|Actavis Group hf|Braun|Gentamícín||10651||10651|15107||1 170640|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|25623|33728|lyfsjukr|||2|1600|0|20,0000|Actavis Group hf|Braun|Gentamícín||25623||25623|33728||1 170651|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|38435|49662|lyfsjukr|||2|2400|0|30,0000|Actavis Group hf|Braun|Gentamícín||38435||38435|49662||1 170697|M05BA0406|Alendronat Actavis|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|3128|2789|lyfalmen|V0203|2789|2|12|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||1244||1244|2789||1 170763|M05BA0706|Risedronate sodium Portfarma|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.03.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|12363|2310|lyfalmen|V0207|2310|2|12|0|84,0000|Portfarma ehf|Portfarma|Rísedrónsýru||896||896|2310||1 170997|L01BC0701|Vidaza|sts|25|mg/ml|4|ml|1|hgl|dreifa|L01BC07|01.09.2009||R|0|0|0|1|0|1|CEE|0|1|0|100|XEU|53610|68536|lyfsjukr|||1|4|0||Celgene Europe ltd|Celgene Europe ltd|Azasitidín||53610||53610|68536||2 171404|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas|handa hundum|QS02CA01|01.01.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|2548|5005|vetalmen|||0|25|0||Vistor hf|Dechra Veterinary Products A/S|||2548||2548|5005||1 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3193|5471|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||3193||3193|5471||1 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3224|5514|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||3224||3224|5514||1 171765|QA04AD9001|Cerenia|töflur|24|mg|4|stk|1|ţpakki||QA04AD90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1361|2675|vetalmen|||0|4|0||Icepharma hf|Zoetis Belgium S.A.|||||1361|2675||2 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2669|4750|lyfalmen|V0247|1748|1|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2669||2669|4750||1 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|4665|7497|lyfalmen|V0248|3361|1|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||4665||4665|7497||1 171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|41668|53683|lyfsjukr|||1|75|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||41668||41668|53683||2 172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|27779|36409|lyfsjukr|||1|50|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||27779||27779|36409||2 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|8512|12792|lyfalmen|V0249|3766|1|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||8512||8512|12792||1 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|15536|22192|lyfalmen|V0252|17537|1|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||15536||15536|22192||1 172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|63891|81323|lyfsjukr|||1|100|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||63891||63891|81323||2 172482|N06DA0303|Nimvastid (Lyfis)|hylki|6|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|30803|33490|lyfalmen|V0346|33490|3|112|0|74,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||24469||24469|33490||2 172567|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.04.2015||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|17732|30563|vetorma|||0|200|0||Icepharma hf|Zoetis Finland OY|Doramectinum||17732||17732|30563||2 172592|N06AX2601|Brintellix|filmhtfl|10|mg|98|stk|1|ţpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|20922|29004|lyfalmen|||1|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||20922||20922|29004||1 172627|C07FB0202|Logimax forte|forđatfl|105|mg|98|stk|1|pakki|ţp 10 + 95 mg|C07FB02|01.07.1999||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|9687|14410|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóđţrýstingslćkkandi lyf||9687||9687|14410||1 172684|N02AA0303|Palladon|forđahlk|4|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|5919|9223|lyfalmen|||1|56|0|11,2000|Icepharma hf|Norpharma |Hýdrómorphón||5919||5919|9223||2 172692|N02AA0303|Palladon|forđahlk|8|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|10996|16211|lyfalmen|||1|56|0|22,4000|Icepharma hf|Norpharma |Hýdrómorphón||10996||10996|16211||2 172723|N05AH0410|Quetiapin Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||N05AH04|01.07.2013||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|2837|2153|lyfalmen|V0284|2109|2|100|0|6,2500|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||782||782|2153||1 172759|N02AA0303|Palladon|forđahlk|16|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|19076|26669|lyfalmen|||1|56|0|44,8000|Icepharma hf|Norpharma |Hýdrómorphón||19076||19076|26669||2 172895|H01CB0501|Signifor|stl|0,9|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|569472|722810|lyfalmen|||1|60|0|45,0000|Vistor hf|Novartis Europharm Ltd|PAsireótiđ disapartate||569472||569472|722810||1 172916|N02AA0303|Palladon|forđahlk|24|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|24877|34006|lyfalmen|||1|56|0|67,2000|Icepharma hf|Norpharma |Hýdrómorphón||24877||24877|34006||2 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|ţpakki||N05CD02|01.12.1972||R|1|0|0|0|0|0|MAB|0|0|1|100|SEK|365|1579|lyfalmen|||1|50|0|50,0000|Vistor hf|Meda AB|Nítrazepam||365||365|1579||1 173284|C10AA0702|Rosuvastatin Actavis|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|9916|12195|lyfalmen|V0118|12183|2|98|0|196,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||8078||8078|12195||1 173310|N05BE0108|Buspiron Mylan|töflur|5|mg|100|stk|1|ţpakki||N05BE01|01.04.1995||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3034|5252|lyfalmen|||2|100|0|16,6667|Icepharma hf|Mylan AB|Búspírón hýdróklóríđ||3034||3034|5252||2 173344|A06AG1101|Microlax|innhl|||5|ml|12|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||3506||1 173518|N05BE0108|Buspiron Mylan|töflur|10|mg|100|stk|1|ţpakki||N05BE01|01.04.1995||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|5367|8463|lyfalmen|||2|100|0|33,3333|Icepharma hf|Mylan AB|Búspírón hýdróklóríđ||5367||5367|8463||2 173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|12311|17171|lyfsjukr|||1|1,6|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||12311||12311|17171||1 173942|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|13438|18573|lyfsjukr|||1|1,5|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||13438||13438|18573||1 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|1780|2545|lyfsjukr|||2|20|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1780||1780|2545||1 174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|ţpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|546|1828|lyfalmen|||1|14|0|5,6000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||546||546|1828||1 174354|J01CA0414|Amoxicilline Actavis Disper|töflur|500|mg|20|stk|1|ţpakki|hrćra vel í vatni og drekka|J01CA04|01.03.2013||R|0|0|0|0|0|0|AVB|0|0|1|100|XEU|1217|2751|lyfalmen|||2|20|0|10,0000|Actavis Group PTC ehf|Actavis BV|Amoxicillín||1217||1217|2751||1 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|ţpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|557|1843|lyfalmen|||1|14|0|7,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||557||557|1843||1 174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|0|0|0|0|G|0|API|0|0|0|100|SEK|1555|3217|lyfalmen|V0368|2451|1|5|0|25,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Brímónidín||1555||1555|3217||1 174522|N04BC0505|Oprymea|forđatfl|0,26|mg|30|stk|1|ţpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|2900|5068|lyfalmen|V0634|5068|2|30|0|3,1200|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||2900||2900|5068|| 174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|0|0|0|0|G|0|API|0|0|0|100|SEK|4560|7353|lyfalmen|V0368|7353|1|15|0|75,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Brímónidín||4560||4560|7353||1 175058|N05AH0413|Quetiapin ratiopharm|forđatfl|50|mg|10|stk|1|ţpakki||N05AH04|01.05.2015||R|1|0|0|0|0|0|TEV|0|0|0|100|IKR|1262|2813|lyfalmen|V0695|2813|2|10|0|1,2500|Medical ehf|Teva Pharma B.V.|Quetíapín||1262||1262|2813||2 175333|QM01AC0603|Rheumocam|mixtúra|15|mg/ml|100|ml|1|glas|handa hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|4979|9617|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|||4979||4979|9617||2 175370|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.08.2015||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|14769|21222|lyfalmen|||1|0,36|0|4,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||14769|21222||1 175600|G03AA0904|Denise|töflur|||63|stk|1|ţpakki|150/20 mcg|G03AA09|01.04.2014||R|0|0|0|0|0|0|RGM|0|0|0|100|IKR|1477|2728|lyfalmen|||2|63|0|84,0000|Medical ehf|ratiopharm GmbH|Desógestrel og ethinylestradíól||1200||1200|2728|31.8.2015|2 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|ţpakki||J05AB11|01.10.1996||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|2795|2447|lyfalmen|V0033|2040|1|10|0|1,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||996||996|2447||1 175868|V03AN0101|Conoxia|lyfjagas|100|%|37|l|1|gashyl|kćlt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|37|0||Ísaga ehf|AGA AB|Súrefni|||||||5 176214|N05AH0301|Zyprexa|húđuđtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.01.1999||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|6178|4810|lyfalmen|V0278|2727|1|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2713||2713|4810||2 176520|M01AH0105|Cloxabix|hylki|100|mg|100|stk|1|ţpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|5502|8126|lyfalmen|V0429|8126|2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||5122||5122|8126||2 176616|N05CH0101|Circadin|forđatfl|2|mg|30|stk|1|ţpakki||N05CH01|01.10.2012||R|1|0|0|0|0|0|RAD|0|0|1|100|DKK|2567|4610|lyfalmen|||2|30|0|30,0000|Vistor hf|RAD Neurim Pharmaceuticals EEC Ltd.|Melatonin||2567||2567|4610||1 176862|C07AG0204|Carvedilol HEXAL|töflur|6,25|mg|100|stk|1|ţpakki||C07AG02|01.01.2015|31.08.2015|R|1|0|0|0|G|0|PCO|0|0|0|100|DKK|2037|3880|lyfalmen|||2|100|1|16,6700|Distica|Distica - óskráđ lyf|Carvedílól||2037||2037|3880||1 177176|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7914|11315|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||7914||7914|11315||2 177454|N02BE0107|Paratabs|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.05.2013||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|1069|2548|lyfalmen|V0231|2548|2|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól||1069||1069|2548||1 177627|QH02AB0201|Dexaject|stl|2|mg/ml|100|ml|1|hgl||QH02AB02|01.06.2013||R|0|0|0|0|0|0|DOR|1|0|0|100|XEU|4274|8279|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|Dexamethasón||4274||4274|8279||2 178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|0|0|0|0|0|0|PCO|0|0|1|100|IKR|723|2071|lyfalmen|||0|1|1|5,3330|Distica|Distica - óskráđ lyf|Tríamcínólón||723||723|2071||1 178223|B01AF0101|Xarelto|filmhtfl|10|mg|100|stk|1|ţpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|31879|42863|lyfalmen|||1|100|0|100,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||31879||31879|42863||2 178722|N06AB0404|Citalopram Bluefish|filmhtfl|40|mg|100|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|5438|3623|lyfalmen|V0320|3623|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||1850||1850|3623||2 179157|L04AB0601|Simponi|stl|50|mg|1|spr|1|spr|áfyllt sprauta|L04AB06|01.06.2011||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|131921|165933|lyfsjukr|||1|1|0|30,1200|Vistor hf|Janssen Biologics B.V.|Golimumab||131921||131921|165933||1 179552|B01AF0101|Xarelto|filmhtfl|15|mg|28|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|8999|13463|lyfalmen|||1|28|0|42,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||8999|13463||2 179557|C10BA0501|Atozet|filmhtfl|50|mg|90|stk|1|ţpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|16644|23593|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||16644||16644|23593||1 180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|108954|137368|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||108954||108954|137368||2 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|4614|7427|lyfalmen|||1|100|0|25,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||4614||4614|7427||1 180500|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|100|stk|1|ţpakki|međ br. losunarhrađa|G04CA02|01.12.2012||R|1|0|0|0|G|0|MED|0|0|0|100|XEU|2425|3825|lyfalmen|V0148|3825|2|100|0|100,0000|Medical ehf|Medical ehf|Tamsúlósín||1997||1997|3825||2 180539|R01AA0705|Otrivin Menthol ukonserveret|nefúđi|1|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.05.2001||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|||5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|742|2098|lyfalmen|||1|5|0||Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||742||742|2098||1 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 181552|QJ51DD1201|Pathozone vet.|spenalyf|250|mg/dćlu|10|ml|10|dćlur|dćla + rýja|QJ51DD12|01.10.1995||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|7487|14375|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|Cefoperazone||7487||7487|14375||2 181750|L01BA0108|Methotrexate Pfizer|irţ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|9102|13013|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Metótrexat||9102||9102|13013||1 181980|C10BA0201|Inegy|töflur|30|mg|28|stk|1|ţpakki|10 mg + 20 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|5697|8918|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||5697||5697|8918||1 182086|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|3|dropaí||S01XA20|01.09.2014||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||5954||2 182307|L04AD0201|Advagraf|forđahlk|0,5|mg|50|stk|1|ţpakki||L04AD02|01.11.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|11223|16524|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||11223||11223|16524||1 182435|A10BB0903|Gliclazide LYFIS|töflur|30|mg|180|stk|1|ţpakki||A10BB09|01.10.2014||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|8700|7683|lyfalmen|V0020|4735|2|180|0|90,0000|LYFIS ehf|LYFIS ehf|Glíklazíđ||4800||4800|7683||2 182502|C01CA0302|Noradrenalin Abcur|irţ|1|mg/ml|5|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|15673|21353|lyfsjukr|||2|50|0|8,3300|Icepharma hf|Abcur AB|Noradrenalín||15673||15673|21353||2 182831|QN51AA0102|Exagon vet.|stl|400|mg/ml|100|ml|5|hgl||QN51AA01|01.09.2014||R|0|0|1|0|0|0|RPG|1|0|0|100|XEU|19261|36712|vetalmen|||0|500|0||Icepharma hf|Richter Pharma AG|Pentobarbital||||19261|36712||2 182862|N04BC0507|Pramipexole Sandoz|forđatfl|2,1|mg|100|stk|1|ţpakki||N04BC05|01.02.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|32177|36623|lyfalmen|V0636|36623|2|100|0|84,0000|Artasan ehf|Sandoz A/S|Pramipexól||26946||26946|36623||1 183093|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2015||R|0|0|0|0|0|0|PIS|0|0|0|100|SEK|3498|5891|lyfalmen|V0698|5891|1|0,25|0||Icepharma hf|Pfizer ApS|Heilabólguveira óvirk, borin međ blóđmaur||3498||3498|5891||2 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|5019|9693|vetalmen|||0|50|0||Vistor hf|Intervet International BV|||5019||5019|9693||1 183516|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|ţpakki||N02CC01|01.03.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1777|1910|lyfalmen|V0234|1910|2|6|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||606||606|1910||2 183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|0|0|0|G|0|ALK|0|0|1|100|DKK|5389|8494|lyfalmen|||1|1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5389|8494||1 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|0|0|0|0|G|0|BRS|0|0|0|100|DKK|1106|2599|lyfalmen|||1|100|0|100,0000|Vistor hf|Bristol-Myers Squibb|Flúdrókortisón||1106||1106|2599||1 184014|A10BX0901|Forxiga|filmhtfl|10|mg|28|stk|1|ţpakki||A10BX09|01.10.2013||R|1|0|0|0|G|0|BRI|0|0|0|100|SEK|5953|9270|lyfalmen|||1|28|0|28,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Dapagliflozín||5953||5953|9270||1 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|548|1831|lyfalmen|||2|100|0|2,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||548||548|1831||1 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1517|2312|lyfalmen|||2|100|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||898||898|2312||1 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|0|0|0|0|G|0|TIL|0|0|0|100|SEK|3288|5602|lyfalmen|V0017|5602|1|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||3288|5602||2 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|ţpakki||L02BG04|01.03.1998||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|49891|65644|lyfalmen|V0185|13848|1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S|Letrózól||49891||49891|65644||1 184341|J01CR0201|Amoksiklav|filmhtfl|625|mg|16|stk|1|ţpakki|500+125 mg|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|1265|2817|lyfalmen|||2|16|0|8,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1265||1265|2817||1 184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|ţpakki||N02CC03|01.05.2001||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|4647|7472|lyfalmen|V0235|5924|1|6|0|6,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||4647||4647|7472||1 185025|R01AC0102|Glinor|nefúđi|5,2|mg/sk|15|ml|1|glas||R01AC01|01.03.2015||L|0|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||0|15|0|1,9500|Medical ehf|ratiopharm GmbH|Krómóglíkatsýra|||||||2 186713|N02AA0506|Oxikodon Depot Actavis|forđatfl|10|mg|28|stk|1|ţpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|898|2312|lyfalmen|V0597|2312|2|28|0|3,7300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||898||898|2312||1 186790|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|33801|12765|lyfalmen|V0607|12645|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Memantín||8492||8492|12765||2 186867|C10BA0501|Atozet|filmhtfl|20|mg|30|stk|1|ţpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|5800|9059|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||5800||5800|9059||1 187154|N06AX1611|Duofaxin|forđatfl|225|mg|98|stk|1|ţpakki||N06AX16|01.07.2015||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|4227|6499|lyfalmen|||2|98|0|220,5000|Vistor hf|MediLink A/S|Venlafaxín||3940||3940|6499||1 187191|A10BX0204|Repaglinide Krka|töflur|0,5|mg|120|stk|1|ţpakki||A10BX02|01.11.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2459|3829|lyfalmen|V0462|3829|2|120|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníđ||2000||2000|3829||2 187399|QP54AA0501|Stronghold|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|5446|9387|vetorma|||0|6|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5446||5446|9387||2 187595|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|4010|6596|lyfalmen|||1|30|0||Vistor hf|Meda AB|Pímekrólímus||4010||4010|6596||1 188338|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|1|dropaí||S01XA20|01.09.2014||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||2702||2 188364|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.08.2012||R|0|0|0|0|0|1|IPI|0|0|0|100|DKK|71846|91216|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Pfizer Limited|Tigecýklín||71846||71846|91216||2 188405|N02CC0403|Rizatriptan Portfarma|munndr.t|10|mg|6|stk|1|ţpakki||N02CC04|01.09.2013||R|0|0|0|0|G|0|PEH|0|0|0|100|XEU|3139|2314|lyfalmen|V0621|1756|2|6|0|6,0000|Portfarma ehf|Portfarma ehf|Rizatriptan||899||899|2314||1 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|0|0|0|0|G|0|DEA|0|0|0|100|XEU|2732|4837|lyfalmen|||1|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2732||2732|4837||1 189052|M05BA0604|Iasibon|irţ|1|mg/ml|2|ml|1|lykja||M05BA06|01.10.2012||R|0|0|0|0|0|1|PSA|0|0|0|100|DKK|8986|12847|lyfsjukr|||2|2|0|0,3400|Portfarma ehf|Pharmathen S.A.|Íbandrónsýra||8986||8986|12847||1 189148|J05AG0501|EDURANT|filmhtfl|25|mg|30|stk|1|glas||J05AG05|01.04.2013||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|42127|54254|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Rilpívírin||42127||42127|54254||1 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|6665|9529|lyfsjukr|||1|10|0||Vistor hf|Novartis Healthcare A/S|Deferoxamín||6665||6665|9529||1 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|2322|4272|lyfalmen|||1|5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2322||2322|4272||1 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|956|2392|lyfalmen|V0413|2392|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||956||956|2392||1 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|463|1714|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||463||463|1714||1 189627|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.11.2011||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|429|613|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Metótrexat||429||429|613||1 190000|N06AX2106|Duloxetin W&H|sţ-hylki|60|mg|28|stk|1|ţpakki||N06AX21|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|4098|6717|lyfalmen|V0693|6717|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||4098||4098|6717||2 190320|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|252|1423|lyfalmen|V0642|1423|2|10|0|2,5000|Vistor hf|Takeda Pharma A/S|Fúrósemíđ||252||252|1423||1 190425|C08CA0502|Adalat Oros|forđatfl|60|mg|98|stk|1|ţpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|7188|10970|lyfalmen|||1|98|0|196,0000|Icepharma hf|Bayer Pharma AG|Nífedipín||||7188|10970||2 190702|M01AB0101|Confortid|eţ-stíll|100|mg|10|stk|1|pakki||M01AB01|01.01.2012||R|0|0|0|0|G|0|AGT|0|0|1|100|DKK|1718|3441|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Indómetacín||1718||1718|3441||1 190728|M01AB0101|Confortid|eţ-stíll|50|mg|10|stk|1|ţpakki||M01AB01|01.08.2012||R|0|0|0|0|G|0|AGT|0|0|1|100|DKK|1038|2505|lyfalmen|||2|10|0|5,0000|Actavis Group hf|Actavis Group hf|Indómetacín||1038||1038|2505||1 190894|N04BC0507|Pramipexole Sandoz|forđatfl|0,52|mg|100|stk|1|ţpakki||N04BC05|01.09.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|12281|18075|lyfalmen|V0635|18075|2|100|0|20,8000|Artasan ehf|Sandoz A/S|Pramipexól||12281||12281|18075||1 191045|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|V0149|2563|0|100|0|10,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||2563||1 191064|B05XC03|Vitalipid Infant|irţ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3595|5140|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Vítamín||3595||3595|5140||2 191079|C10AA0702|Rosuvastatin Actavis|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|6527|7477|lyfalmen|V0117|7462|2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||4650||4650|7477||1 191247|B05XC02|Vitalipid Adult|irţ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3388|4844|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Vítamín||3388||3388|4844||2 191254|B05XC01|Soluvit|irs|||10|ml|10|hgl||B05XC|01.10.1985||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3534|5053|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Vítamín||3534||3534|5053||2 191403|R01AA0503|Nezeril|nefúđi|0,25|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|7,5|0|4,6875|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1 191587|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|60|ml|1|hgl||L01XA02|01.03.2015||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|8019|11465|lyfsjukr|||2|60|0||Alvogen HS|Hospira Nordic AB|Karbóplatín||8019||8019|11465||1 191742|C08CA0202|Plendil|forđatfl|2,5|mg|98|stk|1|ţpakki||C08CA02|01.08.2012||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|3545|5956|lyfalmen|V0201|5274|1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||3545||3545|5956||1 191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|485|1744|lyfalmen|||1|4|0||Icepharma hf|Pfizer ApS|Klóramfeníkól||485||485|1744||2 192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|ţpakki||N06AX11|01.12.2011||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|3571|5991|lyfalmen|||2|96|0|48,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||3571||3571|5991||1 192514|M01AH0106|Celecoxib Actavis|hylki|100|mg|100|stk|1|ţpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|AGP|0|0|1|100|XEU|5964|8126|lyfalmen|V0429|8126|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||5122||5122|8126||1 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|||100|stk|1|glas||C03AB01|01.12.1972||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|1496|3135|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||1496||1496|3135||1 192644|C10BA0501|Atozet|filmhtfl|90|mg|30|stk|1|ţpakki|10 mg + 80 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|6080|9445|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||6080||6080|9445||1 192699|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6928|9905|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6928||6928|9905||2 192867|S01BA0103|Ozurdex|vefjalyf|700|mcg|1|stk|1|pakki|til ísetningar, vefjalyf|S01BA01|01.10.2012||R|0|1|0|1|0|1|API|0|1|0|100|SEK|162836|204382|lyfsjukr|||2|1|0||Vistor hf|Allergan Pharmaceuticals Ireland|Dexametasón||162836||162836|204382||1 193122|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|ţpakki||N02CC01|01.07.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2539|2188|lyfalmen|V0233|2188|2|12|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||808||808|2188||2 193242|A07DA0301|Imodium|filmhtfl|2|mg|100|stk|1|ţpakki||A07DA03|01.02.2014||R|1|0|0|0|G|0|MCS|0|0|0|100|SEK|900|2315|lyfalmen|V0447|2205|1|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ||900||900|2315||1 193432|N03AX2201|Fycompa|filmhtfl|10|mg|28|stk|1|ţpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|21614|29879|lyfalmen|||1|28|0|35,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||21614||21614|29879||1 193821|A12AA0601|Calcium-Sandoz|freyđit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|0|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyfalmen|||0|20|0|7,5500|Artasan ehf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2338||1 193999|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|250|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|47834|77108|veteldis|||0|250|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||47834||47834|77108||1 194356|J02AC0102|Candizol|hylki|150|mg|4|stk|1|ţpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|2031|1902|lyfalmen|V0556|1861|2|4|0|3,0000|Actavis Group hf|Actavis hf|Flúkónazól||600||600|1902||1 194404|QM01AC0606|Meloxidolor|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|5101|9848|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||5101||5101|9848||2 194672|A02BC0508|Esomeprazol Actavis|sţ-tfl|40|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|6055|5267|lyfalmen|V0012|5267|2|100|0|133,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3045||3045|5267||1 195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|G|0|MYL|0|0|0|100|SEK|1600|3279|lyfalmen|||2|250|0|83,3300|Icepharma hf|Mylan AB|Atenólól||1600||1600|3279||2 195445|N05AE0403|Ziprasidon Actavis|hylki|40|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.06.2013||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|13340|19414|lyfalmen|V0609|19414|2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||13340||13340|19414||1 195455|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|||100|ml|50|pokar|leysir f.stungulyf|V07AB|01.07.2013||L|0|0|0|0|0|0|BAM|0|0|0|100|IKR|||lyfalmen|||0|5000|0||Icepharma hf|Baxter Medical AB|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||12898||2 195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|56101|71634|lyfsjukr|||1|2,5|0|30,0000|Icepharma hf|E. Merck AB|Sómatrópín||56101||56101|71634||2 195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|130846|164596|lyfsjukr|||1|1|0|30,1200|Vistor hf|Janssen Biologics B.V.|Golimumab||130846||130846|164596||1 195618|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|938|2367|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||938||938|2367||1 195669|D01AC2002|Pevisone|krem|||15|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|636|1952|lyfalmen|||1|15|0||Vistor hf|Janssen-Cilag AB|Blöndur||636||636|1952||1 195768|R01BA0101|Rinexin|forđatfl|50|mg|30|stk|1|ţpakki||R01BA01|01.03.1981||R|1|0|0|0|G|0|REP|0|0|1|100|SEK|338|1542|lyfalmen|||1|30|0|15,0000|Vistor hf|Recip AB|Fenýlprópanólamín||338||338|1542||1 195776|R01BA0101|Rinexin|forđatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|1|0|0|0|G|0|REP|0|0|1|100|SEK|715|2060|lyfalmen|||1|100|0|50,0000|Vistor hf|Recip AB|Fenýlprópanólamín||715||715|2060||1 196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|G|0|MYL|0|0|0|100|SEK|2045|3891|lyfalmen|||2|250|0|166,6700|Icepharma hf|Mylan AB|Atenólól||2045||2045|3891||2 196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|ţp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|1432|3047|lyfalmen|||1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Levónorgestrel og ethinylestradíól||1432||1432|3047||2 196444|M04AA0105|Allonol|töflur|300|mg|100|stk|1|ţpakki||M04AA01|01.06.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1681|3390|lyfalmen|||2|100|0|75,0000|Medical ehf|ratiopharm GmbH|Allópúrinol||1681||1681|3390||2 196551|N02BE0114|Pinex|mixtúra|24|mg/ml|100|ml|1|fl||N02BE01|01.07.2012||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|100|0|0,8000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 196851|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.05.2012||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|8237|12414|lyfalmen|||1|100|0|0,8333|Artasan ehf|Aspen Pharma Trading Limited|Labetalól||8237||8237|12414||1 196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|20504|27361|lyfsjukr|||1|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||20504|27361||1 197160|M04AA0105|Allonol|töflur|100|mg|100|stk|1|ţpakki||M04AA01|01.05.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|575|1627|lyfalmen|V0119|1627|2|100|0|25,0000|Medical ehf|ratiopharm GmbH|Allópúrinol||400||400|1627||2 197320|L04AB0204|Inflectra|irţ|100|mg|1|hgl|1|pakki||L04AB02|01.01.2015||R|0|0|0|1|0|1|SCO|0|1|0|100|XEU|59086|75346|lyfsjukr|||2|1|0|26,6700|Scope Pharma ehf|Hospira UK Limited|Infliximab||59086||59086|75346||1 197554|N07BA0147|Nicorette QuickMist|munnhúđi|1|mg/sk|150|skammtar|1|fl|1 x 150 úđaskammtar|N07BA01|01.01.2013||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|150|0|0,4400|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|ţpakki||N05BA12|01.10.1990||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|792|2166|lyfalmen|||1|20|0|20,0000|Icepharma hf|Pfizer ApS|Alprazólam||792||792|2166||1 197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|ţpakki||N05BA12|01.10.1990||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2594|4647|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Alprazólam||2594||2594|4647||1 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1857|3632|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1857||1857|3632||1 198220|QJ51DD1201|Pathozone vet.|spenalyf|250|mg/dćlu|10|ml|10|dćlur|dćla + rýja|QJ51DD12|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|7487|14375|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|Cefoperazone||7487||7487|14375||2 198334|M02AA1502|Voltaren|hlaup|11,6|mg/g|150|g|1|túpa||M02AA15|01.02.2015||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|150|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 198582|C09CA0106|Losatrix|filmhtfl|50|mg|100|stk|1|ţpakki||C09CA01|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|2212|3003|lyfalmen|V0069|3003|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Lósartan||1400||1400|3003||2 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|6638|9490|lyfsjukr|||1|200|0||Icepharma hf|Pfizer ApS|Flúóróúracíl||6638||6638|9490||1 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|33359|44734|lyfalmen|||1|100|0||Icepharma hf|Pfizer ApS|Estramústín||33359||33359|44734||1 199272|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.12.2011|30.06.2015|R|1|0|0|0|0|0|APC|0|0|0|100|XEU|7905|4082|lyfalmen|||2|100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||2184||2184|4082||1 199319|A10BG0304|Pioglitazone Accord|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.12.2013|31.07.2015|R|1|1|0|0|G|0|AHL|0|0|0|100|XEU|5821|4016|lyfalmen|||2|98|0|49,0000|Portfarma ehf|Accord Healthcare Limited|Píóglítazón||2136||2136|4016||1 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|ţpakki||N05CD05|01.11.1981||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|585|1882|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||585||585|1882||1 199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|87117|110209|lyfsjukr|||1|0,6|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||87117|110209||1 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|4319|7021|lyfalmen|V0126|7021|1|8|0|8,0000|Icepharma hf|Pfizer ApS|Kabególín||4319||4319|7021||1 199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|0|0|0|0|0|1|JAB|0|0|0|100|XEU|49552|63489|lyfsjukr|||1|5|0|0,4000|Janssen Biologics B.V.|Janssen Biologics B.V.|Abciximab||49552||49552|63489||2 199940|L01XC1101|Yervoy|stţ|5|mg/ml|40|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|2388303|2972240|lyfsjukr|||1|40|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||2388303||2388303|2972240||1 370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|578|826|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Roche|Fýtómenadíón||578||578|826||2 370173|QH01CA9301|Suprelorin|vefjalyf|9,4|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|30763|58534|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||30763||30763|58534||1 370395|J01CA0413|Amoxin|filmhtfl|375|mg|20|stk|1|ţpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|1425|2743|lyfalmen|||2|20|0|7,5000|Medical ehf|ratiopharm GmbH|Amoxicillín||1211||1211|2743||2 370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|0|0|0|0|0|1|PAD|0|0|0|100|DKK|543|776|lyfsjukr|||1|1|0|0,3333|Icepharma hf|PharmaCoDane ApS|Cefazólín||543||543|776||2 371284|D11AH0201|Elidel|krem|1|%|60|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|8708|13062|lyfalmen|||1|60|0||Vistor hf|Meda AB|Pímekrólímus||8708||8708|13062||1 371583|A06AG1001|Klyx|innhl|||240|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|240|0|1,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||||1 371609|A06AG1001|Klyx|innhl|||120|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|120|0|1,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||||1 371617|A06AG1001|Klyx|innhl|||120|ml|10|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|DKK|||lyfalmen|||0|1200|0|10,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||9395||1 371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|ţpakki||A02BA02|01.10.1995||L|1|0|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||0|10|0|5,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|ţpakki||N05AL05|01.01.2005||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|3715|6190|lyfalmen|||1|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||3715||3715|6190||1 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|0|0|0|0|G|0|ROC|0|0|0|100|DKK|3384|5734|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3384||3384|5734||2 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|ţp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|ţp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 372571|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|ţpakki||G03CA04|01.08.2015||L|0|0|0|0|G|0|PTL|0|0|0|100|DKK|||lyfalmen|V0704|2413|0|15|0|37,5000|Navamedic AB|Aspen Pharma Trading Limited|Estríól|||||2413||1 373001|G03AB0501|Gracial|töflur|||66|stk|1|pakki|ţp 3 x (15+7 stk)|G03AB05|01.07.1998||R|0|0|0|0|0|0|PTL|0|0|0|100|DKK|2321|4271|lyfalmen|V0703|4271|1|66|0|66,0000|Navamedic AB|Aspen Pharma Trading Limited|Desógestrel og ethinylestradíól||2321||2321|4271||1 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|ţpakki||N05AL05|01.01.2005||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|12454|18294|lyfalmen|||1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||12454||12454|18294||1 373251|L03AB1301|Plegridy|stl|||2|áf-penni|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|119885|150963|lyfsjukr|||1|2|0||Icepharma hf|Biogen Idec Ltd|Peginterferón beta-1a||119885||119885|150963||2 373324|R03AK0602|Seretide Diskus|innönddu|150|mcg/sk|60|skammtar|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|4518|7295|lyfalmen|||1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||4518||4518|7295||1 373340|R03AK0602|Seretide Diskus|innönddu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|7012|10728|lyfalmen|V0436|10728|1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||7012||7012|10728||1 373365|R03AK0602|Seretide Diskus|innönddu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|9194|13731|lyfalmen|V0437|13731|1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||9194||9194|13731||1 373853|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.06.2012||R|0|0|0|0|G|0|MED|0|0|0|100|XEU|5871|8638|lyfalmen|V0420|4947|2|30|0|30,0000|Medical ehf|Medical ehf|Bíkalútamíđ||5494||5494|8638||2 373857|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|ţpakki||C07AB03|01.10.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|411|1467|lyfalmen|V0541|1467|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Atenólól||284||284|1467||1 373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1462|3089|lyfalmen|V0126|1755|1|2|0|2,0000|Icepharma hf|Pfizer ApS|Kabególín||1462||1462|3089||1 374143|L01XE1201|Caprelsa|filmhtfl|100|mg|30|stk|1|ţpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|AZA|0|0|0|100|SEK|338976|423451|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Vandetaníb||338976||338976|423451||1 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|ţpakki||A10BA02|01.01.1987||R|1|0|0|0|G|0|MCK|0|0|0|100|SEK|502|1767|lyfalmen|||1|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||502||502|1767|31.8.2015|2 374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5411|7736|lyfsjukr|||1|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||5411||5411|7736||2 374279|L04AD0104|Ciqorin|hylki|25|mg|50|stk|1|ţpakki||L04AD01|01.04.2014||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|6800|6857|lyfalmen|||2|50|0|5,0000|Medical ehf|Teva Pharma B.V.|Ciklospórín||4200||4200|6857||2 374319|H02AB0205|Dexametason Abcur|töflur|4|mg|100|stk|1|ţpakki||H02AB02|01.11.2013||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|19208|26836|lyfalmen|||2|100|0|266,6600|Icepharma hf|Abcur AB|Dexametasón||19208||19208|26836||2 374348|G04CA0201|Omnic|forđahlk|0,4|mg|30|stk|1|ţpakki||G04CA02|01.08.1998||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|3554|5968|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||3554||3554|5968||1 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|ţpakki||J05AB11|01.01.2003||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|12603|18482|lyfalmen|||1|60|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||12603||12603|18482||1 374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forđaverkun|G01AF05|01.01.1997||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|15|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 374527|J07CA0602|Pentavac|sts|||0,5|ml|1|hgl|leysir, dreifa|J07CA06|01.04.2015||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|4219|6883|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||4219||4219|6883||2 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|áf.spr|einnota dćla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|6690|10284|lyfalmen|||1|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||6690||6690|10284||1 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|áf.spr|einnota dćla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|7896|11944|lyfalmen|||1|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||7896||7896|11944||1 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dćla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|9247|13804|lyfalmen|||1|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||9247||9247|13804||1 374672|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|50|stk|1|ţpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|9198|12065|lyfalmen|V0383|10125|2|50|0|12,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||7984||7984|12065||2 376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|ţpakki||B01AC24|01.06.2011||R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|27031|36731|lyfalmen|V0459|36731|1|168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||27031||27031|36731||1 376387|R03AK1001|Relvar Ellipta|innönddu|206|mcg/sk|30|skammtar|1|pakki|184+22 mcg|R03AK10|01.04.2014||R|0|0|0|0|G|0|GGL|0|0|0|100|GBP|8422|12668|lyfalmen|||1|30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Vilanterol og flútícason||8422||8422|12668||1 376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|16809|23802|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||16809||16809|23802||1 376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|86354|111763|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||86354||86354|111763||1 376974|L01XX4301|Erivedge|hylki|150|mg|28|stk|1|glas||L01XX43|01.10.2014||R|1|1|0|1|0|1|RRL|0|0|0|100|DKK|806434|1004838|lyfsjukr|||1|28|0||Icepharma hf|Roche Registration Limited|Vismodegibum||806434||806434|1004838||2 377134|QP54AA0105|Noromectin|stl|1|% w/v|250|ml|1|hgl|lausn|QP54AA01|01.03.2014||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|11809|20354|vetorma|||0|250|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||11809||11809|20354||2 377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|ţpakki||J01FA09|01.04.1992||R|1|0|0|0|0|0|ABS|0|0|1|100|DKK|3967|6536|lyfalmen|V0116|4793|1|14|0|14,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||3967||3967|6536||1 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|ţpakki||J05AB11|01.10.1996||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|12206|8722|lyfalmen|V0182|5343|1|42|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||5555||5555|8722||1 378535|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1830|3595|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1830||1830|3595||1 378686|D11AX1801|Solaraze|hlaup|3|%|100|g|1|túpa||D11AX18|01.08.2012||R|0|0|0|0|0|0|ALM|0|0|0|100|XEU|15178|21739|lyfalmen|||1|100|0||Vistor hf|Almirall S.A.|Önnur húđlyf-Diclofenacum||15178||15178|21739||1 379158|R01AD0901|Nasonex|nefúđi|50|mcg/sk|140|skammtar|1|úđagl|18 g í pakkn.|R01AD09|01.02.2015||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1639|3332|lyfalmen|||1|140|0|35,0000|Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1639||1639|3332||1 379521|QP54AB5208|Cydectin TriclaMox|mixtúra|51|mg/ml|1|l|1|glas|1 mg/ml + 50 mg/ml|QP54AB52|01.03.2014||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|7709|13287|vetorma|||0|1|0||Icepharma hf|Zoetis Finland OY|||7709||7709|13287||2 379570|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.03.2012||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|144733|181867|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||||144733|181867||1 379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|92763|117231|lyfsjukr|||1|2|0|14,2900|Vistor hf|Novartis Healthcare A/S|Oktreótíđ||92763||92763|117231||1 379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|122017|153615|lyfsjukr|||1|2|0|28,5700|Vistor hf|Novartis Healthcare A/S|Oktreótíđ||122017||122017|153615||1 379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|157577|197842|lyfsjukr|||1|2|0|42,8600|Vistor hf|Novartis Healthcare A/S|Oktreótíđ||157577||157577|197842||1 379760|L03AB1001|PegIntron|sts|150|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|133673|168112|lyfsjukr|||1|4|0|80,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||133673||133673|168112||1 379796|N04BC0406|Ropinirole Portfarma|forđatfl|2|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|8512|6102|lyfalmen|V0532|6102|2|84|0|28,0000|Portfarma ehf|Portfarma|Rópíníról||3651||3651|6102||1 379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1551|3211|lyfalmen|||2|12,5|0|2,5000|Actavis Group hf|Actavis Group hf|Díazepam||1551||1551|3211||1 379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|2072|3928|lyfalmen|||2|12,5|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||2072||2072|3928||1 380162|H01BA0201|Minirin|nefúđi|0,1|mg/ml|5|ml|3|úđagl||H01BA02|01.09.2013||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|19344|27008|lyfalmen|||1|15|0|60,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||19344||19344|27008||1 380374|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1504|3146|lyfalmen|V0676|3146|1|30|0||Icepharma hf|Bayer AB|Azelainsýra||1504||1504|3146||2 380466|B01AF0201|Eliquis|filmhtfl|2,5|mg|168|stk|1|ţpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|27349|37133|lyfalmen|V0653|37133|1|168|0|84,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||27349|37133||1 380732|C10AA0703|Rosuvastatin Krka|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|20000|25308|lyfalmen|V0195|25308|2|100|0|400,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||18000||18000|25308||2 380833|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|30|stk|1|ţpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|10506|5485|lyfalmen|V0606|5485|2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Memantín||3203||3203|5485||2 381005|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 381231|QP54AA0501|Stronghold|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2941|5069|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2941||2941|5069||2 381505|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|7063|4398|lyfalmen|V0143|4398|3|12|0|12,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||2413||2413|4398||2 381589|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.06.2015||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|41610|55170|lyfalmen|||1|1,08|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||41610|55170||1 382162|N04BC0406|Ropinirole Portfarma|forđatfl|4|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|15042|10298|lyfalmen|V0533|10298|2|84|0|56,0000|Portfarma ehf|Portfarma|Rópíníról||6700||6700|10298||1 382190|G04BE0307|Sildenafil Mylan|filmhtfl|25|mg|4|stk|1|ţpakki||G04BE03|01.03.2014||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|3600|4144|lyfalmen|V0141|4144|2|4|0|2,0000|Icepharma hf|Mylan AB|Síldenafíl||2229||2229|4144||2 382383|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|kćlt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5 382474|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|20|l|1|hylki|undir ţrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|20|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 382764|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|4669|7503|lyfalmen|||2|120|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||4669||4669|7503||1 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|6086|9453|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Bambúteról||6086||6086|9453||1 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|ţpakki|230+20 mg|QP52AA51|01.06.2000||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1190|2051|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||1190||1190|2051||2 383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|ţpakki|230+20 mg|QP52AA51|01.06.2000||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|7171|12360|vetorma|||0|20|0||Icepharma hf|Bayer Animal Health GmbH|||7171||7171|12360||2 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|60|0||Actavis Group hf|Actavis hf|Ketókónazól|||||||1 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|120|0||Actavis Group hf|Actavis hf|Ketókónazól|||||||1 383428|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.04.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1509|3153|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||1509||1509|3153||1 383445|J05AG0101|Viramune|forđatfl|400|mg|30|stk|1|ţpakki||J05AG01|01.03.2013||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|36684|47485|lyfsjukr|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Nevírapín||36684||36684|47485||1 384064|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|56|stk|1|ţpakki|hart|A02BC01|01.06.2015||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2373|2848|lyfalmen|V0006|1990|2|56|0|56,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||1287||1287|2848||2 384125|A10BX1201|Jardiance|filmhtfl|10|mg|30|stk|1|ţpakki||A10BX12|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|6499|10022|lyfalmen|||1|30|0||Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||6499||6499|10022||1 384716|D01AE1504|Terbinafin Actavis|krem|10|mg/g|15|g|1|túpa||D01AE15|01.09.2015||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|15|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Terbínafín|||||||1 385214|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|25|lykja|dreifa|H02AB01|01.07.2014|31.07.2015|R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|10468|15484|lyfalmen|||1|25|0|116,6700|Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||10468||10468|15484||1 385238|C10BA0201|Inegy|töflur|50|mg|28|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|7024|10744|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||7024||7024|10744||1 386278|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|5712|3511|lyfalmen|V0144|3272|3|8|0|16,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||1769||1769|3511||2 386465|QC01CE9001|Vetmedin vet.|tuggutfl|5|mg|50|stk|1|glas|fyrir hunda|QC01CE90|01.07.2015||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|5043|9738|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||5043||5043|9738||1 386953|L02BG0301|Arimidex|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.1998||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|44441|58751|lyfalmen|V0184|5259|1|98|0|98,0000|Vistor hf|AstraZeneca AB|Anastrózól||44441||44441|58751||1 386959|C03DA0402|Eplerenone Portfarma|filmhtfl|50|mg|100|stk|1|ţpakki||C03DA04|01.08.2014||R|1|0|0|0|0|0|PEH|0|0|0|100|DKK|26816|22107|lyfalmen|V0111|22107|2|100|0|100,0000|Portfarma ehf|Portfarma ehf|Eplerenón||15469||15469|22107||1 387012|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|3|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|0|G|0|UKL|0|0|0|100|USD|8862|13274|lyfalmen|V0670|13274|1|15|0||Vistor hf|Alcon Laboratories (UK) Ltd.|Brimoníđ og brinzolamiđ||8862||8862|13274||1 387579|N05BA1206|Alprazolam Krka|forđatfl|0,5|mg|60|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|861|2014|lyfalmen|V0308|2014|2|60|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||681||681|2014||2 387759|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.04.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|107769|135894|lyfsjukr|||1|4|0|64,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||107769||107769|135894||1 387854|QM01AE9103|Carprofelican|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|5358|10336|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||5358||5358|10336|31.8.2015|2 387991|R03DC0304|Montelukast Teva|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.01.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|12417|6119|lyfalmen|V0491|6096|2|98|0|49,0000|Medical ehf|Teva Pharma B.V.|Montelúkast||3664||3664|6119||2 388198|L01XE0901|Torisel|irţ|30|mg|1|hgl|1|pakki||L01XE09|01.09.2012||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|141022|177252|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Limited|Temsirolímus||141022||141022|177252||1 388256|N01BB2001|Emla|krem|||5|g|5|túpa|+12 umbúđ.|N01BB20|01.01.1987||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2893|5058|lyfalmen|||1|25|0||Vistor hf|AstraZeneca A/S DK|Blöndur||2893||2893|5058||1 388264|N01BB2001|Emla|krem|||30|g|1|túpa||N01BB20|01.01.1987||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3647|6096|lyfalmen|||1|30|0||Vistor hf|AstraZeneca A/S DK|Blöndur||3647||3647|6096||1 388272|N01BB2001|Emla|plástur|||2|stk|1|pakki||N01BB20|01.04.1994||L|0|0|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||0|2|0||Vistor hf|AstraZeneca A/S DK|Blöndur|||||||1 388278|N01AH0601|Remifentanil Actavis|sts/irs|5|mg|5|hgl|1|pakki|ţykkni,lausn|N01AH06|01.04.2013|31.08.2015|R|0|0|1|0|0|1|AGP|0|0|0|100|XEU|7280|10408|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||7280||7280|10408||1 388280|N01BB2001|Emla|plástur|||20|stk|1|pakki||N01BB20|01.04.1994||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|7076|10816|lyfalmen|||1|20|0||Vistor hf|AstraZeneca A/S DK|Blöndur||7076||7076|10816||1 388482|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.06.2011||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|1548|1781|lyfalmen|V0466|1781|2|28|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||512||512|1781||1 388898|S01ED5116|Taptiqom|augndr|||0,3|ml|90|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|9082|13577|lyfalmen|||1|27|0|90,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||9082||9082|13577||2 389106|G03FA0103|Femanor|töflur|||84|stk|1|pakki|ţp 2+1 mg |G03FA01|01.08.1998||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|2451|4450|lyfalmen|V0410|4450|1|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2451||2451|4450||1 389122|G03FB0503|Femasekvens|töflur|||84|stk|1|pakki|ţp samsett pk. |G03FB05|01.08.1998||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|1744|3477|lyfalmen|||1|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||1744||1744|3477||1 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|ţpakki||G03CA03|01.05.1997||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|669|1997|lyfalmen|V0128|1997|1|84|0|84,0000|Vistor hf|BioPhausia AB|Estradíól||669||669|1997||1 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|ţpakki||G03CA03|01.05.1997||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|531|1807|lyfalmen|||1|84|0|42,0000|Vistor hf|BioPhausia AB|Estradíól||531||531|1807||1 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|818|2202|lyfalmen|V0367|1611|1|3|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||818||818|2202||1 389414|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|2498|2147|lyfalmen|V0143|1466|3|4|0|4,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||778||778|2147||2 389443|N04BC0504|Oprymea (Lyfis)|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|3608|4981|lyfalmen|V0267|4981|3|100|0|7,2000|LYFIS ehf|LYFIS ehf|Pramipexól||2837||2837|4981||2 389637|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg)|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|43389|57420|lyfalmen|||1|1,5|0|12,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||43389|57420||2 389939|N05CF0106|Zopiclone Actavis|filmhtfl|7,5|mg|30|stk|1|ţpakki||N05CF01|01.05.2013||R|1|0|0|0|0|0|APC|0|0|0|100|SEK|331|1204|lyfalmen|V0312|1204|2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zópíklón||93||93|1204||1 389944|L04AD0201|Advagraf|forđahlk|1|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|15973|22745|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||15973||15973|22745||1 390699|N05CM1801|Dexdor|irţ|100|mcg/ml|2|ml|25|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|76210|96644|lyfsjukr|||1|50|0|5,0000|Vistor hf|Orion Corporation|Dexmedetómid||76210||76210|96644||1 390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|0|0|0|0|G|0|BRS|0|0|1|100|DKK|2714|4812|lyfalmen|||1|100|0|6,6667|Vistor hf|Bristol-Myers Squibb|Nýstatín||2714||2714|4812||1 390784|A10BG0303|Pioglitazone Teva Pharma|töflur|15|mg|28|stk|1|ţpakki||A10BG03|01.11.2012|31.07.2015|R|1|1|0|0|G|0|TEV|0|0|0|100|XEU|2358|1954|lyfalmen|||2|28|0|14,0000|Medical ehf|Teva Pharma B.V.|Píóglítazón||638||638|1954||2 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|ţpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|6503|10027|lyfalmen|V0429|8126|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Celekoxíb||6503||6503|10027||1 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|ţpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|2568|4611|lyfalmen|V0037|3638|1|20|0|20,0000|Icepharma hf|Pfizer ApS|Celekoxíb||2568||2568|4611||1 391010|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg)|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|22594|31119|lyfalmen|||1|0,75|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||22594|31119||2 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|12532|18392|lyfalmen|V0196|14660|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Celekoxíb||12532||12532|18392||1 391376|J05AE1401|Olysio|hylki|150|mg|28|stk|1|pakki||J05AE14|01.09.2014||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|1351364|1682578|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Simeprevír||||1351364|1682578||1 391653|L01XE0102|Imatinib Accord|filmhtfl|400|mg|30|stk|1|ţpakki||L01XE01|01.11.2013||R|0|0|0|1|0|1|AHL|0|1|0|100|DKK|321509|255564|lyfsjukr|||2|30|0||Portfarma ehf|Accord Healthcare Limited|Imatiníb||203988||203988|255564||1 391730|N01BB0203|Xylocain|húđúđi|100|mg/ml|50|ml|1|glas|+ sk-úđari|N01BB02|01.10.1990||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2330|4283|lyfalmen|V0656|4283|1|50|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2330||2330|4283||1 391954|N07BC0202|Metadon Abcur|töflur|20|mg|20|stk|1|ţpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|2221|4133|lyfalmen|||1|20|0|20,0000|Icepharma hf|Abcur AB|Metadón||2221||2221|4133||2 392000|G03AA0706|Erlibelle|töflur|||63|stk|1|ţpakki||G03AA07|01.08.2014||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|596|1897|lyfalmen|V0545|1897|2|63|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Levónorgestrel og ethinylestradíól||596||596|1897||1 392225|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plastf|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|188959|236872|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||188959||188959|236872||2 392402|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|4243|5647|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||3321||3321|5647||1 392438|N07XX0901|Tecfidera|hylki|120|mg|14|stk|1|ţpakki||N07XX09|01.12.2014||R|0|0|0|1|0|1|BIB|0|1|0|100|XEU|43907|56468|lyfsjukr|||1|14|0|3,5000|Icepharma hf|Biogen Idec Ltd|Dimethyl fumarate||43907||43907|56468||2 392563|A04AA0101|Zofran|mixtúra|0,8|mg/ml|50|ml|1|glas||A04AA01|01.03.2013||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|9935|14751|lyfalmen|||1|50|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||9935||9935|14751||1 393192|N05AH0409|Quetiapin Orion|filmhtfl|200|mg|100|stk|1|ţpakki||N05AH04|01.10.2012|31.07.2015|R|1|0|0|0|G|0|OPF|0|0|0|100|IKR|20927|9679|lyfalmen|||2|100|0|50,0000|Portfarma ehf|Orion Corporation|Quetíapín||6250||6250|9679||1 393642|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||10|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||3053||2 393735|H02AB0908|Plenadren|töflur|20|mg|50|stk|1|glas|međ breyttan losunarhrađa|H02AB09|01.01.2013||R|1|0|0|0|G|0|SPR|0|0|1|100|DKK|66433|86566|lyfalmen|||1|50|0|33,3300|Lyfjaver ehf|ViroPharma SPRL|Hýdrókortisón||66433||66433|86566||2 393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dćlu|1|stk|24|spr||QJ51CF02|01.09.1983||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|5222|10078|vetalmen|||0|24|0||Icepharma hf|Zoetis Finland OY|||5222||5222|10078||2 393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 393939|S01EE0403|Travoprost Portfarma|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.01.2015||R|0|0|0|0|G|0|POF|0|0|0|100|USD|2194|3898|lyfalmen|V0669|3898|2|2,5|0|25,0000|Portfarma ehf|Portfarma|Travóprost||2050||2050|3898||1 393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|138162|172624|lyfsjukr|||1|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||137301||137301|172624||1 395539|C10BA0501|Atozet|filmhtfl|50|mg|30|stk|1|ţpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|5943|9256|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||5943||5943|9256||1 395732|C09CA0305|Valsartan ratiopharm|filmhtfl|160|mg|98|stk|1|ţpakki||C09CA03|01.02.2015||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3895|3691|lyfalmen|V0679|3691|2|98|0|196,0000|Medical ehf|ratiopharm GmbH|Valsartan||1900||1900|3691||2 395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|G|0|LVR|0|0|0|100|NOK|18127|25469|lyfalmen|V0356|25469|3|360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||18127||18127|25469||3 395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|166673|209155|lyfsjukr|||1|300|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||166673||166673|209155||2 396120|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|60|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|4600|7408|lyfalmen|||2|60|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||4600||4600|7408||1 396318|R06AX2201|Kestine|filmhtfl|10|mg|100|stk|1|ţpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|3764|6257|lyfalmen|||1|100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||3764||3764|6257||1 396319|QN01BA0201|Procamidor vet.|stl|20|mg/ml|100|ml|10|hgl||QN01BA02|01.03.2014||R|0|0|0|0|0|0|RPG|1|0|0|100|DKK|19792|37720|vetalmen|||0|1000|0||Icepharma hf|Richter Pharma AG|Procaine Hydrochlorid||19792||19792|37720||2 396865|QN03AX9001|Pexion|töflur|100|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|5227|10087|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||5227||5227|10087||1 397161|J01CA0414|Amoxicilline Actavis Disper|töflur|375|mg|20|stk|1|ţpakki|hrćra vel í vatni og drekka|J01CA04|01.03.2013||R|0|0|0|0|0|0|AVB|0|0|1|100|XEU|1176|2695|lyfalmen|||2|20|0|7,5000|Actavis Group PTC ehf|Actavis BV|Amoxicillín||1176||1176|2695||1 397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|0|0|0|1|0|1|MKA|0|1|0|100|SEK|26127|34355|lyfsjukr|||1|20|0||Icepharma hf|Merck KgaA|Cetúxímab||26127||26127|34355||2 397520|J01CF0104|Dicloxacillin Bluefish|hylki|500|mg|30|stk|1|ţpakki||J01CF01|01.08.2015||R|0|0|0|0|0|0|BLP|0|0|1|100|IKR|2737|4449|lyfalmen|V0337|4449|2|30|0|7,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Díkloxacillín||2450||2450|4449||2 397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|ţpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|5130|7334|lyfsjukr|||1|60|0||Icepharma hf|Roche|Capecitabín||5130||5130|7334||2 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|ţpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|29496|38545|lyfsjukr|||1|120|0||Icepharma hf|Roche|Capecitabín||29496||29496|38545||2 397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyfalmen|||0|2|0||Vistor hf|Ferring Lćgemidler A/S|Natríumpicosúlfat|||||5406||1 398698|N05AH0412|Quetiapin Sandoz|forđatfl|400|mg|100|stk|1|ţpakki||N05AH04|01.12.2014||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|41762|48515|lyfalmen|V0261|48515|2|100|0|100,0000|Artasan ehf|Sandoz A/S|Quetíapín||36348||36348|48515||1 398821|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|56|stk|1|ţpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|7175|3829|lyfalmen|V0012|2950|3|56|0|74,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||2000||2000|3829||2 399241|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2010|30.06.2015|R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|2124|3660|lyfalmen|||3|28|0|28,0000|LYFIS ehf|LYFIS ehf|Klópídógrel||1877||1877|3660||2 399309|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.08.2015||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|29330|39639|lyfalmen|||1|0,72|0|8,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||29330|39639||1 399510|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|ţpakki||N02AX02|01.05.2012||R|1|0|1|0|G|0|GLP|0|0|1|100|SEK|344|1550|lyfalmen|V0225|1539|1|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||344||344|1550||1 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|ţpakki||N03AX09|01.03.1999||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|2049|2310|lyfalmen|V0244|2001|1|56|0|9,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||896||896|2310||1 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|8385|12617|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8385||8385|12617||1 399746|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.03.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|33283|43255|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||33283|43255||1 399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|2|0||Artasan ehf|Novartis Healthcare A/S-A|Pencíklóvír|||||||1 399856|L03AB1101|Pegasys|stl|180|mcg/pen|0,5|ml|4|lyfjap|áfylltur lyfjapenni|L03AB11|01.05.2012||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|105986|133677|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||105986||105986|133677||2 400044|S03CA0102|Sofradex|aug.eydr|||8|ml|1|glas||S03CA01|01.03.1980||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|1181|2702|lyfalmen|||1|8|0||Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1181||1181|2702||1 400101|R05DB2002|Pektolin|mixtúra|||150|ml|1|glas||R05DB20|01.06.1981||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group hf|Actavis hf|Blöndur|||||||1 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|ţpakki||C10AB04|01.04.1988||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4732|7589|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||4732||4732|7589||1 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|208|1363|lyfalmen|||1|25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||208||208|1363||1 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|377|1595|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||377||377|1595||1 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|180|1324|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||180||180|1324||1 400573|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|ţpakki||C10AX09|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|5010|7972|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||5010||5010|7972||1 400574|N07XX0901|Tecfidera|hylki|240|mg|56|stk|1|ţpakki||N07XX09|01.12.2014||R|0|0|0|1|0|1|BIB|0|1|0|100|XEU|175627|220291|lyfsjukr|||1|56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Dimethyl fumarate||175627||175627|220291||2 401084|M01AH0105|Cloxabix|hylki|200|mg|20|stk|1|ţpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|2173|3638|lyfalmen|V0037|3638|2|20|0|20,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||1861||1861|3638||2 401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|ţpakki||B01AC24|01.06.2011||R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|9339|13931|lyfalmen|V0459|12244|1|56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||9339||9339|13931||1 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|705|2047|lyfalmen|||1|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||705||705|2047||1 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1128|2629|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1128||1128|2629||1 402203|D07AC1302|Ovixan|húđlausn|0,1|%|100|ml|1|dropaí||D07AC13|01.08.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|1367|2958|lyfalmen|||2|100|0||Vistor hf|Galenica AB|Mómetasón||1367||1367|2958||1 402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|1847|3630|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1847||1847|3630||1 402873|N06DA0302|Exelon (Lyfjaver)|forđapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|DKK|13084|19091|lyfalmen|V0349|19091|3|30|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||13084||13084|19091|| 402988|J02AC0102|Candizol|hylki|50|mg|30|stk|1|ţpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|5748|3279|lyfalmen|V0552|3155|2|30|0|7,5000|Actavis Group hf|Actavis hf|Flúkónazól||1600||1600|3279||1 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|4775|9230|vetalmen|||0|20|0||Vistor hf|Intervet International BV|||4775||4775|9230||1 403550|C08CA0302|Lomir Retard|forđahlk|2,5|mg|100|stk|1|ţpakki||C08CA03|01.10.1992||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|5112|8112|lyfalmen|||1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S|Ísradipín||5112||5112|8112||1 403856|L01BA0108|Methotrexate Pfizer|irţ|100|mg/ml|50|ml|1|hgl||L01BA01|01.10.2011||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|34357|44590|lyfsjukr|||1|50|0||Icepharma hf|Pfizer ApS|Metótrexat||||34357|44590||1 403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|1127|2628|lyfalmen|||1|13,5|0||Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||1127||1127|2628||1 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||1898||2 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|60514|77122|lyfsjukr|||1|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||60514||60514|77122||1 404818|C03AA0305|Hydromed|töflur|25|mg|100|stk|1|ţpakki||C03AA03|01.06.2013||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1105|2597|lyfalmen|||2|100|0|100,0000|Vistor hf|MediLink A/S|hýdróklórtíazíđ||1105||1105|2597||1 404832|R02AA0306|Strepsils Jordbćr Sukkerfri|sogtfl|||36|stk|1|ţpakki||R02AA03|01.03.2014||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|636|909|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Fýtómenadíón||636||636|909||2 404997|A10BX1001|Lyxumia|stl|||2|áf-penni|1|pakki|10 og 20 mcg|A10BX10|01.10.2013||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|10003|14844|lyfalmen|||1|2|0|1,5000|Vistor hf|Sanofi-aventis groupe|Lixisenatíd||10003||10003|14844||1 405019|C03CA0110|Impugan|töflur|40|mg|250|stk|1|glas||C03CA01|01.11.2013||R|1|0|0|0|G|0|AGT|0|0|0|100|SEK|812|2194|lyfalmen|||2|250|0|250,0000|Actavis Group hf|Actavis Group hf|Fúrósemíđ||812||812|2194||1 405076|C03EA0114|Diuramin mite|töflur|27,5|mg|100|stk|1|ţpakki|2,5+25 mg|C03EA01|01.05.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1398|2177|lyfalmen|V0559|2169|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Hýdróklórtíazíđ og kalíumsparandi lyf||800||800|2177||2 405129|QP54AA0501|Stronghold|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|2940|5067|vetorma|||0|2,25|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2940||2940|5067||2 405168|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|0|KAB|0|0|0|100|DKK|||lyfalmen|||0|400|0||Icepharma hf|Fresenius Kabi AB|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||2133||2 405589|J07BD5203|Priorix|sts|||0,5|ml|1|hgl|+ einnota dćla|J07BD52|01.03.1999||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|1962|3777|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||1962||1962|3777||1 405597|J07BD5203|Priorix|sts|||0,5|ml|10|hgl||J07BD52|01.11.2001||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|20914|28994|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||20914||20914|28994||1 405677|J01DD0401|Rocephalin|irţ|2|g|1|hgl|1|pakki|lausn|J01DD04|01.03.2013||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|3391|4848|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Roche|Ceftríaxón||3391||3391|4848||2 405823|C10BA0501|Atozet|filmhtfl|90|mg|90|stk|1|ţpakki|10 mg + 80 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|17056|24114|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||17056||17056|24114||1 405998|A10BA0202|Metformin Actavis|filmhtfl|1000|mg|60|stk|1|ţpakki||A10BA02|01.11.2014||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|457|1705|lyfalmen|V0502|1705|2|60|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||457||457|1705||1 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|18998|26571|lyfalmen|||1|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||18998||18998|26571||1 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|57279|74988|lyfalmen|||1|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||57279||57279|74988||1 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|67240|87587|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||67240||67240|87587||1 406894|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|67193|85429|lyfsjukr|||1|7,5|0|37,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||67193||67193|85429||1 407923|N06AB1007|Escitalopram Bluefish|filmhtfl|10|mg|28|stk|1|ţpakki||N06AB10|01.08.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|1320|2893|lyfalmen|V0319|2893|2|28|0|28,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||1320||1320|2893||2 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|156|1291|lyfalmen|||1|25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||156||156|1291||1 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|338|1542|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||338||338|1542||1 408145|B01AF0101|Xarelto|filmhtfl|2,5|mg|100|stk|1|ţpakki|stakskammtaţynna|B01AF01|01.04.2015||R|1|1|0|0|G|0|BGB|0|0|0|100|DKK|15814|22544|lyfalmen|||1|100|0|25,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||15814||15814|22544||2 408156|A10BB0904|Zodediab|töflur|30|mg|90|stk|1|ţpakki||A10BB09|01.03.2015||R|1|0|0|0|G|0|IPC|0|0|0|100|IKR|2744|4853|lyfalmen|||2|90|0|45,0000|Portfarma ehf|Alvogen IPco S.á.r.l.|Glíklazíđ||2744||2744|4853|31.8.2015|1 408266|N05BA1206|Alprazolam Krka|forđatfl|1|mg|60|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|1819|2904|lyfalmen|V0310|2904|2|60|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1328||1328|2904||2 408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1593|3269|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||1593||1593|3269||1 409019|QP54AA0501|Stronghold|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|3055|5266|vetorma|||0|1,5|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3055||3055|5266||2 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|3578|6001|lyfalmen|||1|35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||3578||3578|6001||1 409425|R01AD0502|Rhinocort Turbuhaler|nefúđad|100|mcg/sk|200|skammtar|1|stauk||R01AD05|01.01.1992||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|3694|6161|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||3694||3694|6161||1 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|ţpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|9485|14131|lyfalmen|||1|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||9485||9485|14131||1 409745|N05AX1302|Xeplion|stl|100|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|67872|88387|lyfalmen|||1|1|0|40,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||67872||67872|88387||1 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|ţpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|7693|11665|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||7693||7693|11665||1 409927|G04BD1201|Betmiga|forđatfl|50|mg|90|stk|1|ţpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|16086|22888|lyfalmen|V0651|22888|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||16086||16086|22888||1 409975|M01AH0105|Cloxabix|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|10602|14660|lyfalmen|V0196|14660|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||9869||9869|14660||2 410077|N02CC0402|Maxalt Smelt|frţ.tfl|5|mg|6|stk|1|ţpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|5073|8059|lyfalmen|V0620|5724|1|6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||5073||5073|8059||1 410173|N02AA0506|Oxikodon Depot Actavis|forđatfl|10|mg|98|stk|1|ţpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|2884|4911|lyfalmen|V0598|4911|2|98|0|13,0700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||2786||2786|4911||1 410382|C03DA0103|Spiron|töflur|100|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|OPF|0|0|0|100|DKK|3443|5161|lyfalmen|V0093|5161|2|100|0|133,3300|Portfarma ehf|Orion Corporation|Spírónólaktón||2968||2968|5161||1 410469|L04AB0202|Remsima|irţ|100|mg|1|hgl|1|pakki||L04AB02|01.01.2014||R|0|1|0|1|0|1|CHH|0|1|0|100|DKK|51251|65602|lyfsjukr|||2|1|0|26,6700|Portfarma ehf|Celltrion Healthcare Hungary Kft.|Infliximab||51251||51251|65602||1 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|ţpakki||P01BA01|01.08.2005||R|1|0|0|0|0|0|REP|0|0|0|100|SEK|990|2439|lyfalmen|||1|20|0|6,2000|Vistor hf|Recip AB|Klórókín||990||990|2439||1 410649|C09CA0305|Valsartan ratiopharm|filmhtfl|40|mg|14|stk|1|ţpakki||C09CA03|01.02.2015||R|1|0|0|0|0|0|RGM|0|0|0|100|IKR|820|2205|lyfalmen|||2|14|0|7,0000|Medical ehf|ratiopharm GmbH|Valsartan||820||820|2205||2 410757|V03AE0203|Sevelamercarbonat W&H|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.04.2015||R|1|1|0|0|0|0|WEH|0|0|0|100|XEU|21055|27369|lyfalmen|V0680|27369|2|180|0|22,5000|Williams & Halls efh|Williams & Halls ehf|Sevelamer||19629||19629|27369||2 411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|ţpakki||M03BX01|01.01.1990||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|592|1891|lyfalmen|||2|50|0|10,0000|Icepharma hf|Mylan AB|Baklófen||592||592|1891||2 411076|N05AD0301|Buronil|húđuđtfl|25|mg|100|stk|1|glas||N05AD03|01.12.2014||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1645|3340|lyfalmen|V0557|3340|1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||1645||1645|3340||1 411184|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|100|stk|1|glas||N02BE01|01.10.2013||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|449|1620|lyfalmen|V0230|1612|2|100|0|16,6667|Medical ehf|ratiopharm GmbH|Paracetamól||395||395|1620||2 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|4528|6474|lyfsjukr|||1|50|0|16,6667|Icepharma hf|Roche|Mídazólam||4528||4528|6474||2 411616|N06BA0404|Methylphenidate Sandoz|forđatfl|36|mg|30|stk|1|glas||N06BA04|01.11.2013||R|1|0|1|0|0|0|SHS|0|0|0|100|DKK|7956|8337|lyfalmen|V0624|8337|2|30|0|36,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||5275||5275|8337||1 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|27799|36434|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Lamívúdín||27799||27799|36434||1 411859|J02AC0102|Candizol|hylki|150|mg|1|stk|1|ţpakki||J02AC01|01.02.2014||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|V0554|1871|2|1|0|0,7500|Actavis Group hf|Actavis hf|Flúkónazól|||||1871||1 411918|N02CC0101|Imigran|nefúđi|20|mg/sk|6|skammtar|1|pakki||N02CC01|01.07.2000||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|8133|12271|lyfalmen|||1|6|0|6,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||8133||8133|12271||1 412049|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.01.1990||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|19063|26653|lyfalmen|||1|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||19063||19063|26653||1 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|međ rotv.|B01AB05|01.02.1999||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|2963|4236|lyfsjukr|||1|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||2963||2963|4236||1 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|0|0|0|0|0|0|MER|1|0|0|100|XEU|2893|5659|vetalmen|||0|100|0||Vistor hf|Merial|||2893||2893|5659||1 412468|QM01AC0606|Meloxidolor|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|4591|8881|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||4591||4591|8881||2 412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|95910|121145|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||95910||95910|121145||2 412581|N05AX1302|Xeplion|stl|75|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|52787|69307|lyfalmen|||1|1|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||52787||52787|69307||1 412825|L02BA0107|Tamoxifen Mylan|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|2975|5171|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Tamoxífen||2975||2975|5171||2 412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3070|5302|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Tamoxífen||3070||3070|5302||2 413177|N05AH0412|Quetiapin Sandoz|forđatfl|200|mg|100|stk|1|ţpakki||N05AH04|01.12.2014||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|24503|25330|lyfalmen|||2|100|0|50,0000|Artasan ehf|Sandoz A/S|Quetíapín||18017||18017|25330|31.7.2015|1 413220|V03AB1703|Methylthioninium chloride Proveblue|stl|5|mg/ml|10|ml|5|lykjur||V03AB17|01.05.2015||R|0|0|0|0|0|1|ROP|0|0|0|100|DKK|31291|40777|lyfsjukr|||1|50|0||Williams & Halls efh|Provepharm SAS|Metýltíónín||31291||31291|40777||2 413988|N02BE0107|Paratabs|filmhtfl|500|mg|20|stk|1|ţpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 414006|N06AB0404|Citalopram Bluefish|filmhtfl|10|mg|30|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|890|1765|lyfalmen|||2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||500||500|1765||2 414167|N06DA0205|Donesyn|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.05.2011||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|17467|7456|lyfalmen|V0342|7307|2|98|0|130,6700|Williams & Halls efh|Williams & Halls ehf|Dónepezíl||4635||4635|7456||2 414680|C03BA1102|Natrilix Retard|forđatfl|1,5|mg|90|stk|1|ţpakki||C03BA11|01.03.1999||R|1|0|0|0|G|0|SEV|0|0|0|100|DKK|3535|5942|lyfalmen|||1|90|0|54,0000|Icepharma hf|Servier|Indapamíđ||3535||3535|5942||2 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1228|2767|lyfalmen|||1|300|0|6,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1228||1228|2767||1 415338|N05AA0201|Nozinan|filmhtfl|25|mg|100|stk|1|ţpakki||N05AA02|01.11.2012||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1629|3318|lyfalmen|||1|100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||1629||1629|3318||1 415368|C02KX0501|Adempas|filmhtfl|2,5|mg|42|stk|1|ţpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BGB|0|1|0|100|DKK|188911|236812|lyfsjukr|||1|42|0||Icepharma hf|Bayer Pharma AG|Riociguatum||188911||188911|236812||2 415946|N03AX1405|Matever|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|9831|6256|lyfalmen|V0253|6256|2|100|0|33,3300|Portfarma ehf|Pharmathen S.A.|Levetíracetam||3763||3763|6256||1 416371|QM01AE9001|Quadrisol|hlaup|100|mg/ml|30|ml|1|spr|f. hesta|QM01AE90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1765|3469|vetalmen|||0|30|0||Icepharma hf|Zoetis Belgium S.A.|Vedaprófen||1765||1765|3469||2 416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.09.1997||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|8821|9081|lyfalmen|V0088|2380|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||5816||5816|9081||1 416630|N06BA0702|Modafinil Bluefish|töflur|100|mg|30|stk|1|ţpakki||N06BA07|01.10.2014||R|1|0|0|1|0|0|BLP|0|0|0|100|IKR|7200|8234|lyfalmen|V0657|8234|2|30|0|10,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Modafinil||5200||5200|8234||2 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.03.2013||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|5069|8053|lyfalmen|||1|300|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||5069||5069|8053||1 416859|A01AA0101|Duraphat|tanndrei|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|0|0|0|0|G|0|GOG|0|0|1|100|XEU|2691|4780|lyfalmen|||1|10|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||2691||2691|4780||2 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|938|2367|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Azelainsýra||938||938|2367||2 417266|N05AH0409|Quetiapin Orion|filmhtfl|100|mg|100|stk|1|ţpakki||N05AH04|01.10.2012||R|1|0|0|0|G|0|OPF|0|0|0|100|IKR|10510|4311|lyfalmen|V0285|4311|2|100|0|25,0000|Portfarma ehf|Orion Corporation|Quetíapín||2350||2350|4311||1 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|ţpakki||J05AF06|01.07.2005||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|45500|58449|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Abacavír||45500||45500|58449||1 417880|B02BD0901|BeneFIX|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD09|01.07.2012||R|0|0|0|1|0|1|IPI|0|1|0|100|DKK|92331|116694|lyfsjukr|||1|1|0|2,2200|Icepharma hf|Pfizer Limited|Storkuţáttur IX||92331||92331|116694||1 418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|ţpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|29940|40410|lyfalmen|V0460|40410|1|180|0|122,7200|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||29940|40410||1 418122|H02AB0205|Dexametason Abcur|töflur|4|mg|20|stk|1|ţpakki||H02AB02|01.11.2013||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|3841|6363|lyfalmen|||2|20|0|53,3300|Icepharma hf|Abcur AB|Dexametasón||3841||3841|6363||2 418592|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|áf.spr||L04AC03|01.06.2012||R|0|0|0|1|0|1|BIO|0|0|0|100|DKK|125120|157474|lyfsjukr|||1|18,76|0|28,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||125120||125120|157474||3 418731|A07EC0201|Mesasal|eţ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|5839|9113|lyfalmen|V0014|8619|1|60|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||5839||5839|9113||1 418981|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|100|stk|1|ţpakki||R06AX27|01.05.2012||R|1|0|0|0|G|0|APC|0|0|1|100|XEU|2184|4082|lyfalmen|V0458|3551|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||2184||2184|4082||1 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|ţpakki||A11CC03|01.11.1979||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|2565|4607|lyfalmen|||1|100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||2565||2565|4607||1 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|ţpakki||A11CC03|01.11.1979||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|6609|10173|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||6609||6609|10173||1 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|46244|59375|lyfsjukr|||1|180|0|30,0000|Vistor hf|M.S.D.|Indínavír||46244||46244|59375||1 419828|N06BA0406|Medikinet CR|hylki|5|mg|30|stk|1|ţpakki|međ breyttan losunarhrađa|N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|3450|5825|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||3450||3450|5825||2 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|1|0|0|1|0|1|ORP|0|0|0|100|DKK|34935|45309|lyfsjukr|||1|100|0|7,5000|Swedish Orphan International AB|Orphan Europe (S)|Mecaptamín||34935||34935|45309||3 419945|D07AD0101|Dermovat|húđlausn|0,5|mg/ml|25|ml|1|glas|í hársvörđ|D07AD01|01.09.1982||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|791|2165|lyfalmen|||1|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||791||791|2165||1 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|11203|16496|lyfalmen|||1|10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||11203||11203|16496||1 420209|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|100|stk|1|ţpakki|hart|A02BC01|01.08.2015||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4359|3554|lyfalmen|V0006|3554|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Ómeprazól||1800||1800|3554||2 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|ţpakki||C01BD01|01.07.1989||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|952|2387|lyfalmen|V0036|2385|1|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||952||952|2387||1 421816|QN04BC0201|Prascend|töflur|1|mg|160|stk|1|ţpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|31442|59822|vetalmen|||0|160|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||31442||31442|59822||1 421938|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|100|stk|1|ţpakki||R06AX27|01.09.2013||R|1|0|0|0|G|0|RGM|0|0|1|100|XEU|2184|3551|lyfalmen|V0458|3551|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Deslóratadín||1798||1798|3551||2 422115|N02AA0506|Oxikodon Depot Actavis|forđatfl|5|mg|28|stk|1|ţpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|564|1853|lyfalmen|V0596|1853|2|28|0|1,8600|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||564||564|1853||1 422121|C07AB0205|Seloken|töflur|50|mg|100|stk|1|ţpakki||C07AB02|01.05.2009||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1320|2893|lyfalmen|V0051|2177|1|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1320||1320|2893||1 422246|C07AB0206|Seloken ZOC|forđatfl|95|mg|98|stk|1|ţpakki||C07AB02|01.07.1988||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2963|5155|lyfalmen|V0049|3393|1|98|0|62,0700|Vistor hf|AstraZeneca A/S DK|Metóprólól||2963||2963|5155||1 422337|C07AB0206|Seloken ZOC|forđatfl|190|mg|98|stk|1|ţpakki||C07AB02|01.07.1988||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|4872|7782|lyfalmen|V0054|5785|1|98|0|124,1300|Vistor hf|AstraZeneca A/S DK|Metóprólól||4872||4872|7782||1 422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|0|0|0|1|0|1|CSB|0|0|0|100|SEK|62070|79058|lyfsjukr|||1|1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||62070||62070|79058||2 422738|G03GA0503|Bemfola|stl|75|ae|0,125|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|2997|5201|lyfalmen|||1|0,125|0|1,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||2997||2997|5201||3 422937|B01AF0101|Xarelto|filmhtfl|2,5|mg|56|stk|1|ţpakki||B01AF01|01.04.2015||R|1|1|0|0|G|0|BGB|0|0|0|100|DKK|8877|13295|lyfalmen|||1|56|0|14,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||8877||8877|13295||2 423361|G03AA1201|Yasmin|filmhtfl|||63|stk|1|ţpakki|3+0,03 mg|G03AA12|01.01.2014||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|2997|5201|lyfalmen|V0192|4312|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||||2997|5201||2 423527|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|56|stk|1|ţpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|4596|3829|lyfalmen|V0011|2925|3|56|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||2000||2000|3829||2 423703|S01GA5101|Antistina-Privin|augndr|5,25|mg/ml|10|ml|1|glas|5+0,25 mg|S01GA51|01.05.2014||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|710|2054|lyfalmen|||1|10|0||Vistor hf|Laboratories THEA|Nafazólín í blöndum međ öđrum efnum||710||710|2054||1 423737|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|10|fl||J01GB03|01.07.2012||R|0|0|0|0|0|1|BRU|0|0|0|100|XEU|20360|27182|lyfsjukr|||2|1200|0|15,0000|Actavis Group hf|B.Braun Melsungen AG|Gentamícín||20360||20360|27182||1 423859|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíđ 20 mg|S01ED51|01.09.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|DKK|5461|8593|lyfalmen|V0373|7015|1|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||5461||5461|8593||2 425181|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|939|2369|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Flúnítrazepam||939||939|2369||2 425608|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|ţpakki|2+0,5 mg|N07BC51|01.08.2011||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|4051|5792|lyfsjukr|||1|28|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||4051||4051|5792||1 425679|C07AG0204|Carvedilol HEXAL|töflur|25|mg|100|stk|1|ţpakki||C07AG02|01.01.2015|30.06.2015|R|1|0|0|0|G|0|PCO|0|0|0|100|DKK|3627|6069|lyfalmen|||2|100|1|66,6700|Distica|Distica - óskráđ lyf|Carvedílól||3627||3627|6069||1 425939|C09CA0102|Lopress|töflur|12,5|mg|100|stk|1|glas||C09CA01|01.06.2012||R|1|0|0|0|G|0|AHF|0|0|0|100|IKR|2248|4000|lyfalmen|||2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group hf|Lósartan||2124||2124|4000||1 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|589|1887|lyfalmen|||1|20|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||589||589|1887||1 426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|769|2135|lyfalmen|||1|30|0|7,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||769||769|2135||1 426859|N03AX1407|Levetiracetam Teva|filmhtfl|250|mg|50|stk|1|ţpakki||N03AX14|01.02.2015||R|1|0|0|0|0|0|TEV|0|0|0|100|IKR|2129|2109|lyfalmen|V0515|2025|2|50|0|8,3300|Medical ehf|Teva Pharma B.V.|Levetíracetam||750||750|2109||2 427075|M01AE0115|Alvofen Express|hylki|400|mg|50|stk|1|ţpakki||M01AE01|01.04.2014||L|1|0|0|0|0|0|IPC|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Portfarma ehf|Alvogen IPco S.á.r.l.|Íbúprófen|||||||1 427186|C10BA0201|Inegy|töflur|90|mg|28|stk|1|ţpakki|10 mg + 80 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|7898|11947|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||7898||7898|11947||1 427321|S01EE0402|IZBA|augndr|30|mcg/ml|2,5|ml|3|glös||S01EE04|01.10.2014||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|7659|11618|lyfalmen|V0658|11618|1|7,5|0|75,0000|Vistor hf|Alcon Laboratories Ltd.|Travóprost||7659||7659|11618||1 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|0|0|0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen|||0|30|0|45,0000|Vistor hf|Boehringer Ingelheim International |Natríum pícósúlfat|||||2846||1 427803|R03AK0604|Relanio|innönddu|300|mcg/sk|180|skammtar|1|pakki|50+250 mcg|R03AK06|01.01.2014||R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|19495|20882|lyfalmen|||2|180|0|90,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||14500||14500|20882||2 428018|R06AX2201|Kestine|filmhtfl|10|mg|10|stk|1|ţpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 428089|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|V0136|1773|0|25|0|5,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||1773||1 428579|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.03.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|39576|51081|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||39576|51081||1 428828|N06DA0303|Nimvastid (Lyfis)|hylki|3|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|28356|31362|lyfalmen|V0344|31362|3|112|0|37,3300|LYFIS ehf|LYFIS ehf|Rívastigmín||22786||22786|31362||2 429098|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3444|4924|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||3444||3444|4924||2 429503|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|glas||J02AC04|01.07.2014||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|89726|113454|lyfsjukr|||1|105|0|5,2500|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||89726||89726|113454||1 429703|A02BC0508|Esomeprazol Actavis|sţ-tfl|40|mg|100|stk|1|glas||A02BC05|01.04.2014|31.07.2015|R|1|0|0|0|G|0|APC|0|0|0|100|XEU|6060|5272|lyfalmen|||2|100|0|133,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3048||3048|5272|| 429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|ţpakki||C03DA01|01.11.1981||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|3796|6301|lyfalmen|V0093|5161|1|100|0|133,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||3796||3796|6301||1 429875|G03GA0503|Bemfola|stl|225|ae|0,375|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|9903|14707|lyfalmen|||1|0,375|0|3,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||9903||9903|14707||3 430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|965|1380|lyfsjukr|||1|50|0||Vistor hf|Janssen-Cilag AB|Fentanýl||965||965|1380||1 430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1340|1916|lyfsjukr|||1|50|0|3,3333|Icepharma hf|Roche|Mídazólam||1340||1340|1916||2 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4157|8057|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||4157||4157|8057||1 430232|L03AB1001|PegIntron|sts|100|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|89866|113628|lyfsjukr|||1|4|0|53,3300|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||89866||89866|113628||1 430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.08.2011||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|18630|5259|lyfalmen|V0184|5259|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Anastrózól||3039||3039|5259||2 430521|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|2758|2347|lyfalmen|V0144|1636|3|4|0|8,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||923||923|2347||2 430710|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áfspr||J07AP03|01.07.1994||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2281|4216|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsađir mótefnavakar||2281||2281|4216||2 430729|A11DA0101|Tiacur|stl|50|mg/ml|2|ml|5|lykjur||A11DA01|01.09.2015||R|0|0|0|0|0|0|ABC|0|0|0|100|SEK|25113|34305|lyfalmen|||1|10|0|10,0000|Icepharma hf|Abcur AB|Thiamine (vit B1)||||25113|34305||2 430862|J01FA1005|Azithromycin Actavis|filmhtfl|500|mg|2|stk|1|ţpakki||J01FA10|01.05.2013||R|1|0|0|0|0|0|AHF|0|0|1|100|XEU|925|2349|lyfalmen|V0173|2349|2|2|0|3,3300|Actavis Group PTC ehf|Actavis Group hf|Azitrómýcín||925||925|2349||1 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|1028|2491|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||1028||1028|2491||1 431154|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.11.2013||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|4|0||Vistor hf|McNeil Sweden AB|Levókabastín|||||||1 431193|N02AB0306|Instanyl|nefúđi|100|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014||R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|9107|13611|lyfalmen|||1|6|0|1,0000|Vistor hf|Takeda Pharma A/S|Fentanýl||9107||9107|13611||1 431495|L01CD0201|Taxotere|irţ|160|mg|8|ml|1|hgl|lausn|L01CD02|01.04.2011||R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|133110|167412|lyfsjukr|||1|8|0||Vistor hf|Aventis Pharma SA|Docetaxel||133110||133110|167412||1 431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|ţpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|1313|2884|lyfalmen|||1|20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||||1313|2884||1 431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|ţpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|4074|6684|lyfalmen|||1|100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||4074||4074|6684||1 431930|N06BA0406|Medikinet CR|hylki|60|mg|30|stk|1|ţpakki|međ breyttan losunarhrađa|N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|11696|17175|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||11696||11696|17175||2 431985|D07XC0101|Diprosalic|húđlausn|||100|ml|1|glas|0,5 mg/ml+20 mg/ml|D07XC01|01.04.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1926|3727|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||1926||1926|3727||1 432410|N06AX2105|Duloxetin Krka|sţ-hylki|60|mg|30|stk|1|ţpakki||N06AX21|01.05.2015||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|4900|7545|lyfalmen|V0693|7197|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||4700||4700|7545||2 432665|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dćlur|einnota dćlur plast|M09AX01|01.10.2011||R|0|0|0|0|G|0|NDR|0|0|0|100|SEK|29013|39238|lyfalmen|||1|12,5|0|34,7222|Vistor hf|Nordic Drugs AB|Natríumhýalúrónat||||29013|39238||1 432972|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|pakki||QJ01CR02|01.02.2012||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|2915|5701|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||2915||2915|5701||2 433126|N02BE0102|Panodil Brus|freyđit|500|mg|20|stk|1|ţpakki||N02BE01|01.05.2014||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyfalmen|||0|20|0|3,3300|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||1755||1 433194|N05AD0301|Buronil|húđuđtfl|25|mg|100|stk|1|glas||N05AD03|01.01.2013||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1645|3340|lyfalmen|V0557|3340|1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||1645||1645|3340||1 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|10274|15217|lyfalmen|||1|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||10274||10274|15217||1 433292|N02AA0106|Contalgin Uno|forđahlk|30|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|2403|4384|lyfalmen|||1|28|0|8,4000|Icepharma hf|Pfizer ApS|Morfín||2403||2403|4384||1 433318|N02AA0106|Contalgin Uno|forđahlk|90|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|5260|8316|lyfalmen|||1|28|0|25,2000|Icepharma hf|Pfizer ApS|Morfín||5260||5260|8316||1 434088|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.03.2013||R|0|0|0|0|0|1|BYP|0|0|0|100|DKK|162928|204497|lyfsjukr|||1|150|0||Icepharma hf|Bayer Pharma AG|Gadóbútról||162928||162928|204497||2 434091|N06DX0102|Memantine Merz|filmhtfl|10|mg|100|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|17094|6345|lyfalmen|V0605|6042|2|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||3828||3828|6345||1 434169|R03DC0304|Montelukast Teva|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.01.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|6495|2285|lyfalmen|V0490|2285|2|98|0|98,0000|Medical ehf|Teva Pharma B.V.|Montelúkast||878||878|2285||2 434261|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|1000|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|NOK|75441|115455|veteldis|||0|1000|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||71622||71622|115455||1 434461|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|ţpakki||N03AX15|01.03.2014||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|8167|12317|lyfalmen|||1|56|0|14,0000|Vistor hf|Eisai Ltd|Zonisamíđ||8167||8167|12317||1 434576|A02BC0403|Rabeprazol Krka|sţ-tfl|20|mg|98|stk|1|ţpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|3931|3691|lyfalmen|V0010|3617|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1900||1900|3691||2 434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|MCS|0|0|1|100|SEK|782|2153|lyfalmen|||1|50|0||Vistor hf|McNeil Sweden AB|Blöndur||782||782|2153||1 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|0|0|0|G|0|MEB|0|0|1|100|SEK|4931|7863|lyfalmen|||1|1|0|0,6000|Vistor hf|Meda AB (V)|Adrenalín tartrat||4931||4931|7863||1 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|0|0|0|G|0|MEB|0|0|1|100|SEK|4931|7863|lyfalmen|||1|1|0|0,3000|Vistor hf|Meda AB (V)|Adrenalín tartrat||4931||4931|7863||1 434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|ţp (10x10 stk)|N06AB03|01.06.1998||R|1|0|0|0|0|0|ELI|0|0|0|100|XEU|9564|14240|lyfalmen|V0315|6034|1|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||9564||9564|14240||2 435728|N06AX1105|Mirtazapine Bluefish|munndr.t|45|mg|96|stk|1|ţpakki||N06AX11|01.04.2014||R|0|0|0|0|0|0|BLP|0|0|0|100|IKR|5573|8747|lyfalmen|||2|96|0|144,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||5573||5573|8747|31.7.2015|2 436010|L01AA0901|Levact|irţ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|202386|253572|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||202386||202386|253572||2 436022|C09DA0308|Diovan Comp 80/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|3286|5599|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan og ţvagrćsilyf||3286||3286|5599||1 436042|R03DC0305|Montelukast Navamedic|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.04.2014||R|1|0|0|0|G|0|ART|0|0|0|100|XEU|6624|6934|lyfalmen|V0491|6096|2|98|0|49,0000|Artasan ehf|Navamedic ASA|Montelúkast||4256||4256|6934||1 436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|ţpakki||M01AE02|01.07.1993||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2 436394|H01BA0202|Octostim|nefúđi|0,15|mg/sk|2,5|ml|1|úđagl||H01BA02|01.01.2013||R|0|0|0|1|0|1|FEL|0|0|0|100|DKK|40074|51701|lyfsjukr|||1|2,5|0|150,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||40074||40074|51701||1 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|1006|2461|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||1006||1006|2461||1 436471|N06DX0105|Memantine Mylan|filmhtfl|10|mg|98|stk|1|ţpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|15579|6258|lyfalmen|V0605|5921|2|98|0|49,0000|Icepharma hf|Generics UK Ltd|Memantín||3765||3765|6258||2 436877|L01AA0901|Levact|irţ|2,5|mg/ml|25|mg|20|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|224962|281650|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||224962||224962|281650||2 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|ţpakki||N05AD01|01.12.1972||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|835|2226|lyfalmen|||1|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||835||835|2226||1 437013|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2010|30.06.2015|R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|7785|6627|lyfalmen|||3|100|0|100,0000|LYFIS ehf|LYFIS ehf|Klópídógrel||4033||4033|6627||2 437223|V10XX0301|Xofigo|stl|1000|kBq/ml|6|ml|1|hgl||V10XX03|01.06.2015||R|0|0|0|1|0|1|BGB|0|1|0|100|DKK|594426|741160|lyfsjukr|||1|6|0||Icepharma hf|Bayer Pharma AG|radium-223 dichloride||594426||594426|741160||2 437767|N03AG0102|Orfiril|sţ-tfl|150|mg|100|stk|1|glas||N03AG01|01.08.2015||R|1|0|0|0|G|0|DEA|0|0|0|100|XEU|1591|3266|lyfalmen|||1|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1591||1591|3266||1 437935|L01AA0901|Levact|irţ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|58186|74227|lyfsjukr|||1|125|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||58186||58186|74227||2 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|dropaí|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|0|0|0|0|G|0|CLA|0|0|1|100|USD|1357|2944|lyfalmen|||1|10|0||Vistor hf|Alcon Nordic A/S|Hýdrókortisón og sýkingalyf||1357||1357|2944||1 438432|N06AX1602|Efexor Depot|forđahlk|75|mg|98|stk|1|ţpakki||N06AX16|01.10.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10316|15275|lyfalmen|V0334|3078|1|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||10316||10316|15275||1 438639|N06DX0107|Zalatine|filmhtfl|10|mg|98|stk|1|ţpakki||N06DX01|01.03.2014||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|10072|5943|lyfalmen|V0605|5921|2|98|0|49,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||3536||3536|5943||2 438759|L01XE1501|Zelboraf|filmhtfl|240|mg|56|stk|1|ţpakki||L01XE15|01.08.2012||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|224684|264536|lyfsjukr|||1|56|0||Icepharma hf|Roche Registration Limited|Vemurafeníb||211202||211202|264536||2 438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.07.1989||L|1|0|0|0|0|0|SIV|0|0|1|100|IKR|||lyflausa|||1|10|0|10,0000|Vistor hf|Bayer AB|Lóratadín|||||||1 438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.07.1989||L|1|0|0|0|0|0|SIV|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Vistor hf|Bayer AB|Lóratadín|||||||1 438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.07.1989||L|1|0|0|0|G|0|SIV|0|0|1|100|DKK|||lyfalmen|V0362|2040|1|100|0|100,0000|Vistor hf|Bayer AB|Lóratadín|||||8649||1 438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|152884|192005|lyfsjukr|||1|2,6|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||152884||152884|192005||1 439198|N04BC0505|Oprymea|forđatfl|0,26|mg|10|stk|1|ţpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|1300|2866|lyfalmen|||2|10|0|1,0400|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||1300||1300|2866|31.7.2015|2 439489|C07FB0201|Logimax|forđatfl|55|mg|98|stk|1|pakki|ţp 5+50 mg|C07FB02|01.04.1997||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|5434|8556|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóđţrýstingslćkkandi lyf||5434||5434|8556||1 439594|C10BA0201|Inegy|töflur|50|mg|98|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|19869|27672|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||19869||19869|27672||1 439719|S01EE0402|IZBA|augndr|30|mcg/ml|2,5|ml|1|glas||S01EE04|01.10.2014||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|2553|4590|lyfalmen|V0658|3873|1|2,5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Travóprost||2553||2553|4590||1 439794|R01AA0704|Otrivin ukonserveret|nefúđi|1|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.05.2001||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 439908|G03AA0904|Denise|töflur|||126|stk|1|ţpakki|150/20 mcg|G03AA09|01.05.2014||R|0|0|0|0|0|0|RGM|0|0|0|100|IKR|2900|3829|lyfalmen|V0065|3829|2|126|0|168,0000|Medical ehf|ratiopharm GmbH|Desógestrel og ethinylestradíól||2000||2000|3829||2 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|1066|2314|lyfalmen|V0163|1968|1|70|0|5,6000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||899||899|2314||1 440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|1309|1872|lyfsjukr|||2|10|0|1,6700|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1309||1309|1872||1 440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|2065|2952|lyfsjukr|||2|10|0|3,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||2065||2065|2952||1 441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|ţpakki||C03DA01|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|860|2260|lyfalmen|V0046|1981|1|100|0|33,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||860||860|2260||1 441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|1068|2546|lyfalmen|||1|30|0||Vistor hf|Janssen-Cilag AB|Blöndur||1068||1068|2546||1 441341|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|977|2421|lyfalmen|V0046|1981|2|100|0|33,3333|Vistor hf|Takeda Pharma A/S|Spírónólaktón||977||977|2421||1 441619|J05AR0801|Eviplera|filmhtfl|470|mg|30|stk|1|glas|200+25+245 mg|J05AR08|01.05.2012||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|112349|141591|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Science International Ltd|Emtrícítabín, rilpívírin og tenófóvír||112349||112349|141591||2 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|ţpakki||G03DC02|01.12.1972||R|0|0|0|0|G|0|BAP|0|0|0|100|DKK|975|2418|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Noretísterón||975||975|2418||2 442407|N05AH0312|Zalasta|töflur|15|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|13443|19545|lyfalmen|V0283|3317|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||13443||13443|19545||2 442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|ţpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|10607|15676|lyfalmen|V0460|13470|1|60|0|40,9000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||10607|15676||1 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dćla|H04AA01|01.01.1989||R|0|0|0|0|G|0|NAS|0|0|1|100|DKK|3117|5367|lyfalmen|||1|1|0|1,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||3117||3117|5367||1 443181|QM01AH9201|Trocoxil|tuggutfl|6|mg|2|stk|1|ţpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1251|2459|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||1251||1251|2459||2 443358|N02AA0101|Contalgin|forđatfl|200|mg|90|stk|1|ţpakki||N02AA01|01.04.1993||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|24421|33430|lyfalmen|||1|90|0|180,0000|Icepharma hf|Pfizer ApS|Morfín||24421||24421|33430||1 443500|L01XA0211|Carboplatin Actavis|irţ|10|mg/ml|45|ml|1|hgl||L01XA02|01.05.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|3312|4735|lyfsjukr|||2|45|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Karbóplatín||3312||3312|4735||1 443904|J01FA0902|Clarithromycin ratiopharm|filmhtfl|500|mg|14|stk|1|ţpakki||J01FA09|01.06.2014||R|1|0|0|0|0|0|TSB|0|0|1|100|IKR|2700|4793|lyfalmen|V0116|4793|2|14|0|14,0000|Medical ehf|Teva Sweden AB|Klaritrómýcín||2700||2700|4793||2 444041|N05AH0501|Sycrest|tungur.t|10|mg|20|stk|1|ţpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|7071|10809|lyfalmen|||1|20|0|10,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7071||7071|10809||1 444102|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|60|stk|1|ţpakki||A06AB06|01.10.2012||R|1|0|0|0|0|0|FMV|0|0|0|100|GBP|1095|2583|lyfalmen|||3|60|0||Icepharma hf|Icepharma hf|Senna||1095||1095|2583||2 444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|ţp (2 x 15 stk)|N06AB03|01.06.1998||R|1|0|0|0|0|0|ELI|0|0|0|100|DKK|2903|5072|lyfalmen|V0061|3272|1|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||2903||2903|5072||2 444362|N01AF0302|Pentocur|sts|1|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|22226|29503|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||22226||22226|29503||2 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|0|0|0|0|G|0|ROC|0|0|0|100|DKK|2316|4264|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2316||2316|4264||2 444574|N07CA0102|Betahistin ratiopharm|töflur|8|mg|100|stk|1|ţpakki||N07CA01|01.12.2013||R|1|0|0|0|0|0|ROY|0|0|0|100|IKR|2250|4173|lyfalmen|||2|100|0|33,3300|Medical ehf|ratiopharm Oy|Betahistín||2250||2250|4173||2 444765|A05AA0207|Ursochol|hylki|250|mg|100|stk|1|ţpakki||A05AA02|01.11.2014||R|1|0|0|0|G|0|IRO|0|0|0|100|XEU|5126|8132|lyfalmen|||2|100|0|33,3300|Artasan ehf|Orifarm Generics A/S|Úrsódeoxýkól sýra||5126||5126|8132||1 445149|R03AK1001|Relvar Ellipta|innönddu|114|mcg/sk|30|skammtar|1|pakki|92+22 mcg|R03AK10|01.04.2014||R|0|0|0|0|G|0|GGL|0|0|0|100|GBP|6581|10134|lyfalmen|||1|30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Vilanterol og flútícason||6581||6581|10134||1 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|0|0|0|0|G|0|LEO|0|0|1|100|DKK|1474|3105|lyfalmen|||1|30|0||Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1474||1474|3105||1 445357|N06AX1105|Mirtazapine Bluefish|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.03.2015||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|998|1765|lyfalmen|V0329|1765|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||500||500|1765||2 445479|N04BC0407|Ropinirol Actavis|forđatfl|2|mg|84|stk|1|ţpakki||N04BC04|01.12.2012|31.07.2015|R|1|0|0|0|G|0|APC|0|0|0|100|XEU|8078|6137|lyfalmen|||2|84|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rópíníról||3677||3677|6137||1 446268|C08CA0502|Adalat Oros|forđatfl|20|mg|98|stk|1|ţpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|4731|7588|lyfalmen|||1|98|0|65,3333|Icepharma hf|Bayer Pharma AG|Nífedipín||||4731|7588||2 446618|N03AF0301|Inovelon|mixtúra|40|mg/ml|460|ml|1|fl||N03AF03|01.09.2012||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|16989|24030|lyfalmen|||1|460|0|13,1400|Vistor hf|Eisai Ltd|Rúfínamíđ||16989||16989|24030||1 447040|N06AX2105|Duloxetin Krka|sţ-hylki|60|mg|100|stk|1|ţpakki||N06AX21|01.05.2015||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|18000|23411|lyfalmen|V0694|22153|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||16500||16500|23411||2 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|9834|14612|lyfalmen|||1|3,6|0|36,0000|Icepharma hf|Pfizer ApS|Dalteparín||9834||9834|14612||1 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|5605|8791|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||5605||5605|8791||1 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|6937|10624|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Dalteparín||6937||6937|10624||1 447145|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|ţpakki||A10BF01|01.09.2014||R|1|0|0|0|G|0|BGB|0|0|0|100|DKK|841|2234|lyfalmen|||1|30|0|5,0000|Icepharma hf|Bayer Pharma AG|Acarbósa||||841|2234||2 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|8255|12439|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8255||8255|12439||1 447596|C07AG0205|Carveratio|töflur|25|mg|100|stk|1|ţpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|2887|5050|lyfalmen|||2|100|0|66,6700|Medical ehf|ratiopharm GmbH|Carvedílól||2887||2887|5050||2 447753|N06AX1105|Mirtazapine Bluefish|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.04.2014||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|1262|1765|lyfalmen|V0330|1765|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||500||500|1765||2 447785|C10AA0703|Rosuvastatin Krka|filmhtfl|5|mg|30|stk|1|ţpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|3300|5618|lyfalmen|V0171|5618|2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||3300||3300|5618||2 448125|C08CA0501|Adalat|töflur|10|mg|100|stk|1|ţpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|2316|4264|lyfalmen|||1|100|0|33,3333|Icepharma hf|Bayer Pharma AG|Nífedipín||||2316|4264||2 448217|C05AA0801|Doloproct|eţ-stíll|||10|stk|1|pakki||C05AA08|01.01.1991||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|692|2029|lyfalmen|V0675|2029|1|10|0||Icepharma hf|Bayer AB|Flúókortólón||692||692|2029||2 448233|C05AA0801|Doloproct|eţ-krem|||30|g|1|túpa||C05AA08|01.01.1991||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1269|2823|lyfalmen|V0674|2823|1|30|0||Icepharma hf|Bayer AB|Flúókortólón||1269||1269|2823||2 448245|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|ţpakki||M03BX01|01.12.1972||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|1966|3782|lyfalmen|V0202|3347|1|50|0|25,0000|Vistor hf|Novartis Healthcare A/S|Baklófen||1966||1966|3782||1 449470|B05BB0120|Natriumhydrogenkarbonat B.Braun|irl|500|mmól/l|0,25|l|1|fl|lausn|B05BB01|01.02.2012||R|0|0|0|0|0|1|BRU|0|0|0|100|XEU|1067|1526|lyfsjukr|||2|0,25|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1067||1067|1526||1 449485|N03AX1603|Pregabalin Krka|hylki|75|mg|56|stk|1|ţpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|5800|8784|lyfalmen|V0686|8784|2|56|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||5600||5600|8784||2 449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|ţpakki||C07AB03|01.01.1991||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1004|2458|lyfalmen|||2|98|0|130,6667|Icepharma hf|Mylan AB|Atenólól||1004||1004|2458||2 449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|4895|6998|lyfsjukr|||2|10|0|8,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||4895||4895|6998||1 449868|B01AF0101|Xarelto|filmhtfl|10|mg|10|stk|1|ţpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|3214|5500|lyfalmen|||1|10|0|10,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||3214||3214|5500||2 449911|A10AC0110|Humulin NPH KwikPen|stl|100|ae/ml|3|ml|5|pennar|áfylltur penni|A10AC01|01.01.2012||R|0|0|0|0|G|0|ELI|0|0|0|100|XEU|4749|7613|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||4749||4749|7613||2 450009|QN51AA0101|Euthasol vet.|stl|400|mg/ml|100|ml|1|fl||QN51AA01|01.07.2012||R|0|0|1|0|0|0|LEV|1|0|0|100|XEU|4344|8412|vetalmen|||0|100|0||Le Vet B.V.|Le Vet B.V.|Pentobarbital||4344||4344|8412||2 450054|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|ţpakki||G03CA04|01.12.2014||R|0|0|0|0|G|0|PTL|0|0|0|100|DKK|1143|2650|lyfalmen|V0659|2650|1|30|0|30,0000|Navamedic AB|Aspen Pharma Trading Limited|Estríól||1143||1143|2650||1 450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|ţpakki|875+125 mg|J01CR02|01.01.1997||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|1115|2314|lyfalmen|V0169|1687|1|12|0|10,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||899||899|2314||1 450201|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.07.2014||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|125332|157738|lyfsjukr|||1|20|0||Vistor hf|Merck Sharp & Dohme Limited|Sugammadex||125332||125332|157738||1 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|ţpakki||N05CF02|01.10.1992||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|2412|3555|lyfalmen|V0313|2549|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||1801||1801|3555||1 450979|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|7217|12439|vetorma|||0|2,5|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||7217||7217|12439||2 450993|R07AX0101|INOmax|innö.gas|800|ppm|10|l|1|gashyl||R07AX01|01.09.2014||R|0|1|0|1|0|1|LIN|0|0|0|100|XEU|19897|26606|lyfsjukr|||1|10|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíđ||||19897|26606||5 451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|37792|48863|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||37792||37792|48863||2 451293|N05AX1204|ABILIFY MAINTENA|sts|400|mg|1|hgl|1|pakki||N05AX12|01.07.2014||R|0|0|0|0|0|0|UKA|0|0|0|100|DKK|44519|58850|lyfalmen|||1|1|0|26,6700|Lundbeck Export A/S|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||44519||44519|58850||1 451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|42017|54117|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||42017||42017|54117||2 451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|56024|71538|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||56024||56024|71538||2 451761|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2013||R|0|0|0|1|G|0|APP|0|0|0|100|XEU|42441|56221|lyfalmen|||1|100|0||Artasan ehf|Aspen Pharma Trading Limited|Búsúlfan||42441||42441|56221||1 452022|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|fl||D01AC08|01.01.2012||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|120|0||Vistor hf|McNeil Sweden AB|Ketókónazól|||||||1 452258|R03AK1101|Flutiform|innúđal|260|mcg/sk|120|skammtar|1|pakki|250+10 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|HAR|0|0|0|100|DKK|7646|11600|lyfalmen|||1|120|0|60,0000|Icepharma hf|Norpharma a/s (N)|Formóteról og flútikasón||7646||7646|11600||2 452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|0|0|0|0|G|0|ROA|0|0|1|100|DKK|1361|2950|lyfalmen|||1|5|0|5,0000|Icepharma hf|Roche A.S.|Ketórólak||1361||1361|2950||2 452467|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.03.2011||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|10388|17905|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||10388||10388|17905||2 452482|V07AB0009|Sterilt Vann B. Braun|leysir|||100|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|2000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||5391||1 452594|A02BC0403|Rabeprazol Krka|sţ-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|3500|2453|lyfalmen|V0010|2067|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1000||1000|2453||2 452814|QC01CE9001|Vetmedin vet.|tuggutfl|1,25|mg|50|stk|1|glas|fyrir hunda|QC01CE90|01.07.2015||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|1580|3105|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||1580||1580|3105||1 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|0|0|0|0|0|0|LAB|0|0|1|100|SEK|9232|13783|lyfalmen|||1|3000|0||Vistor hf|Laboratories 3M Santé|Imikvímóđ||9232||9232|13783||1 452866|B05AA0114|Albuman|irl|200|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SSB|0|0|0|100|XEU|7672|10969|lyfsjukr|||1|100|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Albúmín||7672||7672|10969||2 452904|N02AA0501|Oxycontin|forđatfl|10|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|1435|3051|lyfalmen|V0597|2312|1|28|0|3,7300|Icepharma hf|Norpharma |Oxýcódon||1435||1435|3051||2 452920|N02AA0501|Oxycontin|forđatfl|10|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|3871|6404|lyfalmen|V0598|4911|1|98|0|13,0700|Icepharma hf|Norpharma |Oxýcódon||3871||3871|6404||2 452995|N02AA0501|Oxycontin|forđatfl|20|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|2730|4834|lyfalmen|V0584|3347|1|28|0|7,4700|Icepharma hf|Norpharma |Oxýcódon||2730||2730|4834||2 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dćl||QP54AA01|01.01.1991||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|1372|2365|vetorma|||0|6,4|0||Vistor hf|Merial (MSD)|Ivermectinum||1372||1372|2365||1 453175|N02AA0501|Oxycontin|forđatfl|20|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|7430|11303|lyfalmen|V0585|8234|1|98|0|26,1300|Icepharma hf|Norpharma |Oxýcódon||7430||7430|11303||2 453498|N02AA0501|Oxycontin|forđatfl|40|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|5261|8318|lyfalmen|V0586|6289|1|28|0|14,9300|Icepharma hf|Norpharma |Oxýcódon||5261||5261|8318||2 453571|N02AA0501|Oxycontin|forđatfl|40|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|14662|21086|lyfalmen|V0587|14118|1|98|0|52,2700|Icepharma hf|Norpharma|Oxýcódon||14662||14662|21086||2 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2558|3657|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer ApS|Ziprasidon||2558||2558|3657||1 454036|A09AA0206|Creon 10.000|sh-hylki|||100|stk|1|plglas||A09AA02|01.07.2013||R|1|0|0|0|G|0|APR|0|0|0|100|DKK|2971|5166|lyfalmen|||1|100|0|16,6700|Vistor hf|Abbott Products GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||2971||2971|5166||1 454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|ţpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|14253|20569|lyfalmen|||1|28|0|18,6667|Icepharma hf|Pfizer ApS|Dónepezíl||14253||14253|20569||1 454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|ţpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|40435|36661|lyfalmen|V0341|7307|1|98|0|65,3333|Icepharma hf|Pfizer ApS|Dónepezíl||26976||26976|36661||1 454491|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|28|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|1131|2209|lyfalmen|V0004|2198|2|28|0|18,6700|Portfarma ehf|Portfarma|Esómeprazól||823||823|2209||1 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|ţpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|15999|22778|lyfalmen|||1|28|0|37,3333|Icepharma hf|Pfizer ApS|Dónepezíl||15999||15999|22778||1 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|ţpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|44550|40835|lyfalmen|V0342|7307|1|98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||30276||30276|40835||1 454819|N02BE0115|Paracet|eţ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|0|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||0|10|0|0,2000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól|||||||1 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|0|0|0|1|0|1|NOE|0|0|0|100|GBP|55760|71210|lyfsjukr|||1|1|0||Vistor hf|Novartis Europharm Ltd|Tópótecan||55760||55760|71210||1 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|1067|2097|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1067||1067|2097||1 454955|J01CA0414|Amoxicilline Actavis Disper|töflur|750|mg|20|stk|1|ţpakki|hrćra vel í vatni og drekka|J01CA04|01.03.2013||R|0|0|0|0|0|0|AVB|0|0|1|100|XEU|1373|2966|lyfalmen|||2|20|0|15,0000|Actavis Group PTC ehf|Actavis BV|Amoxicillín||1373||1373|2966||1 455406|L01XA0101|Cisplatin Strides|irţ|1|mg/ml|100|ml|1|hgl||L01XA01|01.11.2013||R|0|0|0|1|0|1|HAS|0|0|0|100|IKR|6344|9070|lyfsjukr|||2|100|0||LYFIS ehf|Mylan Hospital AS|Cisplatín||||6344|9070||2 455501|QM01AE9001|Quadrisol|hlaup|100|mg/ml|30|ml|3|spr|f. hesta|QM01AE90|01.02.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5295|10216|vetalmen|||0|90|0||Icepharma hf|Zoetis Belgium S.A.|Vedaprófen||5295||5295|10216||2 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|ţpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|488|1748|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||488||488|1748||1 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|ţpakki||J01AA02|01.01.2009||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|843|2237|lyfalmen|||2|15|0|15,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||843||843|2237||1 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|ţpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|1721|3445|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||1721||1721|3445||1 456895|N05AH0206|Clozapin Medical|töflur|100|mg|100|stk|1|ţpakki||N05AH02|01.06.2015||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|5630|8509|lyfalmen|V0277|8495|2|100|0|33,3300|Medical ehf|Medical ehf|Klózapín||5400||5400|8509||2 456989|R03AK0604|Relanio|innönddu|550|mcg/sk|180|skammtar|1|pakki|50+500 mcg|R03AK06|01.01.2014||R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|26905|26586|lyfalmen|||2|180|0|90,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||19010||19010|26586||2 457149|N06AB1007|Escitalopram Bluefish|filmhtfl|20|mg|98|stk|1|ţpakki||N06AB10|01.08.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|4950|3967|lyfalmen|V0327|3967|2|98|0|196,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||2100||2100|3967||2 457282|N06AB1007|Escitalopram Bluefish|filmhtfl|15|mg|98|stk|1|ţpakki||N06AB10|01.08.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|5470|4517|lyfalmen|V0326|4517|2|98|0|147,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||2500||2500|4517||2 457508|J07AH0801|Nimenrix|sts|5|mcg|0,5|ml|1|hgl|+áfyllt sprauta|J07AH08|01.07.2013||R|0|0|0|0|0|0|GSB|0|0|0|100|GBP|7667|11629|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals|Hreinsađir fjórgildi A,C,Y,W-135 og fl.||7667||7667|11629||1 457692|L01BA0109|Metoject|stl|50|mg/ml|0,45|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3040|5261|lyfalmen|||1|0,45|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3040||3040|5261||2 457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.05.2011||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|2532|1643|lyfalmen|V0003|1643|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||412||412|1643||1 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|1|0|0|0|0|0|CHE|0|0|1|100|DKK|1063|2539|lyfalmen|||1|25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||1063||1063|2539||1 458149|L01XE2101|Stivarga|filmhtfl|40|mg|84|stk|1|glas|3 x 28|L01XE21|01.06.2014||R|0|0|0|1|0|1|BGB|0|0|0|100|DKK|639177|796817|lyfsjukr|||1|84|0||Icepharma hf|Bayer Pharma AG|Regorafenib||639177||639177|796817||2 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|ţpakki||J01CA08|01.12.1980||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|1226|2764|lyfalmen|V0577|2345|1|20|0|6,6667|Vistor hf|LEO Pharma A/S|Pívmecillínam||1226||1226|2764||1 458491|C05AA0801|Doloproct|eţ-krem|||30|g|1|túpa||C05AA08|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1269|2823|lyfalmen|V0674|2823|1|30|0||Icepharma hf|Bayer AB|Flúókortólón||1269||1269|2823||2 458805|B01AF0201|Eliquis|filmhtfl|2,5|mg|60|stk|1|ţpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|9778|13335|lyfalmen|V0653|13262|1|60|0|30,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||8906||8906|13335||1 459037|L01XE2301|Tafinlar|hylki|75|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|GBP|1196853|1490410|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||1196853||1196853|1490410||1 459242|L03AB1301|Plegridy|stl|||2|áf.spr|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|119885|150963|lyfsjukr|||1|2|0||Icepharma hf|Biogen Idec Ltd|Peginterferón beta-1a||119885||119885|150963||2 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|796|1138|lyfsjukr|||1|2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||796||796|1138||1 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|1458|2085|lyfsjukr|||1|4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1458||1458|2085||1 459447|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|19717|37578|vetalmen|||0|10|0||Icepharma hf|Zoetis Belgium S.A.|||19717||19717|37578||2 459678|N06AX2106|Duloxetin W&H|sţ-hylki|30|mg|28|stk|1|ţpakki||N06AX21|01.08.2015||R|0|0|0|0|0|0|WEH|0|0|0|100|XEU|2637|4706|lyfalmen|V0692|4706|2|28|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||2637||2637|4706||2 459766|N05AH0501|Sycrest|tungur.t|5|mg|20|stk|1|ţpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|7125|10883|lyfalmen|||1|20|0|5,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7125||7125|10883|31.7.2015|1 459812|N05AH0411|Quetiapine Teva|filmhtfl|25|mg|100|stk|1|ţpakki||N05AH04|01.09.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|2500|2177|lyfalmen|V0284|2109|2|100|0|6,2500|Medical ehf|Teva Sweden AB|Quetíapín||800||800|2177||2 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|ţpakki||B02AA02|01.04.1989||R|1|0|0|0|G|0|MAS|0|0|1|100|SEK|1553|3214|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AS|Tranexamsýra||1553||1553|3214||1 460170|J07BC0202|Avaxim|stl|||0,5|ml|1|dćla|einnota dćla|J07BC02|01.04.1998||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|3743|6228|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||3743||3743|6228||2 460293|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|ţpakki||J04AB02|01.09.2012||R|1|0|0|0|G|0|SAD|0|0|0|100|DKK|7650|11606|lyfalmen|||1|100|0|25,0000|Icepharma hf|Sandoz GmbH|Rífampicín||7650||7650|11606||2 460339|L01XC0301|Herceptin|stl|600|mg/hgl|5|ml|1|hgl||L01XC03|01.12.2013||R|0|0|0|1|0|1|ROC|0|1|0|100|DKK|226419|283462|lyfsjukr|||1|5|0||Icepharma hf|Roche|Trastuzumab||226419||226419|283462||2 460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|pakki||QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|5846|11262|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||5846||5846|11262||2 461035|N02AA0506|Oxikodon Depot Actavis|forđatfl|20|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|5200|8234|lyfalmen|V0585|8234|2|98|0|26,1300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||5200||5200|8234||1 461107|L03AB1001|PegIntron|sts|80|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|81079|102700|lyfsjukr|||1|4|0|42,6700|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||81079||81079|102700||1 461113|L01XE1801|Jakavi|töflur|20|mg|56|stk|1|ţpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|519416|647868|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||519416||519416|647868||1 461206|J02AC0104|Fluconazol ratiopharm|hylki|150|mg|1|stk|1|ţpakki||J02AC01|01.08.2013||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyfalmen|V0554|1871|2|1|0|0,7500|Medical ehf|ratiopharm GmbH|Flúkónazól|||||1871||2 461641|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.09.2015||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|313329|391554|lyfsjukr|||1|50|0||Vistor hf|Merck Sharp & Dohme Limited|Sugammadex||313329||313329|391554||1 461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1989||R|1|0|0|0|0|0|AGP|0|0|1|100|IKR|202|1354|lyfalmen|||2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||202||202|1354||1 461774|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr||M09AX01|01.08.2015||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|6745|10360|lyfalmen|V0209|10360|2|2|0|5,7222|Vistor hf|Takeda Pharma A/S|Natríumhýalúrónat||6745||6745|10360||1 462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|516|1787|lyfalmen|||1|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||516||516|1787||1 462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|575|1868|lyfalmen|||1|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||575||575|1868||1 462049|C08CA0501|Adalat|töflur|20|mg|100|stk|1|ţpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|2669|4750|lyfalmen|||1|100|0|66,6667|Icepharma hf|Bayer Pharma AG|Nífedipín||||2669|4750||2 462070|A10BX0901|Forxiga|filmhtfl|10|mg|98|stk|1|ţpakki||A10BX09|01.09.2015||R|1|0|0|0|G|0|BRI|0|0|0|100|SEK|19237|26873|lyfalmen|V0476|26873|1|98|0|98,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Dapagliflozín||19237||19237|26873||1 462358|A07EA0601|Entocort|endaţ.dr|20|mcg/ml|7|stk|1|ţpakki|samsett pk|A07EA06|01.04.1993||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|6029|9375|lyfalmen|||1|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||6029||6029|9375||1 462813|A07AA0906|Vancomycin Xellia|hylki|125|mg|28|stk|1|ţpakki|hart hylki|A07AA09|01.01.2011||R|1|0|0|0|G|0|XEL|0|0|1|100|DKK|15472|22111|lyfalmen|||2|28|0|1,7500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||15472||15472|22111||1 462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|6231|11992|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||||6231|11992||2 463197|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA01|01.10.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|743|1665|lyfalmen|V0108|1665|2|100|0|33,3400|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||428||428|1665||2 463251|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|16626|6096|lyfalmen|V0605|6042|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Memantín||3647||3647|6096||2 463262|N06AB1007|Escitalopram Bluefish|filmhtfl|10|mg|98|stk|1|ţpakki||N06AB10|01.08.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2698|2590|lyfalmen|V0325|2590|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||1100||1100|2590||2 463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4970|9600|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||4970||4970|9600||2 463642|J01XA0107|Vancomycin Xellia|irs|1|g/hgl|1|hgl|1|pakki||J01XA01|01.04.2013||R|0|0|0|0|0|1|XEL|0|0|0|100|XEU|656|938|lyfsjukr|||2|1|0|0,5000|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||656||656|938||1 463654|J05AE1001|Prezista|filmhtfl|800|mg|30|stk|1|plglas||J05AE10|01.08.2013||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|52830|67566|lyfsjukr|||1|30|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||||52830|67566||1 463861|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2026|3865|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||2026||2026|3865||1 463941|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|ţpakki||M01AX05|01.11.2012||L|1|0|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||0|60|0|52,8000|Icepharma hf|Laboratories Expansvience|Glúkósamín|||||||2 464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|ţpakki||N02BE01|01.04.1992||L|1|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 464226|C07AG0205|Carveratio|töflur|12,5|mg|100|stk|1|ţpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|2614|4674|lyfalmen|||2|100|0|33,3300|Medical ehf|ratiopharm GmbH|Carvedílól||2614||2614|4674||2 464591|J01FA0902|Clarithromycin ratiopharm|filmhtfl|250|mg|14|stk|1|ţpakki||J01FA09|01.06.2014||R|1|0|0|0|0|0|TSB|0|0|1|100|IKR|1756|3493|lyfalmen|||2|14|0|7,0000|Medical ehf|Teva Sweden AB|Klaritrómýcín||1756||1756|3493||2 465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.10.2011||R|0|0|0|0|G|0|APC|0|0|0|100|DKK|2781|4904|lyfalmen|V0376|4904|2|7,5|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||2781||2781|4904||1 465203|QJ01RA0103|Depomycine, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.12.1982||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1104|2170|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1104||1104|2170||1 465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1118|2197|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1118||1118|2197||1 465333|L01BA0109|Metoject|stl|50|mg/ml|0,6|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3369|5713|lyfalmen|||1|0,6|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3369||3369|5713||2 465472|M05BA0803|Zoledronic acid Actavis|irţ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.06.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|10376|14765|lyfsjukr|||2|5|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zoledronsýra||10376||10376|14765||1 465848|A07DA0303|Immex|töflur|2|mg|100|stk|1|ţpakki||A07DA03|01.06.2015||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|820|2205|lyfalmen|V0447|2205|2|100|0|20,0000|Portfarma ehf|Portfarma|Lóperamíđ||820||820|2205||1 466003|N06AB0310|Seromex|hylki|20|mg|30|stk|1|ţpakki||N06AB03|01.02.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1601|2177|lyfalmen|V0038|2177|2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Flúoxetín||800||800|2177||2 466029|N06AB0310|Seromex|hylki|20|mg|100|stk|1|ţpakki||N06AB03|01.02.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4767|3416|lyfalmen|V0039|3416|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Flúoxetín||1700||1700|3416||2 466086|N02AA0101|Contalgin|forđatfl|10|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|620|1930|lyfalmen|||1|25|0|2,5000|Icepharma hf|Pfizer ApS|Morfín||620||620|1930||1 466094|N02AA0101|Contalgin|forđatfl|10|mg|100|stk|1|ţpakki||N02AA01|01.08.1984||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|2278|4212|lyfalmen|||1|100|0|10,0000|Icepharma hf|Pfizer ApS|Morfín||2278||2278|4212||1 466122|G03AA0702|Microgyn|töflur|||63|stk|1|ţpakki||G03AA07|01.08.2013||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|1201|2729|lyfalmen|V0545|1897|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Levónorgestrel og ethinylestradíól||||1201|2729||2 466169|N02AA0101|Contalgin|forđatfl|30|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|1374|2967|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Morfín||1374||1374|2967||1 466219|N02AA0101|Contalgin|forđatfl|30|mg|100|stk|1|ţpakki||N02AA01|01.08.1984||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|4761|7629|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Morfín||4761||4761|7629||1 466278|L01XC1401|Kadcyla|irţ|100|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|262912|328849|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration Limited|Trastuzumab emtansine||262912||262912|328849||2 466394|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|ţpakki||N03AX15|01.03.2014||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|19154|26768|lyfalmen|||1|98|0|49,0000|Vistor hf|Eisai Ltd|Zonisamíđ||19154||19154|26768||1 466466|N02AA0101|Contalgin|forđatfl|60|mg|25|stk|1|ţpakki||N02AA01|01.10.1995||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|2554|4592|lyfalmen|||1|25|0|15,0000|Icepharma hf|Pfizer ApS|Morfín||2554||2554|4592||1 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|6947|10638|lyfalmen|||1|50|0|5,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||6947||6947|10638||1 466680|N02AA0101|Contalgin|forđatfl|100|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|4202|6860|lyfalmen|||1|25|0|25,0000|Icepharma hf|Pfizer ApS|Morfín||4202||4202|6860||1 466723|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|2,5|l|1|hylki|undir ţrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|2,5|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|ţpakki||N06AG02|01.10.1990||R|1|0|0|0|G|0|MAS|0|0|0|100|SEK|3633|6077|lyfalmen|V0063|4848|1|100|0|50,0000|Vistor hf|Meda AS|Móklóbemíđ||3633||3633|6077||1 467432|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|ţpakki||QJ01CA04|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|8542|16376|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||8542||8542|16376||2 467459|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6271|8966|lyfsjukr|||1|2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6271||6271|8966||2 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|13592|19733|lyfalmen|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||13592||13592|19733||1 467699|G03FA1701|Angemin|töflur|||84|stk|1|ţpakki|2+1 mg|G03FA17|01.10.2012||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|5774|9024|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrogen||5774||5774|9024||2 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|25971|35390|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||25971||25971|35390||1 467756|A10BX1001|Lyxumia|stl|20|mcg|2|áf-penni|1|pakki||A10BX10|01.10.2013||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|10003|14844|lyfalmen|||1|2|0|2,0000|Vistor hf|Sanofi-aventis groupe|Lixisenatíd||10003||10003|14844||1 467810|J01DI0201|Zinforo|irţ|600|mg|10|hgl|1|pakki|lausn|J01DI02|01.04.2013||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|82138|104017|lyfsjukr|||1|10|0|5,0000|Vistor hf|AstraZeneca AB|Ceftarólin||82138||82138|104017||1 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|0|0|0|0|0|1|JAS|0|0|0|100|SEK|422|603|lyfsjukr|||1|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||422||422|603||1 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|5956|6386|lyfalmen|V0317|2560|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3858||3858|6386||1 468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|284|406|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Fentanýl||284||284|406||1 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|8672|6352|lyfalmen|V0318|2666|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3833||3833|6352||1 468537|QP54AA0501|Stronghold|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2187|3770|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2187||2187|3770||2 468568|J01XA0107|Vancomycin Xellia|irs|500|mg/hgl|1|hgl|1|pakki||J01XA01|01.04.2013||R|0|0|0|0|0|1|XEL|0|0|0|100|XEU|373|533|lyfsjukr|||2|1|0|0,2500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||373||373|533||1 468803|M05BA0705|Risedronat Actavis|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.03.2011||R|1|0|0|0|G|0|APC|0|0|0|100|IKR|4530|2310|lyfalmen|V0207|2310|2|12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||896||896|2310||1 468825|QM01AC0603|Rheumocam|stl|20|mg/ml|50|ml|1|hgl|handa nautg, svínum og hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|5803|11180|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals|||5803||5803|11180||2 468996|A02BC0402|Rabeprazol Actavis|sţ-tfl|10|mg|100|stk|1|glas||A02BC04|01.01.2012||R|0|0|0|0|G|0|APC|0|0|0|100|IKR|4172|5200|lyfalmen|V0467|4380|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2996||2996|5200||1 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|ţpakki||C10AB04|01.07.1991||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3789|6291|lyfalmen|||1|98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||3789||3789|6291||1 469375|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|glas||N03AX14|01.11.2012|30.06.2015|R|1|0|0|0|0|0|APC|0|0|0|100|XEU|11270|6991|lyfalmen|||2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||4297||4297|6991||1 469422|G03AB0501|Gracial|töflur|||66|stk|1|pakki|ţp 3 x (15+7 stk)|G03AB05|01.08.2015||R|0|0|0|0|0|0|PTL|0|0|0|100|DKK|2321|4271|lyfalmen|V0703|4271|1|66|0|66,0000|Navamedic AB|Aspen Pharma Trading Limited|Desógestrel og ethinylestradíól||2321||2321|4271||1 469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|7192|10283|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||7192||7192|10283||2 469794|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 469817|N02AX0206|Nobligan Retard|forđatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|5864|9148|lyfalmen|V0228|8746|1|100|0|66,6667|Icepharma hf|Grunenthal|Tramadól||5864||5864|9148||2 469847|M01AH0106|Celecoxib Actavis|hylki|200|mg|20|stk|1|ţpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|AGP|0|0|1|100|XEU|2340|3638|lyfalmen|V0037|3638|2|20|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||1861||1861|3638||1 469874|N02AX0206|Nobligan Retard|forđatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|4768|7639|lyfalmen|V0227|6892|1|100|0|50,0000|Icepharma hf|Grunenthal|Tramadól||4768||4768|7639||2 469932|N02AX0206|Nobligan Retard|forđatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|3113|5361|lyfalmen|V0226|4738|1|100|0|33,3333|Icepharma hf|Grunenthal|Tramadól||3113||3113|5361||2 470148|N06BA0404|Methylphenidate Sandoz|forđatfl|54|mg|30|stk|1|glas||N06BA04|01.09.2013||R|1|0|1|0|0|0|SHS|0|0|0|100|DKK|10061|9322|lyfalmen|V0622|9322|2|30|0|54,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||5991||5991|9322||1 470352|M05BA0804|Zoledronic acid medac|irţ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.12.2013||R|0|0|0|1|0|1|WIL|0|0|0|100|XEU|13553|18716|lyfsjukr|||2|5|0|1,0000|Williams & Halls efh|medac Gesellschaft|Zoledronsýra||13553||13553|18716||2 470385|R03BA0501|Flixotide|innúđal|250|mcg/sk|120|skammtar|1|stauk||R03BA05|01.04.1995||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|5166|8187|lyfalmen|||1|120|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5166||5166|8187||1 470397|N05CM1801|Dexdor|irţ|100|mcg/ml|4|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|25254|33269|lyfsjukr|||1|16|0|1,6000|Vistor hf|Orion Corporation|Dexmedetómid||25254||25254|33269||1 470933|QJ51RC2002|Ampiclox vet.|spenalyf|||3|g|24|spr|spenadćlur|QJ51RC20|01.03.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4170|8082|vetalmen|||0|72|0||Icepharma hf|Zoetis Finland OY|||4170||4170|8082||2 471042|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1035|2034|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||1035||1035|2034||2 471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|ţpakki||A10BB07|01.07.1990||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|857|2256|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Glípízíđ||857||857|2256||1 471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|ţpakki||L01AA01|01.01.1988||R|0|0|0|0|G|0|BAM|0|0|0|100|SEK|5421|8538|lyfalmen|V0156|8538|1|100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||5421||5421|8538||2 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|0|0|0|0|0|0|ORC|1|0|0|100|DKK|4425|8566|vetalmen|||0|10|0||Vistor hf|Orion Corporation|Atipamesól||4425||4425|8566||1 472092|C07AB0206|Seloken ZOC|forđatfl|47,5|mg|98|stk|1|ţpakki||C07AB02|01.07.1989||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1826|3590|lyfalmen|V0048|2423|1|98|0|31,0300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1826||1826|3590||1 472099|R02AA0307|Strepsils Warm|sogtfl|||24|stk|1|ţpakki||R02AA03|01.08.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 472332|J07BC0201|Havrix|stl|1440|ein/ml|0,5|ml|1|dćla|einnota dćla|J07BC02|01.10.1995||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|3449|5824|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||3449||3449|5824||1 472338|S01AA2701|APROKAM|sts|50|mg|10|hgl|1|pakki|lausn|S01AA27|01.04.2013||R|0|0|0|1|0|1|TEA|0|0|0|100|SEK|11476|16133|lyfsjukr|||1|10|0||Vistor hf|Laboratories THEA|Cefuroxím||11476||11476|16133||1 472599|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|98|stk|1|glas||A02BC05|01.08.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|6868|5371|lyfalmen|V0012|5162|3|98|0|130,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||3120||3120|5371||2 472759|R06AX2701|Aerius|filmhtfl|5|mg|100|stk|1|ţpakki||R06AX27|01.11.2012||R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|4269|6952|lyfalmen|V0458|3551|1|100|0|100,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||4269||4269|6952||1 472984|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|1|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|0|G|0|UKL|0|0|0|100|USD|3023|5237|lyfalmen|V0670|4425|1|5|0||Vistor hf|Alcon Laboratories (UK) Ltd.|Brimoníđ og brinzolamiđ||3023||3023|5237||1 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|10683|15147|lyfsjukr|||1|400|0||Vistor hf|Meda AB|Dextran||10683||10683|15147||1 474043|N01AH0601|Remifentanil Actavis|sts/irs|2|mg|5|hgl|1|pakki|ţykkni,lausn|N01AH06|01.06.2012||R|0|0|1|0|0|1|AGP|0|0|0|100|XEU|2607|3727|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||2607||2607|3727||1 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2 474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|15|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2 474551|R01AD0901|Nasonex|nefúđi|50|mcg/sk|140|skammtar|1|úđagl|18 g í pakkn.|R01AD09|01.05.1998|31.07.2015|R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1652|3350|lyfalmen|||1|140|0|35,0000|Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1652||1652|3350||1 474608|QB03AC0001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC|01.08.2011||R|0|0|0|0|0|0|PHM|0|0|0|100|DKK|28254|53774|vetalmen|||0|1200|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíđ||28254||28254|53774||2 474628|N05AH0313|Olanzapin Sandoz|filmhtfl|10|mg|250|stk|1|glas||N05AH03|01.05.2013||R|2|0|0|0|G|0|SHS|0|0|0|100|DKK|29883|11937|lyfalmen|||2|250|0|250,0000|Artasan ehf|Sandoz A/S|Olanzapín||7891||7891|11937||1 474657|N04BC0504|Oprymea (Lyfis)|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|744|2100|lyfalmen|V0266|2093|3|30|0|1,0600|LYFIS ehf|LYFIS ehf|Pramipexól||744||744|2100||2 475338|QI09AL0101|Eryseng Parvo|stl|||50|ml|1|hgl|dreifa|QI09AL01|01.10.2014||R|0|0|0|0|0|0|LHS|0|0|0|100|IKR|9978|17198|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Porcine parvovirus + erysipelothrix||9978||9978|17198||2 475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|1|0|0|0|G|0|APC|0|0|0|100|IKR|1100|2590|lyfalmen|||2|100|0|26,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Warfarín||1100||1100|2590||1 475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|1|0|0|0|0|0|AGP|0|0|1|100|IKR|497|1760|lyfalmen|||2|20|0|6,6667|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema međ geđlyfjum||497||497|1760||1 475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|1|0|0|0|0|0|AGP|0|0|1|100|IKR|627|1939|lyfalmen|||2|30|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema međ geđlyfjum||627||627|1939||1 475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|1|0|1|0|0|0|AGP|0|0|1|100|IKR|1486|3122|lyfalmen|||2|100|0|33,3333|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema međ geđlyfjum||1486||1486|3122||1 475798|R03AC1302|Oxis Turbuhaler|innönddu|4,5|mcg/sk|60|skammtar|1|stauk||R03AC13|01.10.1997||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|2666|4746|lyfalmen|||1|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||2666||2666|4746||1 475822|R03AC1302|Oxis Turbuhaler|innönddu|9|mcg/sk|60|skammtar|1|stauk||R03AC13|01.10.1997||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|3477|5862|lyfalmen|||1|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||3477||3477|5862||1 475862|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|28|stk|1|ţpakki|hart|A02BC01|01.04.2015||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2 476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|61513|78365|lyfsjukr|||1|1,2|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||61513|78365||1 476580|R03AC0206|Ventoline|lausn|2|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|1146|2654|lyfalmen|||1|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||1146||1146|2654||1 476873|B05BA0314|Glucos Baxter Viaflo|irl|100|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4529|6475|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||||4529|6475||2 477017|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|ţpakki||C10AX09|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|16372|23249|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||16372||16372|23249||1 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|ţpakki|250 + 100 mg|P01BB51|01.02.2006||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|5681|8896|lyfalmen|||1|12|0|3,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Prógúaníl í blöndum||5681||5681|8896||1 477295|N05AH0413|Quetiapin ratiopharm|forđatfl|300|mg|100|stk|1|ţpakki||N05AH04|01.05.2015||R|1|0|0|0|G|0|TEV|0|0|0|100|IKR|28055|36059|lyfalmen|V0272|34973|2|100|0|75,0000|Medical ehf|Teva Pharma B.V.|Quetíapín||26500||26500|36059||2 477382|N05AH0410|Quetiapin Actavis|forđatfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|33829|39659|lyfalmen|||2|100|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Quetíapín||29346||29346|39659|31.8.2015|1 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||20|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||2979||2 477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||50|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||0|500|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||3057||2 477631|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja|dreifa|H02AB01|01.10.2013||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|683|2016|lyfalmen|||1|1|0|4,6700|Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||683||683|2016||1 477752|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||2979||2 477760|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||0|500|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||3057||2 477941|L01XX4401|Zaltrap|irţ|25|mg/ml|4|ml|1|hgl|lausn|L01XX44|01.06.2013||R|0|0|0|1|0|1|SGA|0|0|0|100|NOK|45096|57947|lyfsjukr|||1|4|0||Vistor hf|Sanofi-aventis groupe|Afliberceptum||45096||45096|57947||1 478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|426|1656|lyfalmen|V0500|1656|2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||421||421|1656||1 478360|QM01AC0603|Rheumocam|stl|5|mg/ml|20|ml|1|hgl|handa hundum og köttum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|7065|13574|vetalmen|||0|20|0||Icepharma hf|Chanelle Pharmaceuticals|||7065||7065|13574||2 479407|L04AA1302|Leflunomide medac|filmhtfl|20|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|G|0|WIL|0|0|0|100|XEU|24130|33062|lyfalmen|||2|100|0|100,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíđ||24130||24130|33062||2 479904|L01XE1401|Bosulif|filmhtfl|100|mg|28|stk|1|ţpakki||L01XE14|01.09.2014||R|1|0|0|1|0|1|PZE|0|0|0|100|DKK|113724|143301|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Ltd.|Bósútíníb||113724||113724|143301||1 480223|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.04.2015||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|4988|8597|vetorma|||0|50|0||Icepharma hf|Zoetis Finland OY|Doramectinum||4988||4988|8597||2 480867|N06DA0205|Donesyn|filmhtfl|5|mg|98|stk|1|ţpakki||N06DA02|01.05.2011||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|15215|7456|lyfalmen|V0341|7307|2|98|0|65,3333|Williams & Halls efh|Williams & Halls ehf|Dónepezíl||4635||4635|7456||2 480932|A10BX0901|Forxiga|filmhtfl|10|mg|98|stk|1|ţpakki||A10BX09|01.10.2013||R|1|0|0|0|G|0|BRI|0|0|0|100|SEK|19237|26873|lyfalmen|V0476|26873|1|98|0|98,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Dapagliflozín||19237||19237|26873||1 481176|N06AX1201|Zyban|forđatfl|150|mg|100|stk|1|ţpakki||N06AX12|01.09.2000||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|15315|21912|lyfalmen|||1|100|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||15315||15315|21912||1 481208|D07AC1302|Ovixan|krem|0,1|%|30|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|722|2070|lyfalmen|||0|30|0||Vistor hf|Galenica AB|Mómetasón||722||722|2070||1 481375|R03AC1901|Striverdi Respimat|innöndl|2,5|mcg|60|skammtar|1|rörlyk||R03AC19|01.08.2014||R|0|0|0|0|G|0|BII|0|0|1|100|DKK|4545|7332|lyfalmen|||1|60|0||Vistor hf|Boehringer Ingelheim International|Olodaterol||4545||4545|7332||1 481534|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|ţpakki||N02AX02|01.05.2012||R|1|0|1|0|G|0|GLP|0|0|1|100|SEK|290|1475|lyfalmen|V0055|1347|1|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||290||290|1475||1 482183|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|hgl||G03BA03|01.05.2014||R|0|0|0|0|G|0|BGB|0|0|0|100|DKK|15139|21690|lyfalmen|||1|4|0|55,5600|Icepharma hf|Bayer Pharma AG|Testósterón||15139||15139|21690||2 482457|N02BA5102|Treo|freyđit|||20|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole|||||||1 483104|L01XC0801|Vectibix|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.03.2013||R|0|1|0|1|0|1|AEB|0|0|0|100|DKK|63865|81290|lyfsjukr|||1|5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||63865||63865|81290||1 483217|B01AF0101|Xarelto|filmhtfl|20|mg|98|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|30834|41541|lyfalmen|||1|98|0|196,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||30834|41541||2 483371|B05AA0114|Albuman|irl|40|g/líter|400|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SSB|0|0|0|100|XEU|6139|8777|lyfsjukr|||1|400|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Albúmín||6139||6139|8777||2 483477|A02BC0403|Rabeprazol Krka|sţ-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|1765|2453|lyfalmen|V0467|2453|2|56|0|28,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1000||1000|2453||2 483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2576|3683|lyfsjukr|||1|50|0|0,5000|Icepharma hf|Pfizer ApS|Flúkónazól||2576||2576|3683||1 483663|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|3|lykja||B03BA03|01.07.2012||R|0|0|0|0|G|0|SHS|0|0|1|100|DKK|6313|9766|lyfalmen|||1|3|0|150,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||6313||6313|9766||1 483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4447|6358|lyfsjukr|||1|100|0|1,0000|Icepharma hf|Pfizer ApS|Flúkónazól||4447||4447|6358||1 483711|S01ED5114|Latanoprost/Timolol Portfarma|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml|S01ED51|01.01.2012||R|0|0|0|0|G|0|POF|0|0|0|100|DKK|2252|4176|lyfalmen|V0374|4176|2|2,5|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||2252||2252|4176||1 483968|C03AA0305|Hydromed|töflur|12,5|mg|100|stk|1|ţpakki||C03AA03|01.06.2013||R|0|0|0|0|G|0|MEV|0|0|0|100|DKK|891|2303|lyfalmen|||2|100|0|50,0000|Vistor hf|MediLink A/S|hýdróklórtíazíđ||891||891|2303||1 483996|N02AX0212|Tramadol Actavis|hylki|50|mg|20|stk|1|ţpakki||N02AX02|01.09.2011||R|1|0|1|0|G|0|AGP|0|0|1|100|XEU|271|1347|lyfalmen|V0055|1347|2|20|0|3,3300|Actavis Group hf|Actavis Group PTC ehf|Tramadól||197||197|1347||1 484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|53141|67953|lyfsjukr|||1|3|0|112,5000|Vistor hf|Ferring|Triptórelín||53141||53141|67953||1 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|ţpakki||D11AX10|01.08.1999||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|5118|8121|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Fínasteríđ||5118||5118|8121||1 484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|0|0|0|1|0|1|AEB|0|0|0|100|DKK|125432|157862|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||125432||125432|157862||1 484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|0|0|0|0|G|0|MEB|0|0|1|100|SEK|1201|2729|lyfalmen|||1|300|0|50,0000|Vistor hf|Meda AB (V)|Benzýdamín||1201||1201|2729||1 484658|B01AF0101|Xarelto|filmhtfl|10|mg|30|stk|1|ţpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|9641|14346|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||9641||9641|14346||2 484721|L04AD0201|Advagraf|forđahlk|3|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|47305|62373|lyfalmen|||1|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||47305||47305|62373||1 485006|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.01.2012||R|0|0|0|0|G|0|ANS|0|0|1|100|XEU|1157|2669|lyfalmen|||1|5|0||Anstalt zur gewerblichen Produktion|Anstalt zur gewerblichen Produktion|Prednisólón||1157||1157|2669||1 485252|L01CD0202|Docetaxel Actavis|irţ|20|mg/ml|7|ml|1|hgl|lausn|L01CD02|01.04.2013||R|0|0|0|1|0|1|AVB|0|0|0|100|XEU|8294|11858|lyfsjukr|||2|7|0||Actavis Group PTC ehf|Actavis BV|Docetaxel||8294||8294|11858||1 485304|C02KX0501|Adempas|filmhtfl|2|mg|84|stk|1|ţpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BGB|0|1|0|100|DKK|380546|475153|lyfsjukr|||1|84|0||Icepharma hf|Bayer Pharma AG|Riociguatum||380546||380546|475153||2 485549|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|180|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|13555|19686|lyfalmen|||2|180|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||13555||13555|19686||1 485764|J05AX1201|Tivicay|filmhtfl|50|mg|30|stk|1|glas||J05AX12|01.04.2014||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|95788|120993|lyfsjukr|||1|30|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Dolutegravír||95788||95788|120993||1 486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|ţpakki||M01AE02|01.04.1995||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|0|0|0|0|G|0|SAC|0|0|1|100|USD|518|1789|lyfalmen|||1|5|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Dexametasón||518||518|1789||1 486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|0|0|0|0|G|0|SAC|0|0|1|100|USD|740|2095|lyfalmen|||1|5|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Dexametasón||740||740|2095||1 487341|A10BG0302|Pioglitazone Actavis|töflur|30|mg|98|stk|1|ţpakki||A10BG03|01.09.2012||R|1|1|0|0|G|0|APC|0|0|0|100|XEU|11581|14244|lyfalmen|||2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||9567||9567|14244||1 487692|L04AB0101|Enbrel|sts|10|mg|4|hgl|1|pakki|+ leysir, lausn|L04AB01|01.12.2012||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|30704|40047|lyfsjukr|||1|4|0|5,7200|Icepharma hf|Pfizer Limited|Etanercept||30704||30704|40047||1 487725|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|51529|65948|lyfsjukr|||1|1,2|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||51529||51529|65948||1 487796|L04AA1302|Leflunomide medac|töflur|10|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|G|0|WIL|0|0|0|100|XEU|28753|36286|lyfalmen|V0453|36286|2|100|0|50,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíđ||26679||26679|36286||2 487827|M01AB0517|Diclomex|sţ-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.04.2013||R|1|0|0|0|G|0|RGM|0|0|1|100|IKR|1033|1902|lyfalmen|V0469|1902|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Díklófenak||600||600|1902||2 488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|ţpakki||M01AX01|01.04.1995||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|831|2220|lyfalmen|||1|20|0|10,0000|Vistor hf|Meda AB|Nabúmeton||831||831|2220||1 488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|2309|4254|lyfalmen|V0198|2753|1|60|0|30,0000|Vistor hf|Meda AB|Nabúmeton||2309||2309|4254||1 488468|L01XE1801|Jakavi|töflur|5|mg|56|stk|1|ţpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|261182|326697|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||261182||261182|326697||1 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|ţpakki||D05BB02|01.04.1992||R|1|0|0|1|G|0|APC|0|0|0|100|DKK|6281|9721|lyfalmen|||1|50|0|14,2857|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||6281||6281|9721||1 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|ţpakki||D05BB02|01.04.1992||R|1|0|0|1|G|0|APC|0|0|0|100|DKK|10416|15413|lyfalmen|||1|50|0|35,7143|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||10416||10416|15413||1 489050|N06AX1105|Mirtazapine Bluefish|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.04.2014||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|2700|2590|lyfalmen|V0331|2590|2|96|0|96,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||1100||1100|2590||2 489149|G03GA0503|Bemfola|stl|150|ae|0,25|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|6465|9975|lyfalmen|||1|0,25|0|2,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||6465||6465|9975||3 489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|83929|106244|lyfsjukr|||1|1,6|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||83929|106244||1 489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|ţpakki||M01AB05|01.01.1996||R|1|0|0|0|0|0|HES|0|0|1|100|DKK|323|1328|lyfalmen|V0188|496|1|10|0|5,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||183||183|1328||1 489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|ţpakki||M01AB05|01.01.1996||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|842|1690|lyfalmen|V0188|1489|1|30|0|15,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||446||446|1690||1 490417|G03FB0504|Evorel Sequi|forđapl|||8|stk|1|pakki||G03FB05|01.08.1999||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|2055|3905|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2055||2055|3905||1 490425|G03FA0104|Evorel Conti|forđapl|||8|stk|1|pakki||G03FA01|01.08.1999||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|1903|3696|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1903||1903|3696||1 490510|G03CX0103|Tibolon Orifarm|töflur|2,5|mg|84|stk|1|ţpakki|3 x 28 stk|G03CX01|01.11.2014||R|0|0|0|0|G|0|IRO|0|0|0|100|XEU|4991|7766|lyfalmen|V0133|7766|2|84|0|84,0000|Artasan ehf|Orifarm Generics A/S|Tíbólón||4860||4860|7766||1 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3676|6136|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Atorvastatín||3676||3676|6136||1 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10061|10052|lyfalmen|V0112|2728|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Atorvastatín||6521||6521|10052||1 490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3724|6202|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Atorvastatín||3724||3724|6202||1 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|12282|13573|lyfalmen|V0113|3210|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Atorvastatín||9079||9079|13573||1 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|14421|16847|lyfalmen|V0114|3210|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Atorvastatín||11458||11458|16847||1 491213|N03AX2201|Fycompa|filmhtfl|6|mg|28|stk|1|ţpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|21614|29879|lyfalmen|V0665|29879|1|28|0|21,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||21614||21614|29879||1 491313|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2012||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|33283|43255|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||33283|43255||1 491321|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.08.2013||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|125855|158388|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||||125855|158388||1 491753|C10AC0103|Questran Loc|mixtduft|4|g|50|sk-pokar|1|pakki||C10AC01|01.12.2014||R|0|0|0|0|0|0|BBB|0|0|0|100|DKK|3491|5881|lyfalmen|||1|50|0|14,2800|Vistor hf|Bristol-Myers Squibb AB|Kólestýramín||3491||3491|5881||1 492377|L01XE1401|Bosulif|filmhtfl|500|mg|28|stk|1|ţpakki||L01XE14|01.09.2014||R|1|0|0|1|0|1|PZE|0|0|0|100|DKK|511757|638342|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Ltd.|Bósútíníb||511757||511757|638342||1 492405|N04BA0202|Madopar Depot|forđahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|3050|5274|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3050||3050|5274||2 492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|ţpakki||A02BC01|01.09.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1 492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|6755|10374|lyfalmen|V0002|5371|1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||6755||6755|10374||1 492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|ţpakki||A02BC01|01.05.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1 492815|C10BA0501|Atozet|filmhtfl|20|mg|90|stk|1|ţpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|16212|23047|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||16212||16212|23047||1 493113|R02AA0306|Strepsils Jordbćr Sukkerfri|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 493218|B03AC0001|Monofer|irl|100|mg/ml|5|ml|1|hgl||B03AC|01.07.2013||R|0|0|0|0|G|0|PAC|0|0|1|100|DKK|25956|35371|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||25956||25956|35371||1 493313|G04BD0704|Tolterodin Actavis|forđahlk|2|mg|100|stk|1|ţpakki||G04BD07|01.01.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|3582|6007|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tólteródín||3582||3582|6007||1 493401|R03DC0305|Montelukast Navamedic|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.04.2014||R|1|0|0|0|G|0|ART|0|0|0|100|XEU|6583|5763|lyfalmen|V0492|3496|2|98|0|39,2000|Artasan ehf|Navamedic ASA|Montelúkast||3405||3405|5763||1 493689|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.07.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|17617|5671|lyfalmen|V0516|5442|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3338||3338|5671||1 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1078|2560|lyfalmen|||1|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1078||1078|2560||1 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|ţpakki||N02CX01|01.04.1974||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2293|4232|lyfalmen|||1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S|Pízótífen||2293||2293|4232||1 494237|L01XC0201|MabThera|irţ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|67111|85327|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration Limited|Rítúxímab||67111||67111|85327||2 494286|L01XC0201|MabThera|irţ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|167778|210529|lyfsjukr|||1|50|0||Icepharma hf|Roche Registration Limited|Rítúxímab||167778||167778|210529||2 494466|J05AE1401|Olysio|hylki|150|mg|7|stk|1|pakki||J05AE14|01.09.2014||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|337837|422035|lyfsjukr|||1|7|0||Vistor hf|Janssen-Cilag International N.V.|Simeprevír||||337837|422035||1 494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburđur, fleyti|D10AF01|01.10.1995||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1871|3652|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1871||1871|3652||1 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2099|3965|lyfalmen|V0128|1997|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2099||2099|3965||1 494724|G03FA0102|Kliogest|töflur|||84|stk|1|skífup||G03FA01|01.10.1986||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3050|5274|lyfalmen|V0410|4450|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3050||3050|5274||1 494740|QA12CC0203|Sedaman vet|irl|200|mg/ml|100|ml|1|hgl||QA12CC02|01.04.2014||R|0|0|0|0|0|0|OOR|0|0|0|100|DKK|2052|4033|vetalmen|||0|100|0||Icepharma hf|Orion Corporation|||2052||2052|4033||2 494831|B01AC0702|Persantin retard|forđahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|1697|3412|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||1697||1697|3412||1 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|ţpakki||A04AA01|01.01.1991||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|20416|6958|lyfalmen|V0384|5568|1|15|0|7,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||4273||4273|6958||1 495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|7941|7082|lyfalmen|V0382|6122|1|10|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||4363||4363|7082||1 495757|N06AX2601|Brintellix|filmhtfl|10|mg|28|stk|1|ţpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|5994|9326|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||5994||5994|9326||1 495820|J05AH0101|Relenza|innúđadu|5|mg/úđask|20|skammtar|1|stauk|+diskhaler|J05AH01|01.02.2000||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|3115|5364|lyfalmen|||1|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zanamivír||3115||3115|5364||1 496040|N06DA0303|Nimvastid (Lyfis)|hylki|4,5|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|30803|33490|lyfalmen|V0345|33490|3|112|0|56,0000|LYFIS ehf|LYFIS ehf|Rívastigmín||24469||24469|33490||2 496174|QJ01MA9001|Baytril vet.|töflur|150|mg|10|stk|1|ţpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4252|8237|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4252||4252|8237||2 496468|A10BG0302|Pioglitazone Actavis|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.09.2012||R|1|1|0|0|G|0|APC|0|0|0|100|XEU|6688|4014|lyfalmen|V0572|4014|2|98|0|49,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||2134||2134|4014||1 496644|L03AB0103|Multiferon|stl|3|millj ae|0,5|ml|6|áf.spr|lausn|L03AB01|01.12.2011||R|0|0|0|1|0|1|SOI|0|1|0|100|DKK|74717|94787|lyfsjukr|||1|3|0|9,0000|Swedish Orphan International AB|Swedish Orphan International AB|Interferón-alfa natural||74717||74717|94787||3 496648|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|486|1745|lyfalmen|V0643|1745|2|20|0|5,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíđ||486||486|1745||1 496935|N02AG0201|Ketogan|eţ-stíll|||10|stk|1|pakki||N02AG02|01.07.1994||R|0|0|1|0|G|0|PER|0|0|0|100|DKK|435|1675|lyfalmen|||1|10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||435||435|1675||1 496950|N02AG0201|Ketogan|töflur|||20|stk|1|ţpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|786|2158|lyfalmen|||1|20|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||786||786|2158||1 497003|L01XE0103|Mylaukim|filmhtfl|400|mg|30|stk|1|ţpakki||L01XE01|01.09.2014||R|0|0|0|1|0|1|WEH|0|1|0|100|XEU|183583|230186|lyfsjukr|||2|30|0||Williams & Halls efh|Williams & Halls ehf|Imatiníb||183583||183583|230186||2 497012|A07AA1201|Dificlir|filmhtfl|200|mg|20|stk|1|ţpakki||A07AA12|01.08.2012||R|1|0|0|0|0|1|APE|0|0|0|100|XEU|230467|288496|lyfsjukr|||1|20|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Fidaxomicin||230467||230467|288496||1 497065|M01AE0219|Alpoxen|töflur|500|mg|100|stk|1|ţpakki||M01AE02|01.05.2014||R|0|0|0|0|G|0|AGP|0|0|1|100|SEK|1634|3115|lyfalmen|V0127|3115|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen||1481||1481|3115||1 497099|N02AG0201|Ketogan|töflur|||100|stk|1|ţpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|2999|5204|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||2999||2999|5204||1 497107|M01AE0219|Alpoxen|töflur|250|mg|100|stk|1|ţpakki||M01AE02|01.05.2014||R|0|0|0|0|G|0|AGP|0|0|1|100|SEK|810|2191|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen||810||810|2191||1 497286|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.12.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1153|1992|lyfalmen|V0056|1990|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|1992||2 497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|ţpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|316|1511|lyfalmen|||2|30|0|15,0000|Actavis Group hf|Actavis hf|Enalapríl||316||316|1511||1 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|606|1910|lyfalmen|V0448|1910|2|100|0|50,0000|Actavis Group hf|Actavis hf|Enalapríl||606||606|1910||1 497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1127|2520|lyfalmen|V0449|2520|2|100|0|200,0000|Actavis Group hf|Actavis hf|Enalapríl||1049||1049|2520||1 497885|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1621|3186|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||1621||1621|3186||2 497983|N04BC0407|Ropinirol Actavis|forđatfl|4|mg|84|stk|1|ţpakki||N04BC04|01.12.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|14014|10298|lyfalmen|V0533|10298|2|84|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rópíníról||6700||6700|10298||1 497995|S01EC0303|Dorzolamide Portfarma|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.10.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|1400|2950|lyfalmen|||2|5|0|16,6667|Portfarma ehf|Portfarma|Dorzólamíđ||1361||1361|2950||1 498051|A10BX0204|Repaglinide Krka|töflur|2|mg|120|stk|1|ţpakki||A10BX02|01.11.2014||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2300|3829|lyfalmen|V0472|3829|2|120|0|60,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníđ||2000||2000|3829||2 498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|15754|22468|lyfalmen|V0608|15952|1|56|0|14,0000|Icepharma hf|Pfizer ApS|Ziprasidon||15754||15754|22468||1 498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|16805|23797|lyfalmen|V0609|19414|1|56|0|28,0000|Icepharma hf|Pfizer ApS|Ziprasidon||16805||16805|23797||1 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|20934|29019|lyfalmen|V0610|19213|1|56|0|42,0000|Icepharma hf|Pfizer ApS|Ziprasidon||20934||20934|29019||1 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|25290|34529|lyfalmen|V0611|25396|1|56|0|56,0000|Icepharma hf|Pfizer ApS|Ziprasidon||25290||25290|34529||1 499070|R01AD0501|Rhinocort Aqua|nefúđi|32|mcg/sk|120|skammtar|1|fl||R01AD05|01.03.2013||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1023|2484|lyfalmen|||1|120|0|19,2000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1023||1023|2484||1 499189|N03AX2201|Fycompa|filmhtfl|4|mg|28|stk|1|ţpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|21614|29879|lyfalmen|V0664|29879|1|28|0|14,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||21614||21614|29879||1 499273|B01AF0101|Xarelto|filmhtfl|20|mg|28|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|8999|13463|lyfalmen|||1|28|0|56,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||8999|13463||2 499436|R03AK1101|Flutiform|innúđal|130|mcg/sk|120|skammtar|1|pakki|125+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|HAR|0|0|0|100|DKK|5828|9098|lyfalmen|||1|120|0|30,0000|Icepharma hf|Norpharma a/s (N)|Formóteról og flútikasón||5828||5828|9098||2 499920|N06AX2601|Brintellix|filmhtfl|20|mg|28|stk|1|ţpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|11989|17578|lyfalmen|||1|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||11989||11989|17578||1 501225|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|185|mg|98|stk|1|ţpakki|160/25 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4880|3861|lyfalmen|||2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og ţvagrćsilyf||2023||2023|3861||2 501278|G04BD1201|Betmiga|forđatfl|25|mg|30|stk|1|ţpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|5512|8663|lyfalmen|||1|30|0|15,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||5512||5512|8663||1 501660|B01AF0101|Xarelto|filmhtfl|2,5|mg|168|stk|1|ţpakki||B01AF01|01.04.2015||R|1|1|0|0|G|0|BGB|0|0|0|100|DKK|26227|35714|lyfalmen|||1|168|0|42,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||26227||26227|35714||2 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2844|4991|lyfalmen|V0434|4727|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2844||2844|4991||2 502956|A11DA0101|Tiacur|stl|25|mg/ml|2|ml|5|lykjur||A11DA01|01.09.2015||R|0|0|0|0|0|0|ABC|0|0|0|100|SEK|15965|22735|lyfalmen|||1|10|0|5,0000|Icepharma hf|Abcur AB|Thiamine (vit B1)||||15965|22735||2 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|19448|26048|lyfsjukr|||1|1|0|37,5000|Vistor hf|Ferring|Triptórelín||19448||19448|26048||1 503265|N06AB1007|Escitalopram Bluefish|filmhtfl|15|mg|28|stk|1|ţpakki||N06AB10|01.08.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|2090|3953|lyfalmen|||2|28|0|42,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||2090||2090|3953||2 503266|N03AX2201|Fycompa|filmhtfl|6|mg|28|stk|1|ţpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|21614|29879|lyfalmen|V0665|29879|1|28|0|21,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||21614||21614|29879||1 503491|N06DA0303|Nimvastid (Lyfis)|hylki|1,5|mg|28|stk|1|ţpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|6799|8313|lyfalmen|V0354|8313|3|28|0|4,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||5258||5258|8313||2 504014|N04BC0407|Ropinirol Actavis|forđatfl|8|mg|84|stk|1|ţpakki||N04BC04|01.12.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|27450|20434|lyfalmen|V0534|20434|2|84|0|112,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rópíníról||14146||14146|20434||1 504020|B05AA0114|Albuman|irl|40|g/líter|250|ml|1|hgl|lausn|B05AA01|01.04.2013||R|0|0|0|0|0|1|SSB|0|0|0|100|XEU|4002|5722|lyfsjukr|||1|250|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Albúmín||4002||4002|5722||2 504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|ţpakki||A10BB12|01.11.2011||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|1539|2667|lyfalmen|V0494|2542|2|90|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Glímepíríđ||1156||1156|2667||1 504120|R03AL0301|ANORO|innönddu|77|mcg/sk|30|skammtar|1|innö.t|55+22 mcg|R03AL03|01.11.2014||R|0|0|0|0|G|0|GGL|0|0|0|100|GBP|8362|12586|lyfalmen|||1|30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Vilanterol og umeclidinium bromide||8362||8362|12586||1 504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|ţpakki||G03CA04|01.01.1988||R|0|0|0|0|G|0|PTL|0|0|0|100|DKK|1589|3263|lyfalmen|||1|90|0|45,0000|Navamedic AB|Aspen Pharma Trading Limited|Estríól||1589||1589|3263||1 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|ţpakki||N05BA08|01.01.1987||R|1|0|0|0|0|0|ROC|0|0|1|100|DKK|1078|2560|lyfalmen|||1|100|0|30,0000|Icepharma hf|Roche|Brómazepam||1078||1078|2560||2 504923|QN04BC0201|Prascend|töflur|1|mg|60|stk|1|ţpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|13009|24851|vetalmen|||0|60|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||13009||13009|24851||1 505647|N07BA0147|Nicorette QuickMist|munnhúđi|1|mg/sk|300|skammtar|1|fl|2 x 150 úđaskammtar|N07BA01|01.11.2012||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|300|0|0,8800|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|1677|2398|lyfsjukr|||1|5|0||Icepharma hf|Pfizer ApS|Doxórúbicín||1677||1677|2398||1 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|3348|4787|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Doxórúbicín||3348||3348|4787||1 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|7641|10924|lyfsjukr|||1|25|0||Icepharma hf|Pfizer ApS|Doxórúbicín||7641||7641|10924||1 506036|N03AX2201|Fycompa|filmhtfl|4|mg|28|stk|1|ţpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|21614|29879|lyfalmen|V0664|29879|1|28|0|14,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||21614||21614|29879||1 506176|N07BC0202|Metadon Abcur|töflur|5|mg|100|stk|1|ţpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|2291|4230|lyfalmen|||1|100|0|25,0000|Icepharma hf|Abcur AB|Metadón||2291||2291|4230||2 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|ţpakki||N06AA12|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|2290|4228|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Doxepín||2290||2290|4228||1 506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|ţpakki||A06AB02|01.12.1975||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl|||||||1 507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|ţpakki||A06AB02|01.12.1975||R|1|0|0|0|0|0|ERC|0|0|0|100|DKK|372|1588|lyfalmen|||1|100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||372||372|1588||1 507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|612|1055|vetorma|||0|24|0||Icepharma hf|Zoetis Finland OY|||612||612|1055||2 507315|L03AB1001|PegIntron|sts|120|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|119942|151034|lyfsjukr|||1|4|0|64,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||119942||119942|151034||1 507758|R03AK0604|Relanio|innönddu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg|R03AK06|01.01.2014||R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|9000|9748|lyfalmen|||2|60|0|30,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||6300||6300|9748||2 507834|N07CA0102|Betahistin ratiopharm|töflur|16|mg|100|stk|1|ţpakki||N07CA01|01.12.2013||R|1|0|0|0|0|0|ROY|0|0|0|100|IKR|3105|5350|lyfalmen|||2|100|0|66,6700|Medical ehf|ratiopharm Oy|Betahistín||3105||3105|5350||2 507915|C03DA0103|Spiron|töflur|50|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|OPF|0|0|0|100|DKK|1813|3572|lyfalmen|V0092|3572|2|100|0|66,6600|Portfarma ehf|Orion Corporation|Spírónólaktón||1813||1813|3572||1 507916|S01AA1301|Fucithalmic|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.08.2015||R|0|0|0|0|G|0|AML|0|0|1|100|DKK|994|2444|lyfalmen|||1|5|0||Vistor hf|Amdipharm Limited|Fúsidínsýra||994||994|2444||1 508350|N03AX1603|Pregabalin Krka|hylki|150|mg|56|stk|1|ţpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|9400|13464|lyfalmen|V0687|13464|2|56|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||9000||9000|13464||2 508589|J02AC0102|Candizol|hylki|150|mg|2|stk|1|ţpakki||J02AC01|01.02.2015||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|612|1851|lyfalmen|V0555|1796|2|2|0|1,5000|Actavis Group hf|Actavis hf|Flúkónazól||563||563|1851||1 508622|C08DA0103|Isoptin retard|forđatfl|240|mg|98|stk|1|ţpakki||C08DA01|01.10.1993||R|1|0|0|0|G|0|ABS|0|0|0|100|DKK|2375|4345|lyfalmen|||1|98|0|98,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||2375||2375|4345||1 508671|QJ01MA9001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4747|9177|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||4747|9177||2 508689|QJ01MA9001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4277|8285|vetalmen|||0|50|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4277||4277|8285||2 508705|QJ01MA9001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|12671|24210|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||12671||12671|24210||2 508921|L01CD0401|Jevtana|irţ|60|mg|1|hgl|1|pakki|+ leysir|L01CD04|01.08.2011||R|0|0|0|1|0|1|SAA|0|1|0|100|NOK|569127|709695|lyfsjukr|||1|1|0||Vistor hf|Sanofi - Aventis|Cabazitaxel||569127||569127|709695||1 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|8449|12706|lyfalmen|||1|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||8449||8449|12706||1 509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988|30.06.2015|L|0|0|0|0|G|0|PTL|0|0|0|100|DKK|||lyfalmen|||0|15|0|75,0000|Navamedic AB|Aspen Pharma Trading Limited|Estríól|||||2800||1 509359|N06AX1611|Duofaxin|forđatfl|75|mg|28|stk|1|ţpakki||N06AX16|01.07.2015||R|1|0|0|0|0|0|MEV|0|0|0|100|DKK|1024|2333|lyfalmen|V0336|2333|2|28|0|21,0000|Vistor hf|MediLink A/S|Venlafaxín||913||913|2333||1 509504|QJ51CR0201|Clavubactin vet.|töflur|312,5|mg|100|stk|1|ţpakki|250 mg+ 62,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|5785|11146|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||5785||5785|11146||2 509577|G03HB0102|Diane mite|töflur|||63|stk|1|ţpakki||G03HB01|01.06.2013||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|2044|3890|lyfalmen|V0134|3083|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Cýpróterón og östrógen||2044||2044|3890||2 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|ţpakki|150+300 mg|J05AR01|01.05.2004||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|52805|67535|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín og lamívúdín||52805||52805|67535||1 509696|N05AH0314|Olanzapine Mylan|filmhtfl|10|mg|28|stk|1|ţpakki||N05AH03|01.12.2013|30.06.2015|R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|1799|1751|lyfalmen|||2|28|0|28,0000|Icepharma hf|Generics UK Ltd|Olanzapín||490||490|1751||2 510200|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|80505|101986|lyfsjukr|||1|1|0|2,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||80505|101986||2 510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|15458|21085|lyfsjukr|||1|1,8|0|12,0000|Icepharma hf|Roche|Epóetín||15458||15458|21085||2 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|23139|30638|lyfsjukr|||1|1,8|0|18,0000|Icepharma hf|Roche|Epóetín||23139||23139|30638||2 510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|37955|49065|lyfsjukr|||1|1,8|0|30,0000|Icepharma hf|Roche|Epóetín||37955||37955|49065||2 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|58663|74820|lyfsjukr|||1|3,6|0|60,0000|Icepharma hf|Roche|Epóetín||58663||58663|74820||2 510553|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|447|1692|lyfalmen|V0601|1529|2|100|0|100,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíđ||447||447|1692||1 510608|L01XX4401|Zaltrap|irţ|25|mg/ml|8|ml|1|hgl|lausn|L01XX44|01.06.2013||R|0|0|0|1|0|1|SGA|0|0|0|100|NOK|90193|114035|lyfsjukr|||1|8|0||Vistor hf|Sanofi-aventis groupe|Afliberceptum||90193||90193|114035||1 510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|153305|192528|lyfsjukr|||1|1,2|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||153305|192528||1 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|3878|4699|lyfalmen|V0445|4699|2|98|0|98,0000|Actavis Group hf|Actavis hf|Fínasteríđ||2632||2632|4699||1 511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2501|4519|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2501||2501|4519||1 511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|20340|27157|lyfsjukr|||1|6000|0||Vistor hf|Meda AB|Dextran||20340||20340|27157||1 511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|||500|ml|12|pokar||B05AA05|01.07.1991||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|12724|17685|lyfsjukr|||1|6000|0||Vistor hf|Meda AB|Dextran||12724||12724|17685||1 511932|G02BA0303|Jaydess|leginnle|13,5|mg|1|stk|1|ţpakki||G02BA03|01.01.2014||R|0|1|0|0|0|0|BAB|0|0|0|100|DKK|15082|21618|lyfalmen|||1|1|0||Icepharma hf|Bayer AB|Plast lyfjalykkja (IUD) međ prógestógen||15082||15082|21618||2 512608|B05XA3101|Peditrace|irţ|||10|ml|10|hgl||B05XA31|01.07.1993||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4882|6980|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ öđrum efnum||4882||4882|6980||2 513133|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.01.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1826|1992|lyfalmen|V0057|1992|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|1992||2 513195|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA01|01.02.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|836|1795|lyfalmen|V0109|1795|2|100|0|66,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||522||522|1795||2 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|0|0|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||0|35|0||Vistor hf|AstraZeneca A/S DK|Lídókaín|||||||1 513391|QJ51CR0201|Clavubactin vet.|töflur|62,5|mg|100|stk|1|ţpakki|50 mg + 12,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2789|5462|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||2789||2789|5462||2 513474|N05AH0501|Sycrest|tungur.t|5|mg|60|stk|1|ţpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|21213|29372|lyfalmen|||1|60|0|15,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||21213||21213|29372||1 513494|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|ţpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2500|4914|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||2500||2500|4914||2 513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|1972|3876|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||1972||1972|3876||2 513947|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|9867|18890|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||9867||9867|18890||2 514090|C09AA0211|Enalapril Krka|töflur|5|mg|250|stk|1|glas||C09AA02|01.06.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2000|3829|lyfalmen|V0450|3829|2|250|0|125,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2000||2000|3829||2 514265|R03AC0302|Bricanyl Turbuhaler|innönddu|0,25|mg/sk|200|skammtar|1|stauk||R03AC03|01.07.1993||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1596|3273|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||1596||1596|3273||1 514840|N06BA0901|Strattera|hylki|100|mg|28|stk|1|ţpakki|hart|N06BA09|01.07.2013||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|19062|26652|lyfalmen|||1|28|0|35,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||||19062|26652||2 514870|N06AX2105|Duloxetin Krka|sţ-hylki|30|mg|30|stk|1|ţpakki||N06AX21|01.05.2015||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|3800|5206|lyfalmen|V0692|5042|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||3000||3000|5206||2 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|ţpakki||N06AX18|01.06.2000||R|1|0|0|0|G|0|PER|0|0|0|100|IKR|4026|4340|lyfalmen|||1|60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2371||2371|4340||1 515239|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|G|0|NYC|0|0|0|100|DKK|||lyfalmen|V0149|2563|0|100|0|10,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2563||1 515247|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|G|0|NYC|0|0|0|100|DKK|||lyfalmen|V0150|2574|0|100|0|20,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2574||1 515399|G03GA0503|Bemfola|stl|300|ae|0,5|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|13012|19000|lyfalmen|||1|0,5|0|4,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||13012||13012|19000||3 516219|J01FA1006|Azithromycin Eberth|irs|500|mg|10|ml|1|hgl||J01FA10|01.12.2012||R|0|0|0|0|0|1|FRI|0|0|0|100|DKK|4992|6146|lyfsjukr|||1|10|0|1,0000|Portfarma ehf|Dr. Friedrich Eberth Arzneimittel GmbH|Azitrómýcín||4299||4299|6146||1 517693|N05AH0413|Quetiapin ratiopharm|forđatfl|200|mg|100|stk|1|ţpakki||N05AH04|01.05.2015||R|1|0|0|0|G|0|TEV|0|0|0|100|IKR|18600|24044|lyfalmen|V0273|24044|2|100|0|50,0000|Medical ehf|Teva Pharma B.V.|Quetíapín||17000||17000|24044||2 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2744|4853|lyfalmen|V0462|2872|1|90|0|11,2500|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||2744||2744|4853||1 517728|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|ţpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|31872|42854|lyfalmen|V0662|42854|1|100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||31872||31872|42854||1 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3011|5221|lyfalmen|||1|90|0|22,5000|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||3011||3011|5221|31.7.2015|1 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3213|5499|lyfalmen|V0472|2872|1|90|0|45,0000|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||3213||3213|5499||1 517824|C01CA0302|Noradrenalin Abcur|irţ|1|mg/ml|10|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|31346|40846|lyfsjukr|||2|100|0|16,6600|Icepharma hf|Abcur AB|Noradrenalín||31346||31346|40846||2 517990|R06AX2201|Kestine|filmhtfl|20|mg|10|stk|1|ţpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|20,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 518241|M01AB0509|Modifenac|forđahlk|75|mg|20|stk|1|ţpakki||M01AB05|01.11.2000||R|1|0|0|0|G|0|AGT|0|0|1|100|DKK|1011|2468|lyfalmen|||1|20|0|15,0000|Actavis Group hf|Actavis Group hf|Díklófenak||1011||1011|2468||1 518258|M01AB0509|Modifenac|forđahlk|75|mg|100|stk|1|ţpakki|međ breyttan losunarhrađa|M01AB05|01.11.2000||R|1|0|0|0|G|0|AGT|0|0|1|100|DKK|3209|5493|lyfalmen|||1|100|0|75,0000|Actavis Group hf|Actavis Group hf|Díklófenak||3209||3209|5493||1 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|ţpakki|3x28 stk|G03AC09|01.01.2001||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1936|3741|lyfalmen|V0590|3079|1|84|0|84,0000|Vistor hf|N.V. Organon|Desógestrel||1936||1936|3741||1 518750|A02BC0508|Esomeprazol Actavis|sţ-tfl|20|mg|28|stk|1|ţpakki||A02BC05|01.01.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|1179|2198|lyfalmen|V0004|2198|2|28|0|18,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||815||815|2198||1 518897|A10BH0501|Trajenta|filmhtfl|5|mg|90|stk|1|ţpakki||A10BH05|01.12.2012||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|17890|25169|lyfalmen|||1|90|0|90,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||17890||17890|25169||1 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|963|2402|lyfalmen|||1|125|0|3,1250|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||963||963|2402||1 519450|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|3711|6184|lyfalmen|V0644|6184|2|125|0|31,2500|Vistor hf|Takeda Pharma A/S|Fúrósemíđ||3711||3711|6184||1 519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|0|0|0|0|0|0|APP|0|0|1|100|SEK|1443|3062|lyfalmen|||1|100|0|2,5000|Artasan ehf|Aspen Pharma Trading Limited|Súlfametoxazól og trímetóprím||1443||1443|3062||1 519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|0|0|0|0|G|0|NYC|0|0|0|100|DKK|6745|10360|lyfalmen|V0209|10360|2|2|0|5,7222|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||6745||6745|10360||1 520029|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.04.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|7897|4080|lyfalmen|V0515|4049|2|100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||2182||2182|4080||1 520186|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|21814|30132|lyfalmen|||1|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||21814|30132||1 520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4384|7110|lyfalmen|V0141|4144|1|4|0|2,0000|Icepharma hf|Pfizer ApS|Síldenafíl||4384||4384|7110||1 520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5049|8026|lyfalmen|V0143|1466|1|4|0|4,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5049||5049|8026||1 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|14228|20538|lyfalmen|V0143|4398|1|12|0|12,0000|Icepharma hf|Pfizer ApS|Síldenafíl||14228||14228|20538||1 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5415|8530|lyfalmen|V0144|1636|1|4|0|8,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5415||5415|8530||1 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|14984|21494|lyfalmen|V0144|4908|1|12|0|24,0000|Icepharma hf|Pfizer ApS|Síldenafíl||14984||14984|21494||1 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1355|2040|lyfalmen|V0056|1990|2|100|0|100,0000|Actavis Group hf|Actavis hf|Amlódipín||700||700|2040||1 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2163|2040|lyfalmen|V0057|1992|2|100|0|200,0000|Actavis Group hf|Actavis hf|Amlódipín||700||700|2040||1 520759|M03BC5101|Norgesic|töflur|||30|stk|1|ţpakki||M03BC51|01.03.1981||R|1|0|0|0|G|0|MEB|0|0|1|100|SEK|311|1504|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||311||311|1504||1 520874|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|G|0|NYC|0|0|0|100|DKK|||lyfalmen|V0135|1763|0|25|0|2,5000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1763||1 520882|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|G|0|NYC|0|0|0|100|DKK|||lyfalmen|V0136|1773|0|25|0|5,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1773||1 522003|QJ51RC2302|Streptocillin, vet.|spenalyf|||8|g|40|spr||QJ51RC23|01.12.1982||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|8988|17223|vetalmen|||0|320|0||Vistor hf|Boehringer Ingelheim Danmark|Prókaínpenicillín í blöndum međ öđrum sýklalyfjum||8988||8988|17223||1 522399|N05AE0403|Ziprasidon Actavis|hylki|20|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.06.2013||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|10808|15952|lyfalmen|V0608|15952|2|56|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||10808||10808|15952||1 522427|L03AB1301|Plegridy|stl|125|mcg|2|áf-penni|1|pakki||L03AB13|01.07.2015||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|119885|150963|lyfsjukr|||1|2|0||Icepharma hf|Biogen Idec Ltd|Peginterferón beta-1a||119885||119885|150963||2 522599|J07CA0202|Tetravac|stl|||0,5|ml|1|spr|einnota dćla|J07CA02|01.10.1999||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2126|4003|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, kíghósti, mćnusótt, stífkrampi||2126||2126|4003||2 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|163897|205702|lyfsjukr|||1|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||163897||163897|205702||1 522797|N02AX0204|Tradolan|filmhtfl|50|mg|250|stk|1|ţpakki||N02AX02|01.08.1998||R|1|0|1|0|G|0|GLP|0|0|1|100|DKK|2572|4616|lyfalmen|||1|250|0|41,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||2572||2572|4616||1 523008|G03AA1208|Cleosensa|filmhtfl|||63|stk|1|ţpakki|3+0,03 mg|G03AA12|01.07.2014||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|2351|4312|lyfalmen|V0192|4312|2|63|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Dróspírenón og ethinylestradíól||2351||2351|4312||1 523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|ţp 30+500 mg|N02AA59|01.11.1998||R|1|0|0|0|0|0|AGP|0|0|1|100|IKR|982|2428|lyfalmen|||2|40|0|13,3333|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema međ geđlyfjum||982||982|2428||1 523151|N05AH0410|Quetiapin Actavis|filmhtfl|100|mg|100|stk|1|ţpakki||N05AH04|01.08.2013||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|5418|4365|lyfalmen|V0285|4311|2|100|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||2389||2389|4365||1 523274|S01XA2008|Artelac|augndr|||10|ml|1|plglas||S01XA20|01.05.1998||L|0|0|0|0|G|0|GEM|0|0|0|100|IKR|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og ađrar óvirkar samsetningar|||||1495||1 523758|L01XE0801|Tasigna|hylki|150|mg|112|stk|1|ţpakki||L01XE08|01.03.2013||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|305132|381359|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||305132||305132|381359||1 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|ţpakki||R06AD02|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|998|2450|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||998||998|2450||1 523967|N02AA0506|Oxikodon Depot Actavis|forđatfl|20|mg|28|stk|1|ţpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|1650|3347|lyfalmen|V0584|3347|2|28|0|7,4700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||1650||1650|3347||1 524215|C01DA1401|Imdur|forđatfl|30|mg|28|stk|1|ţpakki||C01DA14|01.07.1993||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|360|1572|lyfalmen|||1|28|0|21,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||360||360|1572||1 524223|C01DA1401|Imdur|forđatfl|30|mg|98|stk|1|ţpakki||C01DA14|01.07.1993||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2235|4153|lyfalmen|||1|98|0|73,5000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||2235||2235|4153||1 524257|L02BB0001|Xtandi|hylki|40|mg|112|stk|1|ţpakki||L02BB|01.07.2014||R|1|0|0|0|0|1|APE|0|1|0|100|XEU|454734|567422|lyfsjukr|||1|112|0||Vistor hf|Astellas Phama Europe B.V.|Enzalutamid||454734||454734|567422||1 524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|ţpakki||A02BC04|01.06.2011||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|8619|6080|lyfalmen|V0010|3617|1|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|6080||1 524934|QM01AE9001|Quadrisol|hlaup|100|mg/ml|30|ml|1|spr|f. hesta|QM01AE90|01.07.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1765|3469|vetalmen|||0|30|0||Icepharma hf|Zoetis Belgium S.A.|Vedaprófen||1765||1765|3469||2 525014|M03BC5101|Norgesic|töflur|||100|stk|1|ţpakki||M03BC51|01.06.1981||R|1|0|0|0|G|0|MEB|0|0|1|100|SEK|641|1959|lyfalmen|||1|100|0|25,0000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||641||641|1959||1 525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|0|0|0|0|0|0|HES|0|0|1|100|DKK|718|2065|lyfalmen|||1|15|0|3,7500|Vistor hf|Novartis Healthcare A/S|Díklófenak||718||718|2065||1 525147|M01AB0504|Klofen-L|forđahlk|100|mg|30|stk|1|glas||M01AB05|01.01.1993||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|1597|3274|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Díklófenak||1597||1597|3274||1 525170|M01AB0504|Klofen-L|forđahlk|100|mg|100|stk|1|glas||M01AB05|01.01.1993||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|4626|7444|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Díklófenak||4626||4626|7444||1 525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|ţpakki||N06BA07|01.03.2002||R|1|0|0|1|0|0|TBP|0|0|0|100|DKK|6943|8740|lyfalmen|V0657|8234|1|30|0|10,0000|Vistor hf|Teva Pharma B.V.|Modafinil||5568||5568|8740||1 525219|QG03XA9101|Improvac|stl|300|mcg|20|ml|12|fl||QG03XA91|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|13087|22557|vetorma|||0|240|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||13087||13087|22557||2 525593|N06DX0103|Nemdatine|filmhtfl|10|mg|100|stk|1|glas||N06DX01|01.08.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|17636|6042|lyfalmen|V0605|6042|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||3608||3608|6042||1 525720|B01AF0101|Xarelto|filmhtfl|20|mg|100|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|31879|42863|lyfalmen|||1|100|0|200,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||31879|42863||2 525757|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|glas||C10AA07|01.03.2014||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|12837|18778|lyfalmen|V0117|7614|1|100|0|100,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||12837||12837|18778||1 525857|B05XA0103|Kaliumklorid B.Braun|irţ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|5045|7213|lyfsjukr|||2|1000|0||Actavis Group hf|Braun|Kalíumklóríđ||5045||5045|7213||1 525865|B05XA0303|Natriumklorid B.Braun|irţ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|4593|6567|lyfsjukr|||2|1000|0||Actavis Group hf|Braun|Natríumklóríđ||4593||4593|6567||1 525998|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||4442||1 526004|V07AB0009|Sterilt Vann B. Braun|leysir|||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||4504||1 526367|N02BE0119|Therimin Honung & Citron|mixtduft|500|mg|10|sk-pokar|1|pakki||N02BE01|01.01.2015||L|0|0|0|0|0|0|NAA|0|0|1|100|IKR|||lyflausa|||0|10|0|16,6700|Artasan ehf|Novartis Healthcare A/S|Paracetamól|||||||1 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|4138|6772|lyfalmen|V0435|6772|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4138||4138|6772||2 526376|N03AG0103|Orfiril Retard|forđatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|G|0|DEA|0|0|0|100|XEU|3862|6392|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3862||3862|6392||1 526521|C03DA0404|Kalspar|filmhtfl|50|mg|100|stk|1|ţpakki||C03DA04|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|15735|22444|lyfalmen|V0111|22107|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Eplerenón||15735||15735|22444||2 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|G|0|DEA|0|0|0|100|XEU|3304|5624|lyfalmen|||1|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3304||3304|5624||1 527112|N02BE0116|Pinex Smelt|munndr.t|250|mg|20|stk|1|ţpakki||N02BE01|01.09.2011||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|20|0|1,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|12064|16864|lyfsjukr|||1|2000|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||12064||12064|16864||1 527453|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|17617|5671|lyfalmen|V0516|5442|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3338||3338|5671||1 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|1370|2962|lyfalmen|||1|5|0||Vistor hf|Alcon Laboratories Ltd.|Emedastín||1370||1370|2962||1 527914|QS02CA0103|Saniotic vet.|eyrnadr|||20|ml|1|glas|fyrir hundi og ketti|QS02CA01|01.08.2015||R|0|0|0|0|0|0|RPG|0|0|0|100|XEU|1697|3335|vetalmen|||0|20|0||Icepharma hf|Richter Pharma AG|||1697||1697|3335||2 528055|C03DA0103|Spiron|töflur|25|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|OPF|0|0|0|100|DKK|931|1981|lyfalmen|V0046|1981|2|100|0|33,3333|Portfarma ehf|Orion Corporation|Spírónólaktón||657||657|1981||1 528214|N04BC0505|Oprymea|forđatfl|0,52|mg|100|stk|1|ţpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|16800|20502|lyfalmen|V0635|18075|2|100|0|20,8000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||14200||14200|20502||2 528267|A02BC0501|Nexium|sţ-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2013||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|10511|6444|lyfalmen|V0011|5223|1|100|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||3900||3900|6444||1 528374|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2012|31.07.2015|R|0|0|0|0|G|0|BGB|0|0|0|100|DKK|15318|21916|lyfalmen|||1|4|0|55,5600|Icepharma hf|Bayer Pharma AG|Testósterón||15318||15318|21916||2 528418|D07AC1302|Ovixan|krem|0,1|%|100|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|2075|3932|lyfalmen|||0|100|0||Vistor hf|Galenica AB|Mómetasón||2075||2075|3932||1 528472|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|G|0|LVR|0|0|0|100|NOK|6115|9493|lyfalmen|V0356|8490|3|120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||6115||6115|9493||3 528584|A07EC0202|Pentasa|forđatfl|1|g|60|stk|1|ţpakki|6 x 10 stk|A07EC02|01.06.2012||R|1|0|0|0|G|0|FEL|0|0|0|100|DKK|6382|9861|lyfalmen|||1|60|0|40,0000|Vistor hf|Ferring Lćgemidler A/S|Mesalazín (5-amínósalicýlsýra)||6382||6382|9861||1 528874|N02CC0405|Rizatriptan ratiopharm|munndr.t|10|mg|18|stk|1|ţpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|8808|5267|lyfalmen|V0621|5267|2|18|0|18,0000|Medical ehf|ratiopharm GmbH|Rizatriptan||3045||3045|5267||2 529289|R02AA0301|Strepsils|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.1982||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 529438|QJ51RC2002|Ampiclox vet.|spenalyf|||3|g|24|spr|spenadćlur|QJ51RC20|01.06.1998||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4170|8082|vetalmen|||0|72|0||Icepharma hf|Zoetis Finland OY|||4170||4170|8082||2 529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|ţpakki||QJ01CA04|01.10.1987||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4434|8583|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||4434||4434|8583||2 529449|A02BC0112|Omezolmyl|sţ-hylki|40|mg|98|stk|1|ţpakki||A02BC01|01.09.2013|30.06.2015|R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|9210|3105|lyfalmen|||2|98|0|196,0000|Icepharma hf|Mylan AB|Ómeprazól||1474||1474|3105||2 529735|N03AB0501|Pro-Epanutin|irţ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|63658|81033|lyfsjukr|||1|100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||63658||63658|81033||1 529993|QM01AH9201|Trocoxil|tuggutfl|20|mg|2|stk|1|ţpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1865|3665|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||1865||1865|3665||2 530109|C10AA0703|Rosuvastatin Krka|filmhtfl|40|mg|30|stk|1|ţpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|6500|10023|lyfalmen|V0194|10023|2|30|0|120,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||6500||6500|10023||2 530162|A06AD6502|Movicol|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.07.2014||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|8|0||Artasan ehf|Norgine A/S|Makrógól 3350|||||||1 530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen|V0592|6071|0|50|0|25,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||6568||1 530322|B01AC0602|Hjarta-Aspirín|sţ-tfl|75|mg|100|stk|1|glas||B01AC06|01.02.2014||L|1|0|0|0|0|0|LYF|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|LYFIS ehf|LYFIS ehf|Asetýlsalicýlsýra|||||||2 530701|QN05CM9204|Nerfasin vet.|stl|20|mg/ml|25|ml|1|hgl|nautg. hestar,hundar og kettir|QN05CM92|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|1517|2982|vetalmen|||0|25|0||Dýraheilsa ehf|Le Vet B.V.|||1517||1517|2982||2 530741|G03FA0105|Activelle|töflur|||84|stk|1|pakki|ţp 1+0,5 mg|G03FA01|01.03.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2651|4725|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2651||2651|4725||1 530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5902|8438|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||5902||5902|8438||2 531305|N03AX1108|Topiramat Bluefish|filmhtfl|50|mg|60|stk|1|ţpakki||N03AX11|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|3008|3361|lyfalmen|V0248|3361|2|60|0|10,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||1660||1660|3361||2 531459|R03CC0303|Bricanyl Retard|forđatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2590|4641|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2590||2590|4641||1 531611|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.04.2015||R|0|0|0|0|0|1|STI|0|0|0|100|NOK|4480|6405|lyfsjukr|||1|5|0|3,3333|Lyfjaver ehf|Sigma-Tau Industrie Farmaceutiche|Oxýtócín||4480||4480|6405||3 531829|N06AX1105|Mirtazapine Bluefish|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.05.2015||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|998|1765|lyfalmen|V0329|1765|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||500||500|1765||2 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|573|1865|lyfalmen|||1|30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||573||573|1865||1 532705|J01EA0107|Trimetoprim Meda|töflur|160|mg|14|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|243|1411|lyfalmen|||1|14|0|5,6000|Vistor hf|Meda AB (V)|Trímetóprím||243||243|1411||1 532721|J01EA0107|Trimetoprim Meda|töflur|160|mg|100|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|1442|3061|lyfalmen|||1|100|0|40,0000|Vistor hf|Meda AB (V)|Trímetóprím||1442||1442|3061|31.7.2015|1 532983|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2007|2869|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||2007||2007|2869||2 533737|R03CC0303|Bricanyl Retard|forđatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1756|3493|lyfalmen|||1|100|0|33,3333|Vistor hf|AstraZeneca A/S DK|Terbútalín||1756||1756|3493||1 533779|A02BC0111|Omeprazol Pensa|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.12.2012||L|1|0|0|0|0|0|PEN|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól|||||||3 534166|N05AB0302|Trilafon Dekanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.04.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|17357|24495|lyfalmen|V0639|24495|1|10|0|154,5714|Vistor hf|Orion Corporation|Perfenazín||17357||17357|24495||1 534471|L04AA1001|Rapamune|filmhtfl|1|mg|100|stk|1|ţpakki||L04AA10|01.06.2012||R|0|0|0|1|G|0|IPI|0|0|0|100|DKK|54487|71457|lyfalmen|||1|100|0|33,3300|Icepharma hf|Pfizer Limited|Sirolimus||54487||54487|71457||1 534497|QJ01CA0402|Vetrimoxin L.A.|stl|150|mg/ml|100|ml|1|hgl||QJ01CA04|01.11.2014||R|0|0|0|0|0|0|CES|0|0|0|100|XEU|2003|3937|vetalmen|||0|100|0||Icepharma hf|Ceva Sante Animale|||2003||2003|3937||2 534512|C10AA0703|Rosuvastatin Krka|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|7700|7614|lyfalmen|V0117|7614|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||4750||4750|7614||2 534652|G03XB0101|Mifepristone Linepharma|töflur|200|mg|1|stk|1|ţpakki||G03XB01|01.05.2014||R|0|0|0|1|0|1|LPF|0|0|0|100|XEU|3007|4295|lyfsjukr|||1|1|0|0,3300|Portfarma ehf|Linepharma France|Mifepriston||3004||3004|4295||1 534885|L01AA0601|Holoxan|sts/irs|1000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|5381|7693|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||5381||5381|7693||2 535265|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|2085|3946|lyfalmen|V0092|3572|2|100|0|66,6667|Vistor hf|Takeda Pharma A/S|Spírónólaktón||2085||2085|3946||1 535446|N02AA0506|Oxikodon Depot Actavis|forđatfl|20|mg|98|stk|1|ţpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|5200|8234|lyfalmen|V0585|8234|2|98|0|26,1300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||5200||5200|8234||1 535773|P03AA5401|Tenutex|áburđur|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||||2 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|G|0|SAC|0|0|0|100|USD|483|1741|lyfalmen|||1|10|0|25,0000|Vistor hf|S.A. Alcon - Couvreur N.V.|Pílókarpín||483||483|1741||1 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|G|0|SAC|0|0|0|100|USD|616|1924|lyfalmen|||1|10|0|25,0000|Vistor hf|S.A. Alcon - Couvreur N.V.|Pílókarpín||616||616|1924||1 536133|A10BA0202|Metformin Actavis|filmhtfl|1000|mg|30|stk|1|ţpakki||A10BA02|01.11.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|376|1442|lyfalmen|V0502|853|2|30|0|15,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||266||266|1442||1 536289|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|27706|36319|lyfsjukr|||1|1,2|0|15,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||27706||27706|36319||1 536460|N05AX1302|Xeplion|stl|150|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|94121|121586|lyfalmen|||1|1|0|60,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||94121||94121|121586||1 536745|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|2691|3847|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||2691||2691|3847||2 537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5769|8248|lyfsjukr|||1|7500|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||5769||5769|8248||2 537811|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|0|0|0|0|G|0|PTL|0|0|0|100|DKK|||lyfalmen|V0704|2413|0|15|0|37,5000|Navamedic AB|Aspen Pharma Trading Limited|Estríól|||||2413||1 537866|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|V0135|1763|0|25|0|2,5000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||1763||1 538181|A02AD0106|Rennie|sog/tugg|||24|stk|1|ţpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538199|A02AD0106|Rennie|sog/tugg|||48|stk|1|ţpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538207|A02AD0106|Rennie|sog/tugg|||96|stk|1|ţpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|107599|135683|lyfsjukr|||1|6|0|61,3953|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||107599||107599|135683||2 538696|C09CA0305|Valsartan ratiopharm|filmhtfl|80|mg|98|stk|1|ţpakki||C09CA03|01.02.2015||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3328|3416|lyfalmen|V0678|3416|2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan||1700||1700|3416||2 538794|N05AH0412|Quetiapin Sandoz|forđatfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2014||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|31733|34973|lyfalmen|V0272|34973|2|100|0|75,0000|Artasan ehf|Sandoz A/S|Quetíapín||25641||25641|34973||1 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|ţpakki||N03AG04|01.10.1992||R|1|0|0|1|G|0|SNO|0|0|0|100|NOK|6894|10565|lyfalmen|||1|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||6894||6894|10565||1 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|589|1887|lyfalmen|||2|25|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||589||589|1887||1 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|595|1895|lyfalmen|||2|100|0|20,0000|Actavis Group hf|Actavis Group hf|Díazepam||595||595|1895||1 539783|D01AC2001|Daktacort|krem|||15|g|1|túpa||D01AC20|01.04.1986||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|McNeil Sweden AB|Blöndur|||||||1 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|1667|3371|lyfalmen|||1|40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1667||1667|3371||1 540009|B05BA1021|SmofKabiven|irl|550|kcal|493|ml|6|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|20356|27177|lyfsjukr|||1|2958|0||Icepharma hf|Fresenius Kabi|Blöndur||20356||20356|27177||2 540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|0|0|0|0|0|0|SON|0|0|1|100|DKK|2588|4638|lyfalmen|||1|250|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||2588||2588|4638||2 540544|N02CC0405|Rizatriptan ratiopharm|munndr.t|10|mg|6|stk|1|ţpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|3174|3228|lyfalmen|V0621|1756|2|6|0|6,0000|Medical ehf|ratiopharm GmbH|Rizatriptan||1563||1563|3228||2 540958|L04AX0401|Revlimid|hylki|2,5|mg|21|stk|1|ţpakki|hart|L04AX04|01.09.2015||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|678978|846319|lyfsjukr|||1|21|0|5,2500|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||||678978|846319||2 540970|QP54AB5207|Equest Pramox vet|hlaup|||11,8|g|1|sk-dćl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2012||R|0|0|0|0|0|0|ZOE|0|0|0|100|XEU|2399|4135|vetorma|||0|11,8|0||Icepharma hf|Zoetis Finland OY|||2399||2399|4135||2 540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíđ 20 mg|S01ED51|01.07.2000||R|0|0|0|0|G|0|SAO|0|0|0|100|DKK|5461|8593|lyfalmen|V0373|7015|1|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||5461||5461|8593||2 541169|R02AA0302|Strepsils med honning og citron|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.1982||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 541834|N06DA0207|Donepezil Bluefish|filmhtfl|5|mg|98|stk|1|ţpakki||N06DA02|01.04.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|12153|7456|lyfalmen|V0341|7307|2|98|0|65,3300|LYFIS ehf|Bluefish Pharmaceuticals AB|Dónepezíl||4635||4635|7456||2 541846|C02KX0501|Adempas|filmhtfl|0,5|mg|42|stk|1|ţpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BGB|0|1|0|100|DKK|188911|236812|lyfsjukr|||1|42|0||Icepharma hf|Bayer Pharma AG|Riociguatum||188911||188911|236812||2 542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|5464|7812|lyfsjukr|||2|800|0|3,3300|Actavis Group hf|Braun|Gentamícín||5464||5464|7812||1 542744|B05BB0214|Plasmalyte Glucos|irl|50|mg/ml|1000|ml|10|pokar||B05BB02|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7350|10508|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar í blöndum međ kol­vetnum||||7350|10508||2 542937|N05AE0403|Ziprasidon Actavis|hylki|60|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.06.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|13181|19213|lyfalmen|V0610|19213|2|56|0|42,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||13181||13181|19213||1 543236|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|ţpakki||N05AA02|01.10.2012||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|556|1842|lyfalmen|||1|100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||556||556|1842||1 543274|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|15127|21675|lyfalmen|||1|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||15127|21675||1 543320|M05BA0409|Alendronat Bluefish|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.09.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|3535|2789|lyfalmen|V0203|2789|2|12|0|84,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Alendrónsýra||1244||1244|2789||2 543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|ţpakki||C07AA03|01.12.1983||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2699|4791|lyfalmen|||1|98|0|65,3333|Vistor hf|Novartis Healthcare A/S|Pindólól||2699||2699|4791||1 543374|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|2064|3116|lyfalmen|||2|5|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||1482||1482|3116|31.8.2015|1 543592|N01AB0701|Suprane|innönd.l|||240|ml|6|glas||N01AB07|01.09.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|71440|90711|lyfsjukr|||1|1440|0||Icepharma hf|Baxter Medical AB|Desflúran||||71440|90711||2 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|0|0|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||0|250|0|21,7857|Vistor hf|Recip AB|Semen psyllii (ispaghula)|||||||1 543744|R01AA0503|Nezeril|nefúđi|0,5|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|7,5|0|9,3750|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1 543755|R03DC0305|Montelukast Navamedic|töflur|10|mg|98|stk|1|ţpakki||R03DC03|01.04.2014||R|1|0|0|0|G|0|ART|0|0|0|100|XEU|6772|2520|lyfalmen|V0490|2285|2|98|0|98,0000|Artasan ehf|Navamedic ASA|Montelúkast||1049||1049|2520||1 543972|J05AE1201|Victrelis|hylki|200|mg|336|stk|1|ţpakki|hörđ|J05AE12|01.01.2012|31.07.2015|R|0|1|0|1|0|1|MLD|0|1|0|100|DKK|444606|554825|lyfsjukr|||1|336|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Boceprevír||444606||444606|554825||1 544186|G04BE0307|Sildenafil Mylan|filmhtfl|50|mg|12|stk|1|ţpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|3647|4400|lyfalmen|V0143|4398|2|12|0|12,0000|Icepharma hf|Mylan AB|Síldenafíl||2415||2415|4400||2 544385|J06BA0208|Privigen|irl|100|mg/ml|400|ml|1|hgl||J06BA02|01.02.2014||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|248619|311072|lyfsjukr|||1|400|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||248619||248619|311072||2 544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|12094|17838|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||12094||12094|17838||1 545090|N04BC0505|Oprymea|forđatfl|2,1|mg|100|stk|1|ţpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|50000|37956|lyfalmen|V0636|36623|2|100|0|84,0000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||28000||28000|37956||2 545104|L01XC0201|MabThera|stl|1400|mg|11,7|ml|1|hgl|lausn|L01XC02|01.10.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|240989|301583|lyfsjukr|||1|11,7|0||Icepharma hf|Roche Registration Limited|Rítúxímab||240989||240989|301583||2 545176|G03HB0103|Cypretyl|töflur|||63|stk|1|ţpakki||G03HB01|01.10.2012||R|0|0|0|0|0|0|RGM|0|0|0|100|XEU|1611|3083|lyfalmen|V0134|3083|2|63|0|84,0000|Medical ehf|ratiopharm GmbH|Cýpróterón og östrógen||1458||1458|3083||2 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|1075|2556|lyfalmen|||1|15|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Múpírócín||1075||1075|2556||1 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|840|2232|lyfalmen|||1|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||840||840|2232||1 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|2073|3930|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||2073||2073|3930||1 545996|V01AA0507|Alutard SQ, birkifrjo|stl|||5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|28063|38036|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|trjáfrjó||28063||28063|38036||1 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|22626|31159|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|trjáfrjó||22626||22626|31159||1 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|||5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|28228|38245|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|grasfrjó||28228||28228|38245||1 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|23981|32873|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|grasfrjó||23981||23981|32873||1 546143|N02BE0108|Paratabs Retard|forđatfl|500|mg|30|stk|1|ţpakki||N02BE01|01.10.1993||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól||||||31.8.2015|1 546168|N02BE0108|Paratabs Retard|forđatfl|500|mg|100|stk|1|glas||N02BE01|01.10.1993||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|1279|2837|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||1279||1279|2837|30.6.2015|1 546722|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|92,5|mg|98|stk|1|ţpakki|80/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3218|2728|lyfalmen|V0580|2728|2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og ţvagrćsilyf||1200||1200|2728||2 546844|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|100|stk|1|glas||A02BC04|01.10.2012||R|0|0|0|0|G|0|APC|0|0|0|100|IKR|3931|3691|lyfalmen|V0010|3691|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1900||1900|3691||1 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|ţpakki||A02BX02|01.01.1986||L|1|0|0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen|||0|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||4912||1 547659|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|2267|2453|lyfalmen|V0004|2198|3|28|0|18,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||1000||1000|2453||2 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|11276|15884|lyfsjukr|||1|100|0|0,3800|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíđ||11276||11276|15884||1 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|3626|5184|lyfsjukr|||1|10|0|0,1000|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíđ||3626||3626|5184||1 547925|B05BB0214|Plasmalyte Glucos|irl|50|mg/ml|500|ml|20|pokar||B05BB02|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|10228|14581|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar í blöndum međ kol­vetnum||||10228|14581||2 548121|L03AB0801|Betaferon|sts|250|mcg/ml|15|spr|1|pakki|+leysir|L03AB08|01.07.2013||R|0|0|0|1|0|1|BYP|0|0|0|100|DKK|99094|125105|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Bayer Pharma AG|Interferón beta-1b||99094||99094|125105||2 548154|N06DX0103|Nemdatine|filmhtfl|20|mg|100|stk|1|glas||N06DX01|01.08.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|35973|12645|lyfalmen|V0607|12645|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||8405||8405|12645||1 548326|M01AE0112|ibuxin rapid|filmhtfl|400|mg|10|stk|1|ţpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|LYFIS ehf|ratiopharm GmbH|Íbúprófen|||||||2 548506|D07AC1301|Elocon|húđlausn|0,1|%|30|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|616|1924|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||616||616|1924||1 548563|S01XA2011|Oculac|augndr|50|mg/ml|10|ml|1|glas|međ rotvörn|S01XA20|01.11.2013||L|0|0|0|0|G|0|CLA|0|0|0|100|DKK|||lyfalmen|||0|10|0||Vistor hf|Alcon Nordic A/S|Gervitár og ađrar óvirkar samsetningar|||||1726||1 548894|B02BC3002|TISSEEL|vefjalím|||2|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|154183|193620|lyfsjukr|||1|20|0||Icepharma hf|Baxter AG|Blöndur||154183||154183|193620||2 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|8273|12463|lyfalmen|||1|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||8273||8273|12463||1 549255|N06DX0102|Memantine Merz|filmhtfl|20|mg|28|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|11811|5394|lyfalmen|V0606|5119|2|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||3137||3137|5394||1 549674|B01AF0101|Xarelto|filmhtfl|15|mg|98|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|30834|41541|lyfalmen|||1|98|0|147,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||30834|41541||2 550020|J07AP0302|Typherix|stl|||0,5|ml|1|spr|m/ ađsk. nál|J07AP03|01.08.2013||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|2571|4126|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Taugaveiki, hreinsađir mótefnavakar||2216||2216|4126||1 550256|J02AC0102|Candizol|hylki|50|mg|7|stk|1|ţpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|1567|1748|lyfalmen|V0551|1723|2|7|0|1,7500|Actavis Group hf|Actavis hf|Flúkónazól||488||488|1748||1 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|60|0|0,4800|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 550731|N02BE0103|Panodil Junior|eţ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 550803|A10BX0204|Repaglinide Krka|töflur|1|mg|120|stk|1|ţpakki||A10BX02|01.11.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2518|3829|lyfalmen|||2|120|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníđ||2000||2000|3829||2 551043|B01AC0701|Persantin|húđuđtfl|100|mg|100|stk|1|ţpakki||B01AC07|01.05.2014||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|1602|3281|lyfalmen|V0122|3281|1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||1602||1602|3281||1 551328|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.06.2013||L|0|0|0|0|0|0|TEA|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Laboratories THEA|Ketotifen|||||||1 551388|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.08.2012||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7896|11289|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Mannitól||7896||7896|11289||2 551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|ţpakki||N02CC03|01.05.2001||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|7825|11847|lyfalmen|V0235|11847|1|12|0|12,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||7825||7825|11847||1 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|1624|3312|lyfalmen|||1|1|0|2,6667|Vistor hf|Meda AB|Tríamcínólón||1624||1624|3312|31.8.2015|1 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|ţpakki||M01AX01|01.04.1995||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|2552|4589|lyfalmen|V0198|4589|1|100|0|50,0000|Vistor hf|Meda AB|Nabúmeton||2552||2552|4589||1 551739|N02AA0102|Morfin|töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|0|0|1|0|0|0|LDR|0|0|0|100|IKR|738|2092|lyfalmen|||0|20|1|2,0000|Parlogis hf|Parlogis - óskráđ lyf|Morfín||738||738|2092||2 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|2157|1854|lyfalmen|V0466|1781|1|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1854||1 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|3752|3544|lyfalmen|V0467|2453|1|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3544||1 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|ţpakki||A02BC04|01.11.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|1510|1105|lyfalmen|V0003|822|1|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||21||21|1105||1 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|3631|1854|lyfalmen|V0003|1643|1|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1854||1 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|7272|3544|lyfalmen|V0010|2067|1|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3544||1 551989|N03AX1406|Zelta|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|17617|5671|lyfalmen|V0516|5442|2|100|0|66,6700|LYFIS ehf|LYFIS ehf|Levetíracetam||3338||3338|5671||2 552328|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1693|2421|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1693||1693|2421||2 552377|M01AE0102|Ibufen|filmhtfl|400|mg|50|stk|1|glas||M01AE01|01.11.2012||L|1|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1 552764|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|100|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|19288|31092|veteldis|||0|100|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||19288||19288|31092||1 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|ţpakki||N03AF02|01.10.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|3055|5281|lyfalmen|||1|100|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||3055||3055|5281||1 553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|ţpakki||N02CC06|01.08.2009||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|11144|16415|lyfalmen|V0237|16415|1|18|0|18,0000|Icepharma hf|Pfizer ApS|Eletriptan||||11144|16415||1 553231|C10AA0506|Atorvaratio|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA05|01.07.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|3260|2728|lyfalmen|V0112|2728|2|100|0|50,0000|Medical ehf|Teva Sweden AB|Atorvastatín||1200||1200|2728||2 553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|ţpakki||N02CC06|01.10.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|3811|6322|lyfalmen|V0237|5472|1|6|0|6,0000|Icepharma hf|Pfizer ApS|Eletriptan||3811||3811|6322||1 553720|L01XE1801|Jakavi|töflur|15|mg|56|stk|1|ţpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|519416|647868|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||519416||519416|647868||1 553923|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|41035|52896|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||41035|52896||2 554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|10702|20474|vetalmen|||0|500|0||Vistor hf|Boehringer Ingelheim Danmark|||10702||10702|20474||1 554582|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|glas||B01AC04|01.11.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|6574|6622|lyfalmen|V0029|6587|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||4029||4029|6622||1 555196|L04AC1001|Cosentyx|stl|150|mg|2|áf-penni|1|pakki||L04AC10|01.07.2015||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|151869|163396|lyfsjukr|||1|2|0||Vistor hf|Novartis Europharm Ltd|Secukinumab||129881||129881|163396||1 555235|N05AB0303|Peratsin|húđuđtfl|4|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|2110|3981|lyfalmen|||2|100|0|13,3300|Vistor hf|Orion Corporation|Perfenazín||2110||2110|3981||1 555268|N05AB0303|Peratsin|húđuđtfl|8|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|2404|4385|lyfalmen|||2|100|0|26,6700|Vistor hf|Orion Corporation|Perfenazín||2404||2404|4385||1 555292|N05AB0303|Peratsin|húđuđtfl|2|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|1815|3574|lyfalmen|||2|100|0|6,6700|Vistor hf|Orion Corporation|Perfenazín||1815||1815|3574||1 555572|S01XA2201|JETREA|stţ|0,5|mg/hgl|0,2|ml|1|hgl||S01XA22|01.12.2014||R|0|1|0|1|0|1|THO|0|0|0|100|USD|540472|674056|lyfsjukr|||1|0,2|0||Vistor hf|ThromboGenics NV|Ocriplasmínum||540472||540472|674056||1 555864|G04BD0804|Solifenacin Actavis|filmhtfl|5|mg|90|stk|1|ţpakki||G04BD08|01.03.2015||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|13675|17823|lyfalmen|V0440|17822|2|90|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Sólífenacín||12082||12082|17823||1 556556|D07AC0104|Diproderm|húđlausn|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.2015|31.07.2015|R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2108|3978|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||2108||2108|3978||1 556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|19827|26519|lyfsjukr|||1|1,03|0|9,0000|Icepharma hf|E. Merck AB|Sómatrópín||19827||19827|26519||2 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|ţpakki||N03AF02|01.02.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|4526|7306|lyfalmen|||1|100|0|30,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||4526||4526|7306||1 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|ţpakki||N03AF02|01.02.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|8825|13223|lyfalmen|||1|100|0|60,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||8825||8825|13223||1 557546|D10AF0202|Zineryt|áburđur|||30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|0|0|0|0|0|0|ASP|0|0|0|100|XEU|1485|3120|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Erýtrómýcín||1485||1485|3120||1 557907|N02BE0109|Panodil Hot|mixtduft|500|mg|10|skammtar|1|pakki||N02BE01|01.10.2014||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 557980|M01AH0105|Cloxabix|hylki|100|mg|20|stk|1|ţpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|2670|4498|lyfalmen|||2|20|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||2486||2486|4498||2 558175|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4228|8192|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||4228||4228|8192||2 558335|C07AG0204|Carvedilol HEXAL|töflur|12,5|mg|100|stk|1|ţpakki||C07AG02|01.01.2015|30.06.2015|R|1|0|0|0|G|0|PCO|0|0|0|100|DKK|2460|4462|lyfalmen|||2|100|1|33,3300|Distica|Distica - óskráđ lyf|Carvedílól||2460||2460|4462||1 558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|ţpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|227842|285232|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||227842|285232||1 559021|C08DA0103|Isoptin retard|forđatfl|120|mg|98|stk|1|ţpakki||C08DA01|01.01.1995||R|1|0|0|0|G|0|ABS|0|0|0|100|DKK|1802|3557|lyfalmen|||1|98|0|49,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||1802||1802|3557||1 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíđ|||||||2 559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1453|3076|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1453||1453|3076||2 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíđ|||||||2 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|4595|7401|lyfalmen|||1|1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||4595||4595|7401||1 559971|C01DA0201|Discotrine|forđapl|10|mg/sólh|30|stk|1|ţpakki||C01DA02|01.01.1994||R|0|0|0|0|G|0|MEB|0|0|0|100|SEK|2831|4973|lyfalmen|||1|30|0|60,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||2831||2831|4973||1 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|0|0|0|0|G|0|GEM|0|0|0|100|XEU|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og ađrar óvirkar samsetningar|||||1491||1 560244|N06AB0404|Citalopram Bluefish|filmhtfl|20|mg|30|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|791|1765|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||500||500|1765|30.6.2015|2 560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|ţpakki||J05AB01|01.07.1989||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|1413|2899|lyfalmen|V0044|2292|1|25|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1324||1324|2899||1 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|2|0||GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Acíklóvír|||||||1 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|1672|3378|lyfalmen|||1|4,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1672||1672|3378||1 560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|5717|8945|lyfalmen|||1|125|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||5717||5717|8945||1 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|6290|9734|lyfalmen|||1|100|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6290||6290|9734||1 560490|C01CX0801|Simdax|irţ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|91139|115211|lyfsjukr|||1|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||91139||91139|115211||1 560557|C01CX0801|Simdax|irţ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|419238|523275|lyfsjukr|||1|20|0|4,5500|Vistor hf|Orion Corporation|Levosimendan||419238||419238|523275||1 560695|L01XE0102|Imatinib Accord|filmhtfl|100|mg|60|stk|1|ţpakki||L01XE01|01.11.2013||R|0|0|0|1|0|1|AHL|0|1|0|100|DKK|158438|140244|lyfsjukr|||2|60|0||Portfarma ehf|Accord Healthcare Limited|Imatiníb||111266||111266|140244||1 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1596|3273|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1596||1596|3273||2 561780|C02KX0501|Adempas|filmhtfl|1,5|mg|42|stk|1|ţpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BGB|0|1|0|100|DKK|188911|236812|lyfsjukr|||1|42|0||Icepharma hf|Bayer Pharma AG|Riociguatum||188911||188911|236812||2 562014|C09BA0201|Daraziđ|töflur|32,5|mg|100|stk|1|glas|20+12,5 mg|C09BA02|01.06.2011||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|1831|2633|lyfalmen|V0098|2395|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Enalapríl og ţvagrćsilyf||1131||1131|2633||1 562176|B02BD0901|BeneFIX|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2013||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|46233|59361|lyfsjukr|||1|1|0|1,1100|Icepharma hf|Pfizer Limited|Storkuţáttur IX||46233||46233|59361||1 562254|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|90|sk-hyl|90 (18x5)|S01EE01|01.03.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|4329|7035|lyfalmen|||1|18|0|90,0000|Vistor hf|Laboratories THEA|Latanóprost||4329||4329|7035||1 562577|J06BA0207|Kiovig|irl|100|mg/ml|300|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|259154|324175|lyfsjukr|||1|300|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||259154||259154|324175||2 562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|1|0|1|GGL|0|1|0|100|GBP|100456|126799|lyfsjukr|||1|1|0|16,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||100456||100456|126799||1 563111|L04AX0501|Esbriet|hylki|267|mg|63|stk|1|ţpakki|hart|L04AX05|01.07.2012||R|1|1|0|1|0|0|RRL|0|0|0|100|DKK|105335|135770|lyfalmen|||1|63|0|7,0000|Icepharma hf|Roche Registration Limited|Pírfenidon||105335||105335|135770||2 563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|752|2111|lyfalmen|||1|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||752||752|2111||1 563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|747|2104|lyfalmen|||1|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||747||747|2104||1 563502|N02AA0101|Contalgin|forđatfl|5|mg|100|stk|1|ţpakki||N02AA01|01.10.1993||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|1282|2841|lyfalmen|||1|100|0|5,0000|Icepharma hf|Pfizer ApS|Morfín||1282||1282|2841||1 563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3330|5660|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3330||3330|5660||2 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3452|5828|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3452||3452|5828||2 563756|H01CB0501|Signifor|stl|0,3|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|430929|547581|lyfalmen|||1|60|0|15,0000|Vistor hf|Novartis Europharm Ltd|PAsireótiđ disapartate||430929||430929|547581||1 563899|QP54AA0105|Noromectin|áhella|0,5|% w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|10570|18218|vetorma|||0|1000|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||10570||10570|18218||2 563918|N02AA0505|Oxycodone ratiopharm|forđatfl|5|mg|28|stk|1|ţpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|1391|2619|lyfalmen|V0596|1853|2|28|0|1,8600|Medical ehf|ratiopharm GmbH|Oxýcódon||1121||1121|2619||2 564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|ţpakki|hart|J05AB04|01.02.2002||R|1|0|0|1|0|1|MLD|0|0|0|100|DKK|64674|82296|lyfsjukr|||1|168|0|33,6000|Vistor hf|Merck Sharp & Dohme Limited|Ribavirin||64674||64674|82296||1 564110|A02BX1302|Galieve Cool Mint|mixtúra|||150|ml|1|glas|dreifa|A02BX13|01.10.2014||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|150|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 564441|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|glas||R06AX27|01.11.2012||R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|1025|2487|lyfalmen|||1|120|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||1025||1025|2487||1 564931|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|5|ml|1|hgl||L01XA02|01.03.2015||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|1281|1831|lyfsjukr|||2|5|0||Alvogen HS|Hospira Nordic AB|Karbóplatín||1281||1281|1831||1 565306|A02BX1302|Galieve Cool Mint|mixtúra|||300|ml|1|glerfl|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|300|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 565400|N05AH0411|Quetiapine Teva|filmhtfl|200|mg|100|stk|1|ţpakki||N05AH04|01.12.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|7600|7958|lyfalmen|V0286|7840|2|100|0|50,0000|Medical ehf|Teva Sweden AB|Quetíapín||5000||5000|7958||2 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|9765|14517|lyfalmen|||1|100|0|50,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||9765||9765|14517||1 565685|QA04AD9001|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|8037|15418|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|||||8037|15418||2 565982|H01BA0401|Glypressin|stl|0,1|mg/ml|8,5|ml|5|lykjur|lausn|H01BA04|01.08.2012||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|22779|30191|lyfsjukr|||1|42,5|0|0,3600|Vistor hf|Ferring Lćgemidler A/S|Terlípressín||22779||22779|30191||1 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|1530|3182|lyfalmen|V0444|2429|1|5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Brinzólamíđ||1530||1530|3182||1 566243|G03AA1207|Cleonita|filmhtfl|||84|stk|1|ţpakki|0,02mg/3mg|G03AA12|01.07.2014||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|2862|5016|lyfalmen|V0193|5016|2|84|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Dróspírenón og ethinylestradíól||2862||2862|5016||1 566924|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|13749|19932|lyfalmen|||2|360|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||13749||13749|19932||1 567028|L01XE0701|Tyverb|filmhtfl|250|mg|84|stk|1|glas||L01XE07|01.02.2012||R|1|0|0|1|0|1|NEL|0|0|0|100|GBP|226978|284157|lyfsjukr|||1|84|0||Vistor hf|Novartis Europharm Ltd|Labatinibum||226978||226978|284157||1 567338|G04BD1201|Betmiga|forđatfl|50|mg|90|stk|1|glas||G04BD12|01.07.2014||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|16086|22888|lyfalmen|V0651|22888|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||16086||16086|22888||1 567400|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.06.2015||L|0|0|0|0|G|0|PTL|0|0|0|100|DKK|||lyfalmen|||0|15|0|75,0000|Navamedic AB|Aspen Pharma Trading Limited|Estríól|||||2797||1 567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|0|0|0|G|0|ALK|0|0|1|100|DKK|5389|8494|lyfalmen|||1|1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5389|8494||1 567503|N05AX0801|Risperdal|filmhtfl|1|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2926|5104|lyfalmen|V0291|2315|1|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||2926||2926|5104||1 567510|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.06.2013||R|1|0|0|0|G|0|APP|0|0|0|100|GBP|3175|5446|lyfalmen|||1|100|0|33,3333|Artasan ehf|Aspen Pharma Trading Limited|Labetalól||3175||3175|5446||1 567511|N05AX0801|Risperdal|filmhtfl|2|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|5921|9226|lyfalmen|V0292|3760|1|60|0|24,0000|Vistor hf|Janssen-Cilag AB|Risperídón||5921||5921|9226||1 567545|R01AC0201|Livostin|nefúđi|0,5|mg/úđask|15|ml|1|glas||R01AC02|01.06.1998||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín|||||||1 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|1201|2729|lyfalmen|||1|3|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Mupirocin||1201||1201|2729||1 568812|N03AX2201|Fycompa|filmhtfl|2|mg|7|stk|1|ţpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|5404|8514|lyfalmen|V0663|8514|1|7|0|1,7500|Vistor hf|Eisai Europe Ltd.|Perampanel||5404||5404|8514||1 568840|C08CA0201|Feldil|forđatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2699|3972|lyfalmen|V0058|3554|2|100|0|100,0000|Actavis Group hf|Actavis hf|Felódipín||2104||2104|3972||1 568865|C08CA0201|Feldil|forđatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|3640|5423|lyfalmen|V0059|4930|2|100|0|200,0000|Actavis Group hf|Actavis hf|Felódipín||3158||3158|5423||1 569257|J05AR1301|Triumeq|filmhtfl|950|mg|30|stk|1|glas|50+600+300 mg|J05AR13|01.12.2014||R|0|1|0|1|0|1|VII|0|0|0|100|GBP|155922|195783|lyfsjukr|||1|30|0||GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Abacavír, dolutegravír og lamivudín||155922||155922|195783||1 569378|L01AA0601|Holoxan|sts/irs|2000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|10795|15286|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||10795||10795|15286||2 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|14284|19625|lyfsjukr|||1|5|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||14284||14284|19625||1 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|16427|22291|lyfsjukr|||1|20|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||16427||16427|22291||1 571030|QM01AA9001|Danilon equidos|kyrni|1,5|g|10|g|18|pokar||QM01AA90|01.07.2014||R|0|0|0|0|0|0|EST|0|0|0|100|DKK|3148|6143|vetalmen|||0|180|0||Vistor hf|Laboratorios Dr. ESTEVE S.A.|Suxibuzone||3148||3148|6143||1 571181|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|76857|97449|lyfsjukr|||1|1,5|0|0,7500|Vistor hf|Takeda Pharma A/S|Náttúrulegir fosfólípíđar||76857||76857|97449||1 571217|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.04.2014||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|41035|52896|lyfsjukr|||1|1|0|1,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||41035|52896||3 571358|L01XC1501|Gazyvaro|irţ|1000|mg|1|hgl|1|pakki||L01XC15|01.02.2015||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|506549|631865|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration Limited|Obinutuzumab||506549||506549|631865||2 571524|A02BX1303|Galieve Peppermint|tuggutfl|||24|stk|1|ţpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|24|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 572422|L04AD0201|Advagraf|forđahlk|5|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|74342|96570|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||74342||74342|96570||1 572798|A02BX1303|Galieve Peppermint|tuggutfl|||48|stk|1|ţpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|48|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 573065|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|98|stk|1|glas||A02BC05|01.08.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|3828|5371|lyfalmen|V0011|5119|3|98|0|65,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||3120||3120|5371||2 573120|N03AX0903|Lamotrin|dreifit.|100|mg|98|stk|1|ţpakki||N03AX09|01.12.2010||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|5300|3504|lyfalmen|V0245|3483|2|98|0|32,6700|Actavis Group hf|Actavis hf|Lamótrigín||1764||1764|3504||1 573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|3924|6477|lyfalmen|V0464|5192|1|2,5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||3924||3924|6477||1 573382|J05AX6501|Harvoni|filmhtfl|490|mg|28|stk|1|glas|400 mg + 90 mg|J05AX65|01.09.2015||R|0|0|0|1|0|1|GIL|0|0|0|100|DKK|2341108|2913543|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Science International Limited|Sofosbuvir og ledipasvir||||2341108|2913543|| 573436|N06DX0102|Memantine Merz|filmhtfl|20|mg|98|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|34732|13098|lyfalmen|V0607|12392|2|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||8734||8734|13098||1 573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|0|0|0|1|0|1|ROC|0|1|0|100|DKK|79631|100899|lyfsjukr|||1|1|0||Icepharma hf|Roche|Trastuzumab||79631||79631|100899||2 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|15519|21161|lyfsjukr|||1|5000|0|2,5000|Vistor hf|AstraZeneca AB|Meropenem||15519||15519|21161||1 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|25443|33504|lyfsjukr|||1|10|0|5,0000|Vistor hf|AstraZeneca AB|Meropenem||25443||25443|33504||1 573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|ţpakki||M01AB05|01.01.1996||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|2364|2689|lyfalmen|V0189|2125|1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||1172||1172|2689||1 573999|G04BE0307|Sildenafil Mylan|filmhtfl|100|mg|12|stk|1|ţpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|5323|4911|lyfalmen|V0144|4908|2|12|0|24,0000|Icepharma hf|Mylan AB|Síldenafíl||2786||2786|4911||2 574377|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.09.2013||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|39576|51081|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||39576|51081||1 574423|L01XC1301|Perjeta|irţ|420|mg|14|ml|1|hgl||L01XC13|01.06.2013||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|388008|484433|lyfsjukr|||1|14|0||Icepharma hf|Roche Registration Limited|Pertuzumab||388008||388008|484433||2 575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|ţpakki||N06AB06|01.10.1995||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2297|2128|lyfalmen|V0151|1647|1|28|0|28,0000|Icepharma hf|Pfizer ApS|Sertralín||764||764|2128||1 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|ţpakki||N06AB06|01.03.2001||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4236|2128|lyfalmen|V0152|2124|1|28|0|56,0000|Icepharma hf|Pfizer ApS|Sertralín||764||764|2128||1 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|ţpakki||N06AB06|01.03.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|12895|6638|lyfalmen|V0323|3611|1|98|0|196,0000|Icepharma hf|Pfizer ApS|Sertralín||4041||4041|6638||1 575571|J01CA0413|Amoxin|filmhtfl|500|mg|20|stk|1|ţpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|1117|2140|lyfalmen|V0159|2060|2|20|0|10,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||773||773|2140||2 575589|J01CA0413|Amoxin|filmhtfl|500|mg|30|stk|1|ţpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|1285|2549|lyfalmen|V0160|2500|2|30|0|15,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||1070||1070|2549||2 575621|J01CA0413|Amoxin|filmhtfl|750|mg|20|stk|1|ţpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|1453|2453|lyfalmen|V0158|2453|2|20|0|15,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||1000||1000|2453||2 576032|N03AX0903|Lamotrin|dreifit.|25|mg|42|stk|1|ţpakki||N03AX09|01.12.2010||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1150|1539|lyfalmen|V0243|1367|2|42|0|3,5000|Actavis Group hf|Actavis hf|Lamótrigín||336||336|1539||1 576714|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.12.2012||R|0|0|0|0|G|0|APP|0|0|0|100|XEU|9459|14096|lyfalmen|||1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Merkaptópúrín||9459||9459|14096||1 577455|C10AA0506|Atorvaratio|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA05|01.07.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|4000|3210|lyfalmen|V0113|3210|2|100|0|100,0000|Medical ehf|Teva Sweden AB|Atorvastatín||1550||1550|3210||2 577711|C01CA0601|Fenylefrin Abcur|stl|0,05|mg/ml|10|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|11626|16319|lyfsjukr|||2|100|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||11626||11626|16319||2 578261|J07AH0703|NeisVac-C|stl|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.07.2015||R|0|0|0|0|0|0|PIS|0|0|0|100|USD|4537|7321|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer ApS|Hreinsuđ meningókokka C, poly­sakkaríđ mótefnavakar||4537||4537|7321||2 578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|ţpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|ICE|0|0|0|100|USD|6289|10840|vetorma|||0|20|0||Icepharma hf|Icepharma hf|||6289||6289|10840||2 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|1124|2623|lyfalmen|||1|10|0|0,3300|Vistor hf|AstraZeneca A/S DK|Terbútalín||1124||1124|2623||1 579421|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|28|stk|1|ţpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|1671|2453|lyfalmen|V0005|2380|3|28|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||1000||1000|2453||2 579854|L04AX0305|Methotrexate Pfizer|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|339|1543|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Metótrexat||339||339|1543||1 579932|C03DA0402|Eplerenone Portfarma|filmhtfl|25|mg|30|stk|1|ţpakki||C03DA04|01.06.2014||R|1|0|0|0|0|0|PEH|0|0|0|100|DKK|7537|5473|lyfalmen|V0107|5473|2|30|0|15,0000|Portfarma ehf|Portfarma ehf|Eplerenón||3194||3194|5473||1 579972|C03DA0403|Eplerenon Bluefish|filmhtfl|50|mg|100|stk|1|ţpakki||C03DA04|01.05.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|30623|24044|lyfalmen|V0111|22107|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||17000||17000|24044||2 580042|C05AA0801|Doloproct|eţ-stíll|||10|stk|1|ţpakki||C05AA08|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|692|2029|lyfalmen|V0675|2029|1|10|0||Icepharma hf|Bayer AB|Flúókortólón||692||692|2029||2 580104|N07BB0501|Selincro|filmhtfl|18|mg|14|stk|1|ţpakki||N07BB05|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|7954|12024|lyfalmen|||1|14|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||7954||7954|12024||1 580960|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1602|2290|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1602||1602|2290||2 581417|S01ED5116|Taptiqom|augndr|||0,3|ml|30|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3027|5243|lyfalmen|||1|9|0|30,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3027||3027|5243||2 581619|N03AX1407|Levetiracetam Teva|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.03.2015||R|1|0|0|0|0|0|TEV|0|0|0|100|IKR|5500|6307|lyfalmen|V0253|6256|2|100|0|33,3300|Medical ehf|Teva Pharma B.V.|Levetíracetam||3800||3800|6307||2 581661|N02CC0403|Rizatriptan Portfarma|munndr.t|5|mg|6|stk|1|ţpakki||N02CC04|01.01.2015||R|0|0|0|0|G|0|PEH|0|0|0|100|XEU|3377|5724|lyfalmen|V0620|5724|2|6|0|3,0000|Portfarma ehf|Portfarma ehf|Rizatriptan||3377||3377|5724||1 581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|13385|25565|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||13385||13385|25565||2 581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|0|0|0|0|G|0|ASN|0|0|0|100|USD|2553|4590|lyfalmen|V0669|3898|0|2,5|0|25,0000|Alcon Nordic A/S|Alcon Laboratories Ltd.|Travóprost||2553||2553|4590||1 581991|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|6438|12385|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||6438||6438|12385||2 582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|1|0|100|XEU|20324|27137|lyfsjukr|||1|1|0|9,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||20324||20324|27137||2 582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|1|0|100|XEU|39772|51325|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||39772||39772|51325||2 582122|G03GA0503|Bemfola|stl|450|ae|0,75|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|17709|24940|lyfalmen|||1|0,75|0|6,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||17709||17709|24940||3 582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|1|0|100|XEU|79544|100790|lyfsjukr|||1|1|0|36,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||79544||79544|100790||2 582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|24845|32760|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jóhexól||24845||24845|32760||2 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|28501|37307|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||28501||28501|37307||2 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|64716|82349|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jóhexól||64716||64716|82349||2 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|25264|33281|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||25264||25264|33281||2 582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|33660|43724|lyfsjukr|||1|1,5|0|18,0000|Icepharma hf|E. Merck AB|Sómatrópín||33660||33660|43724||2 583105|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.08.2013||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|2365|3686|lyfalmen|V0376|1635|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||1896||1896|3686||1 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|51613|66052|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||51613||51613|66052||2 583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|ţpakki||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|958|2395|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Sótalól||958||958|2395||2 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|87162|110265|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||87162||87162|110265||2 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|27614|36204|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||27614||27614|36204||2 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|44182|56810|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||44182||44182|56810||2 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|82842|104892|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||82842||82842|104892||2 583776|L01XE2301|Tafinlar|hylki|50|mg|28|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|GBP|186170|233403|lyfsjukr|||1|28|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||186170||186170|233403||1 584133|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|17178|23225|lyfsjukr|||1|1,2|0|9,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||17178||17178|23225||1 584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|ţpakki||N06AG02|01.07.1995||R|1|0|0|0|G|0|MAS|0|0|0|100|SEK|1639|3332|lyfalmen|||1|30|0|30,0000|Vistor hf|Meda AS|Móklóbemíđ||1639||1639|3332|30.6.2015|1 584479|G04BE0307|Sildenafil Mylan|filmhtfl|50|mg|4|stk|1|ţpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|1579|2172|lyfalmen|V0143|1466|2|4|0|4,0000|Icepharma hf|Mylan AB|Síldenafíl||796||796|2172||2 585130|N06DA0301|Exelon|forđapl|13,3|mg/sólh|60|pokar|1|pakki||N06DA03|01.02.2014||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|39993|53125|lyfalmen|||1|60|0|84,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||39993||39993|53125||1 585516|A10BX1201|Jardiance|filmhtfl|25|mg|90|stk|1|ţpakki||A10BX12|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|19187|26810|lyfalmen|||1|90|0||Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||19187||19187|26810||1 585661|B01AB0101|Heparin Leo|stl|100|ae/ml|10|ml|10|hgl||B01AB01|01.03.2014||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|5606|8792|lyfalmen|||1|100|0|1,0000|Vistor hf|LEO Pharma A/S|Heparín||5606||5606|8792||1 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|4181|5978|lyfsjukr|||1|25|0|12,5000|Vistor hf|LEO Pharma A/S|Heparín||4181||4181|5978||1 585869|J07BC0201|Havrix|stl|1440|ein/ml|1|ml|1|dćla|einnota dćla|J07BC02|01.07.1994||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|4867|7775|lyfalmen|||1|1|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||4867||4867|7775||1 585975|C07AB0312|Atenolol LYFIS|filmhtfl|25|mg|100|stk|1|ţpakki||C07AB03|01.05.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|435|1467|lyfalmen|V0541|1467|2|100|0|33,3300|LYFIS ehf|LYFIS ehf|Atenólól||284||284|1467||2 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|28567|38674|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||28567||28567|38674||1 586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1612|3295|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1612||1612|3295||1 586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|13145|18209|lyfsjukr|||2|800|0|10,0000|Actavis Group hf|Braun|Gentamícín||13145||13145|18209||1 586241|J01GB0101|Tobi Podhaler|innönddu|28|mg|224|stk|1|ţpakki|hart hylki+innönd.tćki|J01GB01|01.04.2012||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|350719|438056|lyfsjukr|||1|224|0|56,0000|Vistor hf|Novartis Europharm Ltd|Tobramýcín||350719||350719|438056||1 586694|N06DX0103|Nemdatine|filmhtfl|20|mg|28|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|11293|5190|lyfalmen|V0606|5119|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||2989||2989|5190||1 586967|B01AF0201|Eliquis|filmhtfl|5|mg|168|stk|1|ţpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|27349|37133|lyfalmen|V0652|37009|1|168|0|168,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||27349|37133||1 587112|M01AH0106|Celecoxib Actavis|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|AGP|0|0|1|100|XEU|11189|14660|lyfalmen|V0196|14660|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||9869||9869|14660||1 587141|N05AE0403|Ziprasidon Actavis|hylki|80|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.06.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|18069|25396|lyfalmen|V0611|25396|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||18069||18069|25396||1 587437|N06DX0103|Nemdatine|filmhtfl|10|mg|28|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|4935|2874|lyfalmen|V0604|2802|2|28|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||1306||1306|2874||1 587522|L04AB0601|Simponi|stl|100|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.11.2014||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|147563|185387|lyfsjukr|||1|1|0|60,2400|Vistor hf|Janssen Biologics B.V.|Golimumab||147563||147563|185387||1 587613|A02BC0112|Omezolmyl|sţ-hylki|40|mg|100|stk|1|ţpakki||A02BC01|01.03.2015||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|6508|3050|lyfalmen|V0001|3050|2|100|0|200,0000|Icepharma hf|Mylan AB|Ómeprazól||1434||1434|3050||2 587641|C09DA0602|Candpress Comp|töflur|28,5|mg|100|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|4302|5135|lyfalmen|V0095|5135|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan og ţvagrćsilyf||2949||2949|5135||1 588457|N06DX0105|Memantine Mylan|filmhtfl|20|mg|98|stk|1|ţpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|31653|13125|lyfalmen|V0607|12392|2|98|0|98,0000|Icepharma hf|Generics UK Ltd|Memantín||8754||8754|13125||2 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|ţpakki||J01FF01|01.10.1995||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2026|3865|lyfalmen|V0461|3862|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2026||2026|3865||1 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|ţpakki||B01AC05|01.04.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|7564|11487|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||7564||7564|11487||1 588669|N03AX2201|Fycompa|filmhtfl|12|mg|28|stk|1|ţpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|21614|29879|lyfalmen|V0668|29879|1|28|0|42,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||21614||21614|29879||1 588911|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|8695|5251|lyfalmen|V0282|4271|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||3033||3033|5251||1 588982|R03AK0604|Relanio|innönddu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg|R03AK06|01.01.2014||R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|6000|7683|lyfalmen|||2|60|0|30,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||4800||4800|7683||2 589153|L01XE2301|Tafinlar|hylki|50|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|GBP|797901|994225|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||797901||797901|994225||1 589358|QP54AA0501|Stronghold|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|5644|9728|vetorma|||0|3|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5644||5644|9728||2 589366|QP54AA0501|Stronghold|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2187|3770|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2187||2187|3770||2 589374|QP54AA0501|Stronghold|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|5446|9387|vetorma|||0|6|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5446||5446|9387||2 589382|QP54AA0501|Stronghold|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2941|5069|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2941||2941|5069||2 589390|QP54AA0501|Stronghold|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|3055|5266|vetorma|||0|1,5|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3055||3055|5266||2 589408|QP54AA0501|Stronghold|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|2940|5067|vetorma|||0|2,25|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2940||2940|5067||2 589888|N01AF0302|Pentocur|sts|0,5|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|11390|16026|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||11390||11390|16026||2 590092|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar|áfylltur penni|L04AB04|01.07.2013||R|0|1|0|1|0|1|ABV|0|1|0|100|DKK|134795|169507|lyfsjukr|||1|1,6|0|27,5900|Vistor hf|AbbVie Ltd.|Adalimumab||134795||134795|169507||1 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa|||0|20|0||Icepharma hf|Bayer AB|Klótrímazól|||||||2 590562|C01DA1403|Ismo|forđatfl|60|mg|98|stk|1|glas||C01DA14|01.10.1999||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2847|3218|lyfalmen|V0041|2657|2|98|0|147,0000|Actavis Group hf|Actavis hf|Ísósorbíđ mónónítrat||1556||1556|3218||1 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|158115|198511|lyfsjukr|||1|1|0|0,7500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||158115||158115|198511||1 591260|N06DA0302|Exelon (Lyfjaver)|forđapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|DKK|12005|17726|lyfalmen|V0347|17726|3|30|0|14,5300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||12005||12005|17726||3 591317|C03DA0403|Eplerenon Bluefish|filmhtfl|50|mg|100|stk|1|ţpakki||C03DA04|01.10.2014||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|30623|24044|lyfalmen|V0111|22107|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||17000||17000|24044||2 591445|H02AB0205|Dexametason Abcur|töflur|1|mg|100|stk|1|ţpakki||H02AB02|01.11.2013||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|8569|12871|lyfalmen|||2|100|0|66,6700|Icepharma hf|Abcur AB|Dexametasón||8569||8569|12871||2 591540|J01CR0202|Augmentin|töflur|625|mg|21|stk|1|ţpakki|500+125 mg|J01CR02|01.09.2015||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|1215|2749|lyfalmen|V0168|2749|1|21|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1215||1215|2749||1 592534|L04AD0104|Ciqorin|hylki|50|mg|50|stk|1|ţpakki||L04AD01|01.04.2014||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|12500|14152|lyfalmen|||2|50|0|10,0000|Medical ehf|Teva Pharma B.V.|Ciklospórín||9500||9500|14152||2 592687|A02BC0112|Omezolmyl|sţ-hylki|40|mg|28|stk|1|ţpakki||A02BC01|01.09.2013|30.06.2015|R|0|0|0|0|0|0|MYL|0|0|0|100|SEK|2514|2281|lyfalmen|||2|28|0|56,0000|Icepharma hf|Mylan AB|Ómeprazól||875||875|2281||2 592977|L01XE1201|Caprelsa|filmhtfl|300|mg|30|stk|1|ţpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|AZA|0|0|0|100|SEK|691660|862091|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Vandetaníb||691660||691660|862091||1 593200|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.04.2014||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|21667|28808|lyfsjukr|||1|1|0|0,5000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||21667|28808||3 593379|A10BG0304|Pioglitazone Accord|töflur|30|mg|98|stk|1|ţpakki||A10BG03|01.12.2013|31.07.2015|R|1|1|0|0|G|0|AHL|0|0|0|100|XEU|10143|14339|lyfalmen|||2|98|0|98,0000|Portfarma ehf|Accord Healthcare Limited|Píóglítazón||9636||9636|14339||1 593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|479|1736|lyfalmen|V0238|779|1|50|0|3,1250|Icepharma hf|Roche|Klónazepam||479||479|1736||2 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|916|2337|lyfalmen|V0238|2337|1|150|0|9,3750|Icepharma hf|Roche|Klónazepam||916||916|2337||2 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1250|2797|lyfalmen|||1|100|0|25,0000|Icepharma hf|Roche|Klónazepam||1250||1250|2797||2 593438|N06AX2106|Duloxetin W&H|sţ-hylki|60|mg|98|stk|1|ţpakki||N06AX21|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|15155|21710|lyfalmen|V0694|21710|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||15155||15155|21710||2 593654|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|17979|25282|lyfalmen|||1|12|0|32,0000|Vistor hf|Meda AB|Tríamcínólón||17979||17979|25282||1 594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|313|539|vetorma|||0|10|0||Icepharma hf|Zoetis Finland OY|||313||313|539||2 595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|5240|7492|lyfsjukr|||1|5|0|5,0000|Vistor hf|Novartis Healthcare A/S|Samtengt laxakalsítónín||5240||5240|7492||1 595198|G04BD1201|Betmiga|forđatfl|25|mg|90|stk|1|ţpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|16086|22888|lyfalmen|||1|90|0|45,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||16086||16086|22888||1 595966|B02BD0207|ReFacto AF|sts|250|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PZE|0|1|0|100|DKK|21621|28750|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer Ltd.|Storkuţáttur VIII||21621||21621|28750||1 595991|J07BB0201|Fluarix|stl|||0,5|ml|1|áfspr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|679|2011|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsađir mótefnavakar||679||679|2011||1 596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|51260|65613|lyfsjukr|||1|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||51260|65613||1 596196|G04BE0308|Sildenafil Portfarma|tuggutfl|100|mg|4|stk|1|ţpakki||G04BE03|01.09.2013||R|1|0|0|0|0|0|PEH|0|0|0|100|XEU|1589|2260|lyfalmen|V0144|1636|2|4|0|8,0000|Portfarma ehf|Portfarma ehf|Síldenafíl||860||860|2260||1 596881|N05CM1801|Dexdor|irţ|100|mcg/ml|2|ml|5|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|15784|21491|lyfsjukr|||1|10|0|1,0000|Vistor hf|Orion Corporation|Dexmedetómid||15784||15784|21491||1 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|ţpakki||J01FF01|01.06.1979||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2164|4055|lyfalmen|||1|24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2164||2164|4055||1 597433|L01XC1101|Yervoy|stţ|5|mg/ml|10|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|597076|744455|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||597076||597076|744455||1 597565|L03AB1301|Plegridy|stl|125|mcg|2|áf.spr|1|pakki||L03AB13|01.07.2015||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|119885|150963|lyfsjukr|||1|2|0||Icepharma hf|Biogen Idec Ltd|Peginterferón beta-1a||119885||119885|150963||2 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 598021|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.06.2014||R|1|0|0|0|G|0|MPH|0|0|0|100|SEK|2700|4793|lyfalmen|||1|100|0|33,3333|Icepharma hf|Mercury Pharmaceuticals Ltd.|Acetazólamíđ||2700||2700|4793||2 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|0|0|0|0|0|0|SNO|0|0|1|100|NOK|358|1569|lyfalmen|||1|150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||358||358|1569||1 598499|M01AE0112|ibuxin rapid|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|LYFIS ehf|ratiopharm GmbH|Íbúprófen|||||||2 598925|M01AE0114|Nurofen Apelsin|mixtúra|40|mg/ml|100|ml|1|glas||M01AE01|01.04.2013||L|0|0|0|0|0|0|REC|0|0|1|100|DKK|||lyfalmen|||0|100|0|3,3333|Vistor hf|Reckitt Benckiser Healthcare Ltd|Íbúprófen|||||1788||1 599010|L01XE1701|INLYTA|filmhtfl|5|mg|56|stk|1|ţpakki||L01XE17|01.05.2013||R|1|0|0|1|0|1|PZE|0|1|0|100|DKK|571727|712928|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Ltd.|Axitinib||571727||571727|712928||1 599320|QV03AB9002|Narcostop|stl|5|mg/ml|10|ml|1|hgl|fyrir hunda og ketti|QV03AB90|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|4202|8143|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Atipamesól||4202||4202|8143||2 599460|S01XA2011|Oculac|augndr|50|mg/ml|0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.11.2013||L|0|0|0|0|G|0|CLA|0|0|0|100|DKK|||lyfalmen|||0|8|0||Vistor hf|Alcon Nordic A/S|Gervitár og ađrar óvirkar samsetningar|||||2080||1 599462|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|28073|38049|lyfalmen|||1|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||28073|38049||1 599883|N06AX1610|Venlafaxine Bluefish|forđahlk|75|mg|100|stk|1|ţpakki|hart|N06AX16|01.05.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|3141|lyfalmen|V0334|3141|2|100|0|75,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3141||2 692098|N06BA0104|Amfetamin Glostrup|töflur|5|mg|100|stk|1|glas||N06BA01|01.07.2011||R|0|0|1|0|0|0|PCO|0|0|0|100|DKK|3811|6322|lyfalmen|||0|100|1|33,3300|Distica|Distica - óskráđ lyf|Amfetamín||||3811|6322||1 916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|ţpakki||A03FA03|01.05.1998||R|0|0|0|0|0|0|PCO|0|0|1|100|SEK|2407|4389|lyfalmen|||0|100|1|33,3333|Distica|Distica - óskráđ lyf|Dómíperídón||2407||2407|4389||1 923351|S01XA2006|Lacri - Lube|augnsm|||3,5|g|1|túpa||S01XA20|01.01.1998||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|480|1737|lyfalmen|||0|3,5|1||Distica|Distica - óskráđ lyf|Gervitár og ađrar óvirkar samsetningar||480||480|1737||1 938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|GBP|6774|10400|lyfalmen|||0|100|1|50,0000|Parlogis hf|Parlogis - óskráđ lyf|Kolkisín||6774||6774|10400||2 938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|0|0|0|0|0|0|LDR|0|0|0|100|GBP|19460|27155|lyfalmen|||0|100|1|2,0000|Parlogis hf|Parlogis - óskráđ lyf|Kaptópríl||19460||19460|27155||2 940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998|31.07.2015|R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|3127|5380|lyfalmen|||0|1|1|33,3300|Distica|Distica - óskráđ lyf|Testósterón||3127||3127|5380||1 944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|5007|7968|lyfalmen|||0|100|1|13,3300|Distica|Distica - óskráđ lyf|Kortisón||5007||5007|7968||1 944852|A06AX0102|Glycerol infant|eţ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|545|1826|lyfalmen|||0|12|1||Parlogis hf|Parlogis - óskráđ lyf|Glýceról||545||545|1826||2 944985|A06AX0103|Glycerol adult|eţ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|664|1990|lyfalmen|||0|12|1||Parlogis hf|Parlogis - óskráđ lyf|Glýceról||664||664|1990||2 945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|0|0|0|0|0|0|PCO|0|0|1|100|IKR|2293|4232|lyfalmen|||0|10|1|10,0000|Distica|Distica - óskráđ lyf|Prómetazín||2293||2293|4232||1 947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|5033|8004|lyfalmen|||0|100|1|66,6667|Parlogis hf|Parlogis - óskráđ lyf|Kortisón||5033||5033|8004||2 951592|H02AB0907|Hydrocortison|töflur|1|mg|100|stk|1|glas||H02AB09|01.08.2009||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|5007|7968|lyfalmen|||0|100|1|3,3300|Distica|Distica - óskráđ lyf|Hýdrókortisón||5007||5007|7968||1 954851|V09AB0301|DaTSCAN|stl|74|MBq/ml|5|ml|1|hgl||V09AB03|01.10.2013||R|0|0|0|1|0|1|GEL|0|0|0|100|NOK|124597|156824|lyfsjukr|||1|5|0||Icepharma hf|GE Healthcare Limited|Lofendýlat||124597||124597|156824||2 957657|A12BA0201|Polycítra - forskriftarlyf|mixtúra|||500|ml|1|fl|Potassium citrats 102 mg/g|A12BA02|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|15120|21666|lyfalmen|||0|500|0|12,7500|PharmArctica ehf|PharmArctica - forskriftarlyf|potassium citrate||15120||15120|21666||2 957665|A12BA0102|Kalíum Klóriđ - forskriftarlyf|mixtúra|33|mg/g|300|ml|1|fl|35,34 mg/ml|A12BA01|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2610|4669|lyfalmen|||0|300|0|3,5400|PharmArctica ehf|PharmArctica - forskriftarlyf|Kalíumklóríđ||2610||2610|4669||2 961393|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|ţpakki||A04AD05|01.01.1998|31.07.2015|R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1257|2806|lyfalmen|||0|20|1|20,0000|Parlogis hf|Parlogis - óskráđ lyf|Metópímazín||1257||1257|2806||2 961591|H02AB0906|Hydrocortisone|töflur|10|mg|20|stk|1|ţpakki||H02AB09|01.08.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1430|3045|lyfalmen|||0|20|1|6,6700|Parlogis hf|Parlogis - óskráđ lyf|Hýdrókortisón||1430||1430|3045||2 961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|6231|9653|lyfalmen|||0|25|1|16,7000|Parlogis hf|Parlogis - óskráđ lyf|Hýdrókortisón||6231||6231|9653||2 962234|R05DA2001|SEM mixtúra - forskriftarlyf|mixtúra|||300|ml|1|fl|Kodein 2,53 mg/ml|R05DA20|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|1610|3292|lyfalmen|||0|300|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Blöndur||1610||1610|3292||2 962242|R05DA2001|SEM mixtúra - forskriftarlyf|mixtúra|||100|ml|1|fl|Kodein 2,53 mg/ml|R05DA20|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|1030|2494|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Blöndur||1030||1030|2494||2 962945|R06AB0201|Polaramin|töflur|2|mg|30|stk|1|ţpakki||R06AB02|01.11.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|3707|6179|lyfalmen|||0|30|1|10,0000|Parlogis hf|Parlogis - óskráđ lyf|Dexklórfeníramín||3707||3707|6179||2 965858|QI04AB0901|Gudair|stl|||30|ml|1|glas|dreifa|QI04AB09|01.09.2014||R|0|0|0|0|0|0|CZV|1|0|0|100|XEU|6140|10583|vetorma|||0|30|0||Vistor hf|CZ Veterinaria SA|Bóluefni gegn Mycobacterium||||6140|10583||1 967367|N05AH0408|Quetiapin Bluefish|filmhtfl|300|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|25000|26953|lyfalmen|||2|60|0|45,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||19300||19300|26953||2 968365|D07CB0101|TNG-smyrsl - forskriftarlyf|smyrsli|||15|ml|1|dos||D07CB01|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|1522|3171|lyfalmen|||0|15|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Triamcinolonum og sýklalyf||1522||1522|3171||2 968373|V03AB1505|Naloxonhydrochlorid - forskriftarlyf|mixtúra|1|mg/ml|500|ml|1|fl||V03AB15|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|18870|26409|lyfalmen|||0|500|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Naloxón||18870||18870|26409||2 968399|A03AA0704|Dicykloverine hydrochloride-forsk.lyf|mixtúra|2|mg/ml|100|ml|1|fl||A03AA07|01.04.2014||R|0|0|0|1|0|0|PAR|0|0|0|100|IKR|7066|10802|lyfalmen|||0|100|0|2,5000|PharmArctica ehf|PharmArctica - forskriftarlyf|Dícýklóverín||7066||7066|10802||2 968406|D05AA0001|Tjara 26 / ASVEP - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2929|5108|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||2929||2929|5108||2 968414|D05AA0002|Koltjörusmyrsl - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|3650|6100|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||3650||3650|6100||2 969149|H03BB0102|Carbimazol|töflur|5|mg|100|stk|1|ţpakki||H03BB01|01.02.2014||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1380|2976|lyfalmen|||0|100|1|33,3333|Parlogis hf|Parlogis - óskráđ lyf|Karbímazól||1380||1380|2976||2 969181|N02AA0111|Morfin "DAK"|töflur|10|mg|100|stk|1|pakki||N02AA01|01.05.2014||R|0|0|1|0|0|0|LDR|0|0|0|100|IKR|2948|5134|lyfalmen|||0|100|1|10,0000|Parlogis hf|Parlogis - óskráđ lyf|Morfín||2948||2948|5134||2 969412|J01CA0416|Amoxicillin AL|mixt.kyr|50|mg/ml|100|ml|1|glas||J01CA04|01.08.2014|31.08.2015|R|0|0|0|0|0|0|PCO|0|0|1|100|XEU|2092|3956|lyfalmen|||2|100|1|5,0000|Distica|Distica - óskráđ lyf|Amoxicillín||||2092|3956||1 969438|J01CA0417|Amoxicillin Sandoz|mixt.kyr|50|mg/ml|100|ml|1|glas||J01CA04|01.04.2015|31.08.2015|R|0|0|0|0|0|0|PCO|0|0|1|100|XEU|2092|3956|lyfalmen|||2|100|1|5,0000|Distica|Distica - óskráđ lyf|Amoxicillín||2092||2092|3956||1 969777|N02AA0111|Morfin "DAK"|töflur|10|mg|10|stk|1|ţpakki||N02AA01|01.07.2014||R|0|0|1|0|0|0|LDR|0|0|0|100|IKR|450|1696|lyfalmen|||0|10|1|1,0000|Parlogis hf|Parlogis - óskráđ lyf|Morfín||450||450|1696||2 969991|N06BA0105|Amfetamine sulfate - forskriftarlyf|töflur|5|mg|30|stk|1|glas||N06BA01|01.08.2015||R|0|0|1|0|0|0|PAR|0|0|0|100|IKR|2495|4510|lyfalmen|||0|30|0|10,0000|PharmArctica ehf|PharmArctica - forskriftarlyf|Amfetamín||2495||2495|4510||2 970013|A01AD1102|Magical Mouthwash - forskriftarlyf|mixtúra|||100|ml|1|fl||A01AD11|01.04.2015||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|3988|6565|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Ýmis lyf||3988||3988|6565||2 980005|C07AA0513|Propranolol hydrochloride-forskriftarlyf|mixtúra|2|mg/ml|100|ml|1|fl||C07AA05|01.12.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|4995|7951|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Própranólól||4995||4995|7951||2